Globe Life (GL) 10-K 26 Feb 25 2024 FY Annual report Financial data

Cover

Cover - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2024	Jan. 31, 2025	Jun. 30, 2024
Entity Listings [Line Items]
Document Type	10-K
Document Annual Report	true
Current Fiscal Year End Date	--12-31
Document Period End Date	Dec. 31, 2024
Document Transition Report	false
Entity File Number	001-08052
Entity Registrant Name	GLOBE LIFE INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	63-0780404
Entity Address, Address Line One	3700 South Stonebridge Drive
Entity Address, City or Town	McKinney
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75070
City Area Code	972
Local Phone Number	569-4000
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction	false
Entity Shell Company	false
Entity Public Float			$ 7.4
Entity Common Stock, Shares Outstanding		83,848,424
Documents Incorporated by Reference	Document Parts Into Which Incorporated Proxy Statement for the Annual Meeting of Stockholders to be held on April 24, 2025 (Proxy Statement) Part III
Entity Central Index Key	0000320335
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Amendment Flag	false
Common Stock, $1.00 par value per share
Entity Listings [Line Items]
Title of 12(b) Security	Common Stock, $1.00 par value per share
Trading Symbol	GL
Security Exchange Name	NYSE
4.250% Junior Subordinated Debentures
Entity Listings [Line Items]
Title of 12(b) Security	4.250% Junior Subordinated Debentures
Trading Symbol	GL PRD
Security Exchange Name	NYSE

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2024
Audit Information [Abstract]
Auditor Firm ID	34
Auditor Name	Deloitte & Touche LLP
Auditor Location	Dallas, Texas

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Investments:
Fixed maturities—available for sale, at fair value (amortized cost: 2024—$18,835,809; 2023—$18,924,914, allowance for credit losses: 2024— $10,395; 2023— $7,115)	$ 17,155,012	$ 17,870,206
Mortgage loans	396,088	279,199
Policy loans	699,669	657,020
Other long-term investments (includes: 2024—$986,766; 2023—$795,583 under the fair value option)	1,235,759	835,878
Short-term investments	85,035	81,740
Total investments	19,571,563	19,724,043
Cash	165,325	103,156
Accrued investment income	269,791	270,396
Other receivables	691,907	630,223
Deferred acquisition costs	6,495,589	6,009,477
Goodwill	490,446	481,791
Other assets	1,391,560	832,413
Total assets	29,076,181	28,051,499
Liabilities:
Future policy benefits at current discount rates: (at original discount rates: 2024—$17,552,564; 2023—$16,984,615)	18,457,263	19,460,353
Unearned and advance premium	257,631	254,567
Policy claims and other benefits payable	532,832	514,875
Other policyholders' funds	468,604	236,958
Total policy liabilities	19,716,330	20,466,753
Current and deferred income taxes	731,255	494,639
Short-term debt	415,401	486,113
Long-term debt (estimated fair value: 2024—$2,122,772; 2023—$1,491,229)	2,324,251	1,629,559
Other liabilities	583,424	487,632
Total liabilities	23,770,661	23,564,696
Commitments and Contingencies (Note 5)
Shareholders' equity:
Preferred stock, par value $1 per share—5,000,000 shares authorized; outstanding: 0 in 2024 and 2023	0	0
Common stock, par value $1 per share—320,000,000 shares authorized; outstanding: (2024—97,218,183 issued; 2023—102,218,183 issued)	97,218	102,218
Additional paid-in-capital	527,795	532,474
Accumulated other comprehensive income (loss)	(2,029,720)	(2,772,419)
Retained earnings	8,002,521	7,478,813
Treasury stock, at cost: (2024—13,240,616 shares; 2023—8,426,854 shares)	(1,292,294)	(854,283)
Total shareholders' equity	5,305,520	4,486,803
Total liabilities and shareholders' equity	$ 29,076,181	$ 28,051,499

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Assets:
Fixed maturities, available for sale, amortized cost	$ 18,835,809	$ 18,924,914
Fixed maturities, available for sale, allowance for credit losses	10,395	7,115
Other long-term investments under fair value option	1,235,759	835,878
Liabilities:
Future policy benefits at original rates	17,552,564	16,984,615
Total long-term debt, fair value	$ 2,122,772	$ 1,491,229
Shareholders' equity:
Preferred stock, par value (in dollars per share)	$ 1	$ 1
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 1	$ 1
Common stock, shares authorized (in shares)	320,000,000	320,000,000
Common stock, shares issued (in shares)	97,218,183	102,218,183
Common stock, shares outstanding (in shares)	97,218,183	102,218,183
Common stock, shares held in treasury (in shares)	13,240,616	8,426,854
Investment funds
Assets:
Other long-term investments under fair value option	$ 986,766	$ 795,583

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenue:
Revenue		$ 4,666,272	$ 4,456,017	$ 4,310,242
Net investment income		1,135,631	1,056,884	991,800
Realized gains (losses)		(24,188)	(65,676)	(76,548)
Other income		354	308	1,246
Total revenue		5,778,069	5,447,533	5,226,740
Benefits and expenses:
Total policyholder benefits		2,894,443	2,864,251	2,825,434
Amortization of deferred acquisition costs		410,001	379,700	348,824
Commissions, premium taxes, and non-deferred acquisition costs		600,753	559,167	506,022
Other operating expense		419,143	347,833	353,954
Interest expense		127,092	102,316	90,395
Total benefits and expenses		4,451,432	4,253,267	4,124,629
Income before income taxes		1,326,637	1,194,266	1,102,111
Income tax benefit (expense)		(255,875)	(223,511)	(207,725)
Net income		$ 1,070,762	$ 970,755	$ 894,386
Basic net income per common share (in dollars per share)		$ 11.99	$ 10.21	$ 9.13
Diluted net income per common share (in dollars per share)		$ 11.94	$ 10.07	$ 9.04
Life premium
Revenue:
Revenue		$ 3,261,347	$ 3,137,244	$ 3,027,824
Benefits and expenses:
Total policyholder benefits	[1]	2,000,977	2,050,789	2,035,693
Health premium
Revenue:
Revenue		1,404,925	1,318,773	1,282,417
Benefits and expenses:
Total policyholder benefits	[2]	851,577	776,362	752,866
Other premium
Revenue:
Revenue		0	0	1
Benefits and expenses:
Total policyholder benefits		$ 41,889	$ 37,100	$ 36,875
[1] Net of total remeasurement, including both the impact of assumption changes and the effect of actual to expected experience adjustments, resulting in a gain (loss) of $107.0 million, $29.4 million, and $(47.4) million for the year ended December 31, 2024, 2023, and 2022, respectively.

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Life insurance
Policyholder benefits net of remeasurement gain (losses)	$ 107,000	$ 29,400	$ (47,400)
Health premium
Policyholder benefits net of remeasurement gain (losses)	$ (3,200)	$ 11,800	$ 15,600

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 1,070,762	$ 970,755	$ 894,386
Unrealized gains (losses) on fixed maturities:
Unrealized holding gains (losses) arising during period	(630,042)	671,211	(5,332,818)
Other reclassification adjustments included in net income	3,764	80,238	32,377
Foreign exchange adjustment on fixed maturities recorded at fair value	3,469	(715)	1,749
Total unrealized investment gains (losses)	(622,809)	750,734	(5,298,692)
Less applicable tax (expense) benefit	130,787	(157,658)	1,112,730
Unrealized gains (losses) on investments, net of tax	(492,022)	593,076	(4,185,962)
Future Policy Benefits:
Change in discount rate on future policy benefits	1,567,530	(731,883)	7,021,147
Less applicable tax (expense) benefit	(329,181)	153,696	(1,474,441)
Future policy benefit adjustments, net of tax	1,238,349	(578,187)	5,546,706
Foreign exchange translation:
Foreign exchange translation adjustments, other than securities	(33,516)	8,102	(26,494)
Less applicable tax (expense) benefit	7,040	(1,702)	5,565
Foreign exchange translation adjustments, other than securities, net of tax	(26,476)	6,400	(20,929)
Pension:
Amortization of pension costs	474	(390)	13,754
Plan amendments	(1,212)	0	0
Experience gain (loss)	29,659	(3,907)	119,055
Pension adjustments	28,921	(4,297)	132,809
Less applicable tax (expense) benefit	(6,073)	902	(27,889)
Pension adjustments, net of tax	22,848	(3,395)	104,920
Other comprehensive income (loss)	742,699	17,894	1,444,735
Comprehensive income (loss)	$ 1,813,461	$ 988,649	$ 2,339,121

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Treasury Stock
Beginning balance at Dec. 31, 2021	$ 2,003,808	$ 0	$ 109,218	$ 520,564	$ (4,235,048)	$ 6,455,733	$ (846,659)
Increase (Decrease) in Stockholders' Equity
Comprehensive income (loss)	2,339,121				1,444,735	894,386
Common dividends declared	(80,956)					(80,956)
Acquisition of treasury stock	(454,638)						(454,638)
Stock-based compensation	35,650			29,119		(345)	6,876
Exercise of stock options	106,592					(29,838)	136,430
Retirement of treasury stock	0		(4,000)	(20,022)		(344,445)	368,467
Ending balance at Dec. 31, 2022	3,949,577	0	105,218	529,661	(2,790,313)	6,894,535	(789,524)
Increase (Decrease) in Stockholders' Equity
Comprehensive income (loss)	988,649				17,894	970,755
Common dividends declared	(85,139)					(85,139)
Acquisition of treasury stock	(511,100)						(511,100)
Stock-based compensation	30,736			18,466			12,270
Exercise of stock options	114,080					(19,395)	133,475
Retirement of treasury stock	0		(3,000)	(15,653)		(281,943)	300,596
Ending balance at Dec. 31, 2023	4,486,803	0	102,218	532,474	(2,772,419)	7,478,813	(854,283)
Increase (Decrease) in Stockholders' Equity
Comprehensive income (loss)	1,813,461				742,699	1,070,762
Common dividends declared	(84,539)					(84,539)
Acquisition of treasury stock	(1,002,109)						(1,002,109)
Stock-based compensation	40,118			22,277		(438)	18,279
Exercise of stock options	51,786					(6,358)	58,144
Retirement of treasury stock	0		(5,000)	(26,956)		(455,719)	487,675
Ending balance at Dec. 31, 2024	$ 5,305,520	$ 0	$ 97,218	$ 527,795	$ (2,029,720)	$ 8,002,521	$ (1,292,294)

Consolidated Statements of Sh_2

Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Stockholders' Equity [Abstract]
Common dividends declared, per share (in dollars per share)	$ 0.96	$ 0.90	$ 0.83

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Cash Flows [Abstract]
Net income	$ 1,070,762	$ 970,755	$ 894,386
Adjustments to reconcile net income to cash provided from operations:
Increase (decrease) in future policy benefits	731,417	834,366	759,426
Increase (decrease) in other policy benefits	19,268	5,448	35,638
Deferral of policy acquisition costs	(913,544)	(850,169)	(828,943)
Amortization of deferred acquisition costs	410,001	379,700	348,824
Change in current and deferred income taxes	77,930	101,448	91,835
Realized (gains) losses	24,188	65,676	76,548
Other, net	(17,582)	(24,799)	44,480
Cash provided from (used for) operating activities	1,402,440	1,482,425	1,422,194
Investments sold or matured:
Fixed maturities available for sale—sold	1,207,237	602,556	390,392
Fixed maturities available for sale—matured or other redemptions	214,442	250,652	462,002
Mortgage loans	54,157	44,004	32,870
Other long-term investments	43,362	151,262	50,281
Total investments sold or matured	1,519,198	1,048,474	935,545
Acquisition of investments:
Fixed maturities—available for sale	(1,379,238)	(1,536,409)	(1,420,220)
Mortgage loans	(174,665)	(158,823)	(77,275)
Other long-term investments	(459,660)	(155,700)	(213,207)
Total investments acquired	(2,013,563)	(1,850,932)	(1,710,702)
Net (increase) decrease in policy loans	(42,649)	(42,154)	(25,232)
Net (increase) decrease in short-term investments	(3,295)	32,381	(44,976)
Additions to property and equipment	(71,045)	(49,553)	(27,929)
Other investing activities	96	0	0
Investments in low-income housing interests	(30,258)	(64,365)	(69,721)
Cash provided from (used for) investing activities	(641,516)	(926,149)	(943,015)
Cash provided from (used for) financing activities:
Issuance of common stock	51,786	114,080	106,592
Cash dividends paid to shareholders	(85,485)	(84,116)	(80,547)
Repayment of debt	0	(165,612)	(150,000)
Proceeds from issuance of debt	530,000	170,000	250,492
Payment for debt issuance costs	(7,253)	(757)	(5,272)
Net borrowing (repayment) of commercial paper	(13,878)	32,961	(46,289)
Proceeds from commercial paper with original maturities greater than 90 days	484,726	0	0
Repayment of commercial paper with original maturities greater than 90 days	(372,011)	0	0
Acquisition of treasury stock	(1,002,109)	(511,100)	(454,638)
Amounts paid to reinsurer	(413,779)	0	0
Net receipts (payments) from deposit-type products	112,168	(96,943)	(112,791)
Cash provided from (used for) financing activities	(715,835)	(541,487)	(492,453)
Effect of foreign exchange rate changes on cash	17,080	(4,192)	13,670
Net increase (decrease) in cash	62,169	10,597	396
Cash at beginning of year	103,156	92,559	92,163
Cash at end of year	$ 165,325	$ 103,156	$ 92,559

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Significant Accounting Policies	Note 1—Significant Accounting Policies Business : (Globe Life), (the Company), refers to Globe Life Inc., an insurance holding company incorporated in Delaware in 1979, and Globe Life Inc. subsidiaries and affiliates. Globe Life Inc.'s direct or indirect primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The underwriting companies are owned by their ultimate corporate parent, Globe Life Inc. (Parent Company). Globe Life provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The Company is organized into three reportable segments: life insurance, supplemental health insurance, and investments. Globe Life markets its insurance products through a number of distribution channels, each of which sells the products of one or more of Globe Life's insurance segments. Our distribution channels consist of the following exclusive agencies: American Income Life Division (American Income), Liberty National Division (Liberty National) and Family Heritage Division (Family Heritage); an independent agency, United American Division (United American); and our Direct to Consumer Division (DTC). Basis of Presentation : The accompanying consolidated financial statements of Globe Life have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP), under guidance issued by the Financial Accounting Standards Board (FASB). The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Use of Estimates : The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. See further documentation in the significant accounting policies or the accompanying notes. Principles of Consolidation : The consolidated financial statements include the results of Globe Life Inc. and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. When Globe Life acquires a subsidiary or a block of business, the assets acquired and the liabilities assumed are measured at fair value at the acquisition date. Any excess of acquisition cost over the fair value of net assets is recorded as goodwill. Expenses incurred to effect the acquisition are charged to earnings as of the acquisition date. Upon acquisition, the accounts and results of operations are consolidated as of and subsequent to the acquisition date. Investments : Globe Life classifies all of its fixed maturity investments as available for sale. Investments classified as available for sale are carried at fair value with unrealized gains and losses, net of taxes, reflected directly in accumulated other comprehensive income (AOCI). Income from investments is recorded in "Net investment income" on the Consolidated Statements of Operations . Gains and losses from sales, maturities, or other redemptions of investments are recorded in "Realized gains (losses)". Gains and losses realized on the disposition of investments are determined on a specific identification basis. Interest income and prepayment fees are recognized when earned. Premiums and discounts are amortized using the effective yield method. When amortized cost of a callable debt security exceeds the first call price, the premium is amortized to the earliest call date. Otherwise, the period of amortization or accretion generally extends from the purchase date to the maturity date. "Policy loans", which represent loans provided to policyholders using cash values as collateral, are carried at unpaid principal balances. "Mortgage loans" or commercial mortgage loans, are a type of investment where the mortgage loan is shared among investors, are accounted for as financing receivables. The commercial mortgage loans are managed by third parties. The Company purchased the legal rights to interests in commercial mortgage loans which are secured by properties such as hotels, retail, multiple family, or offices. The commercial mortgage loans typically have a term of 3 years with the option to extend up to 2 years. The commercial mortgage loans are recorded at unpaid principal balance, net of unamortized origination fees and net of allowance for loan losses. Interest income, net of the amortization of origination fees, is recorded in "Net investment income" under the effective yield method. Our unfunded commitment balance to the commercial loan borrowers was $22 million as of December 31, 2024. "Other long-term investments" include investment funds, equity securities, company-owned life insurance (COLI) and real estate. Investments in equity securities are reported at fair value with changes in fair value, net of taxes, reflected directly in "Realized gains (losses)" in the Consolidated Statements of Operations . COLI is reported at the cash surrender value; changes in the cash surrender value are recorded in net investment income. Investments in real estate are reported at cost less accumulated depreciation. Depreciation is recorded on a straight-line basis over the estimated useful life. The investment funds consist of limited partnerships whereby the Company has a pro-rata share of ownership ranging from less than 1% to 20%. For each investment, the Company has elected the fair value option, but would have been otherwise accounted for as an equity method investment. The fair value option is assessed for each individual investment at the inception of the investment. Each limited partnership investment is evaluated under applicable GAAP to determine if it is a variable interest entity (VIE) and would qualify for consolidation. Primary beneficiaries are required to consolidate VIEs. The investments are not consolidated because the Company has no power to control the activities that most significantly affect the economic performance of these entities and therefore the Company is not the primary beneficiary of any of these interests. Globe Life's involvement is limited to its limited partnership interest in the entities. The Company has not provided any other financial support to the entities beyond its commitments to fund its limited partnership interests, and there are no arrangements or agreements with any of the interests to provide other financial support. The maximum loss exposure relative to these interests is limited to their carrying value and future commitments. The Company has approximately 2% of total assets in low-income housing tax credits and certain limited partnerships (investment funds) that qualify as unconsolidated VIEs. The limited partnership investments are reported at the Company's pro-rata share of the investment fund's net asset value or its equivalent (NAV), as a practical expedient for fair value. Changes in the NAV are recorded in net income and increase the carrying value on the balance sheet. The amount of change in NAV attributable to the net operating results of the fund is recorded in "Net investment income" with the remaining balance of the change reflected in "Realized gains (losses)." Distributions received from the funds reduce the carrying value. Our maximum exposure to loss is equal to the outstanding carrying value and future funding commitments. The Company had $239 million of capital called during the year from existing investment funds, reducing our unfunded commitments. Our unfunded commitments were $433 million as of December 31, 2024. "Short-term investments" include investments in interest-bearing assets with original maturities of twelve months or less. Fair Value Measurements, Investments in Securities : Globe Life measures the fair value of its "fixed maturities" based on a hierarchy consisting of three levels which indicate the quality of the fair value measurements as described below: • Level 1— fair values are based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access as of the measurement date. • Level 2— fair values are based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, or inputs that can otherwise be corroborated by observable market data. • Level 3— fair values are based on inputs that are considered unobservable where there is little, if any, market activity for the asset or liability as of the measurement date. In this circumstance, the Company has to rely on values derived by independent brokers or internally-developed assumptions. Unobservable inputs are developed based on the best information available to the Company which may include the Company’s own data or bid and ask prices in the dealer market. Certain investments, such as investment funds, that are measured at fair value using the net asset value per share or its equivalent, as a practical expedient, have not been classified in the fair value hierarchy. The net asset value is provided by general partners or managers. The great majority of Globe Life's "fixed maturities" are not actively traded and direct quotes are not generally available. Management therefore determines the fair values of these securities after consideration of data provided by third-party pricing services, independent broker/dealers, and other resources. At December 31, 2024, the Company's investments in fixed maturities were primarily composed of the following significant security types: corporate securities, state and municipal securities, U.S. government direct, guaranteed, and government-sponsored enterprises securities. The remaining security types represented approximately 1% of the total in the aggregate. Approximately 98% of the fair value of "fixed maturities" reported at December 31, 2024 was determined using data provided by third-party pricing services. Prices provided by these services are not binding offers but are estimated exit values. Third-party pricing services use proprietary pricing models to determine security values by discounting cash flows using a market-adjusted spread to a benchmark yield. For all asset classes within Globe Life's significant security types, third-party pricing services use a common valuation technique to model the price of the investments using observable market data. The foundation for these models consists of developing yield spreads based on multiple observable market inputs, including but not limited to: benchmark yield curves, actual trading activity, new issue yields, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, sector-specific data, economic data, and other inputs that are corroborated in the market. Pricing vendors monitor and review their pricing data continuously with current market and economic data feeds, augmented by ongoing communication within the dealer community. Using the observable market inputs described above, spreads to an appropriate benchmark yield are further developed by the vendors for each security based on security-specific and/or sector-specific risk factors, such as a security’s terms and conditions (coupon, maturity, and call features), credit rating, sector, liquidity, collateral or other cash flow options, and other factors that could impact the risk of the security. Embedded repayment options, such as call and redemption features, are also taken into account in the pricing models. When the spread is determined, it is added to the security’s benchmark yield. The security's expected cash flows are discounted using this spread-adjusted yield, and the resulting present value of the discounted cash flows is the evaluated price. When third-party vendor prices are not available, the Company attempts to obtain valuations from other sources, including but not limited to broker/dealers, broker quotes, and prices on comparable securities. When valuations have been obtained for all securities in the portfolio, management reviews and analyzes the prices to ensure their reasonableness, taking into account available and observable information. The Company utilizes pricing from multiple pricing providers and applies a hierarchy of sources to determine price. When two or more valuations are available for a security and the variance between the prices is 10% or less, the close correlation suggests similar observable inputs were used in deriving the price, and the price is selected based on hierarchy of pricing providers. Securities valued in this manner are classified as Level 2. When the variance between two or more valuations for a security exceeds 10%, additional analysis is performed to evaluate the reasonableness of the fair value using the hierarchy and upon the evaluation company may elect to use the hierarchy of pricing providers or use additional resources such as broker quotes, prices on comparable securities, recent trades, and any other observable market data to corroborate the pricing provider. If fair value differences from pricing providers are determined to be unreasonable and additional pricing resources utilizing observable market data cannot corroborate the price within a reasonable tolerance, then the security will be classified as Level 3. Globe Life invests in private placement fixed maturities. Private placement fixed maturities are generally not an active market. Private placement valuations are based on observable inputs, such as the benchmark treasury rate, published sector indices, and/or publicly traded comparables and unobservable inputs such as an internally-developed credit ratings, public private spreads and/or private letter ratings assigned by the nationally recognized statistical rating organizations. If observable inputs cannot be corroborated, the fair values are classified as Level 3. Refer to Note 4—Investments under the caption Quantitative Information about Level 3 Fair Value Measurements . The fair values for each class of security and by valuation hierarchy level are indicated in Note 4—Investments under the caption Fair value measurements, and Note 10—Postretirement Benefits under the caption Pension Assets . Fair Value Measurements, Other Financial Instruments : Fair values for cash and cash equivalents, short-term investments, short-term debt, receivables, and payables approximate carrying value. Cash and cash equivalents are classified as Level 1. Fair values of commercial mortgage loans are determined based upon expected cash flows discounted at an appropriate risk-adjusted rate and are classified as Level 3. The fair value of investments in limited partnerships that provide low-income housing tax credits is based on discounted projected cash flows and are classified as Level 3. Policy loans are an integral part of Globe Life's subsidiaries’ life insurance policies in force and their fair values cannot be valued separately from the insurance contracts. Investment funds are based on net asset value and are excluded from the fair value hierarchy. The fair values of Globe Life's long and short-term debt issues are based on the same methodology as investments in fixed maturities. At December 31, 2024, observable inputs were available for these debt securities and as such were classified as Level 2 in the valuation hierarchy. The fair value for each debt instrument as of December 31, 2024 is disclosed in Note 12—Debt . As described in Note 10—Postretirement Benefits , Globe Life maintains a nonqualified supplemental retirement plan. Accordingly, the assets that support the liability for this plan are considered general assets of the Company. These assets consist of the cash value of company-owned life insurance policies (COLI) and exchange traded funds (ETFs). Fair values for the ETFs are derived from direct quotes and are considered Level 1 in the fair value hierarchy. Current Expected Credit Loss Reserve (fixed maturities) : At the onset of the evaluation, the Company individually assesses each fixed maturity, on a quarterly basis, to determine whether it intends to sell, or it is more likely than not that it will be required to sell the security before recovery of its amortized cost basis. If either of the criteria are met, the Company will write down the fixed maturity's amortized cost basis to fair value through "Realized gains (losses)". If neither of the aforementioned criteria are met, the Company will evaluate whether the decline in fair value has resulted from a credit event. The Company will evaluate many factors, as further described below, to determine the present value of the expected cash flows. A credit loss occurs when the present value of the expected cash flows is less than the amortized cost basis. This will result in the recording of an allowance for credit losses as a contra asset account to the amortized cost basis with an offsetting provision for credit losses in " Realized gains (losses)" on the Consolidated Statements of Operations . Additionally, the current expected credit loss (CECL) methodology includes a fair value floor where the allowance for credit loss for a security cannot exceed the difference between fair value and amortized cost. When it is determined that there is not a credit loss, the decline in fair value is recognized in Other Comprehensive Income . All changes in the allowance for credit losses are recorded as provision for (or reversal of) credit loss expense. Losses recorded to the allowance for credit losses are management's best estimate of the uncollectibility of principal and interest of a fixed maturity. The evaluation of Globe Life's securities for credit losses is a process that is undertaken at least quarterly and is overseen by a team of investment and accounting professionals. The process for making this determination is highly subjective and involves the careful consideration of many factors. The factors considered include, but are not limited to: • The Company’s lack of intent to sell the debt security before recovery; • Whether it is more likely than not the Company will be required to sell prior to maturity; • The reason(s) for the credit related losses; • The financial condition of the issuer and the prospects for recovery in fair value of the security; • Expected future cash flows. The relative weight given to each of these factors can change over time as facts and circumstances change. In many cases, management believes it is appropriate to give more consideration to prospective factors than to retrospective factors. Prospective factors that are given more weight include prospects for recovery, the Company’s ability and general intent to hold the security until anticipated recovery, and expected future cash flows. Among the facts and information considered in the process are: • Financial statements of the issuer; • Changes in credit ratings of the issuer; • The value of underlying collateral; • News and information included in press releases issued by the issuer; • News and information reported in the media concerning the issuer; • News and information published by or otherwise provided by securities, economic, or research analysts; • The nature and amount of recent and expected future sources and uses of cash; • Default on a required payment; • Issuer bankruptcy filings. The expected cash flows are determined using judgment and the best information available to the Company. Inputs used to derive expected cash flows generally include expected default rates, current levels of subordination, and estimated recovery rate. The discount rate utilized in the discounted cash flows is the effective interest rate, which is the rate of return implicit in the asset at acquisition. Current Expected Credit Loss Reserve (mortgage loans) : The Company evaluates the performance and credit quality of the commercial mortgage loan portfolio at least on a quarterly basis, or as needed, by utilizing common metrics such as loan-to-value or debt-service ratios as well as covenants, local market conditions, borrower quality, and underlying collateral. The fair value of the underlying collateral is based on a third-party appraisal of the property at origination of the loan. The fair value is assessed on an annual basis or more frequently when a loan is materially underperforming, 30 days delinquent, or in technical default. The Company determines the probability of estimated losses for the performing commercial mortgage loan portfolio on a pool basis each quarter and records an allowance. The allowance for credit losses is based on estimates, historical experience, probability of loss, value of the underlying collateral, and macro factors that affect the collectability of the loan. If management determines that foreclosure of a particular property is probable, or determines the loan is collateral dependent, the company may elect the practical expedient. for an individual mortgage loan to estimate the expected credit losses, which are based on the fair value of the property less amortized cost, adjusted for selling and other associated costs. See Note 4—Investments for current activity. Cash : " Cash" consists of balances on hand and on deposit in banks and financial institutions. Accrued investment income : "Accrued investment income" consists of interest income or dividends earned on the investment portfolio, but which are yet to be received as of the balance sheet date. The Company will write off accrued investment income that is deemed to be uncollectible related to the fixed maturities. " Accrued investment income As a practical expedient, the Company excludes the accrued investment income from the amortized cost basis of the investment and separately reports it in another financial statement line item, "Accrued investment income." Accordingly, the amount will be excluded from disclosures within Note 4—Investments . Other Receivables : Agent debit balances primarily represent commissions advanced to insurance agents, a common industry practice. Generally, commissions are paid to an agent when due over the life of a policy as premiums are paid. However, some agents may qualify to have their commissions (primarily first-year commissions) paid in advance of when the commissions are earned. To the extent an advance is made, we will generally advance up to 65% of first year commissions. This creates an agent debit balance which is classified within “Other receivables”. These balances are repaid to the Company over time, generally one year, as the premiums associated with the advanced commissions are collected by the Company and a portion of the agents' commissions on such premiums are retained in order to repay the balances. If an agent has an agent debit balance with the Company, commissions earned by that agent are generally first applied to reduce the amounts owed to the Company. Any excess will be paid to the agent in cash. The balances were $542 million at December 31, 2024 and $501 million at December 31, 2023. When an agent sells a policy, commissions are advanced to the agent, and the collection of the advance is made as long as the policy stays in force. While there is a susceptibility to loss should an agent terminate or excessive policy lapses occur, the ability of the Company to continue to collect an agent's commission streams over time from prior sales of policies reduces the Company's exposure to loss. Commissions are earned by the agent over the contract period as long as premium is paid by the policyholder and the policy stays in force. As the commissions are earned by the agent and commission expense is incurred by the Company the agent debit balance is reduced. The portion of commission expense incurred related to non-level commissions is deferred and recorded as “Deferred acquisition cost.” The portion of level commission is recognized as an expense within “Commissions, premium taxes, and non-deferred acquisition costs.” The Company has a very low inherent risk with regard to the collection of agent debit balances and views these balances as recoverable since they are, in aggregate, less than the estimated present value of future commissions discounted at a conservative rate which includes assumptions for lapses and mortality. The Company’s security, or collateral, is in the form of future commission streams collected over the life of the policies sold by the respective agents, which ultimately revert to the Company in the event an agent is terminated. The Company evaluated the agent debit balances on a pool basis to determine the allowance for credit losses, as the loans have similar characteristics. A provision for credit losses will be recorded in "Realized gains (losses)" on the Consolidated Statements of Operations and the asset balance will be reflected in agent debit balances, net of allowance for credit losses ("Other receivables"). As of December 31, 2024 and 2023, the allowance for credit losses was $1.4 million and $1.2 million, respectively. Deferred Acquisition Costs : Certain costs of acquiring new insurance business are deferred and recorded as an asset. These costs are capitalized on a grouped contract basis and amortized over the expected term of the related contracts, and are essential for the acquisition of new insurance business. Deferred acquisition costs (DAC) are directly related to the successful issuance of an insurance contract, and primarily include sales commissions, policy issue costs, direct to consumer advertising costs, and underwriting costs. Additionally, DAC includes the value of business acquired (VOBA), which are the costs of acquiring blocks of insurance from other companies or through the acquisition of other companies. These costs represent the difference between the fair value of the contractual insurance assets acquired and liabilities assumed, compared against the assets and liabilities for insurance contracts that the company issues or holds measured in accordance with GAAP. DAC is amortized on a constant-level basis over the expected term of the grouped contracts, with the related expense included in amortization of deferred acquisition costs on the Consolidated Statements of Operations . The in-force metric used to compute the DAC amortization rate is annualized premium in force. The assumptions used to amortize acquisition costs include mortality, morbidity, and lapses. These assumptions are reviewed at least annually and revised in conjunction with any change in the future policy benefit assumptions. The effect of changes in the assumptions are recognized over the remaining expected contract term as a revision of future amortization amounts. VOBA is amortized on a basis that is consistent with DAC, as described above, and is subject to periodic recoverability and loss recognition testing to determine if there is a premium deficiency. These tests evaluate whether the present value of future contract-related cash flows will support the capitalized VOBA asset. These cash flows consist primarily of premium income, less benefits and expenses. The present value of these cash flows, less the liability for future policy benefits, is then compared with the unamortized balance. In the event the estimated present value of net cash flows is less, the deficiency would be recognized by a charge to earnings and either a reduction of unamortized acquisition costs or an increase in the liability for future policy benefits. Refer to Note 7—DAC . Advertising Costs : Costs related to advertising are generally charged to expense as incurred. However, certain Direct to Consumer advertising costs are capitalized when there is a reliable and demonstrated relationship between total costs and future benefits that is a direct result of incurring these costs. Advertising costs consist primarily of internet advertising costs and the production and distribution costs of direct mail advertising materials, and when capitalized are included as a component of DAC. Additionally, they are amortized in the same manner as other DAC. Advertising costs charged to earnings and included in commissions, premium taxes, and non-deferred acquisition costs were $15.7 million, $19.2 million, and $9.4 million in 2024, 2023, and 2022, respectively. Unamortized capitalized advertising costs included within DAC were $1.6 billion at December 31, 2024 and $1.6 billion at December 31, 2023. Goodwill : The excess cost of a business acquired over the fair value of net assets acquired is reported as goodwill. In accordance with the guidance, goodwill is subject to impairment testing on an annual basis, or whenever potential impairment triggers occur. Impairment testing involves the performance of a qualitative analysis, which involves assessing current events and circumstances to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. In the event the fair value is less than the carrying value, further testing is required to determine the amount of impairment, if any. If there is an impairment in the goodwill of any reporting unit, it is written down and charged to earnings in the period of the test. Globe Life tests its goodwill annually as of June 30th for each of the years 2022 through 2024. The Company's goodwill was not impaired in any of those periods. The Company completed the acquisition of Evry Health during 2024 resulting in an increase in goodwill of $8.7 million. Low-Income Housing Tax Credit Interests : Globe Life invests in limited partnerships that provide low-income housing tax credits and other related federal income tax benefits to the Company. Globe Life holds passive interests in limited partnerships that provide investment returns through the provision of tax benefits (principally from the transfer of federal or state tax credits related to federal low-income housing). These investments are considered to be VIEs and do not qualify for consolidation. The carrying value of the Company's investment in these entities was $270 million and $267 million at December 31, 2024 and 2023, respectively, and was included in "Other assets" on the Consolidated Balance Sheets . As of December 31, 2024, Globe Life was obligated under future commitments of $76 million, which are recorded in "Other liabilities." For guaranteed investments acquired prior to January 1, 2015, the Company utilizes the effective-yield method of amortization, while the proportional method of amortization is utilized for all non-guaranteed and guaranteed investments acquired on or after January 1, 2015. All net amortization expense and income tax benefits are recorded in "Income tax benefit (expense)" on the Consolidated Statements of Operations . Property and Equipment : Property and equipment, included in “Other assets,” is reported at cost less accumulated depreciation. Depreciation is recorded primarily on the straight line method over the estimated useful lives of these assets which range from three fifteen Year Ended December 31, 2024 2023 Property and equipment, net of accumulated depreciation: Company occupied real estate $ 36,656 $ 32,566 Data processing equipment 219,614 198,150 Transportation equipment 26,346 7,405 Furniture and equipment 1,656 1,776 Total property and equipment, net of depreciation $ 284,272 $ 239,897 Future Policy Benefits : The liability for future policy benefits for traditional and limited-payment long duration life and health products comprises approximately 93% of the total liability for future policy benefits. The liability is determined each reporting period based on the net level premium method. This method requires the liability for future policy benefits be calculated as the present value of estimated future policyholder benefits and the related termination expenses, less the present value of estimated future net premiums to b

Statutory Accounting

Statutory Accounting	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Statutory Accounting	Note 2—Statutory Accounting Our U.S. based life insurance subsidiaries of Globe Life are required to file statutory financial statements with state insurance regulatory authorities. Accounting principles used to prepare these statutory financial statements differ from GAAP. Consolidated net income and shareholders’ equity (capital and surplus) on a statutory basis for the insurance subsidiaries were as follows: Net Income Shareholders’ Equity Year Ended December 31, At December 31, 2024 2023 2022 2024 2023 Life insurance subsidiaries $ 688,665 $ 434,952 $ 444,294 $ 1,690,663 $ 1,660,104 The excess, if any, of shareholders' equity of the insurance subsidiaries on a GAAP basis over that determined on a statutory basis is not available for distribution by the insurance subsidiaries to the Parent Company without regulatory approval. Insurance subsidiaries’ statutory capital and surplus necessary to satisfy regulatory requirements in the aggregate was $627 million at December 31, 2024. More information on the restrictions on the payment of dividends can be found in Note 13—Shareholders' Equity . The Company's statutory financial statements are presented on the basis of accounting practices prescribed by the insurance department of the state of domicile of each insurance subsidiary. While all states have adopted the National Association of Insurance Commissioners’ ("NAIC") statutory accounting practices ("NAIC SAP") as the basis for statutory accounting, certain states have retained prescribed practices of their respective insurance code or administrative code which can differ from NAIC SAP. For Globe Life's life insurance companies, there are no significant differences between NAIC SAP and the accounting practices prescribed by the states of domicile.

Supplemental Information about

Supplemental Information about Changes to Accumulated Other Comprehensive Income	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Supplemental Information about Changes to Accumulated Other Comprehensive Income	Note 3—Supplemental Information about Changes to Accumulated Other Comprehensive Income Components of Accumulated Other Comprehensive Income : An analysis of the change in balance by component of Accumulated Other Comprehensive Income is as follows for each of the years 2022 through 2024: Available for Sale Assets Future Policy Benefits Foreign Exchange Pension Adjustments Total For the year ended December 31, 2022: Balance at January 1, 2022 $ 2,765,290 $ (6,915,910) $ 19,248 $ (103,676) $ (4,235,048) Other comprehensive income (loss) before reclassifications, net of tax (4,211,540) 5,546,706 (20,929) 94,055 1,408,292 Reclassifications, net of tax 25,578 — — 10,865 36,443 Other comprehensive income (loss) (4,185,962) 5,546,706 (20,929) 104,920 1,444,735 Balance at December 31, 2022 (1,420,672) (1,369,204) (1,681) 1,244 (2,790,313) For the year ended December 31, 2023: Other comprehensive income (loss) before reclassifications, net of tax 529,688 (578,187) 6,400 (3,087) (45,186) Reclassifications, net of tax 63,388 — — (308) 63,080 Other comprehensive income (loss) 593,076 (578,187) 6,400 (3,395) 17,894 Balance at December 31, 2023 (827,596) (1,947,391) 4,719 (2,151) (2,772,419) For the year ended December 31, 2024: Other comprehensive income (loss) before reclassifications, net of tax (494,996) 1,238,349 (26,476) 22,474 739,351 Reclassifications, net of tax 2,974 — — 374 3,348 Other comprehensive income (loss) (492,022) 1,238,349 (26,476) 22,848 742,699 Balance at December 31, 2024 $ (1,319,618) $ (709,042) $ (21,757) $ 20,697 $ (2,029,720) Reclassification adjustments : Reclassification adjustments out of Accumulated Other Comprehensive Income are presented below for the three years ended December 31, 2024. Year Ended December 31, Affected line items in the Statement of Operations Component Line Item 2024 2023 2022 Unrealized investment (gains) losses on available for sale assets: Realized (gains) losses $ 14,843 $ 84,416 $ 32,165 Realized (gains) losses Amortization of (discount) premium (11,079) (4,178) 212 Net investment income Total before tax 3,764 80,238 32,377 Tax (790) (16,850) (6,799) Income taxes Total after-tax 2,974 63,388 25,578 Pension adjustments: Amortization of prior service cost 1,071 1,075 1,077 Other operating expense Amortization of actuarial (gain) loss (597) (1,465) 12,677 Other operating expense Total before tax 474 (390) 13,754 Tax (100) 82 (2,889) Income taxes Total after-tax 374 (308) 10,865 Total reclassification (after-tax) $ 3,348 $ 63,080 $ 36,443

Investments

Investments	12 Months Ended
	Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Investments	1.20x Total % of Gross Total Loan-to-value ratio (2) : Less than 70% $ 88,507 $ 64,494 $ 196,867 $ 349,868 87 70% to 80% — — — — — 81% to 90% — — — — — Greater than 90% 16,136 37,728 — 53,864 13 Total $ 104,643 $ 102,222 $ 196,867 403,732 100 Less allowance for credit losses (7,644) Total, net of allowance for credit losses $ 396,088 (1) Annual net operating income divided by annual mortgage debt service (principal and interest). (2) Loan balance divided by stabilized appraised value at origination, including planned renovations and stabilized occupancy. Updated internal valuations are used when a loan is materially underperforming. December 31, 2023 Recorded Investment Debt Service Coverage Ratios (1) <1.00x 1.00x—1.20x >1.20x Total % of Gross Total Loan-to-value ratio (2) : Less than 70% $ 27,091 $ 180,761 $ 58,364 $ 266,216 94 70% to 80% — — — — — 81% to 90% 8,468 — 1,153 9,621 3 Greater than 90% 7,034 — — 7,034 3 Total $ 42,593 $ 180,761 $ 59,517 282,871 100 Less allowance for credit losses (3,672) Total, net of allowance for credit losses $ 279,199 (1) Annual net operating income divided by annual mortgage debt service (principal and interest). (2) Loan balance divided by stabilized appraised value at origination, including planned renovations and stabilized occupancy. Updated internal valuations are used when a loan is materially underperforming. As of December 31, 2024, the Company had 35 loans in the portfolio. During the quarter, the Company evaluated its commercial mortgage loan portfolio on both an individual and pooling basis to determine the allowance for credit losses and determined six loans were collateral dependent or likely to foreclose. The allowance for credit losses on the six loans was determined using the practical expedient which was based on an estimate of fair value of the underlying collateral plus costs to sell the asset. The total principal balance of the six loans was $53.9 million and the allowance for these loans using the practical expedient was $3.9 million as of December 31, 2024. For the year ended December 31, 2024, the allowance for credit losses increased by $4.0 million to $7.6 million. Year Ended December 31, 2024 2023 Allowance for credit losses beginning balance $ 3,672 $ 1,789 Provision (reversal) for credit losses 3,972 1,883 Allowance for credit losses ending balance $ 7,644 $ 3,672 As of December 31, 2024, there were five commercial mortgage loans in non-accrual status with an outstanding principal balance of $53 million. There was also one delinquent commercial mortgage loan with outstanding interest of $31 thousand. At December 31, 2023 the Company had no commercial mortgage loans in non-accrual status. The Company's unfunded commitment balance to commercial loan borrowers was $22 million as of December 31, 2024. Other Long-Term Investments : Other long-term investments consist of the following assets: December 31, 2024 2023 Investment funds $ 986,766 $ 795,583 Company-owned life insurance 202,734 — Other 46,259 40,295 Total $ 1,235,759 $ 835,878 The following table presents additional information about the Company's investment funds as of December 31, 2024 and December 31, 2023 at fair value: Fair Value Unfunded Commitments (2) Investment Category 2024 2023 2024 Redemption Term/Notice (1) Commercial mortgage loans $ 566,142 $ 411,315 $ 189,725 Fully redeemable and non-redeemable with varying terms. Opportunistic and private credit 202,008 181,410 191,192 Fully redeemable and non-redeemable with varying terms. Infrastructure 179,627 165,887 — Fully redeemable and non-redeemable with varying terms. Other 38,989 36,971 52,479 Non-redeemable with varying terms Total investment funds $ 986,766 $ 795,583 $ 433,396 (1) Non-redeemable funds generally have an expected life of 7 to 12 years from fund closing with extension options of 1 to 4 years. Redemptions are paid out throughout the life of the funds at the General Partner's discretion. Redeemable funds can generally be redeemed over 6 to 36 months upon request from limited partners. (2) Unfunded commitments include unfunded balances during the investment period. After an investment period ends, the fund can call capital based on limited and specified reasons. As of December 31, 2024, unfunded commitments totaled $645 million, including funds past the investment period. The Company had $239 million of capital called during the period from existing investment funds, as compared to $154 million in 2023. The Company's unfunded commitments were $433 million as of December 31, 2024." id="sjs-B4">Note 4—Investments Portfolio Composition : Summaries of fixed maturities available for sale by amortized cost, fair value, and allowance for credit losses at December 31, 2024 and 2023, and the corresponding amounts of gross unrealized gains and losses recognized in accumulated other comprehensive income (loss) are as follows. Redeemable preferred stock is included within "Corporates, by sector." At December 31, 2024 Amortized Allowance for Credit Losses Gross Gross Fair Value (1) % of Total Fixed Maturities (2) Fixed maturities available for sale: U.S. Government direct, guaranteed, and government-sponsored enterprises $ 401,753 $ — $ 1 $ (42,794) $ 358,960 2 States, municipalities, and political subdivisions 3,300,901 — 20,662 (534,759) 2,786,804 16 Foreign governments 36,883 — 18 (8,870) 28,031 — Corporates, by sector: Industrials 7,889,074 (7,098) 105,610 (805,330) 7,182,256 42 Financial 5,006,375 — 82,598 (413,043) 4,675,930 27 Utilities 2,081,366 — 39,716 (118,007) 2,003,075 12 Total corporates 14,976,815 (7,098) 227,924 (1,336,380) 13,861,261 81 Collateralized debt obligations 36,923 — 5,943 — 42,866 — Other asset-backed securities 82,534 (3,297) 39 (2,186) 77,090 1 Total fixed maturities $ 18,835,809 $ (10,395) $ 254,587 $ (1,924,989) $ 17,155,012 100 (1) Amount reported in the balance sheet. (2) At fair value. At December 31, 2023 Amortized Allowance for Credit Losses Gross Gross Fair Value (1) % of Total Fixed Maturities (2) Fixed maturities available for sale: U.S. Government direct, guaranteed, and government-sponsored enterprises $ 398,450 $ — $ 7 $ (32,306) $ 366,151 2 States, municipalities, and political subdivisions 3,296,305 — 47,346 (403,329) 2,940,322 16 Foreign governments 44,453 — 1 (10,348) 34,106 — Corporates, by sector: Industrials 8,016,126 (7,115) 213,078 (566,847) 7,655,242 43 Financial 5,028,151 — 112,368 (388,340) 4,752,179 27 Utilities 2,017,967 — 73,925 (94,130) 1,997,762 11 Total corporates 15,062,244 (7,115) 399,371 (1,049,317) 14,405,183 81 Collateralized debt obligations 37,110 — 5,036 — 42,146 — Other asset-backed securities 86,352 — 3 (4,057) 82,298 1 Total fixed maturities $ 18,924,914 $ (7,115) $ 451,764 $ (1,499,357) $ 17,870,206 100 (1) Amount reported in the balance sheet. (2) At fair value. At December 31, 2024 and 2023, the Company had unfunded commitments of $167 million and $0, respectively, in fixed maturity investments. The Company has exposure to real estate investment trusts with an average rating of BBB+, which had a fair value of $405 million (2% of the total fixed maturity portfolio) and $425 million (2% of the total fixed maturity portfolio) at December 31, 2024 and December 31, 2023, respectively. A schedule of fixed maturities available for sale by contractual maturity date at December 31, 2024, is shown below on an amortized cost basis, net of allowance for credit losses, and on a fair value basis. Actual disposition dates could differ from contractual maturities due to call or prepayment provisions. At December 31, 2024 Amortized Fair Fixed maturities available for sale: Due in one year or less $ 126,902 $ 126,643 Due after one year through five years 728,959 741,488 Due after five years through ten years 1,869,090 1,873,345 Due after ten years through twenty years 8,729,774 8,118,486 Due after twenty years 7,254,503 6,175,067 Mortgage-backed and asset-backed securities 116,186 119,983 $ 18,825,414 $ 17,155,012 Analysis of investment operations: "Net investment income" for the three years ended December 31, 2024 is summarized as follows: Year Ended December 31, 2024 2023 2022 Fixed maturities available for sale $ 981,439 $ 944,628 $ 910,284 Policy loans 52,625 49,011 46,586 Mortgage loans 27,809 19,541 9,719 Other long-term investments (1) 81,834 54,655 40,837 Short-term investments 11,151 6,322 2,156 1,154,858 1,074,157 1,009,582 Less investment expense (19,227) (17,273) (17,782) Net investment income $ 1,135,631 $ 1,056,884 $ 991,800 (1) For the years ended 2024, 2023, and 2022, the investment funds, accounted for under the fair value option method, recorded $74.8 million, $52.3 million, and $40.3 million, respectively, in net investment income. Refer to Other Long-Term Investments below for further discussion on the investment funds. Selected information about sales of fixed maturities available for sale is as follows: Year Ended December 31, 2024 2023 2022 Fixed maturities available for sale: Proceeds from sales (1) $ 1,207,237 $ 602,556 $ 390,392 Gross realized gains 21,196 5,554 1,296 Gross realized losses (32,956) (80,823) (57,996) (1) Includes unsettled trades of $866 thousand, $0, and $0 as of December 31, 2024, 2023, and 2022, respectively. An analysis of "realized gains (losses)" is as follows: Year Ended December 31, 2024 2023 2022 Realized investment gains (losses): Fixed maturities available for sale: Sales and other (1) $ (11,563) $ (77,301) $ (32,552) Provision for credit losses (3,280) (7,115) 387 Fair value option—change in fair value (16,717) 15,102 (29,353) Mortgage loans (3,972) (5,603) (963) Other investments 2,936 1,792 4,681 Realized gains (losses) from investments (32,596) (73,125) (57,800) Other gains (losses) 8,408 7,449 (18,748) Total realized gains (losses) (24,188) (65,676) (76,548) Applicable tax 5,080 13,792 16,075 Realized gains (losses), net of tax $ (19,108) $ (51,884) $ (60,473) (1) For the years ended 2024, 2023, and 2022, the Company recorded $105.6 million, $50.9 million, and $147.6 million of issuer-initiated exchanges of fixed maturities (noncash transactions) that resulted in $0, $(1.9) million, and $1.9 million, respectively, in realized gains (losses). During the year ended December 31, 2023, the Company sold $66 million in securities relating to holdings in Signature Bank New York and First Republic Bank, which entered receivership during the first half of 2023. Year Ended December 31, 2024 2023 2022 Change in unrealized investment gains (losses) on: Fixed maturities available for sale $ (622,809) $ 750,734 $ (5,298,692) Fair value measurements: The following tables represent the fair value of fixed maturities measured on a recurring basis at December 31, 2024 and 2023: Fair Value Measurement at December 31, 2024: Quoted Prices in Significant Other Significant Total Fair Fixed maturities available for sale U.S. Government direct, guaranteed, and government-sponsored enterprises $ — $ 358,960 $ — $ 358,960 States, municipalities, and political subdivisions — 2,786,804 — 2,786,804 Foreign governments — 28,031 — 28,031 Corporates, by sector: Industrials — 6,998,900 183,356 7,182,256 Financial — 4,551,737 124,193 4,675,930 Utilities — 1,890,559 112,516 2,003,075 Total corporates — 13,441,196 420,065 13,861,261 Collateralized debt obligations — — 42,866 42,866 Other asset-backed securities — 65,907 11,183 77,090 Total fixed maturities $ — $ 16,680,898 $ 474,114 $ 17,155,012 Percentage of total — % 97 % 3 % 100 % Fair Value Measurement at December 31, 2023: Quoted Prices in Significant Other Significant Total Fair Fixed maturities available for sale U.S. Government direct, guaranteed, and government-sponsored enterprises $ — $ 366,151 $ — $ 366,151 States, municipalities, and political subdivisions — 2,940,322 — 2,940,322 Foreign governments — 34,106 — 34,106 Corporates, by sector: Industrials — 7,440,493 214,749 7,655,242 Financial — 4,621,160 131,019 4,752,179 Utilities — 1,888,797 108,965 1,997,762 Total corporates — 13,950,450 454,733 14,405,183 Collateralized debt obligations — — 42,146 42,146 Other asset-backed securities — 82,298 — 82,298 Total fixed maturities $ — $ 17,373,327 $ 496,879 $ 17,870,206 Percentage of total — % 97 % 3 % 100 % The following tables represent changes in fixed maturities measured at fair value on a recurring basis using significant unobservable inputs (Level 3): Analysis of Changes in Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Asset- Collateralized Corporates Total Balance at January 1, 2022 $ — $ 63,505 $ 641,688 $ 705,193 Included in realized gains / losses — — — — Included in other comprehensive income — (13,771) (91,385) (105,156) Acquisitions (1) — — — — Sales — — — — Amortization — 4,519 7 4,526 Other (2) — (3,889) (72,227) (76,116) Transfers into Level 3 (3) — — — — Transfers out of Level 3 (3) — — — — Balance at December 31, 2022 — 50,364 478,083 528,447 Included in realized gains / losses — — — — Included in other comprehensive income — (8,230) 4,541 (3,689) Acquisitions (1) — — — — Sales — — — — Amortization — 4,569 155 4,724 Other (2) — (4,557) (28,046) (32,603) Transfers into Level 3 (3) — — — — Transfers out of Level 3 (3) — — — — Balance at December 31, 2023 — 42,146 454,733 496,879 Included in realized gains / losses — — 740 740 Included in other comprehensive income 37 907 (4,607) (3,663) Acquisitions (1) 8,948 — 14,800 23,748 Sales — — — — Amortization — 4,548 217 4,765 Other (2) — (4,735) (45,818) (50,553) Transfers into Level 3 (3) 2,198 — — 2,198 Transfers out of Level 3 (3) — — — — Balance at December 31, 2024 $ 11,183 $ 42,866 $ 420,065 $ 474,114 (1) Acquisitions of Level 3 investments in each of the years 2022 through 2024 are comprised of private placement fixed maturities and equities. (2) Includes capitalized interest, foreign exchange adjustments, and principal repayments. (3) Considered to be transferred at the end of the period. Transfers into Level 3 occur when observable inputs are no longer available. Transfers out of Level 3 occur when observable inputs become available. Changes in unrealized gains and losses for Level 3 securities during the period included in accumulated other comprehensive income for assets held at the end of the reporting period: Asset- Collateralized Corporates Total 2022 $ — $ (13,771) $ (91,385) $ (105,156) 2023 — (8,230) 4,541 (3,689) 2024 37 907 (4,607) (3,663) Transfers between levels within the hierarchy occur when there are changes in the observability of the inputs and market data. Transfers into Level 3 occur when there is little unobservable market activity for the asset/liability as of the measurement date and the Company is required to rely upon internally-developed assumptions or third parties. Transfers out of Level 3 occur when quoted prices in active markets becomes available for identical assets/ liabilities or the ability to corroborate by observable market data. The following table represents quantitative information about Level 3 fair value measurements: Quantitative Information about Level 3 Fair Value Measurements As of December 31, 2024 Fair Value Valuation Significant Unobservable Range Weighted- Average (1) Private placement fixed maturities $ 420,065 Determination of credit spread Credit rating B to AA BBB+ Collateralized debt obligations 42,866 Discounted Cash Flows Discount rate 11.75% 11.75% Asset-backed securities 11,183 Determination of credit spread Credit rating CC - BBB BB $ 474,114 (1) Unobservable inputs were weighted by the relative fair value of the instruments. Private placement fixed maturities and asset-backed securities are valued based on the contractual cash flows discounted by a yield determined as a treasury benchmark rate adjusted for a credit spread. The credit spread is developed from observable indices for similar securities and unobservable indices for private securities or private comparable securities for corresponding credit ratings. The credit ratings for the securities may be considered unobservable inputs, as they are private letter ratings issued by a nationally recognized statistical rating organization or are assigned by the third-party investment manager based on a quantitative and qualitative assessment of the credit underwritten. A higher (lower) credit rating would result in a higher (lower) valuation. The collateral underlying collateralized debt obligations consists primarily of trust preferred securities issued by banks and insurance companies. Collateralized debt obligations are valued at the present value of expected future cash flows using an unobservable discount rate. Expected cash flows are determined by scheduling the projected repayment of the collateral assuming no future defaults, deferrals, or recoveries. The discount rate is risk-adjusted to take these items into account. A significant increase (decrease) in the discount rate will produce a significant decrease (increase) in fair value. Additionally, a significant increase (decrease) in the cash flow expectations would result in a significant increase (decrease) in fair value. For more information regarding valuation procedures, please refer to Note 1—Significant Accounting Policies under the caption Fair Value Measurements, Investments in Securities. Unrealized Loss Analysis : The following table discloses information about fixed maturities available for sale in an unrealized loss position. Less than Twelve Months Twelve Months or Longer Total Number of issues (CUSIPs) held: As of December 31, 2024 705 1,498 2,203 As of December 31, 2023 151 1,614 1,765 Globe Life's entire fixed maturity portfolio consisted of 2,552 issues by 1,014 different issuers at December 31, 2024 and 2,473 issues by 980 different issuers at December 31, 2023. The weighted-average quality rating of all unrealized loss positions at amortized cost was A- as of December 31, 2024 and December 31, 2023. The following tables disclose unrealized investment losses by class and major sector of fixed maturities available for sale at December 31, 2024 and December 31, 2023. Analysis of Gross Unrealized Investment Losses At December 31, 2024 Less than Twelve Months Twelve Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Fixed maturities available for sale: Investment grade securities: U.S. Government direct, guaranteed, and government-sponsored enterprises $ 11,268 $ (290) $ 347,527 $ (42,504) $ 358,795 $ (42,794) States, municipalities, and political subdivisions 778,244 (32,894) 1,532,264 (501,865) 2,310,508 (534,759) Foreign governments — — 24,925 (8,870) 24,925 (8,870) Corporates, by sector: Industrials 1,487,940 (73,404) 3,433,034 (690,920) 4,920,974 (764,324) Financial 961,932 (52,946) 1,785,130 (333,873) 2,747,062 (386,819) Utilities 546,965 (20,214) 540,077 (90,996) 1,087,042 (111,210) Total corporates 2,996,837 (146,564) 5,758,241 (1,115,789) 8,755,078 (1,262,353) Collateralized debt obligations — — — — — — Other asset-backed securities 23,231 (95) 42,639 (2,091) 65,870 (2,186) Total investment grade securities 3,809,580 (179,843) 7,705,596 (1,671,119) 11,515,176 (1,850,962) Below investment grade securities: Corporates, by sector: Industrials 54,199 (2,656) 142,638 (38,350) 196,837 (41,006) Financial 2,990 (53) 126,811 (26,171) 129,801 (26,224) Utilities 19,263 (1,113) 24,003 (5,684) 43,266 (6,797) Total corporates 76,452 (3,822) 293,452 (70,205) 369,904 (74,027) Collateralized debt obligations — — — — — — Other asset-backed securities — — 2,198 — 2,198 — Total below investment grade securities 76,452 (3,822) 295,650 (70,205) 372,102 (74,027) Total fixed maturities $ 3,886,032 $ (183,665) $ 8,001,246 $ (1,741,324) $ 11,887,278 $ (1,924,989) Gross unrealized losses may fluctuate quarter over quarter due to factors in the market that affect our holdings, such as changes in interest rates or credit spreads. The Company considers many factors when determining whether an allowance for a credit loss should be recorded. While the Company holds securities that may be in an unrealized loss position from time to time, Globe Life does not generally intend to sell and it is unlikely that the Company will be required to sell the fixed maturities prior to their anticipated recovery or maturity due to the strong cash flows generated by its insurance operations. Analysis of Gross Unrealized Investment Losses At December 31, 2023 Less than Twelve Months Twelve Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Fixed maturities available for sale: Investment grade securities: U.S. Government direct, guaranteed, and government-sponsored enterprises $ — $ — $ 364,006 $ (32,306) $ 364,006 $ (32,306) States, municipalities, and political subdivisions 252,800 (3,520) 1,610,163 (399,809) 1,862,963 (403,329) Foreign governments — — 32,591 (10,348) 32,591 (10,348) Corporates, by sector: Industrials 191,573 (3,881) 4,317,827 (530,011) 4,509,400 (533,892) Financial 242,099 (6,584) 2,341,424 (339,628) 2,583,523 (346,212) Utilities 81,194 (648) 686,043 (91,959) 767,237 (92,607) Total corporates 514,866 (11,113) 7,345,294 (961,598) 7,860,160 (972,711) Collateralized debt obligations — — — — — — Other asset-backed securities — — 70,956 (3,648) 70,956 (3,648) Total investment grade securities 767,666 (14,633) 9,423,010 (1,407,709) 10,190,676 (1,422,342) Below investment grade securities: Corporates, by sector: Industrials 10,745 (199) 145,697 (32,756) 156,442 (32,955) Financial 25,563 (2,602) 151,190 (39,526) 176,753 (42,128) Utilities — — 19,654 (1,523) 19,654 (1,523) Total corporates 36,308 (2,801) 316,541 (73,805) 352,849 (76,606) Collateralized debt obligations — — — — — — Other asset-backed securities — — 11,288 (409) 11,288 (409) Total below investment grade securities 36,308 (2,801) 327,829 (74,214) 364,137 (77,015) Total fixed maturities $ 803,974 $ (17,434) $ 9,750,839 $ (1,481,923) $ 10,554,813 $ (1,499,357) Gross unrealized losses increased from $1.50 billion at December 31, 2023 to $1.92 billion at December 31, 2024, an increase of $426 million. The increase in the gross unrealized losses from the prior year was primarily attributable to the increase in market interest rates. Fixed Maturities, Allowance for Credit Losses : A summary of the activity in the allowance for credit losses is as follows. Refer to Note 1—Significant Accounting Policies for factors considered in the recording of the allowance for credit losses. Year Ended December 31, 2024 2023 Allowance for credit losses beginning balance $ 7,115 $ — Additions to allowance for which credit losses were not previously recorded 3,297 72,508 Additions (reductions) to allowance for fixed maturities that previously had an allowance (17) (65,393) Reduction of allowance for which the Company intends to sell or more likely than not will be required to sell or sold during the period — — Allowance for credit losses ending balance $ 10,395 $ 7,115 As of December 31, 2024, the Company had one fixed maturity security in non-accrual status with an amortized cost of $5.5 million and an allowance of $3.3 million. As of December 31, 2023, there were no fixed maturities in non-accrual status. During the year ended December 31, 2023, the Company sold $66 million in securities for which there was a provision for credit losses relating to holdings in Signature Bank New York and First Republic Bank, which entered receivership during the first half of 2023. Concentrations of Credit Risk : Globe Life maintains a diversified investment portfolio with limited concentration in any given issuer. At December 31, 2024, the investment portfolio, at fair value, consisted of the following: Investment grade fixed maturities: Corporates 68 % States, municipalities, and political subdivisions 14 U.S. Government direct, guaranteed, and government-sponsored enterprises 2 Other 1 Below investment grade fixed maturities: Corporates 2 87 Other Policy loans, which are secured by the underlying insurance policy values 4 Other investments 9 100 % As of December 31, 2024, state and municipal governments represented 14% of invested assets at fair value. Such investments are made throughout the U.S. At December 31, 2024, the state and municipal bond portfolio at fair value was invested in securities issued within the following states: Texas (21%), California (10%), New York (7%), Florida (5%), and Pennsylvania (4%). Otherwise, there was no concentration within any given state greater than 4%. Corporate fixed maturities represent 71% of Globe Life's invested assets. These investments are spread across a wide range of industries. Below are the ten largest industry concentrations held in the portfolio of corporate fixed maturities at December 31, 2024, based on fair value: Insurance 18 % Electric utilities 11 Banks 7 Oil and natural gas pipelines 6 Chemicals 5 Transportation 4 Telecommunications 3 Food 3 Diversified financial services 3 Real estate investment trusts 3 At December 31, 2024, 2% of invested assets at fair value were represented by fixed maturities rated below investment grade. Par value of these investments was $648 million, amortized cost was $529 million, and fair value was $462 million. While these investments could be subject to additional credit risk, such risk should generally be reflected in their fair value. Securities, cash, and short-term investments held on deposit with various state and federal regulatory authorities had an amortized cost and fair value, respectively, of $1.0 billion and $955 million at December 31, 2024 and $1.0 billion and $983 million at December 31, 2023. Mortgage Loans (commercial mortgage loans): Summaries of commercial mortgage loans by property type and geographical location at December 31, 2024 and 2023 are as follows: 2024 2023 Carrying Value % of Total Carrying Value % of Total Property type: Multi-family $ 111,234 28 $ 116,299 42 Industrial 110,456 28 57,267 20 Retail 65,612 16 23,925 9 Hospitality 73,931 19 43,897 16 Mixed use 35,960 9 34,749 12 Office 6,539 2 6,734 2 Total recorded investment 403,732 102 282,871 101 Less allowance for credit losses (7,644) (2) (3,672) (1) Carrying value, net of allowance for credit losses $ 396,088 100 $ 279,199 100 2024 2023 Carrying Value % of Total Carrying Value % of Total Geographic location: Texas $ 75,131 19 $ 45,111 16 Florida 63,308 16 48,233 17 New Jersey 51,744 13 44,574 16 California 48,371 12 54,721 20 Alabama 35,850 9 11,003 4 New York 34,975 9 20,284 7 Other 94,353 24 58,945 21 Total recorded investment 403,732 102 282,871 101 Less allowance for credit losses (7,644) (2) (3,672) (1) Carrying value, net of allowance for credit losses $ 396,088 100 $ 279,199 100 The following tables are reflective of the key factors, debt service coverage ratios, and loan-to-value ("LTV") ratios that are utilized by management to monitor the performance of the portfolios. The Company only makes new investments in commercial mortgage loans that have a LTV ratio less than 80%. LTV ratios that exceed 80% are generally as a result of decreases in the valuation of the underlying property. Generally, a higher LTV ratio and a lower debt service coverage ratio can potentially equate to higher risk of loss. December 31, 2024 Recorded Investment Debt Service Coverage Ratios (1) <1.00x 1.00x—1.20x >1.20x Total % of Gross Total Loan-to-value ratio (2) : Less than 70% $ 88,507 $ 64,494 $ 196,867 $ 349,868 87 70% to 80% — — — — — 81% to 90% — — — — — Greater than 90% 16,136 37,728 — 53,864 13 Total $ 104,643 $ 102,222 $ 196,867 403,732 100 Less allowance for credit losses (7,644) Total, net of allowance for credit losses $ 396,088 (1) Annual net operating income divided by annual mortgage debt service (principal and interest). (2) Loan balance divided by stabilized appraised value at origination, including planned renovations and stabilized occupancy. Updated internal valuations are used when a loan is materially underperforming. December 31, 2023 Recorded Investment Debt Service Coverage Ratios (1) <1.00x 1.00x—1.20x >1.20x Total % of Gross Total Loan-to-value ratio (2) : Less than 70% $ 27,091 $ 180,761 $ 58,364 $ 266,216 94 70% to 80% — — — — — 81% to 90% 8,468 — 1,153 9,621 3 Greater than 90% 7,034 — — 7,034 3 Total $ 42,593 $ 180,761 $ 59,517 282,871 100 Less allowance for credit losses (3,672) Total, net of allowance for credit losses $ 279,199 (1) Annual net operating income divided by annual mortgage debt service (principal and interest). (2) Loan balance divided by stabilized appraised value at origination, including planned renovations and stabilized occupancy. Updated internal valuations are used when a loan is materially underperforming. As of December 31, 2024, the Company had 35 loans in the portfolio. During the quarter, the Company evaluated its commercial mortgage loan portfolio on both an individual and pooling basis to determine the allowance for credit losses and determined six loans were collateral dependent or likely to foreclose. The allowance for credit losses on the six loans was determined using the practical expedient which was based on an estimate of fair value of the underlying collateral plus costs to sell the asset. The total principal balance of the six loans was $53.9 million and the allowance for these loans using the practical expedient was $3.9 million as of December 31, 2024. For the year ended December 31, 2024, the allowance for credit losses increased by $4.0 million to $7.6 million. Year Ended December 31, 2024 2023 Allowance for credit losses beginning balance $ 3,672 $ 1,789 Provision (reversal) for credit losses 3,972 1,883 Allowance for credit losses ending balance $ 7,644 $ 3,672 As of December 31, 2024, there were five commercial mortgage loans in non-accrual status with an outstanding principal balance of $53 million. There was also one delinquent commercial mortgage loan with outstanding interest of $31 thousand. At December 31, 2023 the Company had no commercial mortgage loans in non-accrual status. The Company's unfunded commitment balance to commercial loan borrowers was $22 million as of December 31, 2024. Other Long-Term Investments : Other long-term investments consist of the following assets: December 31, 2024 2023 Investment funds $ 986,766 $ 795,583 Company-owned life insurance 202,734 — Other 46,259 40,295 Total $ 1,235,759 $ 835,878 The following table presents additional information about the Company's investment funds as of December 31, 2024 and December 31, 2023 at fair value: Fair Value Unfunded Commitments (2) Investment Category 2024 2023 2024 Redemption Term/Notice (1) Commercial mortgage loans $ 566,142 $ 411,315 $ 189,725 Fully redeemable and non-redeemable with varying terms. Opportunistic and private credit 202,008 181,410 191,192 Fully redeemable and non-redeemable with varying terms. Infrastructure 179,627 165,887 — Fully redeemable and non-redeemable with varying terms. Other 38,989 36,971 52,479 Non-redeemable with varying terms Total investment funds $ 986,766 $ 795,583 $ 433,396 (1) Non-redeemable funds generally have an expected life of 7 to 12 years from fund closing with extension options of 1 to 4 years. Redemptions are paid out throughout the life of the funds at the General Partner's discretion. Redeemable funds can generally be redeemed over 6 to 36 months upon request from limited partners. (2) Unfunded commitments include unfunded balances during the investment period. After an investment period ends, the fund can call capital based on limited and specified reasons. As of December 31, 2024, unfunded commitments totaled $645 million, including funds past the investment period. The Company had $239 million of capital called during the period from existing investment funds, as compared to $154 million in 2023. The Company's unfunded commitments were $433 million as of December 31, 2024.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 5—Commitments and Contingencies Reinsurance : Insurance affiliates of Globe Life reinsure a portion of insurance risk that is in excess of their retention limits. Current retention limits for new business written on ordinary life insurance range up to $500 thousand per life. Life insurance ceded represented 0.3% of total life insurance in force at December 31, 2024 and 2023. Insurance ceded on life and accident and health products represented 0.2% of premium income for 2024 and 2023. In the fourth quarter of 2024, the Company entered into a coinsurance agreement to cede a majority of its annuity business to a third-party insurer. Annuities ceded represented 68% of our direct annuity balance. The insurance affiliates of Globe Life would be liable for the reinsured risks ceded to other companies to the extent that such reinsuring companies are unable to meet their obligations. Insurance affiliates also assume insurance risks of other external companies. Life reinsurance assumed represented 0.8% and 0.9% of life insurance in force at December 31, 2024 and 2023, respectively, and reinsurance assumed on life and accident and health products represented 0.9% and 1.3% of premium income for 2024 and 2023, respectively. Leases : Globe Life primarily leases office space and other equipment under a variety of operating lease arrangements. Rental expense for the three years ended December 31, 2024 is as follows: Year Ended December 31, 2024 2023 2022 Rental expense $ 3,208 $ 3,519 $ 4,239 Future minimum rental commitments required under operating leases having remaining noncancelable lease terms in excess of one year at December 31, 2024 were as follows: Year Ended December 31, 2025 2026 2027 2028 2029 Thereafter Operating lease commitments $ 2,117 $ 1,883 $ 1,417 $ 867 $ 487 $ 4,195 Purchase Commitments : Globe Life has various long-term noncancelable purchase commitments as well as commitments to provide capital for low-income housing tax credit interests. See further discussion related to tax credits in Note 1—Significant Accounting Policies . Year Ended December 31, 2025 2026 2027 2028 2029 Thereafter Purchase commitments (1) $ 47,538 $ 29,742 $ 34,443 $ 15,266 $ 11,440 $ 203,445 (1) Includes low-income housing tax credits with non-funded commitments of $76 million at December 31, 2024. Investments : Globe Life is committed to invest under certain contracts related to investments in fixed maturities, limited partnerships and commercial mortgage loans. See Note 4—Investments for unfunded commitment table. Guarantees : At December 31, 2024, Globe Life had no guarantee agreements which were either Parent Company guarantees of subsidiary obligations to a third party or Parent Company guarantees of obligations between wholly-owned subsidiaries. As of December 31, 2024, Globe Life had no liability with respect to these guarantees. Letters of credit —Globe Life has guaranteed letters of credit in connection with its credit facility with a group of banks as disclosed in Note 12—Debt . The letters of credit were issued by TMK Re, Ltd., a wholly-owned subsidiary, to secure TMK Re, Ltd.’s obligation for claims on certain policies reinsured by TMK Re, Ltd. that were sold by other Globe Life insurance companies. These letters of credit facilitate TMK Re, Ltd.’s ability to reinsure the business of Globe Life's insurance carriers. The agreement was amended on March 29, 2024 and now expires in 2029 . The maximum amount of letters of credit available is $250 million. The Parent Company would be liable to the extent that TMK Re, Ltd. does not pay the reinsured party. The amount of letters of credit outstanding at December 31, 2024 was $115 million. Unclaimed Property Audits : Globe Life subsidiaries are currently the subject of audits regarding the identification, reporting and escheatment of unclaimed property arising from life insurance policies and a limited number of annuity contracts. These audits are being conducted by private entities that have contracted with forty-seven states through their respective Departments of Revenue, and have not resulted in any financial assessment from any state nor indicated any liability. The audits are wide-ranging and seek large amounts of data regarding claims handling, procedures, and payments of contract benefits arising from unreported death claims. No estimate of range can be made at this time for loss contingencies related to possible administrative penalties or amounts that could be payable to the states for the escheatment of abandoned property. Litigation : Globe Life Inc. and its subsidiaries, in common with the insurance industry in general, are subject to litigation, including: putative class action litigation; alleged breaches of contract; torts, including bad faith and fraud claims based on alleged wrongful or fraudulent acts of agents of the Parent Company's insurance subsidiaries; alleged employment discrimination; alleged worker misclassification; and miscellaneous other causes of action. Based upon information presently available, and in light of legal and other factual defenses available to the Parent Company and its subsidiaries, management does not believe that it is reasonably possible that such litigation will have a material adverse effect on Globe Life Inc.'s financial condition, future operating results or liquidity; however, assessing the eventual outcome of litigation necessarily involves forward-looking speculation as to judgments to be made by judges, juries and appellate courts in the future. This bespeaks caution, particularly in states with reputations for high punitive damage verdicts. On July 22, 2022, putative class and collective action litigation was filed against Arias Agencies and American Income (collectively, “Defendants”) in United States District Court for the Western District of Pennsylvania ( David Burkes v. Arias Agencies and American Income Life Insurance Company , Case No. 2:22-cv-1054). The complaint alleges that insurance agent trainees should have been classified as employees, and after contracting should have been classified as employees instead of independent contractors. Plaintiff David Burkes is a former Pennsylvania independent sales agent and asserts claims under Pennsylvania law on behalf of a putative class of all individuals who trained to become and/or worked as sales agents for American Income in the three years prior to July 22, 2022 through case conclusion. Burkes makes claims (a) under the Pennsylvania Minimum Wage Act and the Pennsylvania Wage Payment and Collection Law for the alleged failure to pay minimum wage, alleged failure to pay for time spent in training, alleged failure to pay for missed meals and rest breaks, allegedly requiring putative class members to pay for work-related expenses, and allegedly subjecting putative class members to “chargebacks”; (b) for unjust enrichment for allegedly benefiting from the uncompensated labor of putative class members; and (c) for the rescission of putative class members’ agent contracts. Burkes also asserts a collective action on behalf of the same group of individuals for minimum wage, overtime, liquidated damages, and attorney’s fees and costs under the Fair Labor Standards Act for the three years prior to July 22, 2022 through case conclusion, as well as a claim that American Income allegedly did not keep accurate records of hours worked by sales agents. On January 26, 2023, the Court entered an order compelling Burkes to arbitrate his claims on an individual basis and staying the case pending completion of arbitration. Burkes’ individual claims, as well as the individual claims of other former agents who are members of the putative class, are currently pending in arbitration. While no assurances can be made, at present management does not believe that it is reasonably possible or probable that this matter will result in a material loss. On April 4, 2023, putative class action litigation was filed against National Income Life Insurance Company (“National Income”) in New York Supreme Court by plaintiffs Melissa K. Goppert, Sarah Valente, James O’Neill, Jennifer Abe, and Emily Herendeen (“Plaintiffs”) ( Goppert, et al. v. National Income Life Insurance Company , Index No. 153096/2023). Plaintiffs are former National Income independent sales agents who allege they should have been classified as employees and assert claims under New York state law on behalf of a putative class of former independent sales agents and individuals who trained to become independent sale agents since March 2017. Plaintiffs make claims under New York’s Minimum Wage Law (NYLL § 633 and 12 NYCRR § 142-2.1); Overtime Compensation Law (NYLL § 633 and 12 NYCRR § 142-2.2); and “Spread of Hours” Law (12 NYCRR § 142-2.4) for the alleged failure to pay minimum wages and overtime pay, including for time spent in training, and attorney’s fees and costs. National Income filed a motion to compel arbitration of each Plaintiff’s claims on an individual basis, which the Court granted in full on January 11, 2024, and on February 7, 2024, Plaintiffs filed a notice of appeal of the Court’s order. On November 21, 2024, the Court’s order compelling arbitration was affirmed. On September 1, 2023, plaintiff Miné Caglar Cost (“Plaintiff”) filed a complaint against American Income in the Superior Court of the State of California for the County of Los Angeles, asserting a single claim for violation of the Private Attorneys General Act (“PAGA”) ( Cost v. American Income Life Insurance Company , et al. , Case No. 23SMCV04113). Plaintiff is a former California independent insurance sales agent who alleges one cause of action for civil penalties under PAGA arising out of alleged violations of the wage-and-hour provisions of the California Labor Code stemming from American Income’s alleged misclassification of Plaintiff and other California-based sales agents as independent contractors. American Income filed a motion to compel arbitration on an individual basis and stay the representative component of Plaintiff’s claims, to which Plaintiff stipulated. On December 12, 2023, the Court approved the parties’ stipulation to compel the matter to individual arbitration and stayed the case pending the completion of the individual arbitration, to commence on October 27, 2025. On November 30, 2023, Globe Life Inc. and its subsidiary, American Income, received subpoenas from the U.S. Attorney’s Office for the Western District of Pennsylvania, seeking documents relating to sales practices by certain independent sales agents contracted to sell American Income policies. Globe Life Inc. and American Income continue to fully cooperate in responding to the Department of Justice’s requests. The Department of Justice has not asserted any claims or made allegations against Globe Life Inc. and American Income, and Globe Life Inc. currently is not aware that any legal proceedings are contemplated by governmental authorities. While no assurances can be made, at present management does not believe that it is reasonably possible or probable that this matter will result in a material loss. In April 2024, Globe Life Inc. received an inquiry from the SEC's Fort Worth Regional Office requesting information related to recent short seller reports making allegations about Globe Life Inc. Globe Life Inc. has provided information in response to the SEC’s requests and continues to cooperate fully with the SEC. At this time, the SEC has not asserted any claims against Globe Life Inc. or indicated that it intends to do so. While no assurances can be made, at present management does not believe that it is reasonably possible or probable that this matter will result in a material loss. On April 30, 2024, a putative securities class action was filed against Globe Life Inc. and six of its current/former executives and directors in the United States District Court for the Eastern District of Texas ( City of Miami Gen. Emp. & Sanitation Emp. Ret. Trust, et al. v. Globe Life Inc. , et al., Case No. 4:24-cv-00376). On July 24, 2024, the Court appointed Lead Plaintiffs and Lead Counsel for the putative class of shareholders. The Lead Plaintiffs filed a Consolidated Complaint on October 4, 2024 that asserts claims under §§ 10(b), 20(a), and 20(A) of the Securities Exchange Act of 1934 and SEC Rules 10b-5(a), 10b-5(b), and 10b-5(c) promulgated thereunder, on behalf of a putative class of purchasers of Globe Life Inc.'s securities from May 8, 2019 through April 10, 2024. The Consolidated Complaint adds four additional executives as defendants and alleges that certain of Globe Life Inc.'s disclosures about financial performance and certain other public statements during the putative class period were materially false or misleading. Defendants filed a motion to dismiss the litigation on December 3, 2024. Globe Life Inc. plans to vigorously defend against the lawsuit. Pursuant to Globe Life Inc.'s Restated Certificate of Incorporation and indemnification agreements with the named defendants, Globe Life Inc. has agreed to indemnify those defendants for all expenses and losses related to the litigation, subject to the terms of those indemnification agreements. The outcome of litigation of this type is inherently uncertain, and there is always the possibility that a Court rules in a manner that is adverse to the interests of Globe Life Inc. and the individual defendants. However, the amount of any such loss in that outcome cannot be reasonably estimated at this time. Further, management cannot reasonably estimate whether an outcome on the putative class action will be resolved in the near term. Also pending in the Eastern District of Texas is a consolidated shareholder derivative suit that is closely related to the putative securities class action disclosed above (the “ City of Miami Matter”). On November 7, 2024, Globe Life Inc. shareholder Jui Cheng Hsiao filed a shareholder derivative complaint against Globe Life Inc. as a nominal defendant, as well as certain current and former Globe Life Inc. executives and members of Globe Life Inc.’s Board of Directors. On November 14, 2024, Globe Life Inc. shareholder Gautam Jadhav filed a shareholder derivative complaint against the same set of defendants. Each shareholder derivative complaint asserts one claim for breach of fiduciary duty against the individual defendants and alleges that the individual defendants breached their fiduciary duties to Globe Life Inc. by causing or permitting Globe Life Inc. to make misleading statements about Globe Life Inc.’s performance and financial results. The allegations are substantially similar to the allegations made in the City of Miami Matter and derive from the Fuzzy Panda short seller report. On November 25, 2024, the two shareholder plaintiffs moved to consolidate the two actions into one action and the Court granted the motion on January 3, 2025 ( In re Globe Life Inc. Stockholder Derivative Litigation , Lead Case No. 4:24-cv-00993-ALM (E.D. Tex.)). The case is before the same Court as the City of Miami Matter. On January 16, 2025, the parties filed a joint motion to stay such proceedings pending the Court’s resolution of the motion to dismiss filed by Globe Life Inc. in the City of Miami Matter. The Court granted such joint motion to stay the proceedings on January 25, 2025.

Policy Liabilities

Policy Liabilities	12 Months Ended
	Dec. 31, 2024
Policyholder Account Balance [Abstract]
Policy Liabilities	Note 6—Policy Liabilities The liability for future policy benefits is determined based on the net level premium method, which requires the liability be calculated as the present value of estimated future policyholder benefits and the related termination expenses, less the present value of estimated future net premiums to be collected from policyholders. The following tables summarize balances and changes in the net liability for future policy benefits, before reinsurance, for traditional life long-duration contracts for the three years ended December 31, 2024: Life Present value of expected future net premiums American Income DTC Liberty National Other Total Balance at January 1, 2022 $ 4,925,192 $ 7,264,905 $ 1,332,469 $ 559,972 $ 14,082,538 Beginning balance at original discount rates 3,906,098 5,533,741 1,040,242 416,141 10,896,222 Effect of changes in assumptions on future cash flows 34,266 79,571 17,719 35,214 166,770 Effect of actual variances from expected experience (121,230) (264,286) (20,027) (10,929) (416,472) Adjusted balance at January 1, 2022 3,819,134 5,349,026 1,037,934 440,426 10,646,520 Issuances (1) 760,857 663,790 104,982 31,815 1,561,444 Interest accrual (2) 176,102 273,494 51,326 21,150 522,072 Net premiums collected (3) (491,168) (605,446) (128,119) (44,182) (1,268,915) Effect of changes in the foreign exchange rate (18,202) — — — (18,202) Ending balance at original discount rates 4,246,723 5,680,864 1,066,123 449,209 11,442,919 Effect of change from original to current discount rates 26,433 229,360 28,284 21,532 305,609 Balance at December 31, 2022 $ 4,273,156 $ 5,910,224 $ 1,094,407 $ 470,741 $ 11,748,528 Balance at January 1, 2023 $ 4,273,156 $ 5,910,224 $ 1,094,407 $ 470,741 $ 11,748,528 Beginning balance at original discount rates 4,246,723 5,680,864 1,066,123 449,209 11,442,919 Effect of changes in assumptions on future cash flows 14,265 36,170 5,178 8,419 64,032 Effect of actual variances from expected experience (155,293) (306,004) (40,961) (18,441) (520,699) Adjusted balance at January 1, 2023 4,105,695 5,411,030 1,030,340 439,187 10,986,252 Issuances (1) 733,702 579,363 127,048 27,959 1,468,072 Interest accrual (2) 200,363 287,615 54,147 22,804 564,929 Net premiums collected (3) (521,521) (613,749) (133,704) (46,001) (1,314,975) Effect of changes in the foreign exchange rate 5,090 — — — 5,090 Ending balance at original discount rates 4,523,329 5,664,259 1,077,831 443,949 11,709,368 Effect of change from original to current discount rates 158,559 388,392 51,885 34,103 632,939 Balance at December 31, 2023 $ 4,681,888 $ 6,052,651 $ 1,129,716 $ 478,052 $ 12,342,307 Life Present value of expected future net premiums American Income DTC Liberty National Other Total Balance at January 1, 2024 $ 4,681,888 $ 6,052,651 $ 1,129,716 $ 478,052 $ 12,342,307 Beginning balance at original discount rates 4,523,329 5,664,259 1,077,831 443,949 11,709,368 Effect of changes in assumptions on future cash flows (82,348) (28,366) (29,292) (982) (140,988) Effect of actual variances from expected experience (229,772) (311,659) (42,620) (14,436) (598,487) Adjusted balance at January 1, 2024 4,211,209 5,324,234 1,005,919 428,531 10,969,893 Issuances (1) 798,952 491,440 120,683 23,911 1,434,986 Interest accrual (2) 220,959 292,843 55,198 22,875 591,875 Net premiums collected (3) (551,066) (603,605) (134,778) (45,041) (1,334,490) Effect of changes in the foreign exchange rate (23,344) — — — (23,344) Ending balance at original discount rates 4,656,710 5,504,912 1,047,022 430,276 11,638,920 Effect of change from original to current discount rates (10,793) 117,994 1,425 9,771 118,397 Balance at December 31, 2024 $ 4,645,917 $ 5,622,906 $ 1,048,447 $ 440,047 $ 11,757,317 (1) Issuances represent the present value, using the original discount rate, of the expected net premiums related to new policies issued during each respective period. (2) The interest accrual is the interest earned on the beginning present value of the expected net premiums, as well as the interest on actual net premiums earned during the period, using the original interest rate. (3) Net premiums collected represent the product of the current period net premium ratio and the gross premiums collected during the period on the in-force business. Life Present value of expected future policy benefits American Income DTC Liberty National Other Total Balance at January 1, 2022 $ 11,773,519 $ 11,859,408 $ 4,542,697 $ 5,488,684 $ 33,664,308 Beginning balance at original discount rates 7,744,201 8,157,259 3,206,164 3,267,306 22,374,930 Effect of changes in assumptions on future cash flows 48,534 104,910 33,457 39,725 226,626 Effect of actual variances from expected experience (127,626) (259,285) (18,535) (12,787) (418,233) Adjusted balance at January 1, 2022 7,665,109 8,002,884 3,221,086 3,294,244 22,183,323 Issuances (1) 760,856 663,786 105,006 31,815 1,561,463 Interest accrual (2) 410,201 433,611 169,578 195,792 1,209,182 Benefit payments (3) (382,142) (622,389) (222,690) (118,147) (1,345,368) Effect of changes in the foreign exchange rate (44,263) — — — (44,263) Ending balance at original discount rates 8,409,761 8,477,892 3,272,980 3,403,704 23,564,337 Effect of change from original to current discount rates 709,343 747,559 156,276 572,446 2,185,624 Balance at December 31, 2022 $ 9,119,104 $ 9,225,451 $ 3,429,256 $ 3,976,150 $ 25,749,961 Balance at January 1, 2023 $ 9,119,104 $ 9,225,451 $ 3,429,256 $ 3,976,150 $ 25,749,961 Beginning balance at original discount rates 8,409,761 8,477,892 3,272,980 3,403,704 23,564,337 Effect of changes in assumptions on future cash flows 13,344 34,407 6,156 11,661 65,568 Effect of actual variances from expected experience (164,900) (318,687) (46,341) (24,195) (554,123) Adjusted balance at January 1, 2023 8,258,205 8,193,612 3,232,795 3,391,170 23,075,782 Issuances (1) 733,700 579,365 127,062 27,959 1,468,086 Interest accrual (2) 452,640 458,587 174,995 204,083 1,290,305 Benefit payments (3) (396,031) (574,812) (196,600) (116,353) (1,283,796) Effect of changes in the foreign exchange rate 13,319 — — — 13,319 Ending balance at original discount rates 9,061,833 8,656,752 3,338,252 3,506,859 24,563,696 Effect of change from original to current discount rates 1,101,794 1,057,764 267,140 732,764 3,159,462 Balance at December 31, 2023 $ 10,163,627 $ 9,714,516 $ 3,605,392 $ 4,239,623 $ 27,723,158 Balance at January 1, 2024 $ 10,163,627 $ 9,714,516 $ 3,605,392 $ 4,239,623 $ 27,723,158 Beginning balance at original discount rates 9,061,833 8,656,752 3,338,252 3,506,859 24,563,696 Effect of changes in assumptions on future cash flows (104,498) (50,106) (41,836) (2,027) (198,467) Effect of actual variances from expected experience (251,310) (335,087) (50,759) (20,954) (658,110) Adjusted balance at January 1, 2024 8,706,025 8,271,559 3,245,657 3,483,878 23,707,119 Issuances (1) 794,225 491,437 120,702 23,912 1,430,276 Interest accrual (2) 492,966 474,451 178,617 210,344 1,356,378 Benefit payments (3) (426,723) (576,499) (204,757) (136,066) (1,344,045) Effect of changes in the foreign exchange rate (57,904) — — — (57,904) Ending balance at original discount rates 9,508,589 8,660,948 3,340,219 3,582,068 25,091,824 Effect of change from original to current discount rates 362,103 464,164 37,298 378,895 1,242,460 Balance at December 31, 2024 $ 9,870,692 $ 9,125,112 $ 3,377,517 $ 3,960,963 $ 26,334,284 (1) Issuances represent the present value, using the original discount rate, of the expected future policy benefits related to new policies issued during each respective period. (2) The interest accrual is the interest earned on the beginning present value of the expected future policy benefits, as well as the interest on actual benefits and expenses paid during the period, using the original interest rate. (3) Benefit payments represent the release of the present value, using the original discount rate, of the actual future policy benefits incurred during the period due to death, surrender, and maturity benefit payments based on the revised expected assumptions. Life Net liability for future policy benefits as of December 31, 2022 American Income DTC Liberty National Other Total Net liability for future policy benefits at original discount rates $ 4,163,038 $ 2,797,028 $ 2,206,857 $ 2,954,495 $ 12,121,418 Effect of changes in discount rate assumptions 682,910 518,199 127,992 550,914 1,880,015 Other adjustments (1) 115 4,913 7,638 48 12,714 Net liability for future policy benefits, after other adjustments, at current discount rates 4,846,063 3,320,140 2,342,487 3,505,457 14,014,147 Reinsurance recoverable (123) — (7,477) (34,830) (42,430) Net liability for future policy benefits, after reinsurance recoverable, at current discount rates $ 4,845,940 $ 3,320,140 $ 2,335,010 $ 3,470,627 $ 13,971,717 (1) Other adjustments include the Company's effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits). Life Net liability for future policy benefits as of December 31, 2023 American Income DTC Liberty National Other Total Net liability for future policy benefits at original discount rates $ 4,538,504 $ 2,992,493 $ 2,260,421 $ 3,062,910 $ 12,854,328 Effect of changes in discount rate assumptions 943,235 669,372 215,255 698,661 2,526,523 Other adjustments (1) 297 3,315 5,764 62 9,438 Net liability for future policy benefits, after other adjustments, at current discount rates 5,482,036 3,665,180 2,481,440 3,761,633 15,390,289 Reinsurance recoverable (141) — (7,719) (37,848) (45,708) Net liability for future policy benefits, after reinsurance recoverable, at current discount rates $ 5,481,895 $ 3,665,180 $ 2,473,721 $ 3,723,785 $ 15,344,581 (1) Other adjustments include the Company's effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits). Life Net liability for future policy benefits as of December 31, 2024 American Income DTC Liberty National Other Total Net liability for future policy benefits at original discount rates $ 4,851,879 $ 3,156,036 $ 2,293,197 $ 3,151,792 $ 13,452,904 Effect of changes in discount rate assumptions 372,896 346,170 35,873 369,124 1,124,063 Other adjustments (1) 122 18 — 33 173 Net liability for future policy benefits, after other adjustments, at current discount rates 5,224,897 3,502,224 2,329,070 3,520,949 14,577,140 Reinsurance recoverable (167) — (7,953) (35,368) (43,488) Net liability for future policy benefits, after reinsurance recoverable, at current discount rates $ 5,224,730 $ 3,502,224 $ 2,321,117 $ 3,485,581 $ 14,533,652 (1) Other adjustments include the Company's effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits). The following tables summarize balances and changes in the net liability for future policy benefits for long-duration health contracts for the three years ended December 31, 2024: Health Present value of expected future net premiums United American Family Heritage Liberty National American Income DTC Total Balance at January 1, 2022 $ 3,611,659 $ 1,944,714 $ 517,368 $ 222,553 $ 121,724 $ 6,418,018 Beginning balance at original discount rates 2,949,851 1,688,590 414,409 178,801 96,776 5,328,427 Effect of changes in assumptions on future cash flows (195,560) (20,931) 19,846 (17,911) (9,035) (223,591) Effect of actual variances from expected experience (37,437) (67,419) (39,029) 7,911 (2,301) (138,275) Adjusted balance at January 1, 2022 2,716,854 1,600,240 395,226 168,801 85,440 4,966,561 Issuances (1) 360,942 241,052 51,827 39,003 8,224 701,048 Interest accrual (2) 122,064 60,303 19,141 7,399 4,554 213,461 Net premiums collected (3) (258,598) (172,376) (50,752) (21,085) (10,467) (513,278) Effect of changes in the foreign exchange rate — — — (1,487) — (1,487) Ending balance at original discount rates 2,941,262 1,729,219 415,442 192,631 87,751 5,366,305 Effect of change from original to current discount rates (32,761) (134,227) 8,048 (2,335) 2,392 (158,883) Balance at December 31, 2022 $ 2,908,501 $ 1,594,992 $ 423,490 $ 190,296 $ 90,143 $ 5,207,422 Balance at January 1, 2023 $ 2,908,501 $ 1,594,992 $ 423,490 $ 190,296 $ 90,143 $ 5,207,422 Beginning balance at original discount rates 2,941,262 1,729,219 415,442 192,631 87,751 5,366,305 Effect of changes in assumptions on future cash flows 466,883 (30,255) (56,964) (6,061) 16,553 390,156 Effect of actual variances from expected experience (27,178) (69,878) (36,850) (11,152) (2,850) (147,908) Adjusted balance at January 1, 2023 3,380,967 1,629,086 321,628 175,418 101,454 5,608,553 Issuances (1) 377,097 266,375 59,768 39,825 14,467 757,532 Interest accrual (2) 139,824 67,743 18,255 8,528 4,616 238,966 Net premiums collected (3) (272,085) (180,031) (51,081) (22,325) (10,657) (536,179) Effect of changes in the foreign exchange rate — — — 423 — 423 Ending balance at original discount rates 3,625,803 1,783,173 348,570 201,869 109,880 6,069,295 Effect of change from original to current discount rates 71,968 (71,432) 9,902 4,512 5,483 20,433 Balance at December 31, 2023 $ 3,697,771 $ 1,711,741 $ 358,472 $ 206,381 $ 115,363 $ 6,089,728 Balance at January 1, 2024 $ 3,697,771 $ 1,711,741 $ 358,472 $ 206,381 $ 115,363 $ 6,089,728 Beginning balance at original discount rates 3,625,803 1,783,173 348,570 201,869 109,880 6,069,295 Effect of changes in assumptions on future cash flows 9,892 (8,117) (3,463) 12,207 4,449 14,968 Effect of actual variances from expected experience (43,846) (56,720) (29,652) (16,088) (2,937) (149,243) Adjusted balance at January 1, 2024 3,591,849 1,718,336 315,455 197,988 111,392 5,935,020 Issuances (1) 480,412 265,166 58,538 44,350 26,149 874,615 Interest accrual (2) 174,269 75,188 16,566 9,787 5,838 281,648 Net premiums collected (3) (297,675) (190,817) (52,284) (24,852) (11,460) (577,088) Effect of changes in the foreign exchange rate — — — (2,132) — (2,132) Ending balance at original discount rates 3,948,855 1,867,873 338,275 225,141 131,919 6,512,063 Effect of change from original to current discount rates (63,325) (132,998) (1,156) (1,894) 1,458 (197,915) Balance at December 31, 2024 $ 3,885,530 $ 1,734,875 $ 337,119 $ 223,247 $ 133,377 $ 6,314,148 (1) Issuances represent the present value, using the original discount rate, of the expected net premiums related to new policies issued during each respective period. (2) The interest accrual is the interest earned on the beginning present value of the expected net premiums, as well as the interest on actual net premiums earned during the period, using the original interest rate. (3) Net premiums collected represent the product of the current period net premium ratio and the gross premiums collected during the period on the in-force business. Health Present value of expected future policy benefits United American Family Heritage Liberty National American Income DTC Total Balance at January 1, 2022 $ 3,810,559 $ 3,840,322 $ 1,201,317 $ 380,915 $ 119,888 $ 9,353,001 Beginning balance at original discount rates 3,090,901 3,193,342 921,608 285,604 95,628 7,587,083 Effect of changes in assumptions on future cash flows (194,936) (27,211) 18,065 (21,559) (8,270) (233,911) Effect of actual variances from expected experience (40,316) (70,690) (40,597) 10,402 (2,621) (143,822) Adjusted balance at January 1, 2022 2,855,649 3,095,441 899,076 274,447 84,737 7,209,350 Issuances (1) 360,642 241,052 52,257 39,006 8,202 701,159 Interest accrual (2) 129,842 120,700 47,719 13,806 4,553 316,620 Benefit payments (3) (265,500) (120,849) (94,187) (20,413) (12,280) (513,229) Effect of changes in the foreign exchange rate — — — (3,133) — (3,133) Ending balance at original discount rates 3,080,633 3,336,344 904,865 303,713 85,212 7,710,767 Effect of change from original to current discount rates (33,804) (330,680) 36,709 9,037 2,320 (316,418) Balance at December 31, 2022 $ 3,046,829 $ 3,005,664 $ 941,574 $ 312,750 $ 87,532 $ 7,394,349 Balance at January 1, 2023 $ 3,046,829 $ 3,005,664 $ 941,574 $ 312,750 $ 87,532 $ 7,394,349 Beginning balance at original discount rates 3,080,633 3,336,344 904,865 303,713 85,212 7,710,767 Effect of changes in assumptions on future cash flows 464,652 (32,428) (60,437) (6,407) 15,930 381,310 Effect of actual variances from expected experience (26,718) (74,797) (36,910) (12,661) (3,325) (154,411) Adjusted balance at January 1, 2023 3,518,567 3,229,119 807,518 284,645 97,817 7,937,666 Issuances (1) 376,573 266,375 59,158 39,825 14,446 756,377 Interest accrual (2) 147,082 134,107 45,614 15,070 4,616 346,489 Benefit payments (3) (300,692) (122,912) (95,471) (24,987) (12,378) (556,440) Effect of changes in the foreign exchange rate — — — 878 — 878 Ending balance at original discount rates 3,741,530 3,506,689 816,819 315,431 104,501 8,484,970 Effect of change from original to current discount rates 72,798 (190,809) 48,989 20,073 4,981 (43,968) Balance at December 31, 2023 $ 3,814,328 $ 3,315,880 $ 865,808 $ 335,504 $ 109,482 $ 8,441,002 Balance at January 1, 2024 $ 3,814,328 $ 3,315,880 $ 865,808 $ 335,504 $ 109,482 $ 8,441,002 Beginning balance at original discount rates 3,741,530 3,506,689 816,819 315,431 104,501 8,484,970 Effect of changes in assumptions on future cash flows 10,680 (5,054) (2,775) 20,293 7,733 30,877 Effect of actual variances from expected experience (35,532) (63,595) (30,258) (18,601) (2,420) (150,406) Adjusted balance at January 1, 2024 3,716,678 3,438,040 783,786 317,123 109,814 8,365,441 Issuances (1) 479,653 265,166 57,862 44,353 26,116 873,150 Interest accrual (2) 180,235 147,615 42,809 16,577 5,837 393,073 Benefit payments (3) (349,706) (138,777) (93,317) (25,214) (13,792) (620,806) Effect of changes in the foreign exchange rate — — — (4,128) — (4,128) Ending balance at original discount rates 4,026,860 3,712,044 791,140 348,711 127,975 9,006,730 Effect of change from original to current discount rates (66,428) (375,498) 13,555 6,592 1,302 (420,477) Balance at December 31, 2024 $ 3,960,432 $ 3,336,546 $ 804,695 $ 355,303 $ 129,277 $ 8,586,253 (1) Issuances represent the present value, using the original discount rate, of the expected future policy benefits related to new policies issued during each respective period. (2) The interest accrual is the interest earned on the beginning present value of the expected future policy benefits, as well as the interest on actual benefits and expenses paid during the period, using the original interest rate. (3) Benefit payments represent the release of the present value, using the original discount rate, of the actual future policy benefits incurred during the period based on the revised expected assumptions. Health Net liability for future policy benefits as of December 31, 2022 United American Family Heritage Liberty National American Income Direct to Consumer Total Net liability for future policy benefits at original discount rates $ 139,371 $ 1,607,125 $ 489,423 $ 111,082 $ (2,539) $ 2,344,462 Effect of changes in discount rate assumptions (1,043) (196,453) 28,661 11,372 (72) (157,535) Other adjustments (1) 4,055 3,172 5,953 48 3,634 16,862 Net liability for future policy benefits, after other adjustments, at current discount rates 142,383 1,413,844 524,037 122,502 1,023 2,203,789 Reinsurance recoverable (3,820) (9,027) (1,498) — — (14,345) Net liability for future policy benefits, after reinsurance recoverable, at current discount rates $ 138,563 $ 1,404,817 $ 522,539 $ 122,502 $ 1,023 $ 2,189,444 (1) Other adjustments include the effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits). Health Net liability for future policy benefits as of December 31, 2023 United American Family Heritage Liberty National American Income Direct to Consumer Total Net liability for future policy benefits at original discount rates $ 115,727 $ 1,723,516 $ 468,249 $ 113,562 $ (5,379) $ 2,415,675 Effect of changes in discount rate assumptions 830 (119,377) 39,087 15,561 (502) (64,401) Other adjustments (1) 10,980 84 9,567 857 6,653 28,141 Net liability for future policy benefits, after other adjustments, at current discount rates 127,537 1,604,223 516,903 129,980 772 2,379,415 Reinsurance recoverable (3,287) (10,718) (1,317) — — (15,322) Net liability for future policy benefits, after reinsurance recoverable, at current discount rates $ 124,250 $ 1,593,505 $ 515,586 $ 129,980 $ 772 $ 2,364,093 (1) Other adjustments include the effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits). Health Net liability for future policy benefits as of December 31, 2024 United American Family Heritage Liberty National American Income Direct to Consumer Total Net liability for future policy benefits at original discount rates 78,005 1,844,171 452,865 123,570 (3,944) 2,494,667 Effect of changes in discount rate assumptions (3,103) (242,500) 14,711 8,486 (156) (222,562) Other adjustments (1) 24,920 22 10,310 814 4,865 40,931 Net liability for future policy benefits, after other adjustments, at current discount rates 99,822 1,601,693 477,886 132,870 765 2,313,036 Reinsurance recoverable (2,768) — (986) — — (3,754) Net liability for future policy benefits, after reinsurance recoverable, at current discount rates $ 97,054 $ 1,601,693 $ 476,900 $ 132,870 $ 765 $ 2,309,282 (1) Other adjustments include the effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits). Remeasurement Gain or Loss —In accordance with the accounting guidance, the Company reviews, and updates as necessary, its assumptions utilized in the calculation of the liability for future benefits annually in the third quarter and recalculates the net premium ratio. The revised net premium ratio is used to update the liability for future policy benefits as of the beginning of the current reporting period, and is compared to the liability using the prior cash flow assumptions. The difference is recorded as a component of the remeasurement gain or loss for the current period, along with the effect of the difference between actual and expected experience for the period. The total remeasurement gain or loss is included in the Consolidated Statements of Operations . The following tables include the total remeasurement gain or loss, bifurcated between the gain or loss due to differences between actual and expected experience and the amount due to assumption updates, for the three years ended December 31, 2024: Year Ended December 31, 2024 2023 2022 Life Remeasurement Gain (Loss)—Experience: American Income $ 19,606 $ 9,430 1,965 Direct to Consumer 21,681 12,201 (2,243) Liberty National 3,966 5,013 (1,348) Other 4,872 4,760 1,354 Total Life Remeasurement Gain (Loss)—Experience 50,125 31,404 (272) Life Remeasurement Gain (Loss)—Assumption Updates: American Income 21,974 308 (8,707) Direct to Consumer 21,744 1,763 (25,334) Liberty National 12,224 (1,248) (7,872) Other 904 (2,836) (5,241) Total Life Remeasurement Gain (Loss)—Assumption Updates 56,846 (2,013) (47,154) Total Life Remeasurement Gain (Loss) 106,971 29,391 (47,426) Health Remeasurement Gain (Loss)—Experience: United American (4,890) (134) 3,502 Family Heritage 6,756 4,638 2,395 Liberty National 2,640 628 1,406 American Income 2,742 1,461 (2,545) Direct to Consumer 22 23 148 Total Health Remeasurement Gain (Loss)—Experience 7,270 6,616 4,906 Health Remeasurement Gain (Loss)—Assumption Updates: United American 1,205 762 (626) Family Heritage (3,063) 2,173 6,283 Liberty National (234) 2,171 1,463 American Income (8,036) 119 3,615 Direct to Consumer (373) 8 (80) Health Remeasurement Gain (Loss)—Assumption Updates (10,501) 5,233 10,655 Total Health Remeasurement Gain (Loss) $ (3,231) $ 11,849 15,561 The Company performed its annual review of assumptions during the third quarter. This review process resulted in favorable changes to its mortality and lapse assumptions on life and unfavorable changes to morbidity assumptions on health. Generally, in our life segment mortality assumptions were decreased across most channels in line with recent experience consistent with decreasing levels of excess deaths. Also, for the life segment lapse rate assumptions were slightly increased across all channels. For the health segment, morbidity assumptions were increased, causing higher future policy benefit reserves. The assumption review process of the life and health segments resulted in a $46.3 million net remeasurement gain in the year ended December 31, 2024 as compared to a $3.2 million net remeasurement gain and a $36.5 million net remeasurement loss in the year ended December 31, 2023 and 2022, respectively. The following table reconciles the liability for future policy benefits to the Consolidated Balance Sheets as of December 31, 2024, 2023, and 2022: At Original Discount Rates At Current Discount Rates As of December 31, As of December 31, 2024 2023 2022 2024 2023 2022 Life (1) : American Income $ 4,851,995 $ 4,538,775 $ 4,163,111 $ 5,224,897 $ 5,482,036 $ 4,846,063 Direct to Consumer 3,156,039 2,992,493 2,797,031 3,502,224 3,665,180 3,320,140 Liberty National 2,293,197 2,260,421 2,206,857 2,329,070 2,481,440 2,342,487 Other 3,151,824 3,062,966 2,954,522 3,520,949 3,761,633 3,505,457 Net liability for future policy benefits—long duration life 13,453,055 12,854,655 12,121,521 14,577,140 15,390,289 14,014,147 Health (1) : United American 100,480 124,021 141,362 99,822 127,537 142,383 Family Heritage 1,844,186 1,723,581 1,607,169 1,601,693 1,604,223 1,413,844 Liberty National 462,712 476,559 494,155 477,886 516,903 524,037 American Income 124,309 114,407 111,128 132,870 129,980 122,502 Direct to Consumer 738 737 979 765 772 1,023 Net liability for future policy benefits—long duration health 2,532,425 2,439,305 2,354,793 2,313,036 2,379,415 2,203,789 Deferred profit liability 178,199 174,717 175,883 178,199 174,717 175,883 Deferred annuity 656,573 773,039 954,318 656,573 773,039 954,318 Interest sensitive life 723,389 732,948 739,105 723,389 732,948 739,105 Other 8,923 9,951 10,106 8,926 9,945 10,099 Total future policy benefits $ 17,552,564 $ 16,984,615 $ 16,355,726 $ 18,457,263 $ 19,460,353 $ 18,097,341 (1) Balances are presented net of the effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits). The following tables provide the weighted-average original and current discount rates for the liability for future policy benefits and the additional insurance liabilities as of December 31, 2024, 2023, and 2022: As of December 31, 2024 2023 2022 Original discount rate Current discount rate Original discount rate Current discount rate Original discount rate Current discount rate Life American Income 5.7 % 5.4 % 5.7 % 4.9 % 5.8 % 5.2 % Direct to Consumer 6.0 % 5.5 % 6.0 % 5.0 % 6.0 % 5.2 % Liberty National 5.6 % 5.5 % 5.6 % 5.0 % 5.6 % 5.2 % Other 6.2 % 5.5 % 6.2 % 5.0 % 6.2 % 5.2 % Health United American 5.1 % 5.2 % 5.1 % 4.8 % 5.2 % 5.1 % Family Heritage 4.2 % 5.3 % 4.3 % 4.9 % 4.3 % 5.2 % Liberty National 5.8 % 5.4 % 5.8 % 4.9 % 5.8 % 5.2 % American Income 5.8 % 5.2 % 5.8 % 4.8 % 5.9 % 5.1 % Direct to Consumer 5.1 % 5.2 % 5.1 % 4.8 % 5.2 % 5.1 % The following table provides the weighted-average durations of the liability for future policy benefits and the additional insurance liabilities as of December 31, 2024, 2023, and 2022: As of December 31, 2024 2023 2022 At original discount rates At current discount rates At original discount rates At current discount rates At original discount rates At current discount rates Life American Income 22.73 22.76 23.01 23.45 22.86 23.28 Direct to Consumer 19.24 20.31 19.58 21.21 20.27 21.80 Liberty National 15.30 15.33 15.13 15.81 14.86 15.39 Other 15.99 16.92 16.26 17.92 16.59 18.15 Health United American 11.72 10.65 11.46 10.89 11.37 10.65 Family Heritage 15.33 14.23 14.99 14.54 14.87 14.22 Liberty National 9.31 9.19 9.17 9.49 9.26 9.47 American Income 12.49 12.56 12.21 12.84 12.12 12.56 Direct to Consumer 11.72 10.65 11.46 10.89 11.37 10.65 The following tables summarize the amount of gross premiums and interest related to long duration life and health contracts that are recognized in the Consolidated Statements of Operations for the three years ended December 31, 2024: Life Year Ended Year Ended Year Ended Gross Interest Gross Interest Gross Interest American Income $ 1,696,918 $ 272,007 $ 1,587,304 $ 252,277 $ 1,503,537 $ 234,098 Direct to Consumer 977,302 181,470 979,739 170,745 973,429 159,945 Liberty National 367,278 122,727 345,196 120,083 322,497 117,681 Other 202,234 185,619 205,998 179,513 208,390 172,967 Total $ 3,243,732 $ 761,823 $ 3,118,237 $ 722,618 $ 3,007,853 $ 684,691 Health Year Ended Year Ended Year Ended Gross Interest Gross Interest Gross Interest United American $ 439,125 $ 5,739 $ 401,834 $ 7,002 $ 380,710 $ 7,532 Family Heritage 427,640 71,900 396,211 65,892 366,803 59,983 Liberty National 189,650 26,144 187,095 27,248 186,268 28,477 American Income 117,644 6,790 113,605 6,542 111,623 6,408 Direct to Consumer 15,033 — 14,283 — 14,290 — Total $ 1,189,092 $ 110,573 $ 1,113,028 $ 106,684 $ 1,059,694 $ 102,400 Gross premiums are included within life and health premium on the Consolidated Statements of Operations , while the related interest expense is included in life and health policyholder benefits. The following tables provide the undiscounted and discounted expected future net premiums, expected future gross premiums, and expected future policy benefits, at both original and current discount rates, for life and health contracts for the three years ended December 31, 2024: Life As of December 31, 2024 As of December 31, 2023 As of December 31, 2022 Not discounted At original discount rates At current discount rates Not discounted At original discount rates At current discount rates Not discounted At original discount rates At current discount rates American Income PV of expected future gross premiums $ 25,492,032 $ 14,410,088 $ 14,471,277 $ 24,265,464 $ 13,695,495 $ 14,264,077 $ 22,662,540 $ 12,832,811 $ 13,006,579 PV of expected future net premiums 8,233,110 4,656,710 4,645,917 8,001,107 4,523,329 4,681,888 7,480,182 4,246,723 4,273,156 PV of expected future policy benefits 31,831,310 9,508,589 9,870,692 30,623,947 9,061,833 10,163,627 28,318,683 8,409,761 9,119,104 DTC PV of expected future gross premiums $ 17,372,446 $ 9,077,304 $ 9,258,880 $ 17,506,091 $ 9,150,049 $ 9,761,706 $ 17,346,469 $ 9,086,945 $ 9,432,882 PV of expected future net premiums 10,481,376 5,504,912 5,622,906 10,774,655 5,664,259 6,052,651 10,769,174 5,680,864 5,910,224 PV of expected future policy benefits 25,841,419 8,660,948 9,125,112 25,723,752 8,656,752 9,714,516 25,356,573 8,477,892 9,225,451 Liberty National PV of expected future gross premiums $ 4,837,598 $ 2,817,204 $ 2,775,304 $ 4,660,783 $ 2,720,264 $ 2,784,916 $ 4,396,685 $ 2,561,304 $ 2,562,342 PV of expected future net premiums 1,849,200 1,047,022 1,048,447 1,897,696 1,077,831 1,129,716 1,885,533 1,066,123 1,094,407 PV of expected future policy benefits 9,073,624 3,340,219 3,377,517 8,905,815 3,338,252 3,605,392 8,613,975 3,272,980 3,429,256 Other PV of expected future gross premiums $ 3,627,855 $ 1,844,670 $ 1,942,849 $ 3,726,111 $ 1,889,930 $ 2,088,668 $ 3,814,915 $ 1,925,650 $ 2,075,874 PV of expected future net premiums 885,362 430,276 440,047 910,786 443,949 478,052 922,500 449,209 470,741 PV of expected future policy benefits 12,466,943 3,582,068 3,960,963 12,431,963 3,506,859 4,239,623 12,371,696 3,403,704 3,976,150 Total PV of expected future gross premiums $ 51,329,931 $ 28,149,266 $ 28,448,310 $ 50,158,449 $ 27,455,738 $ 28,899,367 $ 48,220,609 $ 26,406,710 $ 27,077,677 PV of expected future net premiums 21,449,048 11,638,920 11,757,317 21,584,244 11,709,368 12,342,307 21,057,389 11,442,919 11,748,528 PV of expected future policy benefits 79,213,296 25,091,824 26,334,284 77,685,477 24,563,696 27,723,158 74,660,927 23,564,337 25,749,961 Health As of December 31, 2024 As of December 31, 2023 As of December 31, 2022 Not discounted At original discount rates At current discount rates Not discounted At original discount rates At current discount rates Not discounted At original discount rates At current discount rates United American PV of expe

Deferred Acquisition Costs

Deferred Acquisition Costs	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Deferred Acquisition Costs	Note 7—Deferred Acquisition Costs The following tables roll forward the deferred policy acquisition costs for the three years ended December 31, 2024: Life American Income DTC Liberty National Other Total Balance at January 1, 2022 $ 1,960,254 $ 1,583,695 $ 566,419 $ 301,647 $ 4,412,015 Capitalizations 450,600 188,083 90,385 13,504 742,572 Amortization expense (141,108) (94,847) (46,081) (16,805) (298,841) Foreign exchange adjustment (11,455) — — — (11,455) Balance at December 31, 2022 $ 2,258,291 $ 1,676,931 $ 610,723 $ 298,346 $ 4,844,291 Balance at January 1, 2023 $ 2,258,291 $ 1,676,931 $ 610,723 $ 298,346 $ 4,844,291 Capitalizations 471,771 159,650 107,230 13,053 751,704 Amortization expense (159,898) (99,464) (51,534) (16,530) (327,426) Foreign exchange adjustment 3,206 — — — 3,206 Balance at December 31, 2023 $ 2,573,370 $ 1,737,117 $ 666,419 $ 294,869 $ 5,271,775 Balance at January 1, 2024 $ 2,573,370 $ 1,737,117 $ 666,419 $ 294,869 $ 5,271,775 Capitalizations 524,980 145,538 119,203 12,172 801,893 Amortization expense (181,431) (101,425) (56,832) (16,535) (356,223) Foreign exchange adjustment (16,690) — — — (16,690) Balance at December 31, 2024 $ 2,900,229 $ 1,781,230 $ 728,790 $ 290,506 $ 5,700,755 Health United American Family Heritage Liberty National American Income DTC Total Balance at January 1, 2022 $ 81,140 $ 388,967 $ 127,537 $ 49,406 $ 2,032 $ 649,082 Capitalizations 2,135 53,117 18,737 12,378 4 86,371 Amortization expense (5,881) (25,476) (13,178) (3,467) (182) (48,184) Foreign exchange adjustment — — — (506) — (506) Balance at December 31, 2022 $ 77,394 $ 416,608 $ 133,096 $ 57,811 $ 1,854 $ 686,763 Balance at January 1, 2023 $ 77,394 $ 416,608 $ 133,096 $ 57,811 $ 1,854 $ 686,763 Capitalizations 1,941 63,366 20,309 12,849 — 98,465 Amortization expense (5,846) (27,131) (13,464) (3,982) (175) (50,598) Foreign exchange adjustment — — — 105 — 105 Balance at December 31, 2023 $ 73,489 $ 452,843 $ 139,941 $ 66,783 $ 1,679 $ 734,735 Balance at January 1, 2024 $ 73,489 $ 452,843 $ 139,941 $ 66,783 $ 1,679 $ 734,735 Capitalizations 2,608 70,311 23,775 14,955 2 111,651 Amortization expense (5,567) (27,035) (14,796) (4,678) (148) (52,224) Foreign exchange adjustment — — — (741) — (741) Balance at December 31, 2024 $ 70,530 $ 496,119 $ 148,920 $ 76,319 $ 1,533 $ 793,421 The following table presents a reconciliation of deferred policy acquisition costs to the Consolidated Balance Sheets for the three years ended December 31, 2024: December 31, 2024 2023 2022 Life American Income $ 2,900,229 $ 2,573,370 $ 2,258,291 Direct to Consumer 1,781,230 1,737,117 1,676,931 Liberty National 728,790 666,419 610,723 Other 290,506 294,869 298,346 Total DAC—Life 5,700,755 5,271,775 4,844,291 Health United American 70,530 73,489 77,394 Family Heritage 496,119 452,843 416,608 Liberty National 148,920 139,941 133,096 American Income 76,319 66,783 57,811 Direct to Consumer 1,533 1,679 1,854 Total DAC—Health 793,421 734,735 686,763 Annuity 1,413 2,967 4,643 Tota l $ 6,495,589 $ 6,009,477 $ 5,535,697

Liability for Unpaid Claims

Liability for Unpaid Claims	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Liability for Unpaid Claims	Note 8—Liability for Unpaid Claims Activity in the liability for unpaid health claims is summarized as follows: Year Ended December 31, 2024 2023 2022 Balance at January 1, $ 194,809 $ 184,286 $ 173,737 Less reinsurance recoverables (2,157) (2,084) (2,628) Net balance at January 1, 192,652 182,202 171,109 Incurred related to: Current year 767,076 697,521 676,189 Prior years (10,460) (4,853) (15,631) Total incurred 756,616 692,668 660,558 Paid related to: Current year 587,473 535,971 517,855 Prior years 152,322 146,247 131,610 Total paid 739,795 682,218 649,465 Net balance at December 31, 209,473 192,652 182,202 Plus reinsurance recoverables 1,521 2,157 2,084 Balance at December 31, $ 210,994 $ 194,809 $ 184,286 At the end of each period, the liability for unpaid health claims includes an estimate of claims incurred but not yet reported to the Company. Such estimates are updated regularly based upon the Company’s most recent claims data with recognition of emerging experience trends. Due to the nature of the Company’s health business, the payment lags are relatively short and most claims are fully paid within a year from the time incurred. Fluctuations in claims experience can lead to either over or under estimation of the liability for any given year. The difference between the estimate made at the end of the prior period and the actual experience during the period is reflected above under the caption "Incurred related to: Prior years." Below is the reconciliation of the liability of "Policy claims and other benefits payable" in the Consolidated Balance Sheets . December 31, 2024 2023 Policy claims and other benefits payable: Life insurance $ 321,838 $ 320,066 Health insurance 210,994 194,809 Total $ 532,832 $ 514,875

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Note 9—Income Taxes The following table discloses significant components of income taxes for each year presented: Year Ended December 31, 2024 2023 2022 Income tax expense (benefit) from operations: Current income tax expense (benefit) $ 218,135 $ 145,880 $ 138,968 Deferred income tax expense (benefit) 37,740 77,631 68,757 255,875 223,511 207,725 Shareholders’ equity: Other comprehensive income (loss) 197,427 4,762 384,035 $ 453,302 $ 228,273 $ 591,760 In each of the years 2022 through 2024, deferred income tax expense (benefit) was incurred because of certain differences between net income before income tax expense (benefit) as reported on the Consolidated Statements of Operations and taxable income as reported on Globe Life's income tax returns. As explained in Note 1—Significant Accounting Policies , these differences caused the consolidated financial statement book values of some assets and liabilities to be different from their respective tax bases. The effective income tax rate differed from the expected U.S. federal statutory rate of 21% as shown below: Year Ended December 31, 2024 % 2023 % 2022 % Expected federal income tax expense (benefit) $ 278,594 21.0 $ 250,796 21.0 $ 231,443 21.0 Increase (reduction) in income taxes resulting from: Low-income housing investments (9,700) (0.7) (14,291) (1.2) (11,443) (1.1) Share-based awards 1,341 0.1 (4,724) (0.4) (5,251) (0.5) Tax-exempt investment income (9,644) (0.7) (9,644) (0.8) (8,961) (0.8) Other tax credits (5,000) (0.4) — — — — Other 284 — 1,374 0.1 1,937 0.2 Income tax expense (benefit) $ 255,875 19.3 $ 223,511 18.7 $ 207,725 18.8 The tax effects of temporary differences that gave rise to significant portions of the deferred tax assets and deferred tax liabilities are presented below: December 31, 2024 2023 Deferred tax assets: Unrealized losses $ 532,756 $ 732,750 Carryover of tax losses 10,342 4,227 Total gross deferred tax assets 543,098 736,977 Less valuation allowance (3,383) — Net deferred tax assets 539,715 736,977 Deferred tax liabilities: Employee and agent compensation 104,385 100,689 Deferred acquisition costs 961,406 892,149 Future policy benefits, unearned and advance premiums, and policy claims 228,117 267,564 Other liabilities 24,432 17,466 Total gross deferred tax liabilities 1,318,340 1,277,868 Net deferred tax liability $ 778,625 $ 540,891 Bermuda Corporate Income Tax Act , The Bermuda Corporate Income Tax Act (the Act) was enacted on December 27, 2023, and included a new corporate income tax (CIT). The Act and CIT go into effect for years beginning after January 1, 2025. The Company is in the process of evaluating the impact the Act will have on the consolidated financial statements; however, the Company does not expect the Act to have a material impact. Inflation Reduction Act , The Inflation Reduction Act (the Act) was enacted on August 16, 2022, and included a new corporate alternative minimum tax (CAMT). The Act and the CAMT go into effect for tax years beginning after 2022. Globe Life Inc., as parent of a tax-controlled group, has determined that it does not reasonably expect to be an applicable corporation on a group basis for the taxable year ended December 31, 2024. Therefore, the Company did not calculate or recognize a payable for CAMT in its 2024 financial statements. Income Tax Return : Globe Life Inc. and its subsidiaries file a life-nonlife consolidated federal income tax return. The statutes of limitations for the Internal Revenue Service's examination and assessment of additional tax are closed for all tax years prior to 2017 with respect to Globe Life's consolidated federal income tax returns. Management concludes that adequate provision has been made in the consolidated financial statements for any potential assessments that may result from current or future tax examinations and other tax-related matters for all open years. Valuations : Globe Life has a $49.2 million net operating loss (NOL) carryforward at December 31, 2024, of which $7.2 million was created prior to 2018 and will begin to expire in 2035 if not otherwise used to offset future taxable income. The remaining NOL carryforward of $42.0 million may be carried forward indefinitely. A valuation allowance is to be recorded when it is more likely than not that deferred tax assets will not be realized by the Company. A valuation allowance has been established in the amount of $3.4 million related to pre-acquisition NOL carryforward deferred tax assets acquired in 2024 as management has determined that the acquired companies will more than likely not have sufficient taxable income in future periods to realize the deferred tax assets. Globe Life's tax liability is adjusted to include a provision for uncertain tax positions taken or expected to be taken in a tax return. However, during the years 2022 through 2024, Globe Life did not have any uncertain tax positions which resulted in unrecognized tax benefits.

Postretirement Benefits

Postretirement Benefits	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Postretirement Benefits	Note 10—Postretirement Benefits Globe Life has qualified noncontributory defined benefit pension plans (Pension Plans) and contributory savings plans that cover substantially all employees. There is also a nonqualified noncontributory supplemental executive retirement plan (SERP) that covers a limited number of officers. The tables included herein will focus on the Pension Plans and SERP. The total cost of these retirement plans charged to operations was as follows: Year Ended December 31, 2024 2023 2022 Plan Type: Defined Contribution Plans (1) $ 6,605 $ 6,390 $ 5,824 Defined Benefit Pension Plans (2) 16,458 15,225 37,040 (1) 401K plans. (2) Qualified pension plans and SERP. Globe Life accrues expense for the defined contribution plans based on a percentage of the employees’ contributions. The plans are funded by the employee contributions and a Globe Life contribution equal to the amount of accrued expense. Plan contributions are both mandatory and discretionary, depending on the terms of the plan. Pension Plans: Cost for the Pension Plans has been calculated on the projected unit credit actuarial cost method. All plan measurements for the pension plans are as of December 31 of the respective year. The pension plans covering the majority of employees are qualified and funded. Contributions are made to funded pension plans subject to minimums required by regulation and maximums allowed for tax purposes. Globe Life's SERP provides an additional supplemental defined pension benefit to a limited number of officers. The supplemental benefit is based on the participant’s qualified plan benefit without consideration to the regulatory limits on compensation and benefit payments applicable to qualified plans, except that eligible compensation is capped at $1 million. The SERP is nonqualified and unfunded. However, a Rabbi Trust has been established to support the liability for this plan. The Rabbi Trust consists of life insurance policies on the lives of plan participants with an unaffiliated insurance carrier as well as an investment account. Since this plan is nonqualified, the investments and the policyholder value of the insurance policies in the Rabbi Trust are not included as defined benefit plan assets, but rather assets of the Company. They are included in “Other Assets” in the Consolidated Balance Sheets . Defined benefit and SERP plan contributions were $24.8 million in 2024, $24.4 million in 2023, and $29.8 million in 2022. In 2025, the Company does not expect to increase contributions to the plans from what was contributed in 2024. Pension Assets: Plan assets in the funded plans consist primarily of investments in marketable fixed maturities and equity securities that are valued at fair value. Globe Life measures the fair value of its financial assets, including the assets in its benefit plans, in accordance with accounting guidance which establishes a hierarchy for asset values and provides a methodology for the measurement of value. Please refer to Note 1—Significant Accounting Policies under the caption Fair Value Measurements , Investments in Securities for a complete discussion of valuation procedures. The following table presents the assets of the Company's Pension Plans at December 31, 2024 and 2023: Pension Assets by Component at December 31, 2024 Fair Value Determined by: Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Observable Inputs (Level 2) Significant Total Amount % of Exchange traded fund (4) $ 35,483 $ — $ — $ 35,483 6 Equity exchange traded fund (1) 322,846 — — 322,846 53 U.S. Government and Agency — 179,418 — 179,418 29 Other bonds — 4 — 4 — Guaranteed annuity contract (2) — 43,893 — 43,893 7 Short-term investments 1,235 — — 1,235 — Other 1,420 — — 1,420 — $ 360,984 $ 223,315 $ — 584,299 95 Other long-term investments (3) 30,546 5 Total pension assets $ 614,845 100 (1) A fund including marketable securities that mirror the S&P 500 index. (2) Representing a guaranteed annuity contract issued by Globe Life Inc.'s subsidiary, American Income Life Insurance Company, to fund the obligations of the American Income Life Insurance Company Collective Bargaining Agreement Employees Pension Plan. (3) Includes non-redeemable investment funds that report the Globe Life Inc. Pension Plan's pro-rata share of the limited partnership's net asset value (NAV) per share, or its equivalent, as a practical expedient for fair value. As of December 31, 2024, the Globe Life Inc. Pension Plan owned less than 1% of two long-term investment funds. (4) A fund including U.S. dollar-denominated investment-grade securities issued by industrial, utility, and financial companies with maturities greater than 10 years. Pension Assets by Component at December 31, 2023 Fair Value Determined by: Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Amount % of Exchange traded fund (4) $ 18,715 $ — $ — $ 18,715 3 Equity exchange traded fund (1) 315,886 — — 315,886 55 U.S. Government and Agency — 167,450 — 167,450 30 Other bonds — 5 — 5 — Guaranteed annuity contract (2) — 43,428 — 43,428 8 Short-term investments 6,506 — — 6,506 1 Other 463 — — 463 — $ 341,570 $ 210,883 $ — 552,453 97 Other long-term investments (3) 18,314 3 Total pension assets $ 570,767 100 (1) A fund including marketable securities that mirror the S&P 500 index. (2) Representing a guaranteed annuity contract issued by Globe Life Inc.'s subsidiary, American Income Life Insurance Company, to fund the obligations of the American Income Life Insurance Company Collective Bargaining Agreement Employees Pension Plan. (3) Includes non-redeemable investment funds that report the Globe Life Inc. Pension Plan's pro-rata share of the limited partnership's net asset value (NAV) per share, or its equivalent, as a practical expedient for fair value. As of December 31, 2023, the Globe Life Inc. Pension Plan owned less than 1% of two long-term investment funds. (4) A fund including U.S. dollar-denominated investment-grade securities issued by industrial, utility, and financial companies with maturities greater than 10 years. Globe Life's investment objectives and goals for its plan assets include generating strong risk-adjusted returns, maintaining diversification, investing in accordance with the liabilities of the plan, and satisfying the liquidity needs of the plan. Globe Life seeks to accomplish these objectives by investing in public and private markets and diversifying across asset classes, industries, sectors, and entities. Globe Life intends to maintain an asset mix that when combined with future plan contributions will produce adequate long-term risk adjusted returns relative to expected changes in the liability as a result of changes to interest rates or earned benefits. The majority of the securities in the portfolio are highly marketable so that there will be adequate liquidity to meet projected payments. There are no specific policies calling for asset durations to match those of benefit obligations. Allowed investments include equity, fixed income, real assets, and short-term investments. Equity securities include common stocks or equivalents, preferred stocks, and/or funds investing primarily in private or public equity investments. Fixed income securities include loans of corporations or commercial real estate as well as marketable debt securities issued by either the U.S. Government, Agencies of the U.S. Government, state, local and municipal governments, domestic and foreign corporations, Special Purpose Vehicles secured by pools of financial assets, and other U.S. financial institutions. Real Assets include equity interest in core or non-core real estate or infrastructure with U.S. or non-U.S. exposure. Short-term investments consist of fixed income securities maturing in one year or less. The assets are to be invested in a mix of allowed investments that best serve the objectives of the pension plan. Factors to be considered in determining the asset mix include funded status, annual pension expense, annual pension contributions, and balance sheet liability. The investment portfolio is well diversified to avoid undue exposure to an asset class, sector, industry, business, or security. The Company does not employ any other special risk management techniques, such as derivatives, in managing the pension investment portfolio. Globe Life's public equity within the pension plan assets consists of an exchange traded fund that mirrors the S&P 500 index which better aligns with a passive approach rather than an actively managed portfolio. At December 31, 2024, there were no restricted investments contained in the portfolio. Plan contributions have been invested primarily in fixed maturity and equity securities during the three years ended December 31, 2024. The following table presents additional information about the Company's investment funds included in pension plan assets as of December 31, 2024 and December 31, 2023 at fair value: Fair Value Unfunded Commitments (2) Investment Category 2024 2023 2024 Redemption Term/Notice (1) Multi-asset class $ 12,383 $ 14,714 $ — Non-redeemable Private equity 18,163 3,600 48,167 Non-redeemable Total $ 30,546 $ 18,314 $ 48,167 (1) Non-redeemable funds generally have an expected life of 7 to 10 years from fund closing with extension options of 2 to 4 years. Redemptions are paid out throughout the life of the funds at the General Partner's discretion. (2) Unfunded commitments include unfunded balances during the investment period. After an investment period ends, the fund can call capital based on limited and specified reasons. As of December 31, 2024, unfunded commitments totaled $57.5 million, including funds past the investment period. SERP: The following tables include premiums paid for COLI for the three years ended December 31, 2024 and investments of the Rabbi Trust for the two years ended December 31, 2024: Year Ended December 31, 2024 2023 2022 Premiums paid for insurance coverage $ 443 $ 443 $ 443 At December 31, 2024 2023 Total investments: COLI $ 57,210 $ 55,185 Exchange traded funds 98,314 86,156 $ 155,524 $ 141,341 Pension Plans and SERP Liabilities: The following table presents the projected benefit obligation (PBO) and accumulated benefit obligation (ABO) for the Pension Plans and SERP at December 31, 2024 and 2023: December 31, 2024 2023 PBO ABO PBO ABO Pension plans $ 561,615 $ 500,010 $ 554,957 $ 493,040 SERP 73,441 68,428 72,603 69,332 Benefit obligation $ 635,056 $ 568,438 $ 627,560 $ 562,372 For the year ended December 31, 2024, the Pension Plans have plan assets with fair values in excess of projected benefit obligations. The projected benefit obligations and the fair value of plan assets were as follows: At December 31, 2024 2023 Funded benefit pension plans PBO $ 561,615 $ 554,957 Funded benefit pension plans fair value of plan assets 614,845 570,767 For the year ended December 31, 2024, the funded benefit pension plans have plan assets with fair value in excess of the accumulated benefit obligations. The accumulated benefit obligations and the fair value of plan assets were as follows: At December 31, 2024 2023 Funded benefit pension plans ABO $ 500,010 $ 493,040 Funded benefit pension plans fair value of plan assets 614,845 570,767 The following table discloses the assumptions used to determine Globe Life's pension liabilities and costs for the appropriate periods. The discount and compensation increase rates are used to determine current year projected benefit obligations and subsequent year pension expense. The long-term rate of return is used to determine current year expense. Differences between assumptions and actual experience are included in actuarial gain or loss. Weighted Average Pension Plan Assumptions For Benefit Obligations at December 31: 2024 2023 Discount rate 5.81 % 5.40 % Rate of compensation increase 4.46 4.40 For Periodic Benefit Cost for the Year: 2024 2023 2022 Discount rate 5.40 % 5.71 % 3.19 % Expected long-term returns 7.18 6.98 6.98 Rate of compensation increase 4.40 4.40 4.43 The discount rate is determined based on the expected duration of plan liabilities. A yield is then derived based on the current market yield of a hypothetical portfolio of high quality corporate bonds that match the liability's average life. The rate of compensation increase is projected based on Company experience, modified as appropriate for future expectations. The expected long-term rate of return on plan assets is management’s best estimate of the average rate of earnings expected to be received on the assets invested in the plan over the benefit period. In determining this assumption, consideration is given to the historical rate of return earned on the assets, the projected returns over future periods, and the discount rate used to compute benefit obligations. Net Periodic Benefit Cost: The following table presents the net periodic benefit cost for the defined benefit plans by expense component for the three years ended December 31, 2024 as follows: Components of Net Periodic Benefit Cost Year Ended December 31, 2024 2023 2022 Service cost—benefits earned during the period $ 24,898 $ 21,568 $ 34,624 Interest cost on projected benefit obligation 33,123 31,367 24,445 Expected return on assets (42,580) (38,625) (35,539) Amortization of prior service cost (credit) 1,071 1,075 1,077 Recognition of actuarial gain (loss) (54) (160) 12,433 Net periodic benefit cost $ 16,458 $ 15,225 $ 37,040 An analysis of the impact on other comprehensive income (loss) concerning pensions and other postretirement benefits is as follows: Year Ended December 31, 2024 2023 2022 Balance at January 1 $ (2,727) $ 1,570 $ (131,239) Amortization of: Prior service cost (credit) 1,071 1,075 1,077 Net actuarial (gain) loss (1) (597) (1,465) 12,677 Total amortization 474 (390) 13,754 Plan amendments (1,212) — — Experience gain (loss) (2) 29,659 (3,907) 119,055 Balance at December 31 $ 26,194 $ (2,727) $ 1,570 (1) Includes amortization of postretirement benefits other than pensions of $(622) thousand in 2024, $(732) thousand in 2023, and $289 thousand in 2022. (2) The increase in the experience gain (loss) is related to an increase in discount rate. The following table presents a reconciliation from the beginning to the end of the year of the PBO for the Pension Plans and SERP, and the plan assets for the Pension Plans. This table also presents the amounts previously recognized as a component of accumulated other comprehensive income. Pension Benefits Year Ended December 31, 2024 2023 Changes in PBO: PBO at beginning of year $ 627,560 $ 562,567 Service cost 24,898 21,568 Interest cost 33,123 31,367 Plan amendments 1,212 — Actuarial loss (gain) (22,964) 40,569 Benefits paid (28,773) (28,511) PBO at end of year 635,056 627,560 Changes in plan assets: Fair value at beginning of year 570,767 499,775 Return on assets 48,084 75,062 Contributions 24,767 24,441 Benefits paid (28,773) (28,511) Fair value at end of year 614,845 570,767 Funded status at year end $ (20,211) $ (56,793) Changes in the PBO related to actuarial losses (gains) are primarily attributed to changes in the discount rate. Year Ended December 31, Amounts recognized in accumulated other comprehensive income consist of: 2024 2023 Net loss (gain) $ (28,720) $ (227) Prior service cost 6,636 6,494 Net amounts recognized at year end $ (22,084) $ 6,267 Globe Life has estimated its expected postretirement benefits to be paid over the next ten years as of December 31, 2024. These estimates use the same assumptions that measure the benefit obligation at December 31, 2024, taking estimated future employee service into account. Those estimated benefits are as follows: For the year(s): 2025 $ 31,035 2026 33,565 2027 36,259 2028 39,032 2029 41,865 2030-2034 243,598

Supplemental Disclosures of Cas

Supplemental Disclosures of Cash Flow Information	12 Months Ended
	Dec. 31, 2024
Supplemental Cash Flow Elements [Abstract]
Supplemental Disclosures of Cash Flow Information	Note 11—Supplemental Disclosures of Cash Flow Information The following table summarizes Globe Life's noncash transactions for the three years ended December 31, 2024, which are not reflected on the Consolidated Statements of Cash Flows : Year Ended December 31, 2024 2023 2022 Stock-based compensation not involving cash $ 40,118 $ 30,736 $ 35,650 Commitments for low-income housing interests 35,000 — 136,882 Exchanges of fixed maturity investments 105,595 50,936 147,612 Net unsettled security trades 2,334 3,833 — Noncash tax credits — 1,083 1,000 The following table summarizes certain amounts paid during the period: Year Ended December 31, 2024 2023 2022 Interest paid $ 116,993 $ 99,545 $ 88,814 Income taxes paid (1) 175,400 121,034 114,888 (1)

Debt

Debt	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Debt	Note 12—Debt On August 23, 2024, Globe Life completed the issuance of $450 million principal amount of 5.85% Senior notes due September 15, 2034. Total proceeds received by the Parent Company from the issuance, net of the underwriters’ discount, were $445 million. The proceeds were used for general corporate purposes, which included open market purchases of shares of its common stock under its share repurchase program. On August 15, 2024, Globe Life amended its term loan agreement increasing the principal amount from $170 million to $250 million, an increase of $80 million. The amendment extends the maturity date from November 11, 2024 to August 15, 2027. The following table presents information about the terms and outstanding balances of Globe Life's debt. Selected Information about Debt Issues As of December 31, 2024 2023 Instrument Issue Date Maturity Date Coupon Rate Par Unamortized Discount & Issuance Costs Book Fair Book Senior notes 09/27/2018 09/15/2028 4.550% $ 550,000 $ (3,001) $ 546,999 $ 542,811 $ 546,283 Senior notes 08/21/2020 08/15/2030 2.150% 400,000 (2,868) 397,132 338,524 396,670 Senior notes (1) 05/19/2022 06/15/2032 4.800% 250,000 (3,728) 246,272 241,083 245,873 Senior notes 08/23/2024 09/15/2034 5.850% 450,000 (5,186) 444,814 451,665 — Junior subordinated debentures 11/17/2017 11/17/2057 5.275% 125,000 (1,557) 123,443 95,865 123,427 Junior subordinated debentures 06/14/2021 06/15/2061 4.250% 325,000 (7,613) 317,387 204,620 317,306 Term loan (2) 05/11/2023 08/15/2027 5.998% 250,000 (1,796) 248,204 248,204 — Total long-term debt 2,350,000 (25,749) 2,324,251 2,122,772 1,629,559 Term loan (2) — — — — 169,549 Commercial paper 419,000 (3,599) 415,401 415,401 316,564 Total short-term debt 419,000 (3,599) 415,401 415,401 486,113 Total debt $ 2,769,000 $ (29,348) $ 2,739,652 $ 2,538,173 $ 2,115,672 (1) An additional $150 million par value and book value is held by insurance subsidiaries that eliminates in consolidation. (2) Interest calculated quarterly using Secured Overnight Financing Rate (SOFR) plus 135 basis points. The commercial paper has the highest priority of all unsecured debt, followed by senior notes then junior subordinated debentures. The senior notes are callable under a make-whole provision, and the junior subordinated debentures are subject to an optional redemption five years from issuance. Interest on the 4.25% junior subordinated debentures and the term loan are payable quarterly while all other long-term debt is payable semi-annually. Contractual Debt Obligations : The following table presents expected scheduled principal payments under our contractual debt obligations: Year Ended December 31, 2025 2026 2027 2028 2029 Thereafter Debt obligations $ 419,000 $ — $ 250,000 $ 550,000 $ — $ 1,550,000 Credit Facility : On March 29, 2024, Globe Life amended the credit agreement dated September 30, 2021, which provides for a $1 billion revolving credit facility that may be increased to $1.25 billion upon approval of the participating banks. The amended credit facility matures March 29, 2029 and may be extended up to two one-year periods upon the Company's request. Pursuant to this agreement, the participating lenders have agreed to make revolving loans to Globe Life and to issue secured or unsecured letters of credit. The Company has not drawn on any of the credit to date. The facility is further designated as a back-up credit line for a commercial paper program under which the Company may either borrow from the credit line or issue commercial paper at any time, with total commercial paper outstanding not to exceed the facility maximum of $1 billion, less any letters of credit issued. Interest is charged at variable rates. In accordance with the agreement, Globe Life is subject to certain covenants regarding capitalization. As of December 31, 2024, the Company was in full compliance with these covenants. Commercial paper outstanding and any long-term debt due within one year are reported as short-term debt on the Consolidated Balance Sheets . The following tables present selected information concerning Globe Life's commercial paper borrowings. Credit Facility—Commercial Paper (Dollar amounts in thousands) At December 31, 2024 2023 Balance commercial paper at end of period (at par value) $ 419,000 $ 319,000 Annualized interest rate 5.22 % 5.71 % Letters of credit outstanding $ 115,000 $ 115,000 Remaining amount available under credit line 466,000 316,000 Credit Facility—Commercial Paper Activity (Dollar amounts in thousands) Year Ended December 31, 2024 2023 2022 Average balance of commercial paper outstanding during period (par value) $ 405,573 $ 290,024 $ 322,531 Daily-weighted average interest rate (annualized) 5.65 % 5.40 % 1.89 % Maximum daily amount outstanding during period (par value) $ 633,425 $ 477,700 $ 500,529 Commercial paper issued during period (par value) 2,052,056 2,029,000 2,269,444 Commercial paper matured during period (par value) (1,952,056) (1,995,000) (2,314,477) Net commercial paper issued (matured) during period (par value) 100,000 34,000 (45,033) The Company increased the commercial paper borrowings by $100 million from the prior year. The Company was able to issue commercial paper as needed under this facility during the year ended December 31, 2024 and 2023. Federal Home Loan Bank : FHLB membership provides certain of our insurance subsidiaries with access to various low-cost collateralized borrowings and funding agreements. The membership requires ownership of FHLB common stock, as well as the purchase of activity-based common stock equal to approximately 4.1% of outstanding borrowings. Globe Life owned $34.5 million in FHLB common stock as of December 31, 2024 and $22.3 million as of December 31, 2023. The FHLB stock is restricted for the duration of the membership and recorded at cost (par) as required by applicable guidance. The FHLB stock is included in "Other long-term investments " in the Consolidated Balance Sheets. Borrowings with the FHLB are subject to the availability of pledged assets at the insurance subsidiaries of Globe Life. As of December 31, 2024, Globe Life's insurance subsidiaries maximum borrowing capacity under the FHLB facility was approximately $730 million, net of outstanding funding agreements and short-term borrowings, on pledged assets with a fair value of $1.3 billion. As of December 31, 2024, $372 million in funding agreements were outstanding with the FHLB, compared to $138 million as of December 31, 2023. This amount is included in "Other policyholders' funds" in the Consolidated Balance Sheets . The Company had no short-term borrowings from the FHLB as of December 31, 2024 and 2023.

Shareholders' Equity

Shareholders' Equity	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Shareholders' Equity	Note 13—Shareholders' Equity Share Data: A summary of common share activity is presented in the following chart. Common Stock Issued Treasury 2022: Balance at January 1, 2022 109,218,183 (9,650,845) Grants of restricted stock — 10,746 Vesting of performance shares — 66,751 Issuance of common stock due to exercise of stock options — 1,519,728 Treasury stock acquired — (4,424,668) Retirement of treasury stock (4,000,000) 4,000,000 Balance at December 31, 2022 105,218,183 (8,478,288) 2023: Grants of restricted stock — 7,110 Vesting of performance shares — 84,298 Issuance of common stock due to exercise of stock options — 1,375,313 Treasury stock acquired — (4,415,287) Retirement of treasury stock (3,000,000) 3,000,000 Balance at December 31, 2023 102,218,183 (8,426,854) 2024: Grants of restricted stock — 7,375 Vesting of performance shares — 143,211 Issuance of common stock due to exercise of stock options — 584,993 Treasury stock acquired — (10,549,341) Retirement of treasury stock (5,000,000) 5,000,000 Balance at December 31, 2024 97,218,183 (13,240,616) There was no activity related to the preferred stock in years 2022 through 2024. Acquisition of Common Shares : Globe Life shares are acquired through open market purchases under the Globe Life stock repurchase program when it is determined to be the best use of Globe Life's excess cash flows. This yields a return that is better than available alternatives and exceeds our cost of equity. When stock options are exercised, proceeds from the exercises are generally used to repurchase approximately the number of shares available with those funds in order to reduce dilution. See the following summary below: Globe Life Share Repurchase Program Share Repurchase for Dilution Purposes Shares Acquired Total Cost Average Price Shares Acquired Total Cost Average Price 2024 10,086 $ 945,637 $ 93.76 501 $ 48,026 $ 95.75 2023 3,369 380,103 112.84 1,080 127,155 117.72 2022 3,322 335,145 100.90 1,103 119,493 108.33 Restrictions : Earnings per Share : A reconciliation of basic and diluted weighted-average shares outstanding used in the computation of basic and diluted earnings per share is as follows: Year Ended December 31, 2024 2023 2022 Basic weighted average shares outstanding 89,278,574 95,098,474 97,927,770 Weighted average dilutive options outstanding 382,848 1,265,367 1,056,874 Diluted weighted average shares outstanding 89,661,422 96,363,841 98,984,644 Antidilutive shares 2,140,787 422,739 31,269 Antidilutive shares are excluded from the calculation of diluted earnings per share. All antidilutive shares noted above result from outstanding out of the money employee and Director stock options.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Note 14—Stock-Based Compensation Globe Life's stock-based compensation consists of stock options, restricted stock, restricted stock units, and performance shares. Certain employees and members of the board of directors (directors) have been granted fixed equity options to buy shares of Globe Life stock at the market value of the stock on the date of grant, under the provisions of the Globe Life stock option plans. The options are exercisable during the period commencing from the date they vest until expiring according to the terms of the grant. Options generally expire the earlier of employee termination or option contract term, which are either seven-year or ten-year terms. However, depending on the circumstances of termination, options may be exercised for a period of time following termination of employment or upon death or disability. Options generally vest in accordance with the following schedule: Shares vested by period Contract Period 6 Months Year 1 Year 2 Year 3 Year 4 Year 5 Directors 7 years 100% —% —% —% —% —% Employees 7 years —% —% 50% 50% —% —% All employee options vest immediately upon retirement on or after the attainment of age 65, upon death, or disability. Globe Life generally issues shares for the exercise of stock options from treasury stock. The Company generally uses the proceeds from option exercises to buy shares of Globe Life common stock in the open market to reduce the dilution from option exercises. A summary of stock compensation activity for each of the three years ended December 31, 2024 is presented below: 2024 2023 2022 Stock-based compensation expense recognized (1) $ 40,118 $ 30,736 $ 35,650 Tax benefit recognized 7,085 11,178 12,738 (1) No stock-based compensation expense was capitalized in any period in accordance with applicable GAAP. Additional stock compensation information is as follows at December 31: 2024 2023 Unrecognized compensation (1) $ 46,956 $ 36,599 Weighted average period of expected recognition (in years) (1) 0.53 0.53 (1) Includes stock options, restricted stock units and performance shares. No equity awards were cash settled during the three years ended December 31, 2024. Options: The following table summarizes information about stock options outstanding at December 31, 2024. Options Outstanding Options Exercisable Range of Number Weighted- Weighted- Number Weighted- $50.64 - $87.60 1,609,506 1.48 $ 81.93 1,609,506 $ 81.93 92.40 - 100.74 1,994,603 2.66 99.47 1,994,603 99.47 103.23 1,187,349 4.15 103.23 734,148 103.23 105.56 - 128.40 1,034,499 5.56 123.96 38,179 108.55 $50.64 - $128.40 5,825,957 3.15 $ 99.74 4,376,436 $ 93.73 An analysis of option activity for each of the three years ended December 31, 2024, is as follows: 2024 2023 2022 Options Weighted-Average Options Weighted-Average Options Weighted-Average Outstanding—beginning of year 5,940,320 $ 96.19 6,962,374 $ 91.73 7,197,662 $ 85.11 Granted: 7-year term 520,810 128.32 497,060 120.49 1,300,211 103.20 Exercised (584,993) 88.52 (1,375,313) 82.95 (1,519,728) 70.14 Expired and forfeited (50,180) 106.62 (143,801) 90.92 (15,771) 96.54 Outstanding—end of year 5,825,957 $ 99.74 5,940,320 $ 96.19 6,962,374 $ 91.73 Exercisable at end of year 4,376,436 $ 93.73 4,003,028 $ 91.23 3,666,871 $ 84.00 Additional information about Globe Life's stock option activity as of December 31, 2024 and 2023 is as follows: 2024 2023 Outstanding options: Weighted-average remaining contractual term (in years) 3.15 3.68 Aggregate intrinsic value $ 81,703 $ 151,685 Exercisable options: Weighted-average remaining contractual term (in years) 2.48 3.01 Aggregate intrinsic value $ 77,946 $ 122,052 Selected stock option activity for the three years ended December 31, 2024, is presented below: 2024 2023 2022 Weighted-average grant-date fair value of options granted $ 33.80 $ 32.25 $ 22.03 Intrinsic value of options exercised 17,127 49,163 58,201 Cash received from options exercised 51,786 114,080 106,592 Actual tax benefit received 2,489 9,379 11,907 Additional information concerning Globe Life's unvested options is as follows at December 31: 2024 2023 Number of shares outstanding 1,449,521 1,937,292 Weighted-average exercise price (per share) $ 117.88 $ 106.42 Weighted-average remaining contractual term (in years) 5.19 5.05 Aggregate intrinsic value $ 3,757 $ 29,634 Globe Life expects that substantially all unvested options will vest. Restricted Stock: Restricted stock grants consist of time-vested grants, restricted stock units, and performance shares. Time-vested restricted stock is available to directors and vests over six months. The directors' restricted stock units vest over six months and are converted to shares upon their retirement from the Board. Employees' restricted stock units vest and become non-forfeitable on the vesting date (generally three years from the grant date) or upon meeting certain retirement criteria, or in the event of death or disability. Director restricted stock and restricted stock units are generally granted on the first business day of the calendar year. Performance shares are granted to a limited number of senior executives. Performance shares have a three-year performance period and are not settled in shares until the certification of the three-year performance period. While the grant specifies a stated target number of shares, the determination of the actual settlement in shares will be based on the achievement of certain performance objectives of Globe Life over the three-year performance period. Certain executive restricted stock and performance share grants contain terms related to age that could accelerate vesting. Following are the restricted stock units outstanding for each of the three years ended December 31, 2024: Year of grants Outstanding as of year end 2022 93,381 2023 163,108 2024 219,864 Below is the final determination of the performance share grants in 2020 to 2022: Year of grants Final settlement of shares Final settlement date 2020 84,298 February 22, 2023 2021 143,211 February 28, 2024 2022 152,680 February 26, 2025 For the 2023 and 2024 performance share grants, actual shares that could be distributed range from 0 to 122 thousand for the 2023 grants and 0 to 145 thousand shares for the 2024 grants. A summary of restricted stock grants for each of the years in the three-year period ended December 31, 2024, is presented in the table below: 2024 2023 2022 Directors restricted stock: Shares 7,375 7,110 10,746 Price per share $ 122.06 $ 119.59 $ 94.94 Aggregate value $ 900 $ 850 $ 1,020 Percent vested 100 % 100 % 100 % Directors restricted stock units (including dividend equivalents): Shares 4,854 9,479 8,956 Price per share $ 120.16 $ 117.73 $ 95.62 Aggregate value $ 583 $ 1,116 $ 856 Percent vested 100 % 100 % 100 % Employees restricted stock units: Shares 101,011 96,975 — Price per share $ 127.29 $ 120.18 $ — Aggregate value $ 12,858 $ 11,654 $ — Percent vested — % — % — % Performance shares: Target shares 96,800 81,300 146,500 Target price per share $ 128.40 $ 120.49 $ 103.23 Aggregate value $ 12,429 $ 9,796 $ 15,123 Percent vested — % — % — % Time-vested restricted stockholders are entitled to dividend payments on the unvested stock. Director restricted stock unit holders are entitled to dividend equivalents. These equivalents are granted in the form of additional restricted stock units and vest immediately upon grant. Dividend equivalents are applicable only to directors' restricted stock units. Performance shares held by employees are not entitled to dividend equivalents and are not entitled to dividend payments until the shares are vested and settled. An analysis of nonvested restricted stock is as follows: Executive Directors Directors Employees Restricted Stock Units Total 2022: Balance at December 31, 2021 342,388 289 289 — 342,966 Grants 146,500 10,746 8,956 — 166,202 Additional performance shares (1) (16,102) — — — (16,102) Restriction lapses (66,751) (11,035) (9,245) — (87,031) Forfeitures (7,500) — — — (7,500) Balance at December 31, 2022 398,535 — — — 398,535 2023: Grants 81,300 7,110 9,479 96,975 194,864 Additional performance shares (1) (28,857) — — — (28,857) Restriction lapses (84,298) (7,110) (9,479) — (100,887) Forfeitures (12,600) — — (4,410) (17,010) Balance at December 31, 2023 354,080 — — 92,565 446,645 2024: Grants 96,800 7,375 4,854 101,011 210,040 Additional performance shares (1) 84,712 — — — 84,712 Restriction lapses (143,211) (7,375) (4,854) (437) (155,877) Forfeitures (6,000) — — (10,008) (16,008) Balance at December 31, 2024 386,381 — — 183,131 569,512 (1) Estimated additional (reduced) share grants expected due to achievement of performance criteria. An analysis of the weighted-average grant-date fair values per share of nonvested restricted stock is as follows for the year 2024: Executive Performance Shares Directors Restricted Stock Directors Restricted Stock Units Employees Restricted Stock Units Grant-date fair value per share at January 1, 2024 $ 105.28 $ — $ — $ 120.16 Grants 128.40 122.06 122.06 127.29 Estimated additional performance shares 107.56 — — — Restriction lapses (98.32) (122.06) (122.06) (94.40) Forfeitures — — — (122.74) Grant-date fair value per share at December 31, 2024 115.78 — — 124.02

Business Segments

Business Segments	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Business Segments	Note 15—Business Segments Premium Income by Distribution Channel For the Year 2024 Life Health Total Distribution Channel Amount % of Amount % of Amount % of American Income $ 1,698,209 52 $ 123,123 9 $ 1,821,332 39 Direct to Consumer 988,522 30 71,993 5 1,060,515 23 Liberty National 371,061 12 190,381 14 561,442 12 United American 6,600 — 591,774 42 598,374 13 Family Heritage 6,661 — 427,654 30 434,315 9 Other 190,294 6 — — 190,294 4 Total premium $ 3,261,347 100 $ 1,404,925 100 $ 4,666,272 100 For the Year 2023 Life Health Total Distribution Channel Amount % of Total Amount % of Total Amount % of Total American Income $ 1,588,702 51 $ 120,332 9 $ 1,709,034 38 Direct to Consumer 991,406 32 68,575 5 1,059,981 24 Liberty National 349,736 11 187,934 14 537,670 12 United American 7,311 — 545,723 42 553,034 13 Family Heritage 6,134 — 396,209 30 402,343 9 Other 193,955 6 — — 193,955 4 Total premium $ 3,137,244 100 $ 1,318,773 100 $ 4,456,017 100 For the Year 2022 Life Health Total Distribution Channel Amount % of Total Amount % of Total Amount % of American Income $ 1,505,034 50 $ 117,353 9 $ 1,622,387 38 Direct to Consumer 985,488 33 71,129 5 1,056,617 24 Liberty National 327,469 11 187,241 15 514,710 12 United American 7,966 — 539,874 42 547,840 13 Family Heritage 5,586 — 366,820 29 372,406 9 Other 196,281 6 — — 196,281 4 $ 3,027,824 100 $ 1,282,417 100 4,310,241 100 Annuity 1 — Total premium $ 4,310,242 100 Due to the nature of the life and health insurance industry, Globe Life has no individual or group which would be considered a major customer. Substantially all of Globe Life's business is conducted in the United States. The measure of profitability established by the chief operating decision makers for the insurance segments is underwriting margin in accordance with the manner in which the segments are managed. It essentially represents gross profit margin on insurance products before insurance administrative expenses and consists primarily of premium less net policy benefits, acquisition expenses, and commissions. The CODMs use the Life and Health segment profit or loss in monitoring the insurance specific business and to analyze performance measures that inform decisions around product pricing and appropriate support services such as agency force and training. Required interest on policy liabilities is reflected as a component of the Investment segment (rather than as a component of underwriting margin in the insurance segment) in order to match this cost with the investment income earned on the assets supporting the policy liabilities. The measure of profitability for the Investment segment is excess investment income, representing the income earned on the investment portfolio in excess of policy requirements. Excess investment income is used to analyze the performance of our investments in relation to our policy required obligations and informs and supports management actions regarding investment related decisions and policy benefits within our product features. Other than the required interest on the insurance segments, no other intersegment revenues or expenses are recognized. Globe Life holds a sizable investment portfolio to support its insurance liabilities, the yield from which is used to offset policy benefit, acquisition, administrative, and tax expenses. This yield or investment income is taken into account when establishing premium rates and profitability expectations for its insurance products. From time to time, investments are sold or called, or experience a credit loss event, each of which are reflected by the Company as realized gain (loss)—investments. These gains or losses generally occur as a result of disposition due to issuer calls, compliance with Company investment policies, or other reasons often beyond management’s control. Unlike investment income, realized gains and losses are incidental to insurance operations, and only overall yields are considered when setting premium rates or insurance product profitability expectations. While these gains and losses are not relevant to segment profitability or core operating results, they can have a material positive or negative result on net income. For these reasons, management removes realized investment gains and losses when it views its segment operations. Management also removes non-operating items unrelated to the Company's core insurance activities when evaluating those results. All other unallocated revenues and expenses, including expenses directly attributable to corporate operations, insurance administrative expense and interest on debt, are disclosed after segment profit or loss within the reconciliation to Income before taxes. Stock-based compensation expense is considered a corporate expense by Globe Life management. Therefore, these items are excluded in its presentation of segment results because accounting guidance requires that operating segment results be presented as management views its business. All of these items are included in “Other operating expense” in the Consolidated Statements of Operations for the appropriate year. See additional detail below in the tables. The following tables set forth a reconciliation of Globe Life's revenues and operations by segment to its major income statement line items. See Note 1—Significant Accounting Policies for additional information concerning reconciling items of segment profits to pretax income. Year Ended December 31, 2024 Life Health Investment Consolidated Revenue: Premium $ 3,261,347 $ 1,404,925 $ — $ 4,666,272 Net investment income — — 1,135,631 1,135,631 Segment revenue 3,261,347 1,404,925 1,135,631 5,801,903 Other income 354 Realized gains (losses) (24,188) Total consolidated revenue $ 5,778,069 Expenses: Policy obligations (1) 2,000,977 851,577 20,969 $ 2,873,523 Required interest on reserves (811,147) (110,342) 950,258 28,769 Amortization of acquisition costs 356,223 52,224 — 408,447 Commissions 159,703 158,869 — 318,572 Premium taxes 68,360 28,421 — 96,781 Non-deferred acquisition costs 134,634 51,753 — 186,387 Segment profit or (loss) $ 1,352,597 $ 372,423 $ 164,404 1,889,424 Insurance administrative expenses: Salaries 129,369 Other employee costs 36,176 Information technology costs 80,555 Legal costs 30,478 Other administrative costs 65,852 Parent expense 12,400 Stock-based compensation expense 40,118 Interest expense 127,092 Legal proceedings 21,575 Non-operating expenses 2,620 Annuity (7,282) Total expenses 4,451,432 . Income before income taxes per Consolidated Statement of Operations $ 1,326,637 (1) Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities . Year Ended December 31, 2023 Life Health Investment Consolidated Revenue: Premium $ 3,137,244 $ 1,318,773 $ — $ 4,456,017 Net investment income — — 1,056,884 1,056,884 Segment revenue 3,137,244 1,318,773 1,056,884 5,512,901 Other income 308 Realized gains (losses) (65,676) Total consolidated revenue $ 5,447,533 Expenses: Policy obligations (1) 2,050,789 776,362 9,061 $ 2,836,212 Required interest on reserves (772,701) (106,516) 917,441 38,224 Amortization of acquisition costs 327,426 50,598 — 378,024 Commissions 145,678 150,192 — 295,870 Premium taxes 64,571 26,440 — 91,011 Non-deferred acquisition costs 128,509 43,760 — 172,269 Segment profit or (loss) $ 1,192,972 $ 377,937 $ 130,382 1,701,291 Insurance administrative expenses: Salaries 119,699 Other employee costs 35,905 Information technology costs 64,998 Legal costs 15,335 Other administrative costs 65,224 Parent expense 10,866 Stock-based compensation expense 30,736 Interest expense 102,316 Legal proceedings 900 Non-operating expenses 4,170 Annuity (8,492) Total expenses 4,253,267 Income before income taxes per Consolidated Statement of Operations $ 1,194,266 (1) Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities . Year Ended December 31, 2022 Life Health Investment Consolidated Revenue: Premium $ 3,027,824 $ 1,282,417 $ — $ 4,310,241 Net investment income — — 991,800 991,800 Segment revenue 3,027,824 1,282,417 991,800 5,302,041 Annuity premium income 1 Other income 1,246 Realized gains (losses) (76,548) Total consolidated revenue $ 5,226,740 Expenses: Policy obligations (1) 2,035,693 752,866 4,372 $ 2,792,931 Required interest on reserves (735,688) (102,315) 882,839 44,836 Amortization of acquisition costs 298,841 48,185 — 347,026 Commissions 140,283 145,185 — 285,468 Premium taxes 61,609 24,653 — 86,262 Non-deferred acquisition costs 97,561 36,706 — 134,267 Segment profit or (loss) $ 1,129,525 $ 377,137 $ 104,589 1,611,251 Insurance administrative expenses: Salaries 129,711 Other employee costs 42,319 Information technology costs 55,526 Legal costs 12,056 Other administrative costs 59,729 Parent expense 11,156 Stock-based compensation expense 35,650 Interest expense 90,395 Legal proceedings 2,496 Non-operating expenses 5,311 Annuity (10,510) Total expenses 4,124,629 Income before income taxes per Consolidated Statement of Operations $ 1,102,111 (1) Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities . Assets for each segment are reported based on a specific identification basis. The insurance segments’ assets contain DAC. The investment segment includes the investment portfolio, cash, and accrued investment income. Goodwill is assigned to the insurance segments at the time of purchase. All other assets are included in the annuity and other corporate category. The tables below reconcile segment assets to total assets as reported on the Consolidated Balance Sheets . Assets by Segment At December 31, 2024 Life Health Investment Consolidated Cash and invested assets $ — $ — $ 19,736,888 $ 19,736,888 Accrued investment income — — 269,791 269,791 Deferred acquisition costs 5,700,755 793,421 — 6,494,176 Goodwill 309,609 180,837 — 490,446 Total segment assets $ 6,010,364 $ 974,258 $ 20,006,679 26,991,301 Annuity and other corporate 2,084,880 Total assets $ 29,076,181 At December 31, 2023 Life Health Investment Consolidated Cash and invested assets $ — $ — $ 19,827,199 $ 19,827,199 Accrued investment income — — 270,396 270,396 Deferred acquisition costs 5,271,775 734,735 — 6,006,510 Goodwill 309,609 172,182 — 481,791 Total segment assets $ 5,581,384 $ 906,917 $ 20,097,595 26,585,896 Annuity and other corporate 1,465,603 Total assets $ 28,051,499 Liabilities for each segment are reported also on a specific identification basis similar to the assets. The insurance segments' liabilities contain future policy benefits, unearned and advance premiums, and policy claims and other benefits payable. Other policyholders' funds and annuities are included in annuity and other corporate as well as current and deferred income taxes payable. Debt represents both short and long-term. The tables below reconcile segment liabilities to total liabilities as reported on the Consolidated Balance Sheets . Liabilities by Segment At December 31, 2024 Life Health Investment Consolidated Future policy benefits $ 15,484,596 $ 2,316,094 $ — $ 17,800,690 Unearned and advance premiums 198,127 59,504 — 257,631 Policy claims and other benefits payable 321,838 210,994 — 532,832 Debt — — 2,739,652 2,739,652 Other 96,604 — 372,000 468,604 Total segment liabilities $ 16,101,165 $ 2,586,592 $ 3,111,652 21,799,409 Annuity and other corporate 1,971,252 Total liabilities $ 23,770,661 At December 31, 2023 Life Health Investment Consolidated Future policy benefits $ 16,304,797 $ 2,382,517 $ — $ 18,687,314 Unearned and advance premiums 196,630 57,937 — 254,567 Policy claims and other benefits payable 320,066 194,809 — 514,875 Debt — — 2,115,672 2,115,672 Other 98,958 — 138,000 236,958 Total segment liabilities $ 16,920,451 $ 2,635,263 $ 2,253,672 21,809,386 Annuity and other corporate 1,755,310 Total liabilities $ 23,564,696

Schedule II. Condensed Financia

Schedule II. Condensed Financial Information of Registrant	12 Months Ended
	Dec. 31, 2024
Condensed Financial Information Disclosure [Abstract]
Schedule II. Condensed Financial Information of Registrant	Globe Life Inc. (PARENT COMPANY) SCHEDULE II. CONDENSED FINANCIAL INFORMATION OF REGISTRANT Condensed Balance Sheets (Dollar amounts in thousands) December 31, 2024 2023 Assets: Investments: Long-term investments $ 39,404 $ 42,360 Short-term investments 29,005 1,005 Total investments 68,409 43,365 Cash 66,770 1,003 Investment in affiliates 7,740,073 6,539,183 Due from affiliates 278,301 105,279 Taxes receivable from affiliates 15,202 14,163 Other assets 193,363 181,443 Total assets $ 8,362,118 $ 6,884,436 Liabilities: Short-term debt $ 415,401 $ 486,113 Long-term debt 2,473,874 1,779,137 Due to affiliates 52,568 — Other liabilities 114,755 132,383 Total liabilities 3,056,598 2,397,633 Shareholders’ equity: Preferred stock 351 351 Common stock 97,218 102,218 Additional paid-in capital 878,306 882,985 Accumulated other comprehensive income (2,029,720) (2,772,419) Retained earnings 8,002,521 7,478,813 Treasury stock (1,643,156) (1,205,145) Total shareholders’ equity 5,305,520 4,486,803 Total liabilities and shareholders’ equity $ 8,362,118 $ 6,884,436 See Notes to Consolidated Financial Statements and accompanying Report of Independent Registered Public Accounting Firm. Globe Life Inc. (PARENT COMPANY) SCHEDULE II. CONDENSED FINANCIAL INFORMATION OF REGISTRANT (continued) Condensed Statement of Operations (Dollar amounts in thousands) Year Ended December 31, 2024 2023 2022 Net investment income $ 38,341 $ 36,237 $ 33,664 Realized gains (losses) 4,158 5,924 (9,643) Total revenue 42,499 42,161 24,021 General operating expenses 75,387 59,051 59,307 Reimbursements from affiliates (53,136) (59,796) (51,312) Interest expense 125,023 107,180 97,051 Total expenses 147,274 106,435 105,046 Operating income (loss) before income taxes and equity in earnings of affiliates (104,775) (64,274) (81,025) Income tax benefit 19,832 10,706 12,426 Net operating loss before equity in earnings of affiliates (84,943) (53,568) (68,599) Equity in earnings of affiliates, net of tax 1,155,705 1,024,323 962,985 Net income 1,070,762 970,755 894,386 Other comprehensive income (loss): Attributable to Parent Company 21,326 1,113 75,076 Attributable to affiliates 721,373 16,781 1,369,659 Comprehensive income (loss) $ 1,813,461 $ 988,649 $ 2,339,121 See Notes to Consolidated Financial Statements and accompanying Report of Independent Registered Public Accounting Firm. Globe Life Inc. (PARENT COMPANY) SCHEDULE II. CONDENSED FINANCIAL INFORMATION OF REGISTRANT (continued) Condensed Statement of Cash Flows (Dollar amounts in thousands) Year Ended December 31, 2024 2023 2022 Net income $ 1,070,762 $ 970,755 $ 894,386 Equity in earnings of affiliates (1,155,705) (1,024,323) (962,985) Cash dividends from subsidiaries 692,690 459,535 407,042 Other, net 55,243 33,846 26,444 Cash provided from operations 662,990 439,813 364,887 Cash provided from (used for) investing activities: Net decrease (increase) in short-term investments (28,000) 13,996 (15,001) Investment in subsidiaries (12) — (10,010) Acquisition of investments (2,850) (3,950) (2,000) Disposition of investments 1 — — Loaned money to affiliates (557,016) (479,629) (846,002) Repayments from affiliates 394,925 505,929 886,002 Additions to properties (19,147) (7,400) — Cash provided from (used for) investing activities (212,099) 28,946 12,989 Cash provided from (used for) financing activities: Repayment of debt — (165,612) (300,000) Proceeds from issuance of debt 530,000 170,000 400,000 Payment for debt issuance costs (7,253) (757) (5,272) Net change in commercial paper held less than 90 days (13,878) 32,961 (46,289) Proceeds from commercial paper with original maturities greater than 90 days 484,726 — — Repayment of commercial paper with original maturities greater than 90 days (372,011) — — Issuance of stock 51,756 114,080 111,970 Acquisitions of treasury stock (1,002,109) (511,100) (454,638) Borrowed money from affiliate 349,000 290,500 22,400 Repayments to affiliates (296,600) (290,500) (22,400) Payment of dividends (108,755) (107,386) (103,817) Cash provided from (used for) financing activities (385,124) (467,814) (398,046) Net increase (decrease) in cash 65,767 945 (20,170) Cash balance at beginning of period 1,003 58 20,228 Cash balance at end of period $ 66,770 $ 1,003 $ 58 See Notes to Consolidated Financial Statements and accompanying Report of Independent Registered Public Accounting Firm. Globe Life Inc. (PARENT COMPANY) SCHEDULE II. CONDENSED FINANCIAL INFORMATION OF REGISTRANT (continued) Notes to Condensed Financial Statements (Dollar amounts in thousands) Note A—Dividends from Subsidiaries Cash dividends paid to Globe Life from the subsidiaries were as follows: Year Ended December 31, 2024 2023 2022 Dividends from subsidiaries $ 692,690 $ 459,535 $ 407,042 Note B—Supplemental Disclosures of Cash Flow Information The following table summarizes non-cash transactions, which are not reflected on the Consolidated Statements of Cash Flows : Year Ended December 31, 2024 2023 2022 Stock-based compensation not involving cash $ 40,118 $ 30,736 $ 35,650 The following table summarizes certain amounts paid (received) during the period: Year Ended December 31, 2024 2023 2022 Interest paid $ 114,459 $ 104,493 $ 96,903 Income taxes paid (received) (13,126) (10,408) (11,537) Note C—Preferred Stock As of December 31, 2024, Globe Life had 351 thousand shares of Cumulative Preferred Stock, Series A, issued and outstanding, of which 280 thousand shares were 6.50% Cumulative Preferred Stock, Series A, and 71 thousand shares were 7.15% Cumulative Preferred Stock, Series A (collectively, the “Series A Preferred Stock”). All issued and outstanding shares of Series A Preferred Stock were held by wholly-owned insurance subsidiaries. In the event of liquidation, the holders of the Series A Preferred Stock at the time outstanding would be entitled to receive a liquidating distribution out of the assets legally available to stockholders in the amount of $1 thousand per share or $351 million in the aggregate, plus any accrued and unpaid dividends, before any distribution is made to holders of Globe Life common stock. Holders of Series A Preferred Stock do not have any voting rights nor have rights to convert such shares into shares of any other class of Globe Life capital stock. See accompanying Report of Independent Registered Public Accounting Firm.

Schedule IV. Reinsurance

Schedule IV. Reinsurance	12 Months Ended
	Dec. 31, 2024
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract]
Schedule IV. Reinsurance	Globe Life Inc. SCHEDULE IV. REINSURANCE (CONSOLIDATED) (Dollar Amounts in thousands) Gross Ceded to Other Companies (1) Assumed Net Percentage For the Year Ended December 31, 2024 Life insurance in force $ 227,975,584 $ 671,056 $ 1,823,957 $ 229,128,485 0.8 Premiums (2) : Life insurance $ 3,235,744 $ 4,649 $ 17,994 $ 3,249,089 0.6 Health insurance 1,384,080 2,449 23,294 1,404,925 1.7 Total premium $ 4,619,824 $ 7,098 $ 41,288 $ 4,654,014 0.9 For the Year Ended December 31, 2023 Life insurance in force $ 225,286,002 $ 685,289 $ 1,996,223 $ 226,596,936 0.9 Premiums (2) : Life insurance $ 3,109,838 $ 4,597 $ 19,104 $ 3,124,345 0.6 Health insurance 1,281,720 2,720 39,773 1,318,773 3.0 Total premium $ 4,391,558 $ 7,317 $ 58,877 $ 4,443,118 1.3 For the Year Ended December 31, 2022 Life insurance in force $ 222,098,389 $ 662,569 $ 2,172,728 $ 223,608,548 1.0 Premiums (2) : Life insurance $ 2,999,637 $ 4,361 $ 19,009 $ 3,014,285 0.6 Health insurance 1,238,498 3,091 47,010 1,282,417 3.7 Total premium $ 4,238,135 $ 7,452 $ 66,019 $ 4,296,702 1.5 (1) No amounts have been netted against ceded premium. (2) Excludes policy charges of $12.3 million, $12.9 million, and $13.5 million in each of the years 2024, 2023, and 2022, respectively. See accompanying Report of Independent Registered Public Accounting Firm.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	Note 16—Subsequent Events On February 3, 2025, Globe Life Inc. announced plans to relocate its corporate headquarters within McKinney, Texas, as part of the Dallas-Fort Worth market. In connection with this relocation, the Company has entered into an agreement to acquire the office building and two adjacent tracts of developable land for $80 million. The Company has evaluated this subsequent event and determined that it does not require adjustments to the financial statements for the period ended December 31, 2024.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net income	$ 1,070,762	$ 970,755	$ 894,386

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Insider Trading Policies and Pr

Insider Trading Policies and Procedures	12 Months Ended
	Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Cybersecurity Risk Management a

Cybersecurity Risk Management and Strategy Disclosure	12 Months Ended
	Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	Risk Management and Strategy We have implemented a comprehensive Enterprise Risk Management (“ERM”) process to identify, assess and manage risks related to our overall organization, including material risks from cybersecurity threats. Our ERM process takes a holistic view of our specific risks and our strategy to anticipate and manage possible risks. Our Executive Vice President, General Counsel and Chief Risk Officer (“CRO”) oversees our ERM program and execution of our risk strategy, including as it relates to cyber risk. The Chief Information Security Officer ("CISO"), who reports to the General Counsel and CRO, leads our cyber risk management and strategy and the Information Security Department. Our cyber risk management and information security strategy includes elements to identify threats, assess risks, implement protective controls, detect attempts from threat actors to compromise the confidentiality, integrity, and availability of information and information systems, respond to those events and ultimately recover from incidents. We use a threat-based approach to identify and assess cyber risks. This approach includes membership in threat intelligence organizations such as the FS-ISAC (Financial Services Information Sharing and Analysis Center) to identify standard and emerging cyber-threats to financial services organizations and specifically to insurance companies. We also monitor for threats through vendor alerts, manufacturer bulletins, and government advisories. Identified threats are analyzed using a recognized risk assessment model to consistently assess the likelihood and impact of these threats. We then map these threats to a well-established industry model called MITRE ATT&CK to identify areas of vulnerability. This analysis produces a likelihood score that is used in conjunction with an impact analysis to calculate the preliminary level of risk. The impact analysis includes factors such as disruption to business operations, employee and customer data, legal issues, reputational harm, and regulatory compliance. Based on the preliminary level of risk, we also analyze compensating controls and other factors to arrive at a residual risk level. If appropriate, additional mitigations may be planned based on this risk level. We manage identified cyber risks by designing and implementing information security policies and controls addressing a wide range of current cyber threats. These policies and associated standards are designed to comply with current applicable legal and regulatory requirements and align with recognized frameworks for cybersecurity risk management. We review and update these policies and controls regularly in order to confirm ongoing alignment with the constantly changing threat landscape and evolving compliance requirements. We assess the effectiveness of our corporate policies and controls internally, as well as through the engagement of external advisors to conduct regular reviews, penetration tests, and vulnerability scans of Company information systems and applications. Results from these assessments help inform updates to risk assessments, changes to security controls and processes, and updates to policies and standards as appropriate. We employ a variety of internal measures to detect, prevent, and reduce the frequency and severity of cybersecurity incidents on the Company’s infrastructure, which may include, but are not limited to, the use of encryption, intrusion prevention, endpoint security, password protection, multi-factor authentication, internal phishing testing, security awareness training, and vulnerability scanning and penetration testing. In addition, cybersecurity is incorporated into our third-party risk management program. We assess the ability of our vendors as appropriate to adequately protect information, which includes requiring agreements that address cybersecurity. We periodically review and assess vendors’ adherence to these agreements and review for information security (including cybersecurity) incidents experienced by our third-party vendors. With respect to our independent sales agents, we require each agent to execute an agent agreement containing terms governing the ownership, use and confidentiality of policyholder and proprietary information. We also engage with agency offices to support their use of measures and safeguards to protect information. Due to the type and volume of information that we collect and store to support our business, including to provide insurance coverage to prospective, current and former policyholders, we are an attractive target for cyber threat actors seeking financial gain. Our failure to maintain the safety of our policyholder’s information could have a material adverse effect on our reputation, financial condition and results of operations. To date, we have not experienced a cybersecurity incident that resulted in a material adverse effect on our business strategy, results of operations, or financial condition; however, we anticipate that our systems and data will continue to face attacks or other cybersecurity risks and there can be no guarantee that we will not experience such an incident in the future. Although we maintain cybersecurity insurance, the costs and expenses related to cybersecurity incidents may not be fully insured. We describe whether and how risks from identified cybersecurity threats, including as a result of previous cybersecurity incidents, have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition under Item 1A. Risk Factors , General Risk Factors, “The failure to maintain effective and efficient information systems at the Company could adversely affect our financial condition and results of operations.”
Cybersecurity Risk Management Processes Integrated [Flag]	true
Cybersecurity Risk Management Processes Integrated [Text Block]	Our cyber risk management and information security strategy includes elements to identify threats, assess risks, implement protective controls, detect attempts from threat actors to compromise the confidentiality, integrity, and availability of information and information systems, respond to those events and ultimately recover from incidents. We use a threat-based approach to identify and assess cyber risks. This approach includes membership in threat intelligence organizations such as the FS-ISAC (Financial Services Information Sharing and Analysis Center) to identify standard and emerging cyber-threats to financial services organizations and specifically to insurance companies. We also monitor for threats through vendor alerts, manufacturer bulletins, and government advisories. Identified threats are analyzed using a recognized risk assessment model to consistently assess the likelihood and impact of these threats. We then map these threats to a well-established industry model called MITRE ATT&CK to identify areas of vulnerability. This analysis produces a likelihood score that is used in conjunction with an impact analysis to calculate the preliminary level of risk. The impact analysis includes factors such as disruption to business operations, employee and customer data, legal issues, reputational harm, and regulatory compliance. Based on the preliminary level of risk, we also analyze compensating controls and other factors to arrive at a residual risk level. If appropriate, additional mitigations may be planned based on this risk level. We manage identified cyber risks by designing and implementing information security policies and controls addressing a wide range of current cyber threats. These policies and associated standards are designed to comply with current applicable legal and regulatory requirements and align with recognized frameworks for cybersecurity risk management. We review and update these policies and controls regularly in order to confirm ongoing alignment with the constantly changing threat landscape and evolving compliance requirements.
Cybersecurity Risk Management Third Party Engaged [Flag]	true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]	true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]	false
Cybersecurity Risk Board of Directors Oversight [Text Block]	Governance Our Board of Directors considers information security to be an enterprise-wide risk management issue and oversees material cybersecurity risks through the Audit Committee. The Audit Committee is designated with the responsibility to monitor and periodically report to the full Board regarding management’s risk management and information security processes. The ERM Committee and the Operational Risk Committee (“ORC”) are the senior management-level entities designated with the responsibility to oversee the execution of our risk strategy, including as it relates to cyber risk. These Committees are composed of an enterprise-wide representative group of the Company’s Executive and Senior Vice Presidents, as well as other essential directors and personnel. The ERM Committee is chaired by our CRO, and the ORC is chaired by our Chief Security Officer (“CSO”). The Chief Information Officer (“CIO”) and CISO serve on both Committees. Our CRO has over a decade of experience managing risks at the Company, including risks from cybersecurity threats. Our current CIO has over 15 years of experience managing risks, including risks from cybersecurity threats. Our current CSO has a Certified Information Systems Security Professional certification, a Certified Information Systems Auditor certification, a Certified in Risk and Information Systems Control certification, and over 20 years of experience in cybersecurity. The CISO serves on both Committees and leads cyber governance and strategy, as well as cyber risk and incident management. The current CISO holds a master’s degree in cybersecurity, has a Certified Information Systems Security Professional certification, and has over a decade of experience in cybersecurity. The CISO assesses cyber risk and provides recommendations for management decision(s) by the ORC on a routine basis. The CISO briefs the Audit Committee on a quarterly basis. These updates include compliance measures designed to meet applicable regulations as well as current or planned changes to the regulations, an overview of the current cyber threats, risk management activities, and discussions of cyber incident investigations that warrant the attention of the Board. The CISO also provides an annual update to the entire Board of Directors on topics such as changes in cybersecurity, top threats facing the Company, key risks and mitigation efforts, and any potential material cybersecurity incidents. The Chair of the Audit Committee also provides a quarterly report to the Board on any information security topics presented to the Audit Committee by management. Incident Management The Company maintains and tests a cybersecurity incident response plan that outlines steps for the containment, investigation of, response to and recovery from cyber events. The plan also includes information pertaining to roles and responsibilities, escalation, third-party support, documentation, reporting, and law enforcement engagement. Escalation is designed to raise awareness of events that may require disclosure to help ensure assessments are performed without unreasonable delay. In alignment with our plan, we maintain playbooks that outline processes for responding to certain incidents commonly observed in the insurance industry. In addition, we have implemented a formal crisis management process, which outlines an incident response communication plan with executive leadership as well as criteria for communication with the chair of the Audit Committee and the Lead Director of the Board.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	Our Board of Directors considers information security to be an enterprise-wide risk management issue and oversees material cybersecurity risks through the Audit Committee. The Audit Committee is designated with the responsibility to monitor and periodically report to the full Board regarding management’s risk management and information security processes. The ERM Committee and the Operational Risk Committee (“ORC”) are the senior management-level entities designated with the responsibility to oversee the execution of our risk strategy, including as it relates to cyber risk. These Committees are composed of an enterprise-wide representative group of the Company’s Executive and Senior Vice Presidents, as well as other essential directors and personnel. The ERM Committee is chaired by our CRO, and the ORC is chaired by our Chief Security Officer (“CSO”). The Chief Information Officer (“CIO”) and CISO serve on both Committees. Our CRO has over a decade of experience managing risks at the Company, including risks from cybersecurity threats. Our current CIO has over 15 years of experience managing risks, including risks from cybersecurity threats. Our current CSO has a Certified Information Systems Security Professional certification, a Certified Information Systems Auditor certification, a Certified in Risk and Information Systems Control certification, and over 20 years of experience in cybersecurity. The CISO serves on both Committees and leads cyber governance and strategy, as well as cyber risk and incident management. The current CISO holds a master’s degree in cybersecurity, has a Certified Information Systems Security Professional certification, and has over a decade of experience in cybersecurity.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	The CISO assesses cyber risk and provides recommendations for management decision(s) by the ORC on a routine basis. The CISO briefs the Audit Committee on a quarterly basis. These updates include compliance measures designed to meet applicable regulations as well as current or planned changes to the regulations, an overview of the current cyber threats, risk management activities, and discussions of cyber incident investigations that warrant the attention of the Board. The CISO also provides an annual update to the entire Board of Directors on topics such as changes in cybersecurity, top threats facing the Company, key risks and mitigation efforts, and any potential material cybersecurity incidents. The Chair of the Audit Committee also provides a quarterly report to the Board on any information security topics presented to the Audit Committee by management.
Cybersecurity Risk Role of Management [Text Block]	Governance Our Board of Directors considers information security to be an enterprise-wide risk management issue and oversees material cybersecurity risks through the Audit Committee. The Audit Committee is designated with the responsibility to monitor and periodically report to the full Board regarding management’s risk management and information security processes. The ERM Committee and the Operational Risk Committee (“ORC”) are the senior management-level entities designated with the responsibility to oversee the execution of our risk strategy, including as it relates to cyber risk. These Committees are composed of an enterprise-wide representative group of the Company’s Executive and Senior Vice Presidents, as well as other essential directors and personnel. The ERM Committee is chaired by our CRO, and the ORC is chaired by our Chief Security Officer (“CSO”). The Chief Information Officer (“CIO”) and CISO serve on both Committees. Our CRO has over a decade of experience managing risks at the Company, including risks from cybersecurity threats. Our current CIO has over 15 years of experience managing risks, including risks from cybersecurity threats. Our current CSO has a Certified Information Systems Security Professional certification, a Certified Information Systems Auditor certification, a Certified in Risk and Information Systems Control certification, and over 20 years of experience in cybersecurity. The CISO serves on both Committees and leads cyber governance and strategy, as well as cyber risk and incident management. The current CISO holds a master’s degree in cybersecurity, has a Certified Information Systems Security Professional certification, and has over a decade of experience in cybersecurity. The CISO assesses cyber risk and provides recommendations for management decision(s) by the ORC on a routine basis. The CISO briefs the Audit Committee on a quarterly basis. These updates include compliance measures designed to meet applicable regulations as well as current or planned changes to the regulations, an overview of the current cyber threats, risk management activities, and discussions of cyber incident investigations that warrant the attention of the Board. The CISO also provides an annual update to the entire Board of Directors on topics such as changes in cybersecurity, top threats facing the Company, key risks and mitigation efforts, and any potential material cybersecurity incidents. The Chair of the Audit Committee also provides a quarterly report to the Board on any information security topics presented to the Audit Committee by management.
Cybersecurity Risk Management Positions or Committees Responsible [Flag]	true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]	Our Board of Directors considers information security to be an enterprise-wide risk management issue and oversees material cybersecurity risks through the Audit Committee. The Audit Committee is designated with the responsibility to monitor and periodically report to the full Board regarding management’s risk management and information security processes. The ERM Committee and the Operational Risk Committee (“ORC”) are the senior management-level entities designated with the responsibility to oversee the execution of our risk strategy, including as it relates to cyber risk. These Committees are composed of an enterprise-wide representative group of the Company’s Executive and Senior Vice Presidents, as well as other essential directors and personnel. The ERM Committee is chaired by our CRO, and the ORC is chaired by our Chief Security Officer (“CSO”). The Chief Information Officer (“CIO”) and CISO serve on both Committees.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]	Our CRO has over a decade of experience managing risks at the Company, including risks from cybersecurity threats. Our current CIO has over 15 years of experience managing risks, including risks from cybersecurity threats. Our current CSO has a Certified Information Systems Security Professional certification, a Certified Information Systems Auditor certification, a Certified in Risk and Information Systems Control certification, and over 20 years of experience in cybersecurity. The CISO serves on both Committees and leads cyber governance and strategy, as well as cyber risk and incident management. The current CISO holds a master’s degree in cybersecurity, has a Certified Information Systems Security Professional certification, and has over a decade of experience in cybersecurity.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	The CISO assesses cyber risk and provides recommendations for management decision(s) by the ORC on a routine basis. The CISO briefs the Audit Committee on a quarterly basis. These updates include compliance measures designed to meet applicable regulations as well as current or planned changes to the regulations, an overview of the current cyber threats, risk management activities, and discussions of cyber incident investigations that warrant the attention of the Board. The CISO also provides an annual update to the entire Board of Directors on topics such as changes in cybersecurity, top threats facing the Company, key risks and mitigation efforts, and any potential material cybersecurity incidents. The Chair of the Audit Committee also provides a quarterly report to the Board on any information security topics presented to the Audit Committee by management.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation : The accompanying consolidated financial statements of Globe Life have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP), under guidance issued by the Financial Accounting Standards Board (FASB). The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Use of Estimates : The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. See further documentation in the significant accounting policies or the accompanying notes.
Use of Estimates	Use of Estimates : The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. See further documentation in the significant accounting policies or the accompanying notes.
Principles of Consolidation	Principles of Consolidation : The consolidated financial statements include the results of Globe Life Inc. and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. When Globe Life acquires a subsidiary or a block of business, the assets acquired and the liabilities assumed are measured at fair value at the acquisition date. Any excess of acquisition cost over the fair value of net assets is recorded as goodwill. Expenses incurred to effect the acquisition are charged to earnings as of the acquisition date. Upon acquisition, the accounts and results of operations are consolidated as of and subsequent to the acquisition date.
Investments	Investments : Globe Life classifies all of its fixed maturity investments as available for sale. Investments classified as available for sale are carried at fair value with unrealized gains and losses, net of taxes, reflected directly in accumulated other comprehensive income (AOCI). Income from investments is recorded in "Net investment income" on the Consolidated Statements of Operations . Gains and losses from sales, maturities, or other redemptions of investments are recorded in "Realized gains (losses)". Gains and losses realized on the disposition of investments are determined on a specific identification basis. Interest income and prepayment fees are recognized when earned. Premiums and discounts are amortized using the effective yield method. When amortized cost of a callable debt security exceeds the first call price, the premium is amortized to the earliest call date. Otherwise, the period of amortization or accretion generally extends from the purchase date to the maturity date. "Policy loans", which represent loans provided to policyholders using cash values as collateral, are carried at unpaid principal balances. "Mortgage loans" or commercial mortgage loans, are a type of investment where the mortgage loan is shared among investors, are accounted for as financing receivables. The commercial mortgage loans are managed by third parties. The Company purchased the legal rights to interests in commercial mortgage loans which are secured by properties such as hotels, retail, multiple family, or offices. The commercial mortgage loans typically have a term of 3 years with the option to extend up to 2 years. The commercial mortgage loans are recorded at unpaid principal balance, net of unamortized origination fees and net of allowance for loan losses. Interest income, net of the amortization of origination fees, is recorded in "Net investment income" under the effective yield method. Our unfunded commitment balance to the commercial loan borrowers was $22 million as of December 31, 2024. "Other long-term investments" include investment funds, equity securities, company-owned life insurance (COLI) and real estate. Investments in equity securities are reported at fair value with changes in fair value, net of taxes, reflected directly in "Realized gains (losses)" in the Consolidated Statements of Operations . COLI is reported at the cash surrender value; changes in the cash surrender value are recorded in net investment income. Investments in real estate are reported at cost less accumulated depreciation. Depreciation is recorded on a straight-line basis over the estimated useful life. The investment funds consist of limited partnerships whereby the Company has a pro-rata share of ownership ranging from less than 1% to 20%. For each investment, the Company has elected the fair value option, but would have been otherwise accounted for as an equity method investment. The fair value option is assessed for each individual investment at the inception of the investment. Each limited partnership investment is evaluated under applicable GAAP to determine if it is a variable interest entity (VIE) and would qualify for consolidation. Primary beneficiaries are required to consolidate VIEs. The investments are not consolidated because the Company has no power to control the activities that most significantly affect the economic performance of these entities and therefore the Company is not the primary beneficiary of any of these interests. Globe Life's involvement is limited to its limited partnership interest in the entities. The Company has not provided any other financial support to the entities beyond its commitments to fund its limited partnership interests, and there are no arrangements or agreements with any of the interests to provide other financial support. The maximum loss exposure relative to these interests is limited to their carrying value and future commitments. The Company has approximately 2% of total assets in low-income housing tax credits and certain limited partnerships (investment funds) that qualify as unconsolidated VIEs. The limited partnership investments are reported at the Company's pro-rata share of the investment fund's net asset value or its equivalent (NAV), as a practical expedient for fair value. Changes in the NAV are recorded in net income and increase the carrying value on the balance sheet. The amount of change in NAV attributable to the net operating results of the fund is recorded in "Net investment income" with the remaining balance of the change reflected in "Realized gains (losses)." Distributions received from the funds reduce the carrying value. Our maximum exposure to loss is equal to the outstanding carrying value and future funding commitments. The Company had $239 million of capital called during the year from existing investment funds, reducing our unfunded commitments. Our unfunded commitments were $433 million as of December 31, 2024.
Fair Value Measurements, Investments in Securities	Fair Value Measurements, Investments in Securities : Globe Life measures the fair value of its "fixed maturities" based on a hierarchy consisting of three levels which indicate the quality of the fair value measurements as described below: • Level 1— fair values are based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access as of the measurement date. • Level 2— fair values are based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, or inputs that can otherwise be corroborated by observable market data. • Level 3— fair values are based on inputs that are considered unobservable where there is little, if any, market activity for the asset or liability as of the measurement date. In this circumstance, the Company has to rely on values derived by independent brokers or internally-developed assumptions. Unobservable inputs are developed based on the best information available to the Company which may include the Company’s own data or bid and ask prices in the dealer market. Certain investments, such as investment funds, that are measured at fair value using the net asset value per share or its equivalent, as a practical expedient, have not been classified in the fair value hierarchy. The net asset value is provided by general partners or managers. The great majority of Globe Life's "fixed maturities" are not actively traded and direct quotes are not generally available. Management therefore determines the fair values of these securities after consideration of data provided by third-party pricing services, independent broker/dealers, and other resources. At December 31, 2024, the Company's investments in fixed maturities were primarily composed of the following significant security types: corporate securities, state and municipal securities, U.S. government direct, guaranteed, and government-sponsored enterprises securities. The remaining security types represented approximately 1% of the total in the aggregate. Approximately 98% of the fair value of "fixed maturities" reported at December 31, 2024 was determined using data provided by third-party pricing services. Prices provided by these services are not binding offers but are estimated exit values. Third-party pricing services use proprietary pricing models to determine security values by discounting cash flows using a market-adjusted spread to a benchmark yield. For all asset classes within Globe Life's significant security types, third-party pricing services use a common valuation technique to model the price of the investments using observable market data. The foundation for these models consists of developing yield spreads based on multiple observable market inputs, including but not limited to: benchmark yield curves, actual trading activity, new issue yields, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, sector-specific data, economic data, and other inputs that are corroborated in the market. Pricing vendors monitor and review their pricing data continuously with current market and economic data feeds, augmented by ongoing communication within the dealer community. Using the observable market inputs described above, spreads to an appropriate benchmark yield are further developed by the vendors for each security based on security-specific and/or sector-specific risk factors, such as a security’s terms and conditions (coupon, maturity, and call features), credit rating, sector, liquidity, collateral or other cash flow options, and other factors that could impact the risk of the security. Embedded repayment options, such as call and redemption features, are also taken into account in the pricing models. When the spread is determined, it is added to the security’s benchmark yield. The security's expected cash flows are discounted using this spread-adjusted yield, and the resulting present value of the discounted cash flows is the evaluated price. When third-party vendor prices are not available, the Company attempts to obtain valuations from other sources, including but not limited to broker/dealers, broker quotes, and prices on comparable securities. When valuations have been obtained for all securities in the portfolio, management reviews and analyzes the prices to ensure their reasonableness, taking into account available and observable information. The Company utilizes pricing from multiple pricing providers and applies a hierarchy of sources to determine price. When two or more valuations are available for a security and the variance between the prices is 10% or less, the close correlation suggests similar observable inputs were used in deriving the price, and the price is selected based on hierarchy of pricing providers. Securities valued in this manner are classified as Level 2. When the variance between two or more valuations for a security exceeds 10%, additional analysis is performed to evaluate the reasonableness of the fair value using the hierarchy and upon the evaluation company may elect to use the hierarchy of pricing providers or use additional resources such as broker quotes, prices on comparable securities, recent trades, and any other observable market data to corroborate the pricing provider. If fair value differences from pricing providers are determined to be unreasonable and additional pricing resources utilizing observable market data cannot corroborate the price within a reasonable tolerance, then the security will be classified as Level 3. Globe Life invests in private placement fixed maturities. Private placement fixed maturities are generally not an active market. Private placement valuations are based on observable inputs, such as the benchmark treasury rate, published sector indices, and/or publicly traded comparables and unobservable inputs such as an internally-developed credit ratings, public private spreads and/or private letter ratings assigned by the nationally recognized statistical rating organizations. If observable inputs cannot be corroborated, the fair values are classified as Level 3. Refer to Note 4—Investments under the caption Quantitative Information about Level 3 Fair Value Measurements . The fair values for each class of security and by valuation hierarchy level are indicated in Note 4—Investments under the caption Fair value measurements, and Note 10—Postretirement Benefits under the caption Pension Assets . Fair Value Measurements, Other Financial Instruments : Fair values for cash and cash equivalents, short-term investments, short-term debt, receivables, and payables approximate carrying value. Cash and cash equivalents are classified as Level 1. Fair values of commercial mortgage loans are determined based upon expected cash flows discounted at an appropriate risk-adjusted rate and are classified as Level 3. The fair value of investments in limited partnerships that provide low-income housing tax credits is based on discounted projected cash flows and are classified as Level 3. Policy loans are an integral part of Globe Life's subsidiaries’ life insurance policies in force and their fair values cannot be valued separately from the insurance contracts. Investment funds are based on net asset value and are excluded from the fair value hierarchy. The fair values of Globe Life's long and short-term debt issues are based on the same methodology as investments in fixed maturities. At December 31, 2024, observable inputs were available for these debt securities and as such were classified as Level 2 in the valuation hierarchy. The fair value for each debt instrument as of December 31, 2024 is disclosed in Note 12—Debt . As described in Note 10—Postretirement Benefits , Globe Life maintains a nonqualified supplemental retirement plan. Accordingly, the assets that support the liability for this plan are considered general assets of the Company. These assets consist of the cash value of company-owned life insurance policies (COLI) and exchange traded funds (ETFs). Fair values for the ETFs are derived from direct quotes and are considered Level 1 in the fair value hierarchy.
Current Expected Credit Loss Reserve (fixed maturities) and Current Expected Credit Loss Reserve (mortgage loans)	Current Expected Credit Loss Reserve (fixed maturities) : At the onset of the evaluation, the Company individually assesses each fixed maturity, on a quarterly basis, to determine whether it intends to sell, or it is more likely than not that it will be required to sell the security before recovery of its amortized cost basis. If either of the criteria are met, the Company will write down the fixed maturity's amortized cost basis to fair value through "Realized gains (losses)". If neither of the aforementioned criteria are met, the Company will evaluate whether the decline in fair value has resulted from a credit event. The Company will evaluate many factors, as further described below, to determine the present value of the expected cash flows. A credit loss occurs when the present value of the expected cash flows is less than the amortized cost basis. This will result in the recording of an allowance for credit losses as a contra asset account to the amortized cost basis with an offsetting provision for credit losses in " Realized gains (losses)" on the Consolidated Statements of Operations . Additionally, the current expected credit loss (CECL) methodology includes a fair value floor where the allowance for credit loss for a security cannot exceed the difference between fair value and amortized cost. When it is determined that there is not a credit loss, the decline in fair value is recognized in Other Comprehensive Income . All changes in the allowance for credit losses are recorded as provision for (or reversal of) credit loss expense. Losses recorded to the allowance for credit losses are management's best estimate of the uncollectibility of principal and interest of a fixed maturity. The evaluation of Globe Life's securities for credit losses is a process that is undertaken at least quarterly and is overseen by a team of investment and accounting professionals. The process for making this determination is highly subjective and involves the careful consideration of many factors. The factors considered include, but are not limited to: • The Company’s lack of intent to sell the debt security before recovery; • Whether it is more likely than not the Company will be required to sell prior to maturity; • The reason(s) for the credit related losses; • The financial condition of the issuer and the prospects for recovery in fair value of the security; • Expected future cash flows. The relative weight given to each of these factors can change over time as facts and circumstances change. In many cases, management believes it is appropriate to give more consideration to prospective factors than to retrospective factors. Prospective factors that are given more weight include prospects for recovery, the Company’s ability and general intent to hold the security until anticipated recovery, and expected future cash flows. Among the facts and information considered in the process are: • Financial statements of the issuer; • Changes in credit ratings of the issuer; • The value of underlying collateral; • News and information included in press releases issued by the issuer; • News and information reported in the media concerning the issuer; • News and information published by or otherwise provided by securities, economic, or research analysts; • The nature and amount of recent and expected future sources and uses of cash; • Default on a required payment; • Issuer bankruptcy filings. The expected cash flows are determined using judgment and the best information available to the Company. Inputs used to derive expected cash flows generally include expected default rates, current levels of subordination, and estimated recovery rate. The discount rate utilized in the discounted cash flows is the effective interest rate, which is the rate of return implicit in the asset at acquisition. Current Expected Credit Loss Reserve (mortgage loans) : The Company evaluates the performance and credit quality of the commercial mortgage loan portfolio at least on a quarterly basis, or as needed, by utilizing common metrics such as loan-to-value or debt-service ratios as well as covenants, local market conditions, borrower quality, and underlying collateral. The fair value of the underlying collateral is based on a third-party appraisal of the property at origination of the loan. The fair value is assessed on an annual basis or more frequently when a loan is materially underperforming, 30 days delinquent, or in technical default. The Company determines the probability of estimated losses for the performing commercial mortgage loan portfolio on a pool basis each quarter and records an allowance. The allowance for credit losses is based on estimates, historical experience, probability of loss, value of the underlying collateral, and macro factors that affect the collectability of the loan.
Cash	Cash : "
Accrued Investment Income	Accrued investment income : "Accrued investment income" consists of interest income or dividends earned on the investment portfolio, but which are yet to be received as of the balance sheet date. The Company will write off accrued investment income that is deemed to be uncollectible related to the fixed maturities. " Accrued investment income As a practical expedient, the Company excludes the accrued investment income from the amortized cost basis of the investment and separately reports it in another financial statement line item, "Accrued investment income." Accordingly, the amount will be excluded from disclosures within Note 4—Investments .
Other Receivables	Other Receivables : Agent debit balances primarily represent commissions advanced to insurance agents, a common industry practice. Generally, commissions are paid to an agent when due over the life of a policy as premiums are paid. However, some agents may qualify to have their commissions (primarily first-year commissions) paid in advance of when the commissions are earned. To the extent an advance is made, we will generally advance up to 65% of first year commissions. This creates an agent debit balance which is classified within “Other receivables”. These balances are repaid to the Company over time, generally one year, as the premiums associated with the advanced commissions are collected by the Company and a portion of the agents' commissions on such premiums are retained in order to repay the balances. If an agent has an agent debit balance with the Company, commissions earned by that agent are generally first applied to reduce the amounts owed to the Company. Any excess will be paid to the agent in cash. The balances were $542 million at December 31, 2024 and $501 million at December 31, 2023. When an agent sells a policy, commissions are advanced to the agent, and the collection of the advance is made as long as the policy stays in force. While there is a susceptibility to loss should an agent terminate or excessive policy lapses occur, the ability of the Company to continue to collect an agent's commission streams over time from prior sales of policies reduces the Company's exposure to loss. Commissions are earned by the agent over the contract period as long as premium is paid by the policyholder and the policy stays in force. As the commissions are earned by the agent and commission expense is incurred by the Company the agent debit balance is reduced. The portion of commission expense incurred related to non-level commissions is deferred and recorded as “Deferred acquisition cost.” The portion of level commission is recognized as an expense within “Commissions, premium taxes, and non-deferred acquisition costs.” The Company has a very low inherent risk with regard to the collection of agent debit balances and views these balances as recoverable since they are, in aggregate, less than the estimated present value of future commissions discounted at a conservative rate which includes assumptions for lapses and mortality. The Company’s security, or collateral, is in the form of future commission streams collected over the life of the policies sold by the respective agents, which ultimately revert to the Company in the event an agent is terminated. The Company evaluated the agent debit balances on a pool basis to determine the allowance for credit losses, as the loans have similar characteristics. A provision for credit losses will be recorded in "Realized gains (losses)" on the Consolidated Statements of Operations and the asset balance will be reflected in agent debit balances, net of allowance for credit losses ("Other receivables"). As of December 31, 2024 and 2023, the allowance for credit losses was $1.4 million and $1.2 million, respectively.
Deferred Acquisition Costs	Deferred Acquisition Costs : Certain costs of acquiring new insurance business are deferred and recorded as an asset. These costs are capitalized on a grouped contract basis and amortized over the expected term of the related contracts, and are essential for the acquisition of new insurance business. Deferred acquisition costs (DAC) are directly related to the successful issuance of an insurance contract, and primarily include sales commissions, policy issue costs, direct to consumer advertising costs, and underwriting costs. Additionally, DAC includes the value of business acquired (VOBA), which are the costs of acquiring blocks of insurance from other companies or through the acquisition of other companies. These costs represent the difference between the fair value of the contractual insurance assets acquired and liabilities assumed, compared against the assets and liabilities for insurance contracts that the company issues or holds measured in accordance with GAAP. DAC is amortized on a constant-level basis over the expected term of the grouped contracts, with the related expense included in amortization of deferred acquisition costs on the Consolidated Statements of Operations . The in-force metric used to compute the DAC amortization rate is annualized premium in force. The assumptions used to amortize acquisition costs include mortality, morbidity, and lapses. These assumptions are reviewed at least annually and revised in conjunction with any change in the future policy benefit assumptions. The effect of changes in the assumptions are recognized over the remaining expected contract term as a revision of future amortization amounts.
Advertising Costs	Advertising Costs
Goodwill	Goodwill : The excess cost of a business acquired over the fair value of net assets acquired is reported as goodwill. In accordance with the guidance, goodwill is subject to impairment testing on an annual basis, or whenever potential impairment triggers occur. Impairment testing involves the performance of a qualitative analysis, which involves assessing current events and circumstances to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. In the event the fair value is less than the carrying value, further testing is required to determine the amount of impairment, if any. If there is an impairment in the goodwill of any reporting unit, it is written down and charged to earnings in the period of the test. Globe Life tests its goodwill annually as of June 30th for each of the years 2022 through 2024. The Company's goodwill was not impaired in any of those periods. The Company completed the acquisition of Evry Health during 2024 resulting in an increase in goodwill of $8.7 million.
Low-Income Housing Tax Credit Interests	Low-Income Housing Tax Credit Interests : Globe Life invests in limited partnerships that provide low-income housing tax credits and other related federal income tax benefits to the Company. Globe Life holds passive interests in limited partnerships that provide investment returns through the provision of tax benefits (principally from the transfer of federal or state tax credits related to federal low-income housing). These investments are considered to be VIEs and do not qualify for consolidation. The carrying value of the Company's investment in these entities was $270 million and $267 million at December 31, 2024 and 2023, respectively, and was included in "Other assets" on the Consolidated Balance Sheets . As of December 31, 2024, Globe Life was obligated under future commitments of $76 million, which are recorded in "Other liabilities." For guaranteed investments acquired prior to January 1, 2015, the Company utilizes the effective-yield method of amortization, while the proportional method of amortization is utilized for all non-guaranteed and guaranteed investments acquired on or after January 1, 2015. All net amortization expense and income tax benefits are recorded in "Income tax benefit (expense)" on the Consolidated Statements of Operations
Property and Equipment	Property and Equipment : Property and equipment, included in “Other assets,” is reported at cost less accumulated depreciation. Depreciation is recorded primarily on the straight line method over the estimated useful lives of these assets which range from three fifteen Year Ended December 31, 2024 2023 Property and equipment, net of accumulated depreciation: Company occupied real estate $ 36,656 $ 32,566 Data processing equipment 219,614 198,150 Transportation equipment 26,346 7,405 Furniture and equipment 1,656 1,776 Total property and equipment, net of depreciation $ 284,272 $ 239,897
Future Policy Benefits	Future Policy Benefits : The liability for future policy benefits for traditional and limited-payment long duration life and health products comprises approximately 93% of the total liability for future policy benefits. The liability is determined each reporting period based on the net level premium method. This method requires the liability for future policy benefits be calculated as the present value of estimated future policyholder benefits and the related termination expenses, less the present value of estimated future net premiums to be collected from policyholders. Net level premiums reflect a recomputed net premium ratio using actual experience since the issue date or January 1, 2021, the Transition Date (1) , and expected future experience. The liability is accrued as premium revenue is recognized and adjusted for differences between actual and expected experience. Long-duration insurance contracts issued by the Company are grouped into cohorts based on the contract issue year, distribution channel, legal entity, and product type. Both the present value of expected future benefit payments and the present value of expected future net premiums are based primarily on assumptions of discount rates, mortality, morbidity, and lapses. Each quarter, the Company remeasures its liability for future policy benefits using current discount rates with the effect of the change recognized in Other Comprehensive Income, a component of shareholders’ equity. In addition, the Company recognizes a liability remeasurement gain or loss within the Consolidated Statements of Operations using original discount rates, and relating to actual experience under the net premium calculation, as compared to the prior reporting period assumptions. The Company regularly reviews its cash flow assumptions (mortality, morbidity, and lapses) used to calculate the change in the liability for future policy benefits. These cash flow assumptions are updated as necessary in the third quarter of every year, or more frequently if suggested by experience. If cash flow assumptions are changed, the net premium ratio is recalculated from the original issue date, or the Transition Date, using actual experience and projected future cash flows. When the expected future net premiums exceed the expected future gross premiums (capping), or the present value of future policyholder benefits exceeds the present value of expected future gross premiums (flooring), the liability for future policy benefits is adjusted with changes recognized in policyholder benefits on the Consolidated Statements of Operations . The cash flow assumptions do not include an adjustment for adverse deviation. Mortality tables used for individual life insurance include various industry tables and reflect modifications based on Company experience. Morbidity assumptions for individual health are based on Company experience and industry data. Lapse assumptions are based on Company experience. The liability for future policy benefits is discounted as noted above, using a current upper-medium grade fixed-income instrument yield that reflects the duration characteristics of the liability for future policy benefits. The methodology for determining current discount rates consists of constructing a discount rate curve intended to be reflective of the currency and tenor of the insurance liability cash flows. The methodology is designed to prioritize observable inputs based on market data available in the local debt markets denominated in the same currency as the policies. For the discount rates applicable to tenors for which the single-A debt market is not liquid or there is little or no observable market data, the Company will use estimation techniques consistent with the fair value guidance in ASC 820. We further accrete interest as a component of policyholder benefits using the original discount rate that is locked-in during the year of contract issuance. The original discount rates (or the locked-in discount rates) are used for interest accretion purposes and for the determination of net premiums, whereas the current discount rates are used for purposes of valuing the liability. The liability for future policy benefits for annuity and interest sensitive life-type products is represented by policy account value. For limited-payment contracts, a deferred profit liability is also recorded, with changes recognized in income over the life of the contract in proportion to the amount of insurance in force. Refer to Note 6—Policy Liabilities .
Reinsurance	Reinsuranc e : In the normal course of business, Globe Life insurance subsidiaries will enter into reinsurance agreements to limit their exposure to the risk of loss as well as enhance their capital position. To qualify for reinsurance accounting in accordance with applicable guidance, the assuming company (reinsurer) must have the “reasonable possibility” that it may realize a “significant loss.” In instances where the ceding company does not transfer significant insurance risk to the reinsurer, deposit accounting is utilized. Any risk charges payable related to reinsurance agreements where deposit accounting is applicable are recorded as an Other Liability. Any balances due to the Company under the terms of the reinsurance agreement are recorded as a reinsurance recoverable within Other Assets on the Consolidated Balance Sheets . Any ceding commission due to the Company under the terms of the reinsurance agreement are recorded in income over the remaining life of the ceding contracts. In the fourth quarter of 2024, the Company entered into a coinsurance agreement to cede a majority of its annuity business to a third-party insurer. The annuity reserves ceded totaled $462 million. The pre-tax ceding commission under the agreement was approximately $50 million and will be recognized into income over the remaining life of the ceded contracts. Amounts paid to the reinsurer upon entering into the coinsurance agreement were $413 million, which are reflected as a cash outflow within financing activities in the Consolidated Statement of Cash Flows . The underlying policies ceded are deposit-type contracts and the coinsurance agreement transfers only timing risk to the reinsurer. Net amounts paid to the reinsurer and reimbursements for losses after inception of the coinsurance agreement are reported as financing activities within "Net receipts (payments) from deposit-type products" . Under the terms of the agreement, the assuming company will be required to maintain assets in trust at 105% of reserves. The Company's annuity business comprises less than 1% of revenue and is not core to the Company's business, therefore we have adjusted our segment reporting to reflect the annuity business as a reconciling item to income before taxes in the segment reporting in this Form 10-K. Prior periods presented have been recast for comparability.
Unearned and Advanced Premium	Unearned and Advanced Premium : Premium collected from both life and health policies that have not been earned and recognized in accordance with applicable GAAP. Refer to Recognition of Premium Revenue below.
Policy Claims and Other Benefits Payable	Policy Claims and Other Benefits Payable :
Current and Deferred Income Taxes	Current and Deferred Income Taxes :
Postretirement Benefits	Postretirement Benefits : Globe Life accounts for its postretirement defined benefit plans by recognizing the funded status of those plans on its Consolidated Balance Sheets in accordance with accounting guidance. Periodic gains and losses attributable to changes in plan assets and liabilities that are not recognized as components of net periodic benefit costs are recognized as components of other comprehensive income, net of tax. The supplemental executive retirement plan is accounted for consistent with the qualified noncontributory pension plan. The assets are included in a Rabbi Trust and recorded in Other Assets on the Consolidated Balance Sheets
Treasury Stock	Treasury Stock :
Recognition of Premium Revenue	Recognition of Premium Revenue : Premium income for traditional long-duration life and health insurance products is recognized evenly over the contract period and when due from the policyholder. Premiums for short-duration health contracts are recognized as revenue over the contract period in proportion to the insurance protection provided. Premiums for universal life-type and annuity contracts are added to the policy account value, and revenues for such products are recognized as charges to the policy account value for mortality, administration, and surrenders (retrospective deposit method). Life premium includes policy charges of $12.3 million, $12.9 million, and $13.5 million for the years ended December 31, 2024, 2023, and 2022, respectively. Other premium consists of annuity policy charges in each year. For limited-payment life insurance products, the profits are recognized over the contract period.
Commission, premium taxes, and non-deferred acquisition costs	Commission, premium taxes, and non-deferred acquisition costs : Commissions represent commission-related amounts that are not deferred. Premium taxes are taxes incurred on premiums written within a state jurisdiction. Non-deferred acquisition costs relate to expenses incurred in the selling or issuing of business which are non-deferrable.
Stock-Based Compensation	Stock-Based Compensation : Globe Life accounts for stock-based compensation by recognizing an expense in the consolidated financial statements based on the “fair value method.” The fair value method requires that a fair value be assigned to a stock option or other stock grant on its grant date and that this value be amortized over the grantees’ service period. The fair value method requires the use of an option valuation model to value employee stock options. Globe Life has elected to use the Black-Scholes valuation model for option expensing. A summary of assumptions for options granted in each of the three years 2022 through 2024 is as follows: 2024 2023 2022 Volatility factor 22.0 % 23.0 % 22.3 % Dividend yield 0.7 % 0.7 % 0.8 % Expected term (in years) 5.10 5.10 5.12 Risk-free rate 4.3 % 4.1 % 1.9 % The expected term is generally derived from Company experience. However, expected terms are determined based on the simplified method as permitted under the ASC 718, Stock Compensation, topic when Company experience is insufficient. On April 26, 2018, the shareholders approved the Globe Life Inc. 2018 Incentive Plan, formerly the Torchmark Corporation 2018 Incentive Plan (the "2018 Incentive Plan"). The 2018 Incentive Plan replaced all previous plans. The 2018 Incentive Plan allows for option grants for employees with a seven-year contractual term which vest over three years in addition to ten-year grants which vest over five years as permitted by the previous plans. Director grants vest over six months. Volatility and risk-free interest rates are assumed over a period of time consistent with the expected term of the option. Volatility is measured on a historical basis. Monthly data points are utilized to derive volatility for periods three years and longer. Expected dividend yield is based on current dividend yield held constant over the expected term. Once the fair value of an option has been determined, it is amortized on a straight-line basis over the employee’s service period for that grant (from the grant date to the date the grant is fully vested). Expenses for restricted stock and restricted stock units are based on the grant date fair value allocated on a straight-line basis over the service period. Performance share expense is recognized based on management’s estimate of the probability of meeting the metrics identified in the performance share award agreement, assigned to each service period as these estimates develop. Stock-based compensation expense is included in “Other operating expense” in the Consolidated Statements of Operations
Earnings Per Share	Earnings per Share : Globe Life presents basic and diluted earnings per common share (EPS) on the face of the Consolidated Statements of Operations
Accounting Pronouncements Yet to be Adopted	Accounting Pronouncements Adopted in the Current Year : ASU No. 2022-03 , Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, adds disclosure requirements specific to equity securities subject to contractual sale restrictions. The disclosures clarify the nature of the contractual sale as well as the duration of the restriction and the circumstances that could cause a lapse in the restriction. This standard is effective for the Company for fiscal years beginning on January 1, 2024 and interim periods within those fiscal years. The adoption of this standard did not have a material impact on the consolidated financial statements. ASU No. 2023-07 , Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , adds disclosure requirements to segment expenses, improving the financial reporting of the entity’s overall performance and assessment of future cash flows. The disclosures required more detailed information related to the entity’s reportable segments. This standard is effective for the Company for annual periods beginning on January 1, 2024 and for interim periods beginning on January 1, 2025, and was implemented on a retrospective basis. Refer to Note 15—Business Segments for further discussion of the Company's segments. Accounting Pronouncements Yet to be Adopted : ASU No. 2023-09 , Income Taxes (Topic 740): Improvements to Income Tax Disclosures , adds disclosure requirements to disaggregate information related to the effective tax rate reconciliation and information on income taxes paid. The disclosures will enhance the assessment of the entity’s operations and related tax risks. This standard is effective for the Company for annual periods beginning on January 1, 2025, and will be implemented on a prospective basis. The Company does not expect the standard will have a material impact on the consolidated financial statements. ASU No. 2024-03 , Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses , adds disclosure requirements to disaggregate information related to an entity's income statement. The disclosures will allow for enhanced transparency of an entity's expenses. This standard is effective for the Company for annual periods beginning on January 1, 2027. The Company is evaluating the standard.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Schedule of Net Balance by Asset Class	See below for a breakout of the net balance by asset class for the year ended December 31, 2024 and 2023: Year Ended December 31, 2024 2023 Property and equipment, net of accumulated depreciation: Company occupied real estate $ 36,656 $ 32,566 Data processing equipment 219,614 198,150 Transportation equipment 26,346 7,405 Furniture and equipment 1,656 1,776 Total property and equipment, net of depreciation $ 284,272 $ 239,897
Schedule of Non-deferred Acquisition Costs Related to Expenses	Non-deferred acquisition costs relate to expenses incurred in the selling or issuing of business which are non-deferrable. 2024 2023 2022 Commissions $ 317,576 $ 295,877 $ 285,477 Premium taxes 96,790 91,021 86,278 Non-deferred acquisition costs 186,387 172,269 134,267 Total $ 600,753 $ 559,167 $ 506,022
Schedule of Assumptions for Options Granted	A summary of assumptions for options granted in each of the three years 2022 through 2024 is as follows: 2024 2023 2022 Volatility factor 22.0 % 23.0 % 22.3 % Dividend yield 0.7 % 0.7 % 0.8 % Expected term (in years) 5.10 5.10 5.12 Risk-free rate 4.3 % 4.1 % 1.9 %

Statutory Accounting (Tables)

Statutory Accounting (Tables)	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Consolidated Net Income and Shareholders' Equity for Insurance Companies	Consolidated net income and shareholders’ equity (capital and surplus) on a statutory basis for the insurance subsidiaries were as follows: Net Income Shareholders’ Equity Year Ended December 31, At December 31, 2024 2023 2022 2024 2023 Life insurance subsidiaries $ 688,665 $ 434,952 $ 444,294 $ 1,690,663 $ 1,660,104

Supplemental Information Abou_2

Supplemental Information About Changes to Accumulated Other Comprehensive Income (Tables)	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Schedule of Change in Balance by Component of Accumulated Other Comprehensive Income	Components of Accumulated Other Comprehensive Income : An analysis of the change in balance by component of Accumulated Other Comprehensive Income is as follows for each of the years 2022 through 2024: Available for Sale Assets Future Policy Benefits Foreign Exchange Pension Adjustments Total For the year ended December 31, 2022: Balance at January 1, 2022 $ 2,765,290 $ (6,915,910) $ 19,248 $ (103,676) $ (4,235,048) Other comprehensive income (loss) before reclassifications, net of tax (4,211,540) 5,546,706 (20,929) 94,055 1,408,292 Reclassifications, net of tax 25,578 — — 10,865 36,443 Other comprehensive income (loss) (4,185,962) 5,546,706 (20,929) 104,920 1,444,735 Balance at December 31, 2022 (1,420,672) (1,369,204) (1,681) 1,244 (2,790,313) For the year ended December 31, 2023: Other comprehensive income (loss) before reclassifications, net of tax 529,688 (578,187) 6,400 (3,087) (45,186) Reclassifications, net of tax 63,388 — — (308) 63,080 Other comprehensive income (loss) 593,076 (578,187) 6,400 (3,395) 17,894 Balance at December 31, 2023 (827,596) (1,947,391) 4,719 (2,151) (2,772,419) For the year ended December 31, 2024: Other comprehensive income (loss) before reclassifications, net of tax (494,996) 1,238,349 (26,476) 22,474 739,351 Reclassifications, net of tax 2,974 — — 374 3,348 Other comprehensive income (loss) (492,022) 1,238,349 (26,476) 22,848 742,699 Balance at December 31, 2024 $ (1,319,618) $ (709,042) $ (21,757) $ 20,697 $ (2,029,720)
Schedule of Reclassifications Out of Accumulated Other Comprehensive Income	Reclassification adjustments : Reclassification adjustments out of Accumulated Other Comprehensive Income are presented below for the three years ended December 31, 2024. Year Ended December 31, Affected line items in the Statement of Operations Component Line Item 2024 2023 2022 Unrealized investment (gains) losses on available for sale assets: Realized (gains) losses $ 14,843 $ 84,416 $ 32,165 Realized (gains) losses Amortization of (discount) premium (11,079) (4,178) 212 Net investment income Total before tax 3,764 80,238 32,377 Tax (790) (16,850) (6,799) Income taxes Total after-tax 2,974 63,388 25,578 Pension adjustments: Amortization of prior service cost 1,071 1,075 1,077 Other operating expense Amortization of actuarial (gain) loss (597) (1,465) 12,677 Other operating expense Total before tax 474 (390) 13,754 Tax (100) 82 (2,889) Income taxes Total after-tax 374 (308) 10,865 Total reclassification (after-tax) $ 3,348 $ 63,080 $ 36,443

Investments (Tables)

Investments (Tables)	12 Months Ended
	Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Schedule of Fixed Maturities and Equity Securities Available for Sale by Component	Summaries of fixed maturities available for sale by amortized cost, fair value, and allowance for credit losses at December 31, 2024 and 2023, and the corresponding amounts of gross unrealized gains and losses recognized in accumulated other comprehensive income (loss) are as follows. Redeemable preferred stock is included within "Corporates, by sector." At December 31, 2024 Amortized Allowance for Credit Losses Gross Gross Fair Value (1) % of Total Fixed Maturities (2) Fixed maturities available for sale: U.S. Government direct, guaranteed, and government-sponsored enterprises $ 401,753 $ — $ 1 $ (42,794) $ 358,960 2 States, municipalities, and political subdivisions 3,300,901 — 20,662 (534,759) 2,786,804 16 Foreign governments 36,883 — 18 (8,870) 28,031 — Corporates, by sector: Industrials 7,889,074 (7,098) 105,610 (805,330) 7,182,256 42 Financial 5,006,375 — 82,598 (413,043) 4,675,930 27 Utilities 2,081,366 — 39,716 (118,007) 2,003,075 12 Total corporates 14,976,815 (7,098) 227,924 (1,336,380) 13,861,261 81 Collateralized debt obligations 36,923 — 5,943 — 42,866 — Other asset-backed securities 82,534 (3,297) 39 (2,186) 77,090 1 Total fixed maturities $ 18,835,809 $ (10,395) $ 254,587 $ (1,924,989) $ 17,155,012 100 (1) Amount reported in the balance sheet. (2) At fair value. At December 31, 2023 Amortized Allowance for Credit Losses Gross Gross Fair Value (1) % of Total Fixed Maturities (2) Fixed maturities available for sale: U.S. Government direct, guaranteed, and government-sponsored enterprises $ 398,450 $ — $ 7 $ (32,306) $ 366,151 2 States, municipalities, and political subdivisions 3,296,305 — 47,346 (403,329) 2,940,322 16 Foreign governments 44,453 — 1 (10,348) 34,106 — Corporates, by sector: Industrials 8,016,126 (7,115) 213,078 (566,847) 7,655,242 43 Financial 5,028,151 — 112,368 (388,340) 4,752,179 27 Utilities 2,017,967 — 73,925 (94,130) 1,997,762 11 Total corporates 15,062,244 (7,115) 399,371 (1,049,317) 14,405,183 81 Collateralized debt obligations 37,110 — 5,036 — 42,146 — Other asset-backed securities 86,352 — 3 (4,057) 82,298 1 Total fixed maturities $ 18,924,914 $ (7,115) $ 451,764 $ (1,499,357) $ 17,870,206 100 (1) Amount reported in the balance sheet. (2) At fair value.
Schedule of Fixed Maturities by Contractual Maturity	A schedule of fixed maturities available for sale by contractual maturity date at December 31, 2024, is shown below on an amortized cost basis, net of allowance for credit losses, and on a fair value basis. Actual disposition dates could differ from contractual maturities due to call or prepayment provisions. At December 31, 2024 Amortized Fair Fixed maturities available for sale: Due in one year or less $ 126,902 $ 126,643 Due after one year through five years 728,959 741,488 Due after five years through ten years 1,869,090 1,873,345 Due after ten years through twenty years 8,729,774 8,118,486 Due after twenty years 7,254,503 6,175,067 Mortgage-backed and asset-backed securities 116,186 119,983 $ 18,825,414 $ 17,155,012
Schedule of Analysis of Investment Operations	"Net investment income" for the three years ended December 31, 2024 is summarized as follows: Year Ended December 31, 2024 2023 2022 Fixed maturities available for sale $ 981,439 $ 944,628 $ 910,284 Policy loans 52,625 49,011 46,586 Mortgage loans 27,809 19,541 9,719 Other long-term investments (1) 81,834 54,655 40,837 Short-term investments 11,151 6,322 2,156 1,154,858 1,074,157 1,009,582 Less investment expense (19,227) (17,273) (17,782) Net investment income $ 1,135,631 $ 1,056,884 $ 991,800 (1) For the years ended 2024, 2023, and 2022, the investment funds, accounted for under the fair value option method, recorded $74.8 million, $52.3 million, and $40.3 million, respectively, in net investment income. Refer to Other Long-Term Investments below
Schedule of Realized Gains (Losses) on Investments	Selected information about sales of fixed maturities available for sale is as follows: Year Ended December 31, 2024 2023 2022 Fixed maturities available for sale: Proceeds from sales (1) $ 1,207,237 $ 602,556 $ 390,392 Gross realized gains 21,196 5,554 1,296 Gross realized losses (32,956) (80,823) (57,996) (1) Includes unsettled trades of $866 thousand, $0, and $0 as of December 31, 2024, 2023, and 2022, respectively. An analysis of "realized gains (losses)" is as follows: Year Ended December 31, 2024 2023 2022 Realized investment gains (losses): Fixed maturities available for sale: Sales and other (1) $ (11,563) $ (77,301) $ (32,552) Provision for credit losses (3,280) (7,115) 387 Fair value option—change in fair value (16,717) 15,102 (29,353) Mortgage loans (3,972) (5,603) (963) Other investments 2,936 1,792 4,681 Realized gains (losses) from investments (32,596) (73,125) (57,800) Other gains (losses) 8,408 7,449 (18,748) Total realized gains (losses) (24,188) (65,676) (76,548) Applicable tax 5,080 13,792 16,075 Realized gains (losses), net of tax $ (19,108) $ (51,884) $ (60,473) (1)
Schedule of Unrealized Gains (Losses) on Investments	An analysis of the net change in unrealized investment gains (losses) is as follows: Year Ended December 31, 2024 2023 2022 Change in unrealized investment gains (losses) on: Fixed maturities available for sale $ (622,809) $ 750,734 $ (5,298,692)
Schedule of Fair Value of Fixed Maturities Measured on a Recurring Basis	The following tables represent the fair value of fixed maturities measured on a recurring basis at December 31, 2024 and 2023: Fair Value Measurement at December 31, 2024: Quoted Prices in Significant Other Significant Total Fair Fixed maturities available for sale U.S. Government direct, guaranteed, and government-sponsored enterprises $ — $ 358,960 $ — $ 358,960 States, municipalities, and political subdivisions — 2,786,804 — 2,786,804 Foreign governments — 28,031 — 28,031 Corporates, by sector: Industrials — 6,998,900 183,356 7,182,256 Financial — 4,551,737 124,193 4,675,930 Utilities — 1,890,559 112,516 2,003,075 Total corporates — 13,441,196 420,065 13,861,261 Collateralized debt obligations — — 42,866 42,866 Other asset-backed securities — 65,907 11,183 77,090 Total fixed maturities $ — $ 16,680,898 $ 474,114 $ 17,155,012 Percentage of total — % 97 % 3 % 100 % Fair Value Measurement at December 31, 2023: Quoted Prices in Significant Other Significant Total Fair Fixed maturities available for sale U.S. Government direct, guaranteed, and government-sponsored enterprises $ — $ 366,151 $ — $ 366,151 States, municipalities, and political subdivisions — 2,940,322 — 2,940,322 Foreign governments — 34,106 — 34,106 Corporates, by sector: Industrials — 7,440,493 214,749 7,655,242 Financial — 4,621,160 131,019 4,752,179 Utilities — 1,888,797 108,965 1,997,762 Total corporates — 13,950,450 454,733 14,405,183 Collateralized debt obligations — — 42,146 42,146 Other asset-backed securities — 82,298 — 82,298 Total fixed maturities $ — $ 17,373,327 $ 496,879 $ 17,870,206 Percentage of total — % 97 % 3 % 100 % The following tables disclose unrealized investment losses by class and major sector of fixed maturities available for sale at December 31, 2024 and December 31, 2023. Analysis of Gross Unrealized Investment Losses At December 31, 2024 Less than Twelve Months Twelve Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Fixed maturities available for sale: Investment grade securities: U.S. Government direct, guaranteed, and government-sponsored enterprises $ 11,268 $ (290) $ 347,527 $ (42,504) $ 358,795 $ (42,794) States, municipalities, and political subdivisions 778,244 (32,894) 1,532,264 (501,865) 2,310,508 (534,759) Foreign governments — — 24,925 (8,870) 24,925 (8,870) Corporates, by sector: Industrials 1,487,940 (73,404) 3,433,034 (690,920) 4,920,974 (764,324) Financial 961,932 (52,946) 1,785,130 (333,873) 2,747,062 (386,819) Utilities 546,965 (20,214) 540,077 (90,996) 1,087,042 (111,210) Total corporates 2,996,837 (146,564) 5,758,241 (1,115,789) 8,755,078 (1,262,353) Collateralized debt obligations — — — — — — Other asset-backed securities 23,231 (95) 42,639 (2,091) 65,870 (2,186) Total investment grade securities 3,809,580 (179,843) 7,705,596 (1,671,119) 11,515,176 (1,850,962) Below investment grade securities: Corporates, by sector: Industrials 54,199 (2,656) 142,638 (38,350) 196,837 (41,006) Financial 2,990 (53) 126,811 (26,171) 129,801 (26,224) Utilities 19,263 (1,113) 24,003 (5,684) 43,266 (6,797) Total corporates 76,452 (3,822) 293,452 (70,205) 369,904 (74,027) Collateralized debt obligations — — — — — — Other asset-backed securities — — 2,198 — 2,198 — Total below investment grade securities 76,452 (3,822) 295,650 (70,205) 372,102 (74,027) Total fixed maturities $ 3,886,032 $ (183,665) $ 8,001,246 $ (1,741,324) $ 11,887,278 $ (1,924,989) Analysis of Gross Unrealized Investment Losses At December 31, 2023 Less than Twelve Months Twelve Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Fixed maturities available for sale: Investment grade securities: U.S. Government direct, guaranteed, and government-sponsored enterprises $ — $ — $ 364,006 $ (32,306) $ 364,006 $ (32,306) States, municipalities, and political subdivisions 252,800 (3,520) 1,610,163 (399,809) 1,862,963 (403,329) Foreign governments — — 32,591 (10,348) 32,591 (10,348) Corporates, by sector: Industrials 191,573 (3,881) 4,317,827 (530,011) 4,509,400 (533,892) Financial 242,099 (6,584) 2,341,424 (339,628) 2,583,523 (346,212) Utilities 81,194 (648) 686,043 (91,959) 767,237 (92,607) Total corporates 514,866 (11,113) 7,345,294 (961,598) 7,860,160 (972,711) Collateralized debt obligations — — — — — — Other asset-backed securities — — 70,956 (3,648) 70,956 (3,648) Total investment grade securities 767,666 (14,633) 9,423,010 (1,407,709) 10,190,676 (1,422,342) Below investment grade securities: Corporates, by sector: Industrials 10,745 (199) 145,697 (32,756) 156,442 (32,955) Financial 25,563 (2,602) 151,190 (39,526) 176,753 (42,128) Utilities — — 19,654 (1,523) 19,654 (1,523) Total corporates 36,308 (2,801) 316,541 (73,805) 352,849 (76,606) Collateralized debt obligations — — — — — — Other asset-backed securities — — 11,288 (409) 11,288 (409) Total below investment grade securities 36,308 (2,801) 327,829 (74,214) 364,137 (77,015) Total fixed maturities $ 803,974 $ (17,434) $ 9,750,839 $ (1,481,923) $ 10,554,813 $ (1,499,357)
Schedule of Fair Value, Assets Measured on Recurring Basis Using Significant Unobservable Inputs	The following tables represent changes in fixed maturities measured at fair value on a recurring basis using significant unobservable inputs (Level 3): Analysis of Changes in Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Asset- Collateralized Corporates Total Balance at January 1, 2022 $ — $ 63,505 $ 641,688 $ 705,193 Included in realized gains / losses — — — — Included in other comprehensive income — (13,771) (91,385) (105,156) Acquisitions (1) — — — — Sales — — — — Amortization — 4,519 7 4,526 Other (2) — (3,889) (72,227) (76,116) Transfers into Level 3 (3) — — — — Transfers out of Level 3 (3) — — — — Balance at December 31, 2022 — 50,364 478,083 528,447 Included in realized gains / losses — — — — Included in other comprehensive income — (8,230) 4,541 (3,689) Acquisitions (1) — — — — Sales — — — — Amortization — 4,569 155 4,724 Other (2) — (4,557) (28,046) (32,603) Transfers into Level 3 (3) — — — — Transfers out of Level 3 (3) — — — — Balance at December 31, 2023 — 42,146 454,733 496,879 Included in realized gains / losses — — 740 740 Included in other comprehensive income 37 907 (4,607) (3,663) Acquisitions (1) 8,948 — 14,800 23,748 Sales — — — — Amortization — 4,548 217 4,765 Other (2) — (4,735) (45,818) (50,553) Transfers into Level 3 (3) 2,198 — — 2,198 Transfers out of Level 3 (3) — — — — Balance at December 31, 2024 $ 11,183 $ 42,866 $ 420,065 $ 474,114 (1) Acquisitions of Level 3 investments in each of the years 2022 through 2024 are comprised of private placement fixed maturities and equities. (2) Includes capitalized interest, foreign exchange adjustments, and principal repayments. (3) Considered to be transferred at the end of the period. Transfers into Level 3 occur when observable inputs are no longer available. Transfers out of Level 3 occur when observable inputs become available. Changes in unrealized gains and losses for Level 3 securities during the period included in accumulated other comprehensive income for assets held at the end of the reporting period: Asset- Collateralized Corporates Total 2022 $ — $ (13,771) $ (91,385) $ (105,156) 2023 — (8,230) 4,541 (3,689) 2024 37 907 (4,607) (3,663)
Schedule of Fair Value Measurement Inputs and Valuation Techniques	The following table represents quantitative information about Level 3 fair value measurements: Quantitative Information about Level 3 Fair Value Measurements As of December 31, 2024 Fair Value Valuation Significant Unobservable Range Weighted- Average (1) Private placement fixed maturities $ 420,065 Determination of credit spread Credit rating B to AA BBB+ Collateralized debt obligations 42,866 Discounted Cash Flows Discount rate 11.75% 11.75% Asset-backed securities 11,183 Determination of credit spread Credit rating CC - BBB BB $ 474,114 (1) Unobservable inputs were weighted by the relative fair value of the instruments.
Schedule of Additional Information about Investments in Unrealized Loss Position	The following table discloses information about fixed maturities available for sale in an unrealized loss position. Less than Twelve Months Twelve Months or Longer Total Number of issues (CUSIPs) held: As of December 31, 2024 705 1,498 2,203 As of December 31, 2023 151 1,614 1,765
Schedule of Fixed Maturities, Allowance for Credit Loss	A summary of the activity in the allowance for credit losses is as follows. Refer to Note 1—Significant Accounting Policies for factors considered in the recording of the allowance for credit losses. Year Ended December 31, 2024 2023 Allowance for credit losses beginning balance $ 7,115 $ — Additions to allowance for which credit losses were not previously recorded 3,297 72,508 Additions (reductions) to allowance for fixed maturities that previously had an allowance (17) (65,393) Reduction of allowance for which the Company intends to sell or more likely than not will be required to sell or sold during the period — — Allowance for credit losses ending balance $ 10,395 $ 7,115
Schedule of Percentages Of Investments By Major Components At Fair Value	At December 31, 2024, the investment portfolio, at fair value, consisted of the following: Investment grade fixed maturities: Corporates 68 % States, municipalities, and political subdivisions 14 U.S. Government direct, guaranteed, and government-sponsored enterprises 2 Other 1 Below investment grade fixed maturities: Corporates 2 87 Other Policy loans, which are secured by the underlying insurance policy values 4 Other investments 9 100 %
Schedule of Industry Concentrations Held In Corporate Portfolio	Below are the ten largest industry concentrations held in the portfolio of corporate fixed maturities at December 31, 2024, based on fair value: Insurance 18 % Electric utilities 11 Banks 7 Oil and natural gas pipelines 6 Chemicals 5 Transportation 4 Telecommunications 3 Food 3 Diversified financial services 3 Real estate investment trusts 3
Schedule of Commercial Mortgage Loan Participations	Summaries of commercial mortgage loans by property type and geographical location at December 31, 2024 and 2023 are as follows: 2024 2023 Carrying Value % of Total Carrying Value % of Total Property type: Multi-family $ 111,234 28 $ 116,299 42 Industrial 110,456 28 57,267 20 Retail 65,612 16 23,925 9 Hospitality 73,931 19 43,897 16 Mixed use 35,960 9 34,749 12 Office 6,539 2 6,734 2 Total recorded investment 403,732 102 282,871 101 Less allowance for credit losses (7,644) (2) (3,672) (1) Carrying value, net of allowance for credit losses $ 396,088 100 $ 279,199 100 2024 2023 Carrying Value % of Total Carrying Value % of Total Geographic location: Texas $ 75,131 19 $ 45,111 16 Florida 63,308 16 48,233 17 New Jersey 51,744 13 44,574 16 California 48,371 12 54,721 20 Alabama 35,850 9 11,003 4 New York 34,975 9 20,284 7 Other 94,353 24 58,945 21 Total recorded investment 403,732 102 282,871 101 Less allowance for credit losses (7,644) (2) (3,672) (1) Carrying value, net of allowance for credit losses $ 396,088 100 $ 279,199 100
Schedule of Commercial Loan Participations, Credit Quality Indicators	1.20x Total % of Gross Total Loan-to-value ratio (2) : Less than 70% $ 88,507 $ 64,494 $ 196,867 $ 349,868 87 70% to 80% — — — — — 81% to 90% — — — — — Greater than 90% 16,136 37,728 — 53,864 13 Total $ 104,643 $ 102,222 $ 196,867 403,732 100 Less allowance for credit losses (7,644) Total, net of allowance for credit losses $ 396,088 (1) Annual net operating income divided by annual mortgage debt service (principal and interest). (2) Loan balance divided by stabilized appraised value at origination, including planned renovations and stabilized occupancy. Updated internal valuations are used when a loan is materially underperforming. December 31, 2023 Recorded Investment Debt Service Coverage Ratios (1) <1.00x 1.00x—1.20x >1.20x Total % of Gross Total Loan-to-value ratio (2) : Less than 70% $ 27,091 $ 180,761 $ 58,364 $ 266,216 94 70% to 80% — — — — — 81% to 90% 8,468 — 1,153 9,621 3 Greater than 90% 7,034 — — 7,034 3 Total $ 42,593 $ 180,761 $ 59,517 282,871 100 Less allowance for credit losses (3,672) Total, net of allowance for credit losses $ 279,199 (1) Annual net operating income divided by annual mortgage debt service (principal and interest). (2) Loan balance divided by stabilized appraised value at origination, including planned renovations and stabilized occupancy. Updated internal valuations are used when a loan is materially underperforming." id="sjs-B17">The following tables are reflective of the key factors, debt service coverage ratios, and loan-to-value ("LTV") ratios that are utilized by management to monitor the performance of the portfolios. The Company only makes new investments in commercial mortgage loans that have a LTV ratio less than 80%. LTV ratios that exceed 80% are generally as a result of decreases in the valuation of the underlying property. Generally, a higher LTV ratio and a lower debt service coverage ratio can potentially equate to higher risk of loss. December 31, 2024 Recorded Investment Debt Service Coverage Ratios (1) <1.00x 1.00x—1.20x >1.20x Total % of Gross Total Loan-to-value ratio (2) : Less than 70% $ 88,507 $ 64,494 $ 196,867 $ 349,868 87 70% to 80% — — — — — 81% to 90% — — — — — Greater than 90% 16,136 37,728 — 53,864 13 Total $ 104,643 $ 102,222 $ 196,867 403,732 100 Less allowance for credit losses (7,644) Total, net of allowance for credit losses $ 396,088 (1) Annual net operating income divided by annual mortgage debt service (principal and interest). (2) Loan balance divided by stabilized appraised value at origination, including planned renovations and stabilized occupancy. Updated internal valuations are used when a loan is materially underperforming. December 31, 2023 Recorded Investment Debt Service Coverage Ratios (1) <1.00x 1.00x—1.20x >1.20x Total % of Gross Total Loan-to-value ratio (2) : Less than 70% $ 27,091 $ 180,761 $ 58,364 $ 266,216 94 70% to 80% — — — — — 81% to 90% 8,468 — 1,153 9,621 3 Greater than 90% 7,034 — — 7,034 3 Total $ 42,593 $ 180,761 $ 59,517 282,871 100 Less allowance for credit losses (3,672) Total, net of allowance for credit losses $ 279,199 (1) Annual net operating income divided by annual mortgage debt service (principal and interest). (2) Loan balance divided by stabilized appraised value at origination, including planned renovations and stabilized occupancy. Updated internal valuations are used when a loan is materially underperforming.
Schedule of Commercial Loan Participations, Allowance for Credit Loss	Year Ended December 31, 2024 2023 Allowance for credit losses beginning balance $ 3,672 $ 1,789 Provision (reversal) for credit losses 3,972 1,883 Allowance for credit losses ending balance $ 7,644 $ 3,672
Schedule of Other Long-Term Investments	Other long-term investments consist of the following assets: December 31, 2024 2023 Investment funds $ 986,766 $ 795,583 Company-owned life insurance 202,734 — Other 46,259 40,295 Total $ 1,235,759 $ 835,878
Schedule of Investment Funds	The following table presents additional information about the Company's investment funds as of December 31, 2024 and December 31, 2023 at fair value: Fair Value Unfunded Commitments (2) Investment Category 2024 2023 2024 Redemption Term/Notice (1) Commercial mortgage loans $ 566,142 $ 411,315 $ 189,725 Fully redeemable and non-redeemable with varying terms. Opportunistic and private credit 202,008 181,410 191,192 Fully redeemable and non-redeemable with varying terms. Infrastructure 179,627 165,887 — Fully redeemable and non-redeemable with varying terms. Other 38,989 36,971 52,479 Non-redeemable with varying terms Total investment funds $ 986,766 $ 795,583 $ 433,396 (1) Non-redeemable funds generally have an expected life of 7 to 12 years from fund closing with extension options of 1 to 4 years. Redemptions are paid out throughout the life of the funds at the General Partner's discretion. Redeemable funds can generally be redeemed over 6 to 36 months upon request from limited partners. (2) Unfunded commitments include unfunded balances during the investment period. After an investment period ends, the fund can call capital based on limited and specified reasons. As of December 31, 2024, unfunded commitments totaled $645 million, including funds past the investment period. The following table presents additional information about the Company's investment funds included in pension plan assets as of December 31, 2024 and December 31, 2023 at fair value: Fair Value Unfunded Commitments (2) Investment Category 2024 2023 2024 Redemption Term/Notice (1) Multi-asset class $ 12,383 $ 14,714 $ — Non-redeemable Private equity 18,163 3,600 48,167 Non-redeemable Total $ 30,546 $ 18,314 $ 48,167 (1) Non-redeemable funds generally have an expected life of 7 to 10 years from fund closing with extension options of 2 to 4 years. Redemptions are paid out throughout the life of the funds at the General Partner's discretion. (2) Unfunded commitments include unfunded balances during the investment period. After an investment period ends, the fund can call capital based on limited and specified reasons. As of December 31, 2024, unfunded commitments totaled $57.5 million, including funds past the investment period.

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Rental Expense for Operating Leases	Rental expense for the three years ended December 31, 2024 is as follows: Year Ended December 31, 2024 2023 2022 Rental expense $ 3,208 $ 3,519 $ 4,239
Schedule of Future Minimum Rental Commitments	Future minimum rental commitments required under operating leases having remaining noncancelable lease terms in excess of one year at December 31, 2024 were as follows: Year Ended December 31, 2025 2026 2027 2028 2029 Thereafter Operating lease commitments $ 2,117 $ 1,883 $ 1,417 $ 867 $ 487 $ 4,195
Schedule of Long-term Purchase Commitment	Year Ended December 31, 2025 2026 2027 2028 2029 Thereafter Purchase commitments (1) $ 47,538 $ 29,742 $ 34,443 $ 15,266 $ 11,440 $ 203,445 (1) Includes low-income housing tax credits with non-funded commitments of $76 million at December 31, 2024.

Policy Liabilities (Tables)

Policy Liabilities (Tables)	12 Months Ended
	Dec. 31, 2024
Policyholder Account Balance [Abstract]
Schedule of Liability for Future Policy Benefit, Activity	The following tables summarize balances and changes in the net liability for future policy benefits, before reinsurance, for traditional life long-duration contracts for the three years ended December 31, 2024: Life Present value of expected future net premiums American Income DTC Liberty National Other Total Balance at January 1, 2022 $ 4,925,192 $ 7,264,905 $ 1,332,469 $ 559,972 $ 14,082,538 Beginning balance at original discount rates 3,906,098 5,533,741 1,040,242 416,141 10,896,222 Effect of changes in assumptions on future cash flows 34,266 79,571 17,719 35,214 166,770 Effect of actual variances from expected experience (121,230) (264,286) (20,027) (10,929) (416,472) Adjusted balance at January 1, 2022 3,819,134 5,349,026 1,037,934 440,426 10,646,520 Issuances (1) 760,857 663,790 104,982 31,815 1,561,444 Interest accrual (2) 176,102 273,494 51,326 21,150 522,072 Net premiums collected (3) (491,168) (605,446) (128,119) (44,182) (1,268,915) Effect of changes in the foreign exchange rate (18,202) — — — (18,202) Ending balance at original discount rates 4,246,723 5,680,864 1,066,123 449,209 11,442,919 Effect of change from original to current discount rates 26,433 229,360 28,284 21,532 305,609 Balance at December 31, 2022 $ 4,273,156 $ 5,910,224 $ 1,094,407 $ 470,741 $ 11,748,528 Balance at January 1, 2023 $ 4,273,156 $ 5,910,224 $ 1,094,407 $ 470,741 $ 11,748,528 Beginning balance at original discount rates 4,246,723 5,680,864 1,066,123 449,209 11,442,919 Effect of changes in assumptions on future cash flows 14,265 36,170 5,178 8,419 64,032 Effect of actual variances from expected experience (155,293) (306,004) (40,961) (18,441) (520,699) Adjusted balance at January 1, 2023 4,105,695 5,411,030 1,030,340 439,187 10,986,252 Issuances (1) 733,702 579,363 127,048 27,959 1,468,072 Interest accrual (2) 200,363 287,615 54,147 22,804 564,929 Net premiums collected (3) (521,521) (613,749) (133,704) (46,001) (1,314,975) Effect of changes in the foreign exchange rate 5,090 — — — 5,090 Ending balance at original discount rates 4,523,329 5,664,259 1,077,831 443,949 11,709,368 Effect of change from original to current discount rates 158,559 388,392 51,885 34,103 632,939 Balance at December 31, 2023 $ 4,681,888 $ 6,052,651 $ 1,129,716 $ 478,052 $ 12,342,307 Life Present value of expected future net premiums American Income DTC Liberty National Other Total Balance at January 1, 2024 $ 4,681,888 $ 6,052,651 $ 1,129,716 $ 478,052 $ 12,342,307 Beginning balance at original discount rates 4,523,329 5,664,259 1,077,831 443,949 11,709,368 Effect of changes in assumptions on future cash flows (82,348) (28,366) (29,292) (982) (140,988) Effect of actual variances from expected experience (229,772) (311,659) (42,620) (14,436) (598,487) Adjusted balance at January 1, 2024 4,211,209 5,324,234 1,005,919 428,531 10,969,893 Issuances (1) 798,952 491,440 120,683 23,911 1,434,986 Interest accrual (2) 220,959 292,843 55,198 22,875 591,875 Net premiums collected (3) (551,066) (603,605) (134,778) (45,041) (1,334,490) Effect of changes in the foreign exchange rate (23,344) — — — (23,344) Ending balance at original discount rates 4,656,710 5,504,912 1,047,022 430,276 11,638,920 Effect of change from original to current discount rates (10,793) 117,994 1,425 9,771 118,397 Balance at December 31, 2024 $ 4,645,917 $ 5,622,906 $ 1,048,447 $ 440,047 $ 11,757,317 (1) Issuances represent the present value, using the original discount rate, of the expected net premiums related to new policies issued during each respective period. (2) The interest accrual is the interest earned on the beginning present value of the expected net premiums, as well as the interest on actual net premiums earned during the period, using the original interest rate. (3) Net premiums collected represent the product of the current period net premium ratio and the gross premiums collected during the period on the in-force business. Life Present value of expected future policy benefits American Income DTC Liberty National Other Total Balance at January 1, 2022 $ 11,773,519 $ 11,859,408 $ 4,542,697 $ 5,488,684 $ 33,664,308 Beginning balance at original discount rates 7,744,201 8,157,259 3,206,164 3,267,306 22,374,930 Effect of changes in assumptions on future cash flows 48,534 104,910 33,457 39,725 226,626 Effect of actual variances from expected experience (127,626) (259,285) (18,535) (12,787) (418,233) Adjusted balance at January 1, 2022 7,665,109 8,002,884 3,221,086 3,294,244 22,183,323 Issuances (1) 760,856 663,786 105,006 31,815 1,561,463 Interest accrual (2) 410,201 433,611 169,578 195,792 1,209,182 Benefit payments (3) (382,142) (622,389) (222,690) (118,147) (1,345,368) Effect of changes in the foreign exchange rate (44,263) — — — (44,263) Ending balance at original discount rates 8,409,761 8,477,892 3,272,980 3,403,704 23,564,337 Effect of change from original to current discount rates 709,343 747,559 156,276 572,446 2,185,624 Balance at December 31, 2022 $ 9,119,104 $ 9,225,451 $ 3,429,256 $ 3,976,150 $ 25,749,961 Balance at January 1, 2023 $ 9,119,104 $ 9,225,451 $ 3,429,256 $ 3,976,150 $ 25,749,961 Beginning balance at original discount rates 8,409,761 8,477,892 3,272,980 3,403,704 23,564,337 Effect of changes in assumptions on future cash flows 13,344 34,407 6,156 11,661 65,568 Effect of actual variances from expected experience (164,900) (318,687) (46,341) (24,195) (554,123) Adjusted balance at January 1, 2023 8,258,205 8,193,612 3,232,795 3,391,170 23,075,782 Issuances (1) 733,700 579,365 127,062 27,959 1,468,086 Interest accrual (2) 452,640 458,587 174,995 204,083 1,290,305 Benefit payments (3) (396,031) (574,812) (196,600) (116,353) (1,283,796) Effect of changes in the foreign exchange rate 13,319 — — — 13,319 Ending balance at original discount rates 9,061,833 8,656,752 3,338,252 3,506,859 24,563,696 Effect of change from original to current discount rates 1,101,794 1,057,764 267,140 732,764 3,159,462 Balance at December 31, 2023 $ 10,163,627 $ 9,714,516 $ 3,605,392 $ 4,239,623 $ 27,723,158 Balance at January 1, 2024 $ 10,163,627 $ 9,714,516 $ 3,605,392 $ 4,239,623 $ 27,723,158 Beginning balance at original discount rates 9,061,833 8,656,752 3,338,252 3,506,859 24,563,696 Effect of changes in assumptions on future cash flows (104,498) (50,106) (41,836) (2,027) (198,467) Effect of actual variances from expected experience (251,310) (335,087) (50,759) (20,954) (658,110) Adjusted balance at January 1, 2024 8,706,025 8,271,559 3,245,657 3,483,878 23,707,119 Issuances (1) 794,225 491,437 120,702 23,912 1,430,276 Interest accrual (2) 492,966 474,451 178,617 210,344 1,356,378 Benefit payments (3) (426,723) (576,499) (204,757) (136,066) (1,344,045) Effect of changes in the foreign exchange rate (57,904) — — — (57,904) Ending balance at original discount rates 9,508,589 8,660,948 3,340,219 3,582,068 25,091,824 Effect of change from original to current discount rates 362,103 464,164 37,298 378,895 1,242,460 Balance at December 31, 2024 $ 9,870,692 $ 9,125,112 $ 3,377,517 $ 3,960,963 $ 26,334,284 (1) Issuances represent the present value, using the original discount rate, of the expected future policy benefits related to new policies issued during each respective period. (2) The interest accrual is the interest earned on the beginning present value of the expected future policy benefits, as well as the interest on actual benefits and expenses paid during the period, using the original interest rate. (3) Benefit payments represent the release of the present value, using the original discount rate, of the actual future policy benefits incurred during the period due to death, surrender, and maturity benefit payments based on the revised expected assumptions. Life Net liability for future policy benefits as of December 31, 2022 American Income DTC Liberty National Other Total Net liability for future policy benefits at original discount rates $ 4,163,038 $ 2,797,028 $ 2,206,857 $ 2,954,495 $ 12,121,418 Effect of changes in discount rate assumptions 682,910 518,199 127,992 550,914 1,880,015 Other adjustments (1) 115 4,913 7,638 48 12,714 Net liability for future policy benefits, after other adjustments, at current discount rates 4,846,063 3,320,140 2,342,487 3,505,457 14,014,147 Reinsurance recoverable (123) — (7,477) (34,830) (42,430) Net liability for future policy benefits, after reinsurance recoverable, at current discount rates $ 4,845,940 $ 3,320,140 $ 2,335,010 $ 3,470,627 $ 13,971,717 (1) Other adjustments include the Company's effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits). Life Net liability for future policy benefits as of December 31, 2023 American Income DTC Liberty National Other Total Net liability for future policy benefits at original discount rates $ 4,538,504 $ 2,992,493 $ 2,260,421 $ 3,062,910 $ 12,854,328 Effect of changes in discount rate assumptions 943,235 669,372 215,255 698,661 2,526,523 Other adjustments (1) 297 3,315 5,764 62 9,438 Net liability for future policy benefits, after other adjustments, at current discount rates 5,482,036 3,665,180 2,481,440 3,761,633 15,390,289 Reinsurance recoverable (141) — (7,719) (37,848) (45,708) Net liability for future policy benefits, after reinsurance recoverable, at current discount rates $ 5,481,895 $ 3,665,180 $ 2,473,721 $ 3,723,785 $ 15,344,581 (1) Other adjustments include the Company's effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits). Life Net liability for future policy benefits as of December 31, 2024 American Income DTC Liberty National Other Total Net liability for future policy benefits at original discount rates $ 4,851,879 $ 3,156,036 $ 2,293,197 $ 3,151,792 $ 13,452,904 Effect of changes in discount rate assumptions 372,896 346,170 35,873 369,124 1,124,063 Other adjustments (1) 122 18 — 33 173 Net liability for future policy benefits, after other adjustments, at current discount rates 5,224,897 3,502,224 2,329,070 3,520,949 14,577,140 Reinsurance recoverable (167) — (7,953) (35,368) (43,488) Net liability for future policy benefits, after reinsurance recoverable, at current discount rates $ 5,224,730 $ 3,502,224 $ 2,321,117 $ 3,485,581 $ 14,533,652 (1) Other adjustments include the Company's effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits). The following tables summarize balances and changes in the net liability for future policy benefits for long-duration health contracts for the three years ended December 31, 2024: Health Present value of expected future net premiums United American Family Heritage Liberty National American Income DTC Total Balance at January 1, 2022 $ 3,611,659 $ 1,944,714 $ 517,368 $ 222,553 $ 121,724 $ 6,418,018 Beginning balance at original discount rates 2,949,851 1,688,590 414,409 178,801 96,776 5,328,427 Effect of changes in assumptions on future cash flows (195,560) (20,931) 19,846 (17,911) (9,035) (223,591) Effect of actual variances from expected experience (37,437) (67,419) (39,029) 7,911 (2,301) (138,275) Adjusted balance at January 1, 2022 2,716,854 1,600,240 395,226 168,801 85,440 4,966,561 Issuances (1) 360,942 241,052 51,827 39,003 8,224 701,048 Interest accrual (2) 122,064 60,303 19,141 7,399 4,554 213,461 Net premiums collected (3) (258,598) (172,376) (50,752) (21,085) (10,467) (513,278) Effect of changes in the foreign exchange rate — — — (1,487) — (1,487) Ending balance at original discount rates 2,941,262 1,729,219 415,442 192,631 87,751 5,366,305 Effect of change from original to current discount rates (32,761) (134,227) 8,048 (2,335) 2,392 (158,883) Balance at December 31, 2022 $ 2,908,501 $ 1,594,992 $ 423,490 $ 190,296 $ 90,143 $ 5,207,422 Balance at January 1, 2023 $ 2,908,501 $ 1,594,992 $ 423,490 $ 190,296 $ 90,143 $ 5,207,422 Beginning balance at original discount rates 2,941,262 1,729,219 415,442 192,631 87,751 5,366,305 Effect of changes in assumptions on future cash flows 466,883 (30,255) (56,964) (6,061) 16,553 390,156 Effect of actual variances from expected experience (27,178) (69,878) (36,850) (11,152) (2,850) (147,908) Adjusted balance at January 1, 2023 3,380,967 1,629,086 321,628 175,418 101,454 5,608,553 Issuances (1) 377,097 266,375 59,768 39,825 14,467 757,532 Interest accrual (2) 139,824 67,743 18,255 8,528 4,616 238,966 Net premiums collected (3) (272,085) (180,031) (51,081) (22,325) (10,657) (536,179) Effect of changes in the foreign exchange rate — — — 423 — 423 Ending balance at original discount rates 3,625,803 1,783,173 348,570 201,869 109,880 6,069,295 Effect of change from original to current discount rates 71,968 (71,432) 9,902 4,512 5,483 20,433 Balance at December 31, 2023 $ 3,697,771 $ 1,711,741 $ 358,472 $ 206,381 $ 115,363 $ 6,089,728 Balance at January 1, 2024 $ 3,697,771 $ 1,711,741 $ 358,472 $ 206,381 $ 115,363 $ 6,089,728 Beginning balance at original discount rates 3,625,803 1,783,173 348,570 201,869 109,880 6,069,295 Effect of changes in assumptions on future cash flows 9,892 (8,117) (3,463) 12,207 4,449 14,968 Effect of actual variances from expected experience (43,846) (56,720) (29,652) (16,088) (2,937) (149,243) Adjusted balance at January 1, 2024 3,591,849 1,718,336 315,455 197,988 111,392 5,935,020 Issuances (1) 480,412 265,166 58,538 44,350 26,149 874,615 Interest accrual (2) 174,269 75,188 16,566 9,787 5,838 281,648 Net premiums collected (3) (297,675) (190,817) (52,284) (24,852) (11,460) (577,088) Effect of changes in the foreign exchange rate — — — (2,132) — (2,132) Ending balance at original discount rates 3,948,855 1,867,873 338,275 225,141 131,919 6,512,063 Effect of change from original to current discount rates (63,325) (132,998) (1,156) (1,894) 1,458 (197,915) Balance at December 31, 2024 $ 3,885,530 $ 1,734,875 $ 337,119 $ 223,247 $ 133,377 $ 6,314,148 (1) Issuances represent the present value, using the original discount rate, of the expected net premiums related to new policies issued during each respective period. (2) The interest accrual is the interest earned on the beginning present value of the expected net premiums, as well as the interest on actual net premiums earned during the period, using the original interest rate. (3) Net premiums collected represent the product of the current period net premium ratio and the gross premiums collected during the period on the in-force business. Health Present value of expected future policy benefits United American Family Heritage Liberty National American Income DTC Total Balance at January 1, 2022 $ 3,810,559 $ 3,840,322 $ 1,201,317 $ 380,915 $ 119,888 $ 9,353,001 Beginning balance at original discount rates 3,090,901 3,193,342 921,608 285,604 95,628 7,587,083 Effect of changes in assumptions on future cash flows (194,936) (27,211) 18,065 (21,559) (8,270) (233,911) Effect of actual variances from expected experience (40,316) (70,690) (40,597) 10,402 (2,621) (143,822) Adjusted balance at January 1, 2022 2,855,649 3,095,441 899,076 274,447 84,737 7,209,350 Issuances (1) 360,642 241,052 52,257 39,006 8,202 701,159 Interest accrual (2) 129,842 120,700 47,719 13,806 4,553 316,620 Benefit payments (3) (265,500) (120,849) (94,187) (20,413) (12,280) (513,229) Effect of changes in the foreign exchange rate — — — (3,133) — (3,133) Ending balance at original discount rates 3,080,633 3,336,344 904,865 303,713 85,212 7,710,767 Effect of change from original to current discount rates (33,804) (330,680) 36,709 9,037 2,320 (316,418) Balance at December 31, 2022 $ 3,046,829 $ 3,005,664 $ 941,574 $ 312,750 $ 87,532 $ 7,394,349 Balance at January 1, 2023 $ 3,046,829 $ 3,005,664 $ 941,574 $ 312,750 $ 87,532 $ 7,394,349 Beginning balance at original discount rates 3,080,633 3,336,344 904,865 303,713 85,212 7,710,767 Effect of changes in assumptions on future cash flows 464,652 (32,428) (60,437) (6,407) 15,930 381,310 Effect of actual variances from expected experience (26,718) (74,797) (36,910) (12,661) (3,325) (154,411) Adjusted balance at January 1, 2023 3,518,567 3,229,119 807,518 284,645 97,817 7,937,666 Issuances (1) 376,573 266,375 59,158 39,825 14,446 756,377 Interest accrual (2) 147,082 134,107 45,614 15,070 4,616 346,489 Benefit payments (3) (300,692) (122,912) (95,471) (24,987) (12,378) (556,440) Effect of changes in the foreign exchange rate — — — 878 — 878 Ending balance at original discount rates 3,741,530 3,506,689 816,819 315,431 104,501 8,484,970 Effect of change from original to current discount rates 72,798 (190,809) 48,989 20,073 4,981 (43,968) Balance at December 31, 2023 $ 3,814,328 $ 3,315,880 $ 865,808 $ 335,504 $ 109,482 $ 8,441,002 Balance at January 1, 2024 $ 3,814,328 $ 3,315,880 $ 865,808 $ 335,504 $ 109,482 $ 8,441,002 Beginning balance at original discount rates 3,741,530 3,506,689 816,819 315,431 104,501 8,484,970 Effect of changes in assumptions on future cash flows 10,680 (5,054) (2,775) 20,293 7,733 30,877 Effect of actual variances from expected experience (35,532) (63,595) (30,258) (18,601) (2,420) (150,406) Adjusted balance at January 1, 2024 3,716,678 3,438,040 783,786 317,123 109,814 8,365,441 Issuances (1) 479,653 265,166 57,862 44,353 26,116 873,150 Interest accrual (2) 180,235 147,615 42,809 16,577 5,837 393,073 Benefit payments (3) (349,706) (138,777) (93,317) (25,214) (13,792) (620,806) Effect of changes in the foreign exchange rate — — — (4,128) — (4,128) Ending balance at original discount rates 4,026,860 3,712,044 791,140 348,711 127,975 9,006,730 Effect of change from original to current discount rates (66,428) (375,498) 13,555 6,592 1,302 (420,477) Balance at December 31, 2024 $ 3,960,432 $ 3,336,546 $ 804,695 $ 355,303 $ 129,277 $ 8,586,253 (1) Issuances represent the present value, using the original discount rate, of the expected future policy benefits related to new policies issued during each respective period. (2) The interest accrual is the interest earned on the beginning present value of the expected future policy benefits, as well as the interest on actual benefits and expenses paid during the period, using the original interest rate. (3) Benefit payments represent the release of the present value, using the original discount rate, of the actual future policy benefits incurred during the period based on the revised expected assumptions. Health Net liability for future policy benefits as of December 31, 2022 United American Family Heritage Liberty National American Income Direct to Consumer Total Net liability for future policy benefits at original discount rates $ 139,371 $ 1,607,125 $ 489,423 $ 111,082 $ (2,539) $ 2,344,462 Effect of changes in discount rate assumptions (1,043) (196,453) 28,661 11,372 (72) (157,535) Other adjustments (1) 4,055 3,172 5,953 48 3,634 16,862 Net liability for future policy benefits, after other adjustments, at current discount rates 142,383 1,413,844 524,037 122,502 1,023 2,203,789 Reinsurance recoverable (3,820) (9,027) (1,498) — — (14,345) Net liability for future policy benefits, after reinsurance recoverable, at current discount rates $ 138,563 $ 1,404,817 $ 522,539 $ 122,502 $ 1,023 $ 2,189,444 (1) Other adjustments include the effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits). Health Net liability for future policy benefits as of December 31, 2023 United American Family Heritage Liberty National American Income Direct to Consumer Total Net liability for future policy benefits at original discount rates $ 115,727 $ 1,723,516 $ 468,249 $ 113,562 $ (5,379) $ 2,415,675 Effect of changes in discount rate assumptions 830 (119,377) 39,087 15,561 (502) (64,401) Other adjustments (1) 10,980 84 9,567 857 6,653 28,141 Net liability for future policy benefits, after other adjustments, at current discount rates 127,537 1,604,223 516,903 129,980 772 2,379,415 Reinsurance recoverable (3,287) (10,718) (1,317) — — (15,322) Net liability for future policy benefits, after reinsurance recoverable, at current discount rates $ 124,250 $ 1,593,505 $ 515,586 $ 129,980 $ 772 $ 2,364,093 (1) Other adjustments include the effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits). Health Net liability for future policy benefits as of December 31, 2024 United American Family Heritage Liberty National American Income Direct to Consumer Total Net liability for future policy benefits at original discount rates 78,005 1,844,171 452,865 123,570 (3,944) 2,494,667 Effect of changes in discount rate assumptions (3,103) (242,500) 14,711 8,486 (156) (222,562) Other adjustments (1) 24,920 22 10,310 814 4,865 40,931 Net liability for future policy benefits, after other adjustments, at current discount rates 99,822 1,601,693 477,886 132,870 765 2,313,036 Reinsurance recoverable (2,768) — (986) — — (3,754) Net liability for future policy benefits, after reinsurance recoverable, at current discount rates $ 97,054 $ 1,601,693 $ 476,900 $ 132,870 $ 765 $ 2,309,282 (1) Other adjustments include the effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits). The following tables include the total remeasurement gain or loss, bifurcated between the gain or loss due to differences between actual and expected experience and the amount due to assumption updates, for the three years ended December 31, 2024: Year Ended December 31, 2024 2023 2022 Life Remeasurement Gain (Loss)—Experience: American Income $ 19,606 $ 9,430 1,965 Direct to Consumer 21,681 12,201 (2,243) Liberty National 3,966 5,013 (1,348) Other 4,872 4,760 1,354 Total Life Remeasurement Gain (Loss)—Experience 50,125 31,404 (272) Life Remeasurement Gain (Loss)—Assumption Updates: American Income 21,974 308 (8,707) Direct to Consumer 21,744 1,763 (25,334) Liberty National 12,224 (1,248) (7,872) Other 904 (2,836) (5,241) Total Life Remeasurement Gain (Loss)—Assumption Updates 56,846 (2,013) (47,154) Total Life Remeasurement Gain (Loss) 106,971 29,391 (47,426) Health Remeasurement Gain (Loss)—Experience: United American (4,890) (134) 3,502 Family Heritage 6,756 4,638 2,395 Liberty National 2,640 628 1,406 American Income 2,742 1,461 (2,545) Direct to Consumer 22 23 148 Total Health Remeasurement Gain (Loss)—Experience 7,270 6,616 4,906 Health Remeasurement Gain (Loss)—Assumption Updates: United American 1,205 762 (626) Family Heritage (3,063) 2,173 6,283 Liberty National (234) 2,171 1,463 American Income (8,036) 119 3,615 Direct to Consumer (373) 8 (80) Health Remeasurement Gain (Loss)—Assumption Updates (10,501) 5,233 10,655 Total Health Remeasurement Gain (Loss) $ (3,231) $ 11,849 15,561 The following table reconciles the liability for future policy benefits to the Consolidated Balance Sheets as of December 31, 2024, 2023, and 2022: At Original Discount Rates At Current Discount Rates As of December 31, As of December 31, 2024 2023 2022 2024 2023 2022 Life (1) : American Income $ 4,851,995 $ 4,538,775 $ 4,163,111 $ 5,224,897 $ 5,482,036 $ 4,846,063 Direct to Consumer 3,156,039 2,992,493 2,797,031 3,502,224 3,665,180 3,320,140 Liberty National 2,293,197 2,260,421 2,206,857 2,329,070 2,481,440 2,342,487 Other 3,151,824 3,062,966 2,954,522 3,520,949 3,761,633 3,505,457 Net liability for future policy benefits—long duration life 13,453,055 12,854,655 12,121,521 14,577,140 15,390,289 14,014,147 Health (1) : United American 100,480 124,021 141,362 99,822 127,537 142,383 Family Heritage 1,844,186 1,723,581 1,607,169 1,601,693 1,604,223 1,413,844 Liberty National 462,712 476,559 494,155 477,886 516,903 524,037 American Income 124,309 114,407 111,128 132,870 129,980 122,502 Direct to Consumer 738 737 979 765 772 1,023 Net liability for future policy benefits—long duration health 2,532,425 2,439,305 2,354,793 2,313,036 2,379,415 2,203,789 Deferred profit liability 178,199 174,717 175,883 178,199 174,717 175,883 Deferred annuity 656,573 773,039 954,318 656,573 773,039 954,318 Interest sensitive life 723,389 732,948 739,105 723,389 732,948 739,105 Other 8,923 9,951 10,106 8,926 9,945 10,099 Total future policy benefits $ 17,552,564 $ 16,984,615 $ 16,355,726 $ 18,457,263 $ 19,460,353 $ 18,097,341 (1) Balances are presented net of the effects of capping and flooring the liability (guidance requires an amount not less than zero at the calculation level of the liability for future policy benefits). The following tables provide the weighted-average original and current discount rates for the liability for future policy benefits and the additional insurance liabilities as of December 31, 2024, 2023, and 2022: As of December 31, 2024 2023 2022 Original discount rate Current discount rate Original discount rate Current discount rate Original discount rate Current discount rate Life American Income 5.7 % 5.4 % 5.7 % 4.9 % 5.8 % 5.2 % Direct to Consumer 6.0 % 5.5 % 6.0 % 5.0 % 6.0 % 5.2 % Liberty National 5.6 % 5.5 % 5.6 % 5.0 % 5.6 % 5.2 % Other 6.2 % 5.5 % 6.2 % 5.0 % 6.2 % 5.2 % Health United American 5.1 % 5.2 % 5.1 % 4.8 % 5.2 % 5.1 % Family Heritage 4.2 % 5.3 % 4.3 % 4.9 % 4.3 % 5.2 % Liberty National 5.8 % 5.4 % 5.8 % 4.9 % 5.8 % 5.2 % American Income 5.8 % 5.2 % 5.8 % 4.8 % 5.9 % 5.1 % Direct to Consumer 5.1 % 5.2 % 5.1 % 4.8 % 5.2 % 5.1 % The following table provides the weighted-average durations of the liability for future policy benefits and the additional insurance liabilities as of December 31, 2024, 2023, and 2022: As of December 31, 2024 2023 2022 At original discount rates At current discount rates At original discount rates At current discount rates At original discount rates At current discount rates Life American Income 22.73 22.76 23.01 23.45 22.86 23.28 Direct to Consumer 19.24 20.31 19.58 21.21 20.27 21.80 Liberty National 15.30 15.33 15.13 15.81 14.86 15.39 Other 15.99 16.92 16.26 17.92 16.59 18.15 Health United American 11.72 10.65 11.46 10.89 11.37 10.65 Family Heritage 15.33 14.23 14.99 14.54 14.87 14.22 Liberty National 9.31 9.19 9.17 9.49 9.26 9.47 American Income 12.49 12.56 12.21 12.84 12.12 12.56 Direct to Consumer 11.72 10.65 11.46 10.89 11.37 10.65 The following tables summarize the amount of gross premiums and interest related to long duration life and health contracts that are recognized in the Consolidated Statements of Operations for the three years ended December 31, 2024: Life Year Ended Year Ended Year Ended Gross Interest Gross Interest Gross Interest American Income $ 1,696,918 $ 272,007 $ 1,587,304 $ 252,277 $ 1,503,537 $ 234,098 Direct to Consumer 977,302 181,470 979,739 170,745 973,429 159,945 Liberty National 367,278 122,727 345,196 120,083 322,497 117,681 Other 202,234 185,619 205,998 179,513 208,390 172,967 Total $ 3,243,732 $ 761,823 $ 3,118,237 $ 722,618 $ 3,007,853 $ 684,691 Health Year Ended Year Ended Year Ended Gross Interest Gross Interest Gross Interest United American $ 439,125 $ 5,739 $ 401,834 $ 7,002 $ 380,710 $ 7,532 Family Heritage 427,640 71,900 396,211 65,892 366,803 59,983 Liberty National 189,650 26,144 187,095 27,248 186,268 28,477 American Income 117,644 6,790 113,605 6,542 111,623 6,408 Direct to Consumer 15,033 — 14,283 — 14,290 — Total $ 1,189,092 $ 110,573 $ 1,113,028 $ 106,684 $ 1,059,694 $ 102,400
Schedule of Undiscounted and Discounted Expected Future Gross Premiums and Expected Future Benefits And Expenses	The following tables provide the undiscounted and discounted expected future net premiums, expected future gross premiums, and expected future policy benefits, at both original and current discount rates, for life and health contracts for the three years ended December 31, 2024: Life As of December 31, 2024 As of December 31, 2023 As of December 31, 2022 Not discounted At original discount rates At current discount rates Not discounted At original discount rates At current discount rates Not discounted At original discount rates At current discount rates American Income PV of expected future gross premiums $ 25,492,032 $ 14,410,088 $ 14,471,277 $ 24,265,464 $ 13,695,495 $ 14,264,077 $ 22,662,540 $ 12,832,811 $ 13,006,579 PV of expected future net premiums 8,233,110 4,656,710 4,645,917 8,001,107 4,523,329 4,681,888 7,480,182 4,246,723 4,273,156 PV of expected future policy benefits 31,831,310 9,508,589 9,870,692 30,623,947 9,061,833 10,163,627 28,318,683 8,409,761 9,119,104 DTC PV of expected future gross premiums $ 17,372,446 $ 9,077,304 $ 9,258,880 $ 17,506,091 $ 9,150,049 $ 9,761,706 $ 17,346,469 $ 9,086,945 $ 9,432,882 PV of expected future net premiums 10,481,376 5,504,912 5,622,906 10,774,655 5,664,259 6,052,651 10,769,174 5,680,864 5,910,224 PV of expected future policy benefits 25,841,419 8,660,948 9,125,112 25,723,752 8,656,752 9,714,516 25,356,573 8,477,892 9,225,451 Liberty National PV of expected future gross premiums $ 4,837,598 $ 2,817,204 $ 2,775,304 $ 4,660,783 $ 2,720,264 $ 2,784,916 $ 4,396,685 $ 2,561,304 $ 2,562,342 PV of expected future net premiums 1,849,200 1,047,022 1,048,447 1,897,696 1,077,831 1,129,716 1,885,533 1,066,123 1,094,407 PV of expected future policy benefits 9,073,624 3,340,219 3,377,517 8,905,815 3,338,252 3,605,392 8,613,975 3,272,980 3,429,256 Other PV of expected future gross premiums $ 3,627,855 $ 1,844,670 $ 1,942,849 $ 3,726,111 $ 1,889,930 $ 2,088,668 $ 3,814,915 $ 1,925,650 $ 2,075,874 PV of expected future net premiums 885,362 430,276 440,047 910,786 443,949 478,052 922,500 449,209 470,741 PV of expected future policy benefits 12,466,943 3,582,068 3,960,963 12,431,963 3,506,859 4,239,623 12,371,696 3,403,704 3,976,150 Total PV of expected future gross premiums $ 51,329,931 $ 28,149,266 $ 28,448,310 $ 50,158,449 $ 27,455,738 $ 28,899,367 $ 48,220,609 $ 26,406,710 $ 27,077,677 PV of expected future net premiums 21,449,048 11,638,920 11,757,317 21,584,244 11,709,368 12,342,307 21,057,389 11,442,919 11,748,528 PV of expected future policy benefits 79,213,296 25,091,824 26,334,284 77,685,477 24,563,696 27,723,158 74,660,927 23,564,337 25,749,961 Health As of December 31, 2024 As of December 31, 2023 As of December 31, 2022 Not discounted At original discount rates At current discount rates Not discounted At original discount rates At current discount rates Not discounted At original discount rates At current discount rates United American PV of expected future gross premiums $ 9,350,851 $ 5,738,332 $ 5,643,454 $ 8,682,707 $ 5,295,148 $ 5,396,402 $ 6,801,987 $ 4,285,863 $ 4,233,647 PV of expected future net premiums 6,442,648 3,948,855 3,885,530 5,955,294 3,625,803 3,697,771 4,680,560 2,941,262 2,908,501 PV of expected future policy benefits 6,584,800 4,026,860 3,960,432 6,148,565 3,741,530 3,814,328 4,915,174 3,080,633 3,046,829 Family Heritage PV of expected future gross premiums $ 7,242,884 $ 4,220,293 $ 3,938,234 $ 6,739,913 $ 3,982,571 $ 3,844,287 $ 6,329,183 $ 3,787,020 $ 3,518,288 PV of expected future net premiums 3,188,017 1,867,873 1,734,875 2,997,954 1,783,173 1,711,741 2,865,334 1,729,219 1,594,992 PV of expected future policy benefits 7,176,690 3,712,044 3,336,546 6,655,694 3,506,689 3,315,880 6,245,843 3,336,344 3,005,664 Liberty National PV of expected future gross premiums $ 2,039,441 $ 1,299,234 $ 1,316,967 $ 2,089,005 $ 1,325,869 $ 1,390,066 $ 2,271,423 $ 1,418,333 $ 1,458,880 PV of expected future net premiums 500,297 338,275 337,119 518,008 348,570 358,472 652,858 415,442 423,490 PV of expected future policy benefits 1,374,959 791,140 804,695 1,413,211 816,819 865,808 1,600,943 904,865 941,574 American Income PV of expected future gross premiums $ 1,770,862 $ 992,641 $ 1,012,919 $ 1,768,231 $ 991,448 $ 1,047,348 $ 1,750,393 $ 977,846 $ 1,004,239 PV of expected future net premiums 400,512 225,141 223,247 359,248 201,869 206,381 342,659 192,631 190,296 PV of expected future policy benefits 709,637 348,711 355,303 640,326 315,431 335,504 617,973 303,713 312,750 Direct to Consumer PV of expected future gross premiums $ 248,646 $ 157,812 $ 159,862 $ 236,776 $ 149,119 $ 156,612 $ 177,131 $ 116,212 $ 119,457 PV of expected future net premiums 208,577 131,919 133,377 174,738 109,880 115,363 133,995 87,751 90,143 PV of expected future policy benefits 204,099 127,975 129,277 163,087 104,501 109,482 127,911 85,212 87,532 Total PV of expected future gross premiums $ 20,652,684 $ 12,408,312 $ 12,071,436 $ 19,516,632 $ 11,744,155 $ 11,834,715 $ 17,330,117 $ 10,585,274 $ 10,334,511 PV of expected future net premiums 10,740,051 6,512,063 6,314,148 10,005,242 6,069,295 6,089,728 8,675,406 5,366,305 5,207,422 PV of expected future policy benefits 16,050,185 9,006,730 8,586,253 15,020,883 8,484,970 8,441,002 13,507,844 7,710,767 7,394,349
Schedule of Policyholder Account Balance	The following table summarizes the balances of, and changes in, policyholders’ account balances for the three years ended December 31, 2024: Policyholders' Account Balances 2024 2023 2022 Interest Sensitive Life Deferred Annuity Other Policy-holders' Funds Interest Sensitive Life Deferred Annuity Other Policy-holders' Funds Interest Sensitive Life Deferred Annuity Other Policy-holders' Funds Balance at January 1, $ 732,948 $ 773,039 $ 236,958 $739,105 $ 954,318 $ 123,236 $ 745,335 $ 1,033,525 $ 99,468 Issuances — 875 — — 896 — — 1,528 — Premiums received 20,928 11,332 240,802 22,036 13,209 122,136 23,439 22,873 30,591 Policy charges (12,295) — — (12,926) — — (13,573) — — Surrenders and withdrawals (22,479) (107,707) (13,897) (21,215) (165,584) (13,042) (21,994) (92,235) (11,615) Benefit payments (30,512) (43,955) — (29,909) (57,937) — (32,889) (44,456) — Interest credited 27,790 23,634 21,165 28,320 28,150 9,314 28,579 32,779 4,589 Other 7,009 (645) (16,424) 7,537 (13) (4,686) 10,208 304 203 Balance at December 31, $ 723,389 $ 656,573 $ 468,604 $ 732,948 $ 773,039 $ 236,958 $ 739,105 $ 954,318 $ 123,236 Weighted-average credit rate 3.82 % 3.31 % 6.00 % 3.85 % 3.26 % 5.17 % 3.85 % 3.30 % 4.12 % Net amount at risk $ 1,663,496 N/A N/A $ 1,766,170 N/A N/A $ 1,873,315 N/A N/A Cash surrender value $ 677,111 $ 656,573 $ 468,604 $ 671,596 $ 773,039 $ 236,958 $ 689,546 $ 954,309 $ 123,236
Schedule of Policyholder Account Balance, Guaranteed Minimum Crediting Rate	The following tables present the policyholders' account balances by range of guaranteed minimum crediting rates and the related range of difference, if any, in basis points between rates being credited to policy holders and the respective guaranteed minimums as of December 31, 2024, 2023, and 2022: At December 31, 2024 Range of guaranteed minimum crediting rates Interest Sensitive Life Deferred Annuity Other Policyholders' Funds At guaranteed minimum: Less than 3.00% $ — $ 1,812 $ 373,584 3.00%-3.99% 29,251 473,191 3,182 4.00%-4.99% 604,412 181,570 55,876 Greater than 5.00% 89,726 — 35,962 Total 723,389 656,573 468,604 51-150 basis points above: Less than 3.00% — — — 3.00%-3.99% — — — 4.00%-4.99% — — — Greater than 5.00% — — — Total — — — Grand Total $ 723,389 $ 656,573 $ 468,604 At December 31, 2023 Range of guaranteed minimum crediting rates Interest Sensitive Life Deferred Annuity Other Policyholders' Funds At guaranteed minimum: Less than 3.00% $ — $ 1,945 $ 138,684 3.00%-3.99% 29,086 574,939 3,790 4.00%-4.99% 613,704 195,390 6,861 Greater than 5.00% 90,158 765 37,556 Total 732,948 773,039 186,891 51-150 basis points above: Less than 3.00% — — — 3.00%-3.99% — — — 4.00%-4.99% — — 50,067 Greater than 5.00% — — — Total — — 50,067 Grand Total $ 732,948 $ 773,039 $ 236,958 At December 31, 2022 Range of guaranteed minimum crediting rates Interest Sensitive Life Deferred Annuity Other Policyholders' Funds At guaranteed minimum: Less than 3.00% $ — $ 2,040 $ 23,042 3.00%-3.99% 28,867 743,299 4,074 4.00%-4.99% 620,594 208,979 58,251 Greater than 5.00% 89,644 — 37,869 Total 739,105 954,318 123,236 51-150 basis points above: Less than 3.00% — — — 3.00%-3.99% — — — 4.00%-4.99% — — — Greater than 5.00% — — — Total — — — Grand Total $ 739,105 $ 954,318 $ 123,236

Deferred Acquisition Costs (Tab

Deferred Acquisition Costs (Tables)	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Schedule of Analysis of Deferred Acquisition Costs	Life American Income DTC Liberty National Other Total Balance at January 1, 2022 $ 1,960,254 $ 1,583,695 $ 566,419 $ 301,647 $ 4,412,015 Capitalizations 450,600 188,083 90,385 13,504 742,572 Amortization expense (141,108) (94,847) (46,081) (16,805) (298,841) Foreign exchange adjustment (11,455) — — — (11,455) Balance at December 31, 2022 $ 2,258,291 $ 1,676,931 $ 610,723 $ 298,346 $ 4,844,291 Balance at January 1, 2023 $ 2,258,291 $ 1,676,931 $ 610,723 $ 298,346 $ 4,844,291 Capitalizations 471,771 159,650 107,230 13,053 751,704 Amortization expense (159,898) (99,464) (51,534) (16,530) (327,426) Foreign exchange adjustment 3,206 — — — 3,206 Balance at December 31, 2023 $ 2,573,370 $ 1,737,117 $ 666,419 $ 294,869 $ 5,271,775 Balance at January 1, 2024 $ 2,573,370 $ 1,737,117 $ 666,419 $ 294,869 $ 5,271,775 Capitalizations 524,980 145,538 119,203 12,172 801,893 Amortization expense (181,431) (101,425) (56,832) (16,535) (356,223) Foreign exchange adjustment (16,690) — — — (16,690) Balance at December 31, 2024 $ 2,900,229 $ 1,781,230 $ 728,790 $ 290,506 $ 5,700,755 Health United American Family Heritage Liberty National American Income DTC Total Balance at January 1, 2022 $ 81,140 $ 388,967 $ 127,537 $ 49,406 $ 2,032 $ 649,082 Capitalizations 2,135 53,117 18,737 12,378 4 86,371 Amortization expense (5,881) (25,476) (13,178) (3,467) (182) (48,184) Foreign exchange adjustment — — — (506) — (506) Balance at December 31, 2022 $ 77,394 $ 416,608 $ 133,096 $ 57,811 $ 1,854 $ 686,763 Balance at January 1, 2023 $ 77,394 $ 416,608 $ 133,096 $ 57,811 $ 1,854 $ 686,763 Capitalizations 1,941 63,366 20,309 12,849 — 98,465 Amortization expense (5,846) (27,131) (13,464) (3,982) (175) (50,598) Foreign exchange adjustment — — — 105 — 105 Balance at December 31, 2023 $ 73,489 $ 452,843 $ 139,941 $ 66,783 $ 1,679 $ 734,735 Balance at January 1, 2024 $ 73,489 $ 452,843 $ 139,941 $ 66,783 $ 1,679 $ 734,735 Capitalizations 2,608 70,311 23,775 14,955 2 111,651 Amortization expense (5,567) (27,035) (14,796) (4,678) (148) (52,224) Foreign exchange adjustment — — — (741) — (741) Balance at December 31, 2024 $ 70,530 $ 496,119 $ 148,920 $ 76,319 $ 1,533 $ 793,421 The following table presents a reconciliation of deferred policy acquisition costs to the Consolidated Balance Sheets for the three years ended December 31, 2024: December 31, 2024 2023 2022 Life American Income $ 2,900,229 $ 2,573,370 $ 2,258,291 Direct to Consumer 1,781,230 1,737,117 1,676,931 Liberty National 728,790 666,419 610,723 Other 290,506 294,869 298,346 Total DAC—Life 5,700,755 5,271,775 4,844,291 Health United American 70,530 73,489 77,394 Family Heritage 496,119 452,843 416,608 Liberty National 148,920 139,941 133,096 American Income 76,319 66,783 57,811 Direct to Consumer 1,533 1,679 1,854 Total DAC—Health 793,421 734,735 686,763 Annuity 1,413 2,967 4,643 Tota l $ 6,495,589 $ 6,009,477 $ 5,535,697

Liability for Unpaid Claims (Ta

Liability for Unpaid Claims (Tables)	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Schedule of Liability for Unpaid Health Claims	Activity in the liability for unpaid health claims is summarized as follows: Year Ended December 31, 2024 2023 2022 Balance at January 1, $ 194,809 $ 184,286 $ 173,737 Less reinsurance recoverables (2,157) (2,084) (2,628) Net balance at January 1, 192,652 182,202 171,109 Incurred related to: Current year 767,076 697,521 676,189 Prior years (10,460) (4,853) (15,631) Total incurred 756,616 692,668 660,558 Paid related to: Current year 587,473 535,971 517,855 Prior years 152,322 146,247 131,610 Total paid 739,795 682,218 649,465 Net balance at December 31, 209,473 192,652 182,202 Plus reinsurance recoverables 1,521 2,157 2,084 Balance at December 31, $ 210,994 $ 194,809 $ 184,286
Schedule of Reconciliation of Policy Claims and Other Benefits Payable	Below is the reconciliation of the liability of "Policy claims and other benefits payable" in the Consolidated Balance Sheets . December 31, 2024 2023 Policy claims and other benefits payable: Life insurance $ 321,838 $ 320,066 Health insurance 210,994 194,809 Total $ 532,832 $ 514,875

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Schedule of Components of Income Taxes	The following table discloses significant components of income taxes for each year presented: Year Ended December 31, 2024 2023 2022 Income tax expense (benefit) from operations: Current income tax expense (benefit) $ 218,135 $ 145,880 $ 138,968 Deferred income tax expense (benefit) 37,740 77,631 68,757 255,875 223,511 207,725 Shareholders’ equity: Other comprehensive income (loss) 197,427 4,762 384,035 $ 453,302 $ 228,273 $ 591,760
Schedule of Effective Income Tax Rate	The effective income tax rate differed from the expected U.S. federal statutory rate of 21% as shown below: Year Ended December 31, 2024 % 2023 % 2022 % Expected federal income tax expense (benefit) $ 278,594 21.0 $ 250,796 21.0 $ 231,443 21.0 Increase (reduction) in income taxes resulting from: Low-income housing investments (9,700) (0.7) (14,291) (1.2) (11,443) (1.1) Share-based awards 1,341 0.1 (4,724) (0.4) (5,251) (0.5) Tax-exempt investment income (9,644) (0.7) (9,644) (0.8) (8,961) (0.8) Other tax credits (5,000) (0.4) — — — — Other 284 — 1,374 0.1 1,937 0.2 Income tax expense (benefit) $ 255,875 19.3 $ 223,511 18.7 $ 207,725 18.8
Schedule of Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities	The tax effects of temporary differences that gave rise to significant portions of the deferred tax assets and deferred tax liabilities are presented below: December 31, 2024 2023 Deferred tax assets: Unrealized losses $ 532,756 $ 732,750 Carryover of tax losses 10,342 4,227 Total gross deferred tax assets 543,098 736,977 Less valuation allowance (3,383) — Net deferred tax assets 539,715 736,977 Deferred tax liabilities: Employee and agent compensation 104,385 100,689 Deferred acquisition costs 961,406 892,149 Future policy benefits, unearned and advance premiums, and policy claims 228,117 267,564 Other liabilities 24,432 17,466 Total gross deferred tax liabilities 1,318,340 1,277,868 Net deferred tax liability $ 778,625 $ 540,891

Postretirement Benefits (Tables

Postretirement Benefits (Tables)	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Schedule of Net Periodic Benefit Cost	The total cost of these retirement plans charged to operations was as follows: Year Ended December 31, 2024 2023 2022 Plan Type: Defined Contribution Plans (1) $ 6,605 $ 6,390 $ 5,824 Defined Benefit Pension Plans (2) 16,458 15,225 37,040 (1) 401K plans. (2) Qualified pension plans and SERP.
Schedule of Pension Assets by Component at Fair Value	The following table presents the assets of the Company's Pension Plans at December 31, 2024 and 2023: Pension Assets by Component at December 31, 2024 Fair Value Determined by: Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Observable Inputs (Level 2) Significant Total Amount % of Exchange traded fund (4) $ 35,483 $ — $ — $ 35,483 6 Equity exchange traded fund (1) 322,846 — — 322,846 53 U.S. Government and Agency — 179,418 — 179,418 29 Other bonds — 4 — 4 — Guaranteed annuity contract (2) — 43,893 — 43,893 7 Short-term investments 1,235 — — 1,235 — Other 1,420 — — 1,420 — $ 360,984 $ 223,315 $ — 584,299 95 Other long-term investments (3) 30,546 5 Total pension assets $ 614,845 100 (1) A fund including marketable securities that mirror the S&P 500 index. (2) Representing a guaranteed annuity contract issued by Globe Life Inc.'s subsidiary, American Income Life Insurance Company, to fund the obligations of the American Income Life Insurance Company Collective Bargaining Agreement Employees Pension Plan. (3) Includes non-redeemable investment funds that report the Globe Life Inc. Pension Plan's pro-rata share of the limited partnership's net asset value (NAV) per share, or its equivalent, as a practical expedient for fair value. As of December 31, 2024, the Globe Life Inc. Pension Plan owned less than 1% of two long-term investment funds. (4) A fund including U.S. dollar-denominated investment-grade securities issued by industrial, utility, and financial companies with maturities greater than 10 years. Pension Assets by Component at December 31, 2023 Fair Value Determined by: Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Amount % of Exchange traded fund (4) $ 18,715 $ — $ — $ 18,715 3 Equity exchange traded fund (1) 315,886 — — 315,886 55 U.S. Government and Agency — 167,450 — 167,450 30 Other bonds — 5 — 5 — Guaranteed annuity contract (2) — 43,428 — 43,428 8 Short-term investments 6,506 — — 6,506 1 Other 463 — — 463 — $ 341,570 $ 210,883 $ — 552,453 97 Other long-term investments (3) 18,314 3 Total pension assets $ 570,767 100 (1) A fund including marketable securities that mirror the S&P 500 index. (2) Representing a guaranteed annuity contract issued by Globe Life Inc.'s subsidiary, American Income Life Insurance Company, to fund the obligations of the American Income Life Insurance Company Collective Bargaining Agreement Employees Pension Plan. (3) Includes non-redeemable investment funds that report the Globe Life Inc. Pension Plan's pro-rata share of the limited partnership's net asset value (NAV) per share, or its equivalent, as a practical expedient for fair value. As of December 31, 2023, the Globe Life Inc. Pension Plan owned less than 1% of two long-term investment funds. (4)
Schedule of Investment Funds	The following table presents additional information about the Company's investment funds as of December 31, 2024 and December 31, 2023 at fair value: Fair Value Unfunded Commitments (2) Investment Category 2024 2023 2024 Redemption Term/Notice (1) Commercial mortgage loans $ 566,142 $ 411,315 $ 189,725 Fully redeemable and non-redeemable with varying terms. Opportunistic and private credit 202,008 181,410 191,192 Fully redeemable and non-redeemable with varying terms. Infrastructure 179,627 165,887 — Fully redeemable and non-redeemable with varying terms. Other 38,989 36,971 52,479 Non-redeemable with varying terms Total investment funds $ 986,766 $ 795,583 $ 433,396 (1) Non-redeemable funds generally have an expected life of 7 to 12 years from fund closing with extension options of 1 to 4 years. Redemptions are paid out throughout the life of the funds at the General Partner's discretion. Redeemable funds can generally be redeemed over 6 to 36 months upon request from limited partners. (2) Unfunded commitments include unfunded balances during the investment period. After an investment period ends, the fund can call capital based on limited and specified reasons. As of December 31, 2024, unfunded commitments totaled $645 million, including funds past the investment period. The following table presents additional information about the Company's investment funds included in pension plan assets as of December 31, 2024 and December 31, 2023 at fair value: Fair Value Unfunded Commitments (2) Investment Category 2024 2023 2024 Redemption Term/Notice (1) Multi-asset class $ 12,383 $ 14,714 $ — Non-redeemable Private equity 18,163 3,600 48,167 Non-redeemable Total $ 30,546 $ 18,314 $ 48,167 (1) Non-redeemable funds generally have an expected life of 7 to 10 years from fund closing with extension options of 2 to 4 years. Redemptions are paid out throughout the life of the funds at the General Partner's discretion. (2) Unfunded commitments include unfunded balances during the investment period. After an investment period ends, the fund can call capital based on limited and specified reasons. As of December 31, 2024, unfunded commitments totaled $57.5 million, including funds past the investment period.
Schedule of Information Regarding the SERP	The following tables include premiums paid for COLI for the three years ended December 31, 2024 and investments of the Rabbi Trust for the two years ended December 31, 2024: Year Ended December 31, 2024 2023 2022 Premiums paid for insurance coverage $ 443 $ 443 $ 443 At December 31, 2024 2023 Total investments: COLI $ 57,210 $ 55,185 Exchange traded funds 98,314 86,156 $ 155,524 $ 141,341
Schedule of Pension Liability	The following table presents the projected benefit obligation (PBO) and accumulated benefit obligation (ABO) for the Pension Plans and SERP at December 31, 2024 and 2023: December 31, 2024 2023 PBO ABO PBO ABO Pension plans $ 561,615 $ 500,010 $ 554,957 $ 493,040 SERP 73,441 68,428 72,603 69,332 Benefit obligation $ 635,056 $ 568,438 $ 627,560 $ 562,372 For the year ended December 31, 2024, the Pension Plans have plan assets with fair values in excess of projected benefit obligations. The projected benefit obligations and the fair value of plan assets were as follows: At December 31, 2024 2023 Funded benefit pension plans PBO $ 561,615 $ 554,957 Funded benefit pension plans fair value of plan assets 614,845 570,767 For the year ended December 31, 2024, the funded benefit pension plans have plan assets with fair value in excess of the accumulated benefit obligations. The accumulated benefit obligations and the fair value of plan assets were as follows: At December 31, 2024 2023 Funded benefit pension plans ABO $ 500,010 $ 493,040 Funded benefit pension plans fair value of plan assets 614,845 570,767
Weighted Average Pension Plan Assumptions	The following table discloses the assumptions used to determine Globe Life's pension liabilities and costs for the appropriate periods. The discount and compensation increase rates are used to determine current year projected benefit obligations and subsequent year pension expense. The long-term rate of return is used to determine current year expense. Differences between assumptions and actual experience are included in actuarial gain or loss. Weighted Average Pension Plan Assumptions For Benefit Obligations at December 31: 2024 2023 Discount rate 5.81 % 5.40 % Rate of compensation increase 4.46 4.40 For Periodic Benefit Cost for the Year: 2024 2023 2022 Discount rate 5.40 % 5.71 % 3.19 % Expected long-term returns 7.18 6.98 6.98 Rate of compensation increase 4.40 4.40 4.43
Components of Net Periodic Pension Costs and Post-Retirement Benefit Costs	The following table presents the net periodic benefit cost for the defined benefit plans by expense component for the three years ended December 31, 2024 as follows: Components of Net Periodic Benefit Cost Year Ended December 31, 2024 2023 2022 Service cost—benefits earned during the period $ 24,898 $ 21,568 $ 34,624 Interest cost on projected benefit obligation 33,123 31,367 24,445 Expected return on assets (42,580) (38,625) (35,539) Amortization of prior service cost (credit) 1,071 1,075 1,077 Recognition of actuarial gain (loss) (54) (160) 12,433 Net periodic benefit cost $ 16,458 $ 15,225 $ 37,040
Analysis of Impact on Other Comprehensive Income (Loss)	An analysis of the impact on other comprehensive income (loss) concerning pensions and other postretirement benefits is as follows: Year Ended December 31, 2024 2023 2022 Balance at January 1 $ (2,727) $ 1,570 $ (131,239) Amortization of: Prior service cost (credit) 1,071 1,075 1,077 Net actuarial (gain) loss (1) (597) (1,465) 12,677 Total amortization 474 (390) 13,754 Plan amendments (1,212) — — Experience gain (loss) (2) 29,659 (3,907) 119,055 Balance at December 31 $ 26,194 $ (2,727) $ 1,570 (1) Includes amortization of postretirement benefits other than pensions of $(622) thousand in 2024, $(732) thousand in 2023, and $289 thousand in 2022. (2) The increase in the experience gain (loss) is related to an increase in discount rate.
Reconciliation of Benefit Obligation and Plan Assets	The following table presents a reconciliation from the beginning to the end of the year of the PBO for the Pension Plans and SERP, and the plan assets for the Pension Plans. This table also presents the amounts previously recognized as a component of accumulated other comprehensive income. Pension Benefits Year Ended December 31, 2024 2023 Changes in PBO: PBO at beginning of year $ 627,560 $ 562,567 Service cost 24,898 21,568 Interest cost 33,123 31,367 Plan amendments 1,212 — Actuarial loss (gain) (22,964) 40,569 Benefits paid (28,773) (28,511) PBO at end of year 635,056 627,560 Changes in plan assets: Fair value at beginning of year 570,767 499,775 Return on assets 48,084 75,062 Contributions 24,767 24,441 Benefits paid (28,773) (28,511) Fair value at end of year 614,845 570,767 Funded status at year end $ (20,211) $ (56,793)
Schedule of Amounts Recognized as Components Accumulated Other Comprehensive Income	Changes in the PBO related to actuarial losses (gains) are primarily attributed to changes in the discount rate. Year Ended December 31, Amounts recognized in accumulated other comprehensive income consist of: 2024 2023 Net loss (gain) $ (28,720) $ (227) Prior service cost 6,636 6,494 Net amounts recognized at year end $ (22,084) $ 6,267
Estimated Future Payments for Post-Retirement Benefit Plans	Globe Life has estimated its expected postretirement benefits to be paid over the next ten years as of December 31, 2024. These estimates use the same assumptions that measure the benefit obligation at December 31, 2024, taking estimated future employee service into account. Those estimated benefits are as follows: For the year(s): 2025 $ 31,035 2026 33,565 2027 36,259 2028 39,032 2029 41,865 2030-2034 243,598

Supplemental Disclosures of C_2

Supplemental Disclosures of Cash Flow Information (Tables)	12 Months Ended
	Dec. 31, 2024
Supplemental Cash Flow Elements [Abstract]
Schedule of Noncash Transactions	The following table summarizes Globe Life's noncash transactions for the three years ended December 31, 2024, which are not reflected on the Consolidated Statements of Cash Flows : Year Ended December 31, 2024 2023 2022 Stock-based compensation not involving cash $ 40,118 $ 30,736 $ 35,650 Commitments for low-income housing interests 35,000 — 136,882 Exchanges of fixed maturity investments 105,595 50,936 147,612 Net unsettled security trades 2,334 3,833 — Noncash tax credits — 1,083 1,000
Schedule of Amounts Paid	The following table summarizes certain amounts paid during the period: Year Ended December 31, 2024 2023 2022 Interest paid $ 116,993 $ 99,545 $ 88,814 Income taxes paid (1) 175,400 121,034 114,888 (1)

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Schedule of Selected Information about Debt Issues	The following table presents information about the terms and outstanding balances of Globe Life's debt. Selected Information about Debt Issues As of December 31, 2024 2023 Instrument Issue Date Maturity Date Coupon Rate Par Unamortized Discount & Issuance Costs Book Fair Book Senior notes 09/27/2018 09/15/2028 4.550% $ 550,000 $ (3,001) $ 546,999 $ 542,811 $ 546,283 Senior notes 08/21/2020 08/15/2030 2.150% 400,000 (2,868) 397,132 338,524 396,670 Senior notes (1) 05/19/2022 06/15/2032 4.800% 250,000 (3,728) 246,272 241,083 245,873 Senior notes 08/23/2024 09/15/2034 5.850% 450,000 (5,186) 444,814 451,665 — Junior subordinated debentures 11/17/2017 11/17/2057 5.275% 125,000 (1,557) 123,443 95,865 123,427 Junior subordinated debentures 06/14/2021 06/15/2061 4.250% 325,000 (7,613) 317,387 204,620 317,306 Term loan (2) 05/11/2023 08/15/2027 5.998% 250,000 (1,796) 248,204 248,204 — Total long-term debt 2,350,000 (25,749) 2,324,251 2,122,772 1,629,559 Term loan (2) — — — — 169,549 Commercial paper 419,000 (3,599) 415,401 415,401 316,564 Total short-term debt 419,000 (3,599) 415,401 415,401 486,113 Total debt $ 2,769,000 $ (29,348) $ 2,739,652 $ 2,538,173 $ 2,115,672 (1) An additional $150 million par value and book value is held by insurance subsidiaries that eliminates in consolidation. (2) Interest calculated quarterly using Secured Overnight Financing Rate (SOFR) plus 135 basis points. Credit Facility—Commercial Paper (Dollar amounts in thousands) At December 31, 2024 2023 Balance commercial paper at end of period (at par value) $ 419,000 $ 319,000 Annualized interest rate 5.22 % 5.71 % Letters of credit outstanding $ 115,000 $ 115,000 Remaining amount available under credit line 466,000 316,000 Credit Facility—Commercial Paper Activity (Dollar amounts in thousands) Year Ended December 31, 2024 2023 2022 Average balance of commercial paper outstanding during period (par value) $ 405,573 $ 290,024 $ 322,531 Daily-weighted average interest rate (annualized) 5.65 % 5.40 % 1.89 % Maximum daily amount outstanding during period (par value) $ 633,425 $ 477,700 $ 500,529 Commercial paper issued during period (par value) 2,052,056 2,029,000 2,269,444 Commercial paper matured during period (par value) (1,952,056) (1,995,000) (2,314,477) Net commercial paper issued (matured) during period (par value) 100,000 34,000 (45,033)
Schedule of Maturities of Long-term Debt	The following table presents expected scheduled principal payments under our contractual debt obligations: Year Ended December 31, 2025 2026 2027 2028 2029 Thereafter Debt obligations $ 419,000 $ — $ 250,000 $ 550,000 $ — $ 1,550,000

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Schedule of Common Stock Activity	A summary of common share activity is presented in the following chart. Common Stock Issued Treasury 2022: Balance at January 1, 2022 109,218,183 (9,650,845) Grants of restricted stock — 10,746 Vesting of performance shares — 66,751 Issuance of common stock due to exercise of stock options — 1,519,728 Treasury stock acquired — (4,424,668) Retirement of treasury stock (4,000,000) 4,000,000 Balance at December 31, 2022 105,218,183 (8,478,288) 2023: Grants of restricted stock — 7,110 Vesting of performance shares — 84,298 Issuance of common stock due to exercise of stock options — 1,375,313 Treasury stock acquired — (4,415,287) Retirement of treasury stock (3,000,000) 3,000,000 Balance at December 31, 2023 102,218,183 (8,426,854) 2024: Grants of restricted stock — 7,375 Vesting of performance shares — 143,211 Issuance of common stock due to exercise of stock options — 584,993 Treasury stock acquired — (10,549,341) Retirement of treasury stock (5,000,000) 5,000,000 Balance at December 31, 2024 97,218,183 (13,240,616)
Schedule of Acquisition of Common Shares	See the following summary below: Globe Life Share Repurchase Program Share Repurchase for Dilution Purposes Shares Acquired Total Cost Average Price Shares Acquired Total Cost Average Price 2024 10,086 $ 945,637 $ 93.76 501 $ 48,026 $ 95.75 2023 3,369 380,103 112.84 1,080 127,155 117.72 2022 3,322 335,145 100.90 1,103 119,493 108.33
Schedule of Reconciliation of Basic and Diluted Weighted Average Shares Outstanding	A reconciliation of basic and diluted weighted-average shares outstanding used in the computation of basic and diluted earnings per share is as follows: Year Ended December 31, 2024 2023 2022 Basic weighted average shares outstanding 89,278,574 95,098,474 97,927,770 Weighted average dilutive options outstanding 382,848 1,265,367 1,056,874 Diluted weighted average shares outstanding 89,661,422 96,363,841 98,984,644 Antidilutive shares 2,140,787 422,739 31,269

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Grant Contract Periods and Vesting Periods	Options generally vest in accordance with the following schedule: Shares vested by period Contract Period 6 Months Year 1 Year 2 Year 3 Year 4 Year 5 Directors 7 years 100% —% —% —% —% —% Employees 7 years —% —% 50% 50% —% —%
Schedule of Stock Compensation Activity	A summary of stock compensation activity for each of the three years ended December 31, 2024 is presented below: 2024 2023 2022 Stock-based compensation expense recognized (1) $ 40,118 $ 30,736 $ 35,650 Tax benefit recognized 7,085 11,178 12,738 (1) No stock-based compensation expense was capitalized in any period in accordance with applicable GAAP.
Schedule of Additional Information of Stock-Based Compensation	Additional stock compensation information is as follows at December 31: 2024 2023 Unrecognized compensation (1) $ 46,956 $ 36,599 Weighted average period of expected recognition (in years) (1) 0.53 0.53 (1)
Schedule of Options Outstanding	Options: The following table summarizes information about stock options outstanding at December 31, 2024. Options Outstanding Options Exercisable Range of Number Weighted- Weighted- Number Weighted- $50.64 - $87.60 1,609,506 1.48 $ 81.93 1,609,506 $ 81.93 92.40 - 100.74 1,994,603 2.66 99.47 1,994,603 99.47 103.23 1,187,349 4.15 103.23 734,148 103.23 105.56 - 128.40 1,034,499 5.56 123.96 38,179 108.55 $50.64 - $128.40 5,825,957 3.15 $ 99.74 4,376,436 $ 93.73
Schedule of Analysis of Option Activity	An analysis of option activity for each of the three years ended December 31, 2024, is as follows: 2024 2023 2022 Options Weighted-Average Options Weighted-Average Options Weighted-Average Outstanding—beginning of year 5,940,320 $ 96.19 6,962,374 $ 91.73 7,197,662 $ 85.11 Granted: 7-year term 520,810 128.32 497,060 120.49 1,300,211 103.20 Exercised (584,993) 88.52 (1,375,313) 82.95 (1,519,728) 70.14 Expired and forfeited (50,180) 106.62 (143,801) 90.92 (15,771) 96.54 Outstanding—end of year 5,825,957 $ 99.74 5,940,320 $ 96.19 6,962,374 $ 91.73 Exercisable at end of year 4,376,436 $ 93.73 4,003,028 $ 91.23 3,666,871 $ 84.00
Schedule of Additional Information on Unvested Options	Additional information about Globe Life's stock option activity as of December 31, 2024 and 2023 is as follows: 2024 2023 Outstanding options: Weighted-average remaining contractual term (in years) 3.15 3.68 Aggregate intrinsic value $ 81,703 $ 151,685 Exercisable options: Weighted-average remaining contractual term (in years) 2.48 3.01 Aggregate intrinsic value $ 77,946 $ 122,052 Selected stock option activity for the three years ended December 31, 2024, is presented below: 2024 2023 2022 Weighted-average grant-date fair value of options granted $ 33.80 $ 32.25 $ 22.03 Intrinsic value of options exercised 17,127 49,163 58,201 Cash received from options exercised 51,786 114,080 106,592 Actual tax benefit received 2,489 9,379 11,907 Additional information concerning Globe Life's unvested options is as follows at December 31: 2024 2023 Number of shares outstanding 1,449,521 1,937,292 Weighted-average exercise price (per share) $ 117.88 $ 106.42 Weighted-average remaining contractual term (in years) 5.19 5.05 Aggregate intrinsic value $ 3,757 $ 29,634
Schedule of Restricted Stock Units Outstanding And Vested	Following are the restricted stock units outstanding for each of the three years ended December 31, 2024: Year of grants Outstanding as of year end 2022 93,381 2023 163,108 2024 219,864
Schedule of Performance Shares Settled	Below is the final determination of the performance share grants in 2020 to 2022: Year of grants Final settlement of shares Final settlement date 2020 84,298 February 22, 2023 2021 143,211 February 28, 2024 2022 152,680 February 26, 2025
Schedule of Restricted Stock and Restricted Stock Units Granted	A summary of restricted stock grants for each of the years in the three-year period ended December 31, 2024, is presented in the table below: 2024 2023 2022 Directors restricted stock: Shares 7,375 7,110 10,746 Price per share $ 122.06 $ 119.59 $ 94.94 Aggregate value $ 900 $ 850 $ 1,020 Percent vested 100 % 100 % 100 % Directors restricted stock units (including dividend equivalents): Shares 4,854 9,479 8,956 Price per share $ 120.16 $ 117.73 $ 95.62 Aggregate value $ 583 $ 1,116 $ 856 Percent vested 100 % 100 % 100 % Employees restricted stock units: Shares 101,011 96,975 — Price per share $ 127.29 $ 120.18 $ — Aggregate value $ 12,858 $ 11,654 $ — Percent vested — % — % — % Performance shares: Target shares 96,800 81,300 146,500 Target price per share $ 128.40 $ 120.49 $ 103.23 Aggregate value $ 12,429 $ 9,796 $ 15,123 Percent vested — % — % — %
Schedule of Analysis of Unvested Restricted Stock	An analysis of nonvested restricted stock is as follows: Executive Directors Directors Employees Restricted Stock Units Total 2022: Balance at December 31, 2021 342,388 289 289 — 342,966 Grants 146,500 10,746 8,956 — 166,202 Additional performance shares (1) (16,102) — — — (16,102) Restriction lapses (66,751) (11,035) (9,245) — (87,031) Forfeitures (7,500) — — — (7,500) Balance at December 31, 2022 398,535 — — — 398,535 2023: Grants 81,300 7,110 9,479 96,975 194,864 Additional performance shares (1) (28,857) — — — (28,857) Restriction lapses (84,298) (7,110) (9,479) — (100,887) Forfeitures (12,600) — — (4,410) (17,010) Balance at December 31, 2023 354,080 — — 92,565 446,645 2024: Grants 96,800 7,375 4,854 101,011 210,040 Additional performance shares (1) 84,712 — — — 84,712 Restriction lapses (143,211) (7,375) (4,854) (437) (155,877) Forfeitures (6,000) — — (10,008) (16,008) Balance at December 31, 2024 386,381 — — 183,131 569,512 (1) Estimated additional (reduced) share grants expected due to achievement of performance criteria.
Schedule of Weighted-Average Grant-Date Fair Values of Unvested Restricted Stock	An analysis of the weighted-average grant-date fair values per share of nonvested restricted stock is as follows for the year 2024: Executive Performance Shares Directors Restricted Stock Directors Restricted Stock Units Employees Restricted Stock Units Grant-date fair value per share at January 1, 2024 $ 105.28 $ — $ — $ 120.16 Grants 128.40 122.06 122.06 127.29 Estimated additional performance shares 107.56 — — — Restriction lapses (98.32) (122.06) (122.06) (94.40) Forfeitures — — — (122.74) Grant-date fair value per share at December 31, 2024 115.78 — — 124.02

Business Segments (Tables)

Business Segments (Tables)	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Schedule of Segment Premium Income by Distribution Channel	The following tables present segment premium revenue by each of Globe Life's distribution channels. Premium Income by Distribution Channel For the Year 2024 Life Health Total Distribution Channel Amount % of Amount % of Amount % of American Income $ 1,698,209 52 $ 123,123 9 $ 1,821,332 39 Direct to Consumer 988,522 30 71,993 5 1,060,515 23 Liberty National 371,061 12 190,381 14 561,442 12 United American 6,600 — 591,774 42 598,374 13 Family Heritage 6,661 — 427,654 30 434,315 9 Other 190,294 6 — — 190,294 4 Total premium $ 3,261,347 100 $ 1,404,925 100 $ 4,666,272 100 For the Year 2023 Life Health Total Distribution Channel Amount % of Total Amount % of Total Amount % of Total American Income $ 1,588,702 51 $ 120,332 9 $ 1,709,034 38 Direct to Consumer 991,406 32 68,575 5 1,059,981 24 Liberty National 349,736 11 187,934 14 537,670 12 United American 7,311 — 545,723 42 553,034 13 Family Heritage 6,134 — 396,209 30 402,343 9 Other 193,955 6 — — 193,955 4 Total premium $ 3,137,244 100 $ 1,318,773 100 $ 4,456,017 100 For the Year 2022 Life Health Total Distribution Channel Amount % of Total Amount % of Total Amount % of American Income $ 1,505,034 50 $ 117,353 9 $ 1,622,387 38 Direct to Consumer 985,488 33 71,129 5 1,056,617 24 Liberty National 327,469 11 187,241 15 514,710 12 United American 7,966 — 539,874 42 547,840 13 Family Heritage 5,586 — 366,820 29 372,406 9 Other 196,281 6 — — 196,281 4 $ 3,027,824 100 $ 1,282,417 100 4,310,241 100 Annuity 1 — Total premium $ 4,310,242 100
Schedule of Reconciliation of Segment Operating Information to Consolidated Statement of Operations	The following tables set forth a reconciliation of Globe Life's revenues and operations by segment to its major income statement line items. See Note 1—Significant Accounting Policies for additional information concerning reconciling items of segment profits to pretax income. Year Ended December 31, 2024 Life Health Investment Consolidated Revenue: Premium $ 3,261,347 $ 1,404,925 $ — $ 4,666,272 Net investment income — — 1,135,631 1,135,631 Segment revenue 3,261,347 1,404,925 1,135,631 5,801,903 Other income 354 Realized gains (losses) (24,188) Total consolidated revenue $ 5,778,069 Expenses: Policy obligations (1) 2,000,977 851,577 20,969 $ 2,873,523 Required interest on reserves (811,147) (110,342) 950,258 28,769 Amortization of acquisition costs 356,223 52,224 — 408,447 Commissions 159,703 158,869 — 318,572 Premium taxes 68,360 28,421 — 96,781 Non-deferred acquisition costs 134,634 51,753 — 186,387 Segment profit or (loss) $ 1,352,597 $ 372,423 $ 164,404 1,889,424 Insurance administrative expenses: Salaries 129,369 Other employee costs 36,176 Information technology costs 80,555 Legal costs 30,478 Other administrative costs 65,852 Parent expense 12,400 Stock-based compensation expense 40,118 Interest expense 127,092 Legal proceedings 21,575 Non-operating expenses 2,620 Annuity (7,282) Total expenses 4,451,432 . Income before income taxes per Consolidated Statement of Operations $ 1,326,637 (1) Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities . Year Ended December 31, 2023 Life Health Investment Consolidated Revenue: Premium $ 3,137,244 $ 1,318,773 $ — $ 4,456,017 Net investment income — — 1,056,884 1,056,884 Segment revenue 3,137,244 1,318,773 1,056,884 5,512,901 Other income 308 Realized gains (losses) (65,676) Total consolidated revenue $ 5,447,533 Expenses: Policy obligations (1) 2,050,789 776,362 9,061 $ 2,836,212 Required interest on reserves (772,701) (106,516) 917,441 38,224 Amortization of acquisition costs 327,426 50,598 — 378,024 Commissions 145,678 150,192 — 295,870 Premium taxes 64,571 26,440 — 91,011 Non-deferred acquisition costs 128,509 43,760 — 172,269 Segment profit or (loss) $ 1,192,972 $ 377,937 $ 130,382 1,701,291 Insurance administrative expenses: Salaries 119,699 Other employee costs 35,905 Information technology costs 64,998 Legal costs 15,335 Other administrative costs 65,224 Parent expense 10,866 Stock-based compensation expense 30,736 Interest expense 102,316 Legal proceedings 900 Non-operating expenses 4,170 Annuity (8,492) Total expenses 4,253,267 Income before income taxes per Consolidated Statement of Operations $ 1,194,266 (1) Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities . Year Ended December 31, 2022 Life Health Investment Consolidated Revenue: Premium $ 3,027,824 $ 1,282,417 $ — $ 4,310,241 Net investment income — — 991,800 991,800 Segment revenue 3,027,824 1,282,417 991,800 5,302,041 Annuity premium income 1 Other income 1,246 Realized gains (losses) (76,548) Total consolidated revenue $ 5,226,740 Expenses: Policy obligations (1) 2,035,693 752,866 4,372 $ 2,792,931 Required interest on reserves (735,688) (102,315) 882,839 44,836 Amortization of acquisition costs 298,841 48,185 — 347,026 Commissions 140,283 145,185 — 285,468 Premium taxes 61,609 24,653 — 86,262 Non-deferred acquisition costs 97,561 36,706 — 134,267 Segment profit or (loss) $ 1,129,525 $ 377,137 $ 104,589 1,611,251 Insurance administrative expenses: Salaries 129,711 Other employee costs 42,319 Information technology costs 55,526 Legal costs 12,056 Other administrative costs 59,729 Parent expense 11,156 Stock-based compensation expense 35,650 Interest expense 90,395 Legal proceedings 2,496 Non-operating expenses 5,311 Annuity (10,510) Total expenses 4,124,629 Income before income taxes per Consolidated Statement of Operations $ 1,102,111 (1) Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities .
Schedule of Assets by Segment	The tables below reconcile segment assets to total assets as reported on the Consolidated Balance Sheets . Assets by Segment At December 31, 2024 Life Health Investment Consolidated Cash and invested assets $ — $ — $ 19,736,888 $ 19,736,888 Accrued investment income — — 269,791 269,791 Deferred acquisition costs 5,700,755 793,421 — 6,494,176 Goodwill 309,609 180,837 — 490,446 Total segment assets $ 6,010,364 $ 974,258 $ 20,006,679 26,991,301 Annuity and other corporate 2,084,880 Total assets $ 29,076,181 At December 31, 2023 Life Health Investment Consolidated Cash and invested assets $ — $ — $ 19,827,199 $ 19,827,199 Accrued investment income — — 270,396 270,396 Deferred acquisition costs 5,271,775 734,735 — 6,006,510 Goodwill 309,609 172,182 — 481,791 Total segment assets $ 5,581,384 $ 906,917 $ 20,097,595 26,585,896 Annuity and other corporate 1,465,603 Total assets $ 28,051,499
Schedule of Liabilities by Segment	The tables below reconcile segment liabilities to total liabilities as reported on the Consolidated Balance Sheets . Liabilities by Segment At December 31, 2024 Life Health Investment Consolidated Future policy benefits $ 15,484,596 $ 2,316,094 $ — $ 17,800,690 Unearned and advance premiums 198,127 59,504 — 257,631 Policy claims and other benefits payable 321,838 210,994 — 532,832 Debt — — 2,739,652 2,739,652 Other 96,604 — 372,000 468,604 Total segment liabilities $ 16,101,165 $ 2,586,592 $ 3,111,652 21,799,409 Annuity and other corporate 1,971,252 Total liabilities $ 23,770,661 At December 31, 2023 Life Health Investment Consolidated Future policy benefits $ 16,304,797 $ 2,382,517 $ — $ 18,687,314 Unearned and advance premiums 196,630 57,937 — 254,567 Policy claims and other benefits payable 320,066 194,809 — 514,875 Debt — — 2,115,672 2,115,672 Other 98,958 — 138,000 236,958 Total segment liabilities $ 16,920,451 $ 2,635,263 $ 2,253,672 21,809,386 Annuity and other corporate 1,755,310 Total liabilities $ 23,564,696

Significant Accounting Polici_4

Significant Accounting Policies - Additional Information (Details) $ in Thousands	3 Months Ended	12 Months Ended
	Dec. 31, 2024 USD ($)	Dec. 31, 2024 USD ($) segment	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Significant Of Accounting Policies [Line Items]
Number of reportable segments | segment		3
Mortgage loans	$ 396,088	$ 396,088	$ 279,199
Concentration risk percentage		100%
Capital called from investment funds		$ 239,000
Investment funds, unfunded commitments	$ 433,000	$ 433,000
Percentage of investment securities not classified as corporate securities, state and municipal securities, redeemable preferred stocks and U.S. government securities (less than)	1%	1%
Fair value determined by third party	98%	98%
Financing Receivable, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration]	Accrued investment income	Accrued investment income
Agent first year commissions (as a percent)		65%
Agent debit balances	$ 542,000	$ 542,000	501,000
Agent debit balances, allowance for credit losses	1,400	1,400	1,200
Advertising costs charged to earnings and included in other operating		15,700	19,200	$ 9,400
Capitalized advertising costs	1,600,000	1,600,000	1,600,000
Increase in goodwill		8,700
Carrying value of investment in low-income housing interests	270,000	270,000	267,000
Obligations under future commitments for low-income housing interests	76,000	76,000
Original cost of property and equipment	527,000	527,000	455,000
Accumulated depreciation	242,000	242,000	215,000
Depreciation expense		27,000	21,000	21,000
Transfer of fixed maturities and accrued investment income in connection with reinsurance transaction		$ 462,000
Coinsurance agreement, ceding commission, before tax	$ 50,000
Assets held in trust of reserves (as a percent)	105%	105%
Insurance policy charges		$ 12,300	12,900	$ 13,500
Commercial loan participations
Significant Of Accounting Policies [Line Items]
Financing receivable, term		3 years
Financing receivable, extension term		2 years
Unfunded Loan Commitment
Significant Of Accounting Policies [Line Items]
Mortgage loans	$ 22,000	$ 22,000
Equity Option | Torchmark Corporation 2018 Incentive Plan
Significant Of Accounting Policies [Line Items]
Term over which monthly data points are used to derive volatility		3 years
Equity Option | Torchmark Corporation 2018 Incentive Plan | Employee | Three Year Vesting Period
Significant Of Accounting Policies [Line Items]
Option grants contractual term		7 years
Vesting period		3 years
Equity Option | Torchmark Corporation 2018 Incentive Plan | Employee | Five Year Vesting Period
Significant Of Accounting Policies [Line Items]
Option grants contractual term		10 years
Vesting period		5 years
Equity Option | Torchmark Corporation 2018 Incentive Plan | Director
Significant Of Accounting Policies [Line Items]
Vesting period		6 months
Life insurance
Significant Of Accounting Policies [Line Items]
Proportion of future policy reserves which are not universal life type		93%
Low-income housing credits and certain limited partnerships | Total Assets | Investment Type
Significant Of Accounting Policies [Line Items]
Concentration risk percentage		2%
Minimum | Equipment and Software
Significant Of Accounting Policies [Line Items]
Property and equipment, estimated useful life	3 years	3 years
Minimum | Building and Improvements
Significant Of Accounting Policies [Line Items]
Property and equipment, estimated useful life	15 years	15 years
Maximum | Equipment and Software
Significant Of Accounting Policies [Line Items]
Property and equipment, estimated useful life	15 years	15 years
Maximum | Building and Improvements
Significant Of Accounting Policies [Line Items]
Property and equipment, estimated useful life	40 years	40 years
Company-owned life insurance
Significant Of Accounting Policies [Line Items]
Accrued interest receivable	$ 4,200	$ 4,200
Investment in Limited Partnerships
Significant Of Accounting Policies [Line Items]
Capital called from investment funds		239,000	$ 154,000
Investment funds, unfunded commitments	$ 433,396	$ 433,396
Investment in Limited Partnerships | Minimum
Significant Of Accounting Policies [Line Items]
Investment funds ownership percentage		1%
Investment in Limited Partnerships | Maximum
Significant Of Accounting Policies [Line Items]
Investment funds ownership percentage		20%

Significant Accounting Polici_5

Significant Accounting Policies - Schedule of Net Balance By Asset Class (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Total property and equipment, net of depreciation	$ 284,272	$ 239,897
Company occupied real estate
Property, Plant and Equipment [Line Items]
Total property and equipment, net of depreciation	36,656	32,566
Data processing equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, net of depreciation	219,614	198,150
Transportation equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, net of depreciation	26,346	7,405
Furniture and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, net of depreciation	$ 1,656	$ 1,776

Significant Accounting Polici_6

Significant Accounting Policies - Schedule of Non-deferred Acquisition Costs Related to Expenses (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Non Deferred Commission	$ 317,576	$ 295,877	$ 285,477
Premium taxes	96,790	91,021	86,278
Non-deferred acquisition costs	186,387	172,269	134,267
Total	$ 600,753	$ 559,167	$ 506,022

Significant Accounting Polici_7

Significant Accounting Policies - Schedule of Assumptions for Options Granted (Details)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Volatility factor	22%	23%	22.30%
Dividend yield	0.70%	0.70%	0.80%
Expected term (in years)	5 years 1 month 6 days	5 years 1 month 6 days	5 years 1 month 13 days
Risk-free rate	4.30%	4.10%	1.90%

Statutory Accounting - Consolid

Statutory Accounting - Consolidated Net Income and Shareholders' Equity for Insurance Companies (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Insurance [Abstract]
Life insurance subsidiaries, net income	$ 688,665	$ 434,952	$ 444,294
Life insurance subsidiaries, shareholders' equity	$ 1,690,663	$ 1,660,104

Statutory Accounting - Addition

Statutory Accounting - Additional Information (Details) $ in Millions	Dec. 31, 2024 USD ($)
Insurance [Abstract]
Surplus adequate to satisfy regulatory compliance	$ 627

Supplemental Information abou_3

Supplemental Information about Changes to Accumulated Other Comprehensive Income - Schedule of Change in Balance by Component (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Increase (Decrease) in AOCI, Net of Tax
Beginning balance	$ 4,486,803	$ 3,949,577	$ 2,003,808
Other comprehensive income (loss) before reclassifications, net of tax	739,351	(45,186)	1,408,292
Reclassifications, net of tax	3,348	63,080	36,443
Other comprehensive income (loss)	742,699	17,894	1,444,735
Ending balance	5,305,520	4,486,803	3,949,577
Total
Increase (Decrease) in AOCI, Net of Tax
Beginning balance	(2,772,419)	(2,790,313)	(4,235,048)
Ending balance	(2,029,720)	(2,772,419)	(2,790,313)
Available for Sale Assets
Increase (Decrease) in AOCI, Net of Tax
Beginning balance	(827,596)	(1,420,672)	2,765,290
Other comprehensive income (loss) before reclassifications, net of tax	(494,996)	529,688	(4,211,540)
Reclassifications, net of tax	2,974	63,388	25,578
Other comprehensive income (loss)	(492,022)	593,076	(4,185,962)
Ending balance	(1,319,618)	(827,596)	(1,420,672)
Future Policy Benefits
Increase (Decrease) in AOCI, Net of Tax
Beginning balance	(1,947,391)	(1,369,204)	(6,915,910)
Other comprehensive income (loss) before reclassifications, net of tax	1,238,349	(578,187)	5,546,706
Reclassifications, net of tax	0	0	0
Other comprehensive income (loss)	1,238,349	(578,187)	5,546,706
Ending balance	(709,042)	(1,947,391)	(1,369,204)
Foreign Exchange
Increase (Decrease) in AOCI, Net of Tax
Beginning balance	4,719	(1,681)	19,248
Other comprehensive income (loss) before reclassifications, net of tax	(26,476)	6,400	(20,929)
Reclassifications, net of tax	0	0	0
Other comprehensive income (loss)	(26,476)	6,400	(20,929)
Ending balance	(21,757)	4,719	(1,681)
Pension Adjustments
Increase (Decrease) in AOCI, Net of Tax
Beginning balance	(2,151)	1,244	(103,676)
Other comprehensive income (loss) before reclassifications, net of tax	22,474	(3,087)	94,055
Reclassifications, net of tax	374	(308)	10,865
Other comprehensive income (loss)	22,848	(3,395)	104,920
Ending balance	$ 20,697	$ (2,151)	$ 1,244

Supplemental Information abou_4

Supplemental Information about Changes to Accumulated Other Comprehensive Income - Schedule of Reclassifications (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Unrealized investment (gains) losses on available for sale assets:
Realized (gains) losses	$ 24,188	$ 65,676	$ 76,548
Net investment income	(1,135,631)	(1,056,884)	(991,800)
Other operating expense	419,143	347,833	353,954
Total before tax	(1,326,637)	(1,194,266)	(1,102,111)
Tax	255,875	223,511	207,725
Total after-tax	(1,070,762)	(970,755)	(894,386)
Reclassification out of Accumulated Other Comprehensive Income
Unrealized investment (gains) losses on available for sale assets:
Total after-tax	3,348	63,080	36,443
Reclassification out of Accumulated Other Comprehensive Income | Unrealized Gains (Losses) on Available for Sale Assets
Unrealized investment (gains) losses on available for sale assets:
Realized (gains) losses	14,843	84,416	32,165
Net investment income	(11,079)	(4,178)	212
Total before tax	3,764	80,238	32,377
Tax	(790)	(16,850)	(6,799)
Total after-tax	2,974	63,388	25,578
Reclassification out of Accumulated Other Comprehensive Income | Pension adjustments:
Unrealized investment (gains) losses on available for sale assets:
Total before tax	474	(390)	13,754
Tax	(100)	82	(2,889)
Total after-tax	374	(308)	10,865
Reclassification out of Accumulated Other Comprehensive Income | Amortization of prior service cost
Unrealized investment (gains) losses on available for sale assets:
Other operating expense	1,071	1,075	1,077
Reclassification out of Accumulated Other Comprehensive Income | Amortization of actuarial (gain) loss
Unrealized investment (gains) losses on available for sale assets:
Other operating expense	$ (597)	$ (1,465)	$ 12,677

Investments - Schedule of Fixed

Investments - Schedule of Fixed Maturities Available for Sale by Component (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 18,835,809	$ 18,924,914
Allowance for Credit Losses	(10,395)	(7,115)
Gross Unrealized Gains	254,587	451,764
Gross Unrealized Losses	(1,924,989)	(1,499,357)
Fair value	$ 17,155,012	$ 17,870,206
Percentage of total fixed maturities (as a percent)	100%	100%
U.S. Government direct, guaranteed, and government-sponsored enterprises
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 401,753	$ 398,450
Allowance for Credit Losses	0	0
Gross Unrealized Gains	1	7
Gross Unrealized Losses	(42,794)	(32,306)
Fair value	$ 358,960	$ 366,151
Percentage of total fixed maturities (as a percent)	2%	2%
States, municipalities, and political subdivisions
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 3,300,901	$ 3,296,305
Allowance for Credit Losses	0	0
Gross Unrealized Gains	20,662	47,346
Gross Unrealized Losses	(534,759)	(403,329)
Fair value	$ 2,786,804	$ 2,940,322
Percentage of total fixed maturities (as a percent)	16%	16%
Foreign governments
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 36,883	$ 44,453
Allowance for Credit Losses	0	0
Gross Unrealized Gains	18	1
Gross Unrealized Losses	(8,870)	(10,348)
Fair value	$ 28,031	$ 34,106
Percentage of total fixed maturities (as a percent)	0%	0%
Corporates
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 14,976,815	$ 15,062,244
Allowance for Credit Losses	(7,098)	(7,115)	$ 0
Gross Unrealized Gains	227,924	399,371
Gross Unrealized Losses	(1,336,380)	(1,049,317)
Fair value	$ 13,861,261	$ 14,405,183
Percentage of total fixed maturities (as a percent)	81%	81%
Corporates | Industrials
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 7,889,074	$ 8,016,126
Allowance for Credit Losses	(7,098)	(7,115)
Gross Unrealized Gains	105,610	213,078
Gross Unrealized Losses	(805,330)	(566,847)
Fair value	$ 7,182,256	$ 7,655,242
Percentage of total fixed maturities (as a percent)	42%	43%
Corporates | Financial
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 5,006,375	$ 5,028,151
Allowance for Credit Losses	0	0
Gross Unrealized Gains	82,598	112,368
Gross Unrealized Losses	(413,043)	(388,340)
Fair value	$ 4,675,930	$ 4,752,179
Percentage of total fixed maturities (as a percent)	27%	27%
Corporates | Utilities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 2,081,366	$ 2,017,967
Allowance for Credit Losses	0	0
Gross Unrealized Gains	39,716	73,925
Gross Unrealized Losses	(118,007)	(94,130)
Fair value	$ 2,003,075	$ 1,997,762
Percentage of total fixed maturities (as a percent)	12%	11%
Collateralized debt obligations
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 36,923	$ 37,110
Allowance for Credit Losses	0	0
Gross Unrealized Gains	5,943	5,036
Gross Unrealized Losses	0	0
Fair value	$ 42,866	$ 42,146
Percentage of total fixed maturities (as a percent)	0%	0%
Other asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 82,534	$ 86,352
Allowance for Credit Losses	(3,297)	0
Gross Unrealized Gains	39	3
Gross Unrealized Losses	(2,186)	(4,057)
Fair value	$ 77,090	$ 82,298
Percentage of total fixed maturities (as a percent)	1%	1%

Investments - Additional Inform

Investments - Additional Information (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($) commercial_mortgage_loan issuer Issue loan extension_option	Dec. 31, 2023 USD ($) Issue commercial_mortgage_loan issuer	Dec. 31, 2022 USD ($)
Debt Securities, Available-for-sale [Line Items]
Investment funds, unfunded commitments	$ 433,000
Fair value	$ 17,155,012	$ 17,870,206
Percentage of fixed maturities at fair value	100%	100%
Fixed maturity, portfolio issues | Issue	2,552	2,473
Fixed portfolio, number of issuers | issuer	1,014	980
Unrealized loss	$ (1,924,989)	$ (1,499,357)
Increase in gross unrealized losses	$ (426,000)
Securities sold with a provision for credit losses		(66,000)
Percentage of invested assets rated below investment grade	2%
Par value of investments rated below investment grade	$ 648,000
Amortized cost of investments rated below investment grade	529,000
Fair value of investments rated below investment grade	462,000
Securities, cash, and short-term investments, amortized cost	1,000,000	1,000,000
Securities, cash, and short-term investments, fair value	$ 955,000	983,000
Number of loans | loan	35
Number of loans collaterally dependent | loan	6
Carrying value	$ 403,732	282,871
Provision (reversal) for credit losses	3,972	1,883
Increase in allowance for credit losses	4,000
Allowance for credit losses	7,644	3,672	$ 1,789
Realized gains (losses)	$ (24,188)	$ (65,676)	$ (76,548)
Number of loans in non-accrual status	5	0
Mortgage loans	$ 396,088	$ 279,199
Other long-term investments under fair value option	1,235,759	835,878
Capital called from investment funds	239,000
Unfunded Loan Commitment
Debt Securities, Available-for-sale [Line Items]
Mortgage loans	$ 22,000
Commercial Portfolio Segment
Debt Securities, Available-for-sale [Line Items]
Financing receivable, number of delinquent loans | commercial_mortgage_loan	1
Outstanding principal on nonaccrual loan	$ 53,000
Delinquent loans, outstanding interest	31
Corporates
Debt Securities, Available-for-sale [Line Items]
Fair value	$ 13,861,261	$ 14,405,183
Percentage of fixed maturities at fair value	81%	81%
Company-owned life insurance
Debt Securities, Available-for-sale [Line Items]
Other long-term investments under fair value option	$ 202,734	$ 0
Senior Loans In Default And On Non Accrual Status
Debt Securities, Available-for-sale [Line Items]
Non-accrual status with an amortized cost	5,500
Debt securities allowance for credit loss	3,300
Collaterally Dependent Loans | Commercial Portfolio Segment
Debt Securities, Available-for-sale [Line Items]
Carrying value	53,900
Provision (reversal) for credit losses	3,900
Fixed maturities available for sale
Debt Securities, Available-for-sale [Line Items]
Investment funds, unfunded commitments	167,000	0
Investment in Limited Partnerships
Debt Securities, Available-for-sale [Line Items]
Investment funds, unfunded commitments	433,396
Capital called from investment funds	239,000	154,000
Real Estate Investment Trust | Fixed maturities available for sale | Corporates
Debt Securities, Available-for-sale [Line Items]
Fair value	$ 405,000	$ 425,000
Percentage of fixed maturities at fair value	2%	2%

Investments - Schedule of Fix_2

Investments - Schedule of Fixed Maturities by Contractual Maturity (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Amortized Cost, net
Due in one year or less	$ 126,902
Due after one year through five years	728,959
Due after five years through ten years	1,869,090
Due after ten years through twenty years	8,729,774
Due after twenty years	7,254,503
Mortgage-backed and asset-backed securities	116,186
Fixed maturities, net of allowance for credit losses	18,825,414
Fair Value
Due in one year or less	126,643
Due after one year through five years	741,488
Due after five years through ten years	1,873,345
Due after ten years through twenty years	8,118,486
Due after twenty years	6,175,067
Mortgage-backed and asset-backed securities	119,983
Fixed maturities, fair value	$ 17,155,012	$ 17,870,206

Investments - Schedule of Analy

Investments - Schedule of Analysis of Investment Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Net Investment Income [Line Items]
Investment income, gross	$ 1,154,858	$ 1,074,157	$ 1,009,582
Less investment expense	(19,227)	(17,273)	(17,782)
Net investment income	1,135,631	1,056,884	991,800
Fixed maturities available for sale
Net Investment Income [Line Items]
Investment income, gross	981,439	944,628	910,284
Policy loans
Net Investment Income [Line Items]
Investment income, gross	52,625	49,011	46,586
Mortgage loans
Net Investment Income [Line Items]
Investment income, gross	27,809	19,541	9,719
Other long-term investments
Net Investment Income [Line Items]
Investment income, gross	81,834	54,655	40,837
Short-term investments
Net Investment Income [Line Items]
Investment income, gross	11,151	6,322	2,156
Fair value option
Net Investment Income [Line Items]
Net investment income	$ 74,800	$ 52,300	$ 40,300

Investments - Schedule of Selec

Investments - Schedule of Selected Information about Sales of Fixed Maturities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Proceeds from sale	$ 1,207,237	$ 602,556	$ 390,392
Gross realized gains	21,196	5,554	1,296
Gross realized losses	(32,956)	(80,823)	(57,996)
Unsettled trades	$ 866	$ 0	$ 0

Investments - Schedule of Reali

Investments - Schedule of Realized Gains (Losses) on Investments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Sales and other	$ (11,563)	$ (77,301)	$ (32,552)
Provision for credit losses	(3,280)	(7,115)	387
Fair value option—change in fair value	(16,717)	15,102	(29,353)
Mortgage loans	(3,972)	(5,603)	(963)
Other investments	2,936	1,792	4,681
Realized gains (losses) from investments	(32,596)	(73,125)	(57,800)
Other gains (losses)	8,408	7,449	(18,748)
Total realized gains (losses)	(24,188)	(65,676)	(76,548)
Applicable tax	5,080	13,792	16,075
Realized gains (losses), net of tax	(19,108)	(51,884)	(60,473)
Exchanges of fixed maturities	105,600	50,900	147,600
Exchanges of fixed maturities, net realized gains	$ 0	(1,900)	$ 1,900
Securities sold with a provision for credit losses		$ 66,000

Investments - Unrealized Gains

Investments - Unrealized Gains (Losses) on Investment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Gain (Loss) on Securities [Line Items]
Change in unrealized investment gains (losses) on	$ (622,809)	$ 750,734	$ (5,298,692)
Fixed maturities available for sale
Gain (Loss) on Securities [Line Items]
Change in unrealized investment gains (losses) on	$ (622,809)	$ 750,734	$ (5,298,692)

Investments - Schedule of Asset

Investments - Schedule of Assets Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	$ 17,155,012	$ 17,870,206
Percentage of total	100%	100%
U.S. Government direct, guaranteed, and government-sponsored enterprises
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	$ 358,960	$ 366,151
States, municipalities, and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	2,786,804	2,940,322
Foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	28,031	34,106
Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	13,861,261	14,405,183
Corporates | Industrials
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	7,182,256	7,655,242
Corporates | Financial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	4,675,930	4,752,179
Corporates | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	2,003,075	1,997,762
Collateralized debt obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	42,866	42,146
Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	77,090	82,298
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	$ 0	$ 0
Percentage of total	0%	0%
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. Government direct, guaranteed, and government-sponsored enterprises
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	$ 0	$ 0
Quoted Prices in Active Markets for Identical Assets (Level 1) | States, municipalities, and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporates | Industrials
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporates | Financial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporates | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Collateralized debt obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0	0
Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	$ 16,680,898	$ 17,373,327
Percentage of total	97%	97%
Significant Other Observable Inputs (Level 2) | U.S. Government direct, guaranteed, and government-sponsored enterprises
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	$ 358,960	$ 366,151
Significant Other Observable Inputs (Level 2) | States, municipalities, and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	2,786,804	2,940,322
Significant Other Observable Inputs (Level 2) | Foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	28,031	34,106
Significant Other Observable Inputs (Level 2) | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	13,441,196	13,950,450
Significant Other Observable Inputs (Level 2) | Corporates | Industrials
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	6,998,900	7,440,493
Significant Other Observable Inputs (Level 2) | Corporates | Financial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	4,551,737	4,621,160
Significant Other Observable Inputs (Level 2) | Corporates | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	1,890,559	1,888,797
Significant Other Observable Inputs (Level 2) | Collateralized debt obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0	0
Significant Other Observable Inputs (Level 2) | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	65,907	82,298
Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	$ 474,114	$ 496,879
Percentage of total	3%	3%
Significant Unobservable Inputs (Level 3) | U.S. Government direct, guaranteed, and government-sponsored enterprises
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	$ 0	$ 0
Significant Unobservable Inputs (Level 3) | States, municipalities, and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0	0
Significant Unobservable Inputs (Level 3) | Foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0	0
Significant Unobservable Inputs (Level 3) | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	420,065	454,733
Significant Unobservable Inputs (Level 3) | Corporates | Industrials
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	183,356	214,749
Significant Unobservable Inputs (Level 3) | Corporates | Financial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	124,193	131,019
Significant Unobservable Inputs (Level 3) | Corporates | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	112,516	108,965
Significant Unobservable Inputs (Level 3) | Collateralized debt obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	42,866	42,146
Significant Unobservable Inputs (Level 3) | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	$ 11,183	$ 0

Investments - Schedule of Chang

Investments - Schedule of Changes in Assets Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Beginning Balance	$ 496,879	$ 528,447	$ 705,193
Included in realized gains / losses	740	0	0
Included in other comprehensive income	(3,663)	(3,689)	(105,156)
Acquisitions	23,748	0	0
Sales	0	0	0
Amortization	4,765	4,724	4,526
Other	(50,553)	(32,603)	(76,116)
Transfers into Level 3	2,198	0	0
Transfers out of Level 3	0	0	0
Ending Balance	$ 474,114	$ 496,879	$ 528,447
Percent of total fixed maturities	100%	100%
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Realized gains (losses)	Realized gains (losses)	Realized gains (losses)
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Asset, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration]	Attributable to Parent Company	Attributable to Parent Company	Attributable to Parent Company
Asset- backed Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Beginning Balance	$ 0	$ 0	$ 0
Included in realized gains / losses			0
Included in other comprehensive income			0
Acquisitions			0
Sales			0
Amortization			0
Other			0
Transfers into Level 3			0
Transfers out of Level 3			0
Ending Balance	11,183	0	0
Collateralized debt obligations
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Beginning Balance	42,146	50,364	63,505
Included in realized gains / losses			0
Included in other comprehensive income			(13,771)
Acquisitions			0
Sales			0
Amortization			4,519
Other			(3,889)
Transfers into Level 3			0
Transfers out of Level 3			0
Ending Balance	42,866	42,146	50,364
Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Beginning Balance	454,733	478,083	641,688
Included in realized gains / losses			0
Included in other comprehensive income			(91,385)
Acquisitions			0
Sales			0
Amortization			7
Other			(72,227)
Transfers into Level 3			0
Transfers out of Level 3			0
Ending Balance	$ 420,065	$ 454,733	$ 478,083
Significant Unobservable Inputs (Level 3)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Percent of total fixed maturities	3%	3%
Significant Unobservable Inputs (Level 3) | Asset- backed Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Included in realized gains / losses	$ 0	$ 0
Included in other comprehensive income	37	0
Acquisitions	8,948	0
Sales	0	0
Amortization	0	0
Other	0	0
Transfers into Level 3	2,198	0
Transfers out of Level 3	0	0
Significant Unobservable Inputs (Level 3) | Collateralized debt obligations
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Included in realized gains / losses	0	0
Included in other comprehensive income	907	(8,230)
Acquisitions	0	0
Sales	0	0
Amortization	4,548	4,569
Other	(4,735)	(4,557)
Transfers into Level 3	0	0
Transfers out of Level 3	0	0
Significant Unobservable Inputs (Level 3) | Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Included in realized gains / losses	740	0
Included in other comprehensive income	(4,607)	4,541
Acquisitions	14,800	0
Sales	0	0
Amortization	217	155
Other	(45,818)	(28,046)
Transfers into Level 3	0	0
Transfers out of Level 3	$ 0	$ 0

Investments - Schedule of Unrea

Investments - Schedule of Unrealized Gains or (Losses) Included in Other Comprehensive Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Change in unrealized gains (losses) for the period	$ (3,663)	$ (3,689)	$ (105,156)
Asset- backed Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Change in unrealized gains (losses) for the period	37	0	0
Collateralized debt obligations
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Change in unrealized gains (losses) for the period	907	(8,230)	(13,771)
Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Change in unrealized gains (losses) for the period	$ (4,607)	$ 4,541	$ (91,385)

Investments - Quantitative Info

Investments - Quantitative Information about Level 3 Fair Value Measurements (Details) $ in Thousands	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value	$ 17,155,012	$ 17,870,206
Collateralized debt obligations
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value	42,866	42,146
Significant Unobservable Inputs (Level 3)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value	474,114	496,879
Significant Unobservable Inputs (Level 3) | Private placement fixed maturities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value	420,065
Significant Unobservable Inputs (Level 3) | Collateralized debt obligations
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value	$ 42,866	$ 42,146
Significant Unobservable Inputs (Level 3) | Collateralized debt obligations | Discounted Cash Flows | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1175
Significant Unobservable Inputs (Level 3) | Collateralized debt obligations | Discounted Cash Flows | Discount rate | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1175
Significant Unobservable Inputs (Level 3) | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value	$ 11,183

Investments - Schedule of Infor

Investments - Schedule of Information about Investments in Unrealized Loss Position (Details) - Issue	Dec. 31, 2024	Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Less than Twelve Months	705	151
Twelve Months or Longer	1,498	1,614
Total	2,203	1,765

Investments - Schedule of Unr_2

Investments - Schedule of Unrealized Investment Losses by Class of Investment (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than Twelve Months	$ 3,886,032	$ 803,974
Unrealized Loss, Less than Twelve Months	(183,665)	(17,434)
Fair Value, Twelve Months or Longer	8,001,246	9,750,839
Unrealized Loss, Twelve Months or Longer	(1,741,324)	(1,481,923)
Fair Value	11,887,278	10,554,813
Unrealized Loss	(1,924,989)	(1,499,357)
Investment Grade
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than Twelve Months	3,809,580	767,666
Unrealized Loss, Less than Twelve Months	(179,843)	(14,633)
Fair Value, Twelve Months or Longer	7,705,596	9,423,010
Unrealized Loss, Twelve Months or Longer	(1,671,119)	(1,407,709)
Fair Value	11,515,176	10,190,676
Unrealized Loss	(1,850,962)	(1,422,342)
Investment Grade | U.S. Government direct, guaranteed, and government-sponsored enterprises
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than Twelve Months	11,268	0
Unrealized Loss, Less than Twelve Months	(290)	0
Fair Value, Twelve Months or Longer	347,527	364,006
Unrealized Loss, Twelve Months or Longer	(42,504)	(32,306)
Fair Value	358,795	364,006
Unrealized Loss	(42,794)	(32,306)
Investment Grade | States, municipalities, and political subdivisions
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than Twelve Months	778,244	252,800
Unrealized Loss, Less than Twelve Months	(32,894)	(3,520)
Fair Value, Twelve Months or Longer	1,532,264	1,610,163
Unrealized Loss, Twelve Months or Longer	(501,865)	(399,809)
Fair Value	2,310,508	1,862,963
Unrealized Loss	(534,759)	(403,329)
Investment Grade | Foreign governments
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than Twelve Months	0	0
Unrealized Loss, Less than Twelve Months	0	0
Fair Value, Twelve Months or Longer	24,925	32,591
Unrealized Loss, Twelve Months or Longer	(8,870)	(10,348)
Fair Value	24,925	32,591
Unrealized Loss	(8,870)	(10,348)
Investment Grade | Corporates
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than Twelve Months	2,996,837	514,866
Unrealized Loss, Less than Twelve Months	(146,564)	(11,113)
Fair Value, Twelve Months or Longer	5,758,241	7,345,294
Unrealized Loss, Twelve Months or Longer	(1,115,789)	(961,598)
Fair Value	8,755,078	7,860,160
Unrealized Loss	(1,262,353)	(972,711)
Investment Grade | Corporates | Industrials
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than Twelve Months	1,487,940	191,573
Unrealized Loss, Less than Twelve Months	(73,404)	(3,881)
Fair Value, Twelve Months or Longer	3,433,034	4,317,827
Unrealized Loss, Twelve Months or Longer	(690,920)	(530,011)
Fair Value	4,920,974	4,509,400
Unrealized Loss	(764,324)	(533,892)
Investment Grade | Corporates | Financial
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than Twelve Months	961,932	242,099
Unrealized Loss, Less than Twelve Months	(52,946)	(6,584)
Fair Value, Twelve Months or Longer	1,785,130	2,341,424
Unrealized Loss, Twelve Months or Longer	(333,873)	(339,628)
Fair Value	2,747,062	2,583,523
Unrealized Loss	(386,819)	(346,212)
Investment Grade | Corporates | Utilities
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than Twelve Months	546,965	81,194
Unrealized Loss, Less than Twelve Months	(20,214)	(648)
Fair Value, Twelve Months or Longer	540,077	686,043
Unrealized Loss, Twelve Months or Longer	(90,996)	(91,959)
Fair Value	1,087,042	767,237
Unrealized Loss	(111,210)	(92,607)
Investment Grade | Collateralized debt obligations
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than Twelve Months	0	0
Unrealized Loss, Less than Twelve Months	0	0
Fair Value, Twelve Months or Longer	0	0
Unrealized Loss, Twelve Months or Longer	0	0
Fair Value	0	0
Unrealized Loss	0	0
Investment Grade | Other asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than Twelve Months	23,231	0
Unrealized Loss, Less than Twelve Months	(95)	0
Fair Value, Twelve Months or Longer	42,639	70,956
Unrealized Loss, Twelve Months or Longer	(2,091)	(3,648)
Fair Value	65,870	70,956
Unrealized Loss	(2,186)	(3,648)
Below Investment Grade
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than Twelve Months	76,452	36,308
Unrealized Loss, Less than Twelve Months	(3,822)	(2,801)
Fair Value, Twelve Months or Longer	295,650	327,829
Unrealized Loss, Twelve Months or Longer	(70,205)	(74,214)
Fair Value	372,102	364,137
Unrealized Loss	(74,027)	(77,015)
Below Investment Grade | Corporates
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than Twelve Months	76,452	36,308
Unrealized Loss, Less than Twelve Months	(3,822)	(2,801)
Fair Value, Twelve Months or Longer	293,452	316,541
Unrealized Loss, Twelve Months or Longer	(70,205)	(73,805)
Fair Value	369,904	352,849
Unrealized Loss	(74,027)	(76,606)
Below Investment Grade | Corporates | Industrials
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than Twelve Months	54,199	10,745
Unrealized Loss, Less than Twelve Months	(2,656)	(199)
Fair Value, Twelve Months or Longer	142,638	145,697
Unrealized Loss, Twelve Months or Longer	(38,350)	(32,756)
Fair Value	196,837	156,442
Unrealized Loss	(41,006)	(32,955)
Below Investment Grade | Corporates | Financial
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than Twelve Months	2,990	25,563
Unrealized Loss, Less than Twelve Months	(53)	(2,602)
Fair Value, Twelve Months or Longer	126,811	151,190
Unrealized Loss, Twelve Months or Longer	(26,171)	(39,526)
Fair Value	129,801	176,753
Unrealized Loss	(26,224)	(42,128)
Below Investment Grade | Corporates | Utilities
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than Twelve Months	19,263	0
Unrealized Loss, Less than Twelve Months	(1,113)	0
Fair Value, Twelve Months or Longer	24,003	19,654
Unrealized Loss, Twelve Months or Longer	(5,684)	(1,523)
Fair Value	43,266	19,654
Unrealized Loss	(6,797)	(1,523)
Below Investment Grade | Collateralized debt obligations
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than Twelve Months	0	0
Unrealized Loss, Less than Twelve Months	0	0
Fair Value, Twelve Months or Longer	0	0
Unrealized Loss, Twelve Months or Longer	0	0
Fair Value	0	0
Unrealized Loss	0	0
Below Investment Grade | Other asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than Twelve Months	0	0
Unrealized Loss, Less than Twelve Months	0	0
Fair Value, Twelve Months or Longer	2,198	11,288
Unrealized Loss, Twelve Months or Longer	0	(409)
Fair Value	2,198	11,288
Unrealized Loss	$ 0	$ (409)

Investments - Schedule of Fix_3

Investments - Schedule of Fixed Maturities, Allowance for Credit Loss (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses beginning balance	$ 7,115
Allowance for credit losses ending balance	10,395	$ 7,115
Corporates
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses beginning balance	7,115	0
Additions to allowance for which credit losses were not previously recorded	3,297	72,508
Additions (reductions) to allowance for fixed maturities that previously had an allowance	(17)	(65,393)
Reduction of allowance for which the Company intends to sell or more likely than not will be required to sell or sold during the period	0	0
Allowance for credit losses ending balance	7,098	7,115
Corporates | Fixed maturities available for sale
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses beginning balance	7,115
Allowance for credit losses ending balance	$ 10,395	$ 7,115

Investments - Concentrations of

Investments - Concentrations of Credit Risk - Investment Portfolio (Details)	12 Months Ended
	Dec. 31, 2024
Debt Securities, Available-for-sale [Line Items]
Concentration risk percentage	100%
State and municipal governments, percent of invested assets at fair value	14%
Texas
Debt Securities, Available-for-sale [Line Items]
State and municipal governments, percent of invested assets at fair value	21%
California
Debt Securities, Available-for-sale [Line Items]
State and municipal governments, percent of invested assets at fair value	10%
New York
Debt Securities, Available-for-sale [Line Items]
State and municipal governments, percent of invested assets at fair value	7%
Florida
Debt Securities, Available-for-sale [Line Items]
State and municipal governments, percent of invested assets at fair value	5%
Pennsylvania
Debt Securities, Available-for-sale [Line Items]
State and municipal governments, percent of invested assets at fair value	4%
Fixed maturities available for sale | Investment portfolio | Credit Concentration Risk
Debt Securities, Available-for-sale [Line Items]
Concentration risk percentage	87%
Policy loans | Investment portfolio | Credit Concentration Risk
Debt Securities, Available-for-sale [Line Items]
Concentration risk percentage	4%
Other | Investment portfolio | Credit Concentration Risk
Debt Securities, Available-for-sale [Line Items]
Concentration risk percentage	9%
Corporates | Investment portfolio | Credit Concentration Risk
Debt Securities, Available-for-sale [Line Items]
Concentration risk percentage	71%
Corporates | Fixed maturities available for sale | Investment Grade | Investment portfolio | Credit Concentration Risk
Debt Securities, Available-for-sale [Line Items]
Concentration risk percentage	68%
Corporates | Fixed maturities available for sale | Below Investment Grade | Investment portfolio | Credit Concentration Risk
Debt Securities, Available-for-sale [Line Items]
Concentration risk percentage	2%
States, municipalities, and political subdivisions | Fixed maturities available for sale | Investment Grade | Investment portfolio | Credit Concentration Risk
Debt Securities, Available-for-sale [Line Items]
Concentration risk percentage	14%
U.S. Government direct, guaranteed, and government-sponsored enterprises | Fixed maturities available for sale | Investment Grade | Investment portfolio | Credit Concentration Risk
Debt Securities, Available-for-sale [Line Items]
Concentration risk percentage	2%
Other | Fixed maturities available for sale | Investment Grade | Investment portfolio | Credit Concentration Risk
Debt Securities, Available-for-sale [Line Items]
Concentration risk percentage	1%

Investments - Concentrations _2

Investments - Concentrations of Credit Risk - Industry Concentrations (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Insurance	18%
Electric utilities	11%
Banks	7%
Oil and natural gas pipelines	6%
Chemicals	5%
Transportation	4%
Telecommunications	3%
Food	3%
Diversified financial services	3%
Real estate investment trusts	3%
Percentage of invested assets rated below investment grade	2%
Par value of investments rated below investment grade	$ 648
Amortized cost of investments rated below investment grade	529
Fair value of investments rated below investment grade	462
Securities, cash, and short-term investments, amortized cost	1,000	$ 1,000
Securities, cash, and short-term investments, fair value	$ 955	$ 983

Investments - Schedule of Comme

Investments - Schedule of Commercial Mortgage Loan Participations (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value	$ 403,732	$ 282,871
Carrying value, gross, percent	102%	101%
Less allowance for credit losses	$ (7,644)	$ (3,672)	$ (1,789)
Allowance for credit losses, percent	(2.00%)	(1.00%)
Carrying value, net of valuation allowance	$ 396,088	$ 279,199
Carrying value, net, percent	100%	100%
Texas
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value	$ 75,131	$ 45,111
Carrying value, gross, percent	19%	16%
Florida
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value	$ 63,308	$ 48,233
Carrying value, gross, percent	16%	17%
New Jersey
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value	$ 51,744	$ 44,574
Carrying value, gross, percent	13%	16%
California
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value	$ 48,371	$ 54,721
Carrying value, gross, percent	12%	20%
Alabama
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value	$ 35,850	$ 11,003
Carrying value, gross, percent	9%	4%
New York
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value	$ 34,975	$ 20,284
Carrying value, gross, percent	9%	7%
Other
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value	$ 94,353	$ 58,945
Carrying value, gross, percent	24%	21%
Multi-family
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value	$ 111,234	$ 116,299
Carrying value, gross, percent	28%	42%
Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value	$ 110,456	$ 57,267
Carrying value, gross, percent	28%	20%
Retail
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value	$ 65,612	$ 23,925
Carrying value, gross, percent	16%	9%
Hospitality
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value	$ 73,931	$ 43,897
Carrying value, gross, percent	19%	16%
Mixed use
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value	$ 35,960	$ 34,749
Carrying value, gross, percent	9%	12%
Office
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value	$ 6,539	$ 6,734
Carrying value, gross, percent	2%	2%

Investments - Schedule of Com_2

Investments - Schedule of Commercial Mortgage Loan Participations Recorded Investment (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net of valuation allowance	$ 396,088	$ 279,199
Carrying value	403,732	282,871
Less allowance for credit losses	$ (7,644)	$ (3,672)	$ (1,789)
Carrying value, net of valuation allowance, percent	100%	100%
Less than 70%
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value	$ 349,868	$ 266,216
Carrying value, net of valuation allowance, percent	87%	94%
70% to 80%
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value	$ 0	$ 0
Carrying value, net of valuation allowance, percent	0%	0%
81% to 90%
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value	$ 0	$ 9,621
Carrying value, net of valuation allowance, percent	0%	3%
Greater than 90%
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value	$ 53,864	$ 7,034
Carrying value, net of valuation allowance, percent	13%	3%
Less Than 1.00x
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net of valuation allowance	$ 104,643	$ 42,593
Less Than 1.00x | Less than 70%
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net of valuation allowance	88,507	27,091
Less Than 1.00x | 70% to 80%
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net of valuation allowance	0	0
Less Than 1.00x | 81% to 90%
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net of valuation allowance	0	8,468
Less Than 1.00x | Greater than 90%
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net of valuation allowance	16,136	7,034
1.00x-1.20x
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net of valuation allowance	102,222	180,761
1.00x-1.20x | Less than 70%
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net of valuation allowance	64,494	180,761
1.00x-1.20x | 70% to 80%
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net of valuation allowance	0	0
1.00x-1.20x | 81% to 90%
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net of valuation allowance	0	0
1.00x-1.20x | Greater than 90%
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net of valuation allowance	37,728	0
Greater Than 1.20x
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net of valuation allowance	196,867	59,517
Greater Than 1.20x | Less than 70%
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net of valuation allowance	196,867	58,364
Greater Than 1.20x | 70% to 80%
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net of valuation allowance	0	0
Greater Than 1.20x | 81% to 90%
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net of valuation allowance	0	1,153
Greater Than 1.20x | Greater than 90%
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net of valuation allowance	$ 0	$ 0

Investments - Schedule of Com_3

Investments - Schedule of Commercial Loan Participations, Allowance for Credit Loss (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses beginning balance	$ 3,672	$ 1,789
Provision (reversal) for credit losses	3,972	1,883
Allowance for credit losses ending balance	$ 7,644	$ 3,672

Investments - Schedule of Other

Investments - Schedule of Other Long-Term Investments (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Long-Term Investment [Line Items]
Commercial mortgage loan participations	$ 1,235,759	$ 835,878
Other
Long-Term Investment [Line Items]
Commercial mortgage loan participations	46,259	40,295
Investment funds
Long-Term Investment [Line Items]
Commercial mortgage loan participations	$ 986,766	$ 795,583

Investments - Schedule of Inves

Investments - Schedule of Investment Funds (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Alternative Investment [Line Items]
Investment funds, Unfunded Commitments	$ 433,000
Unfunded commitments, including past investment period	$ 57,500
Minimum
Alternative Investment [Line Items]
Expected life of non-redeemable funds	7 years
Extension options term of non-redeemable funds	1 year
Expected life of redeemable funds	6 months
Maximum
Alternative Investment [Line Items]
Expected life of non-redeemable funds	10 years
Expected life of non-redeemable funds	12 years
Extension options term of non-redeemable funds	4 years
Expected life of redeemable funds	36 months
Commercial mortgage loans
Alternative Investment [Line Items]
Investment funds, Fair Value	$ 566,142	$ 411,315
Investment funds, Unfunded Commitments	189,725
Opportunistic and private credit
Alternative Investment [Line Items]
Investment funds, Fair Value	202,008	181,410
Investment funds, Unfunded Commitments	191,192
Infrastructure
Alternative Investment [Line Items]
Investment funds, Fair Value	179,627	165,887
Investment funds, Unfunded Commitments	0
Other
Alternative Investment [Line Items]
Investment funds, Fair Value	38,989	36,971
Investment funds, Unfunded Commitments	52,479
Investment funds
Alternative Investment [Line Items]
Investment funds, Fair Value	986,766	$ 795,583
Investment funds, Unfunded Commitments	433,396
Unfunded commitments, including past investment period	$ 645,000

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details)				3 Months Ended	12 Months Ended
	Nov. 25, 2024 complainant	Sep. 26, 2024 complainant	Apr. 30, 2024 complainant	Dec. 31, 2024 USD ($) guarantee	Dec. 31, 2024 USD ($) state guarantee	Dec. 31, 2023 USD ($)	Dec. 31, 2022	Nov. 14, 2024 claim
Obligation with Joint and Several Liability Arrangement [Line Items]
Retention limits per life					$ 500,000
Life insurance ceded as percent of total life insurance in force					0.30%	0.30%
Life and accident and health insurance ceded as a percent of premium income					0.20%	0.20%
Percentage of annuities ceded				68%
Life insurance assumed as a percent of life insurance in force					0.80%	0.90%
Life and accident and health insurance assumed as a percent of premium income					0.90%	1.30%	1.50%
Number of guarantee agreements | guarantee				0	0
Guaranty liabilities				$ 0	$ 0
Letters of credit facility outstanding				115,000,000	$ 115,000,000	$ 115,000,000
Number of states private entities contracted with for audits | state					47
Number of complainants | complainant	2	6	6
Number of claims | claim								1
Letter of Credit
Obligation with Joint and Several Liability Arrangement [Line Items]
Letter of credit maximum available amount				$ 250,000,000	$ 250,000,000

Commitments and Contingencies_2

Commitments and Contingencies - Schedule of Rental Expenses (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Rental expense	$ 3,208	$ 3,519	$ 4,239

Commitments and Contingencies_3

Commitments and Contingencies - Schedule of Future Minimum Rental Commitments (Details) $ in Thousands	Dec. 31, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2025	$ 2,117
2026	1,883
2027	1,417
2028	867
2029	487
Thereafter	$ 4,195

Commitments and Contingencies_4

Commitments and Contingencies - Low-Income Housing Commitments (Details) $ in Thousands	Dec. 31, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2025	$ 47,538
2026	29,742
2027	34,443
2028	15,266
2029	11,440
Thereafter	203,445
Tax credits	$ 76,000

Policy Liabilities - Schedule o

Policy Liabilities - Schedule of Liability for Future Policy Benefit, Activity (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Net liability for future policy benefits—long duration health	$ 18,457,263	$ 19,460,353	$ 18,097,341
Life
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning balance	12,342,307	11,748,528	14,082,538
Beginning balance	11,709,368	11,442,919	10,896,222
Effect of changes in assumptions on future cash flows		(140,988)	64,032	$ 166,770
Effect of actual variances from expected experience		(598,487)	(520,699)	(416,472)
Adjusted balance		10,969,893	10,986,252	10,646,520
Issuances	1,434,986	1,468,072	1,561,444
Interest accrual	591,875	564,929	522,072
Net premiums collected	(1,334,490)	(1,314,975)	(1,268,915)
Effect of changes in the foreign exchange rate	(23,344)	5,090	(18,202)
Ending balance	11,638,920	11,709,368	11,442,919
Effect of change from original to current discount rates	118,397	632,939	305,609
Ending balance	11,757,317	12,342,307	11,748,528
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning balance	27,723,158	25,749,961	33,664,308
Beginning balance	24,563,696	23,564,337	22,374,930
Effect of changes in assumptions on future cash flows		(198,467)	65,568	226,626
Effect of actual variances from expected experience		(658,110)	(554,123)	(418,233)
Adjusted balance		23,707,119	23,075,782	22,183,323
Issuances	1,430,276	1,468,086	1,561,463
Interest accrual	1,356,378	1,290,305	1,209,182
Benefit payments	(1,344,045)	(1,283,796)	(1,345,368)
Effect of changes in the foreign exchange rate	(57,904)	13,319	(44,263)
Ending balance	25,091,824	24,563,696	23,564,337
Effect of changes in discount rate assumptions	1,242,460	3,159,462	2,185,624
Ending balance	26,334,284	27,723,158	25,749,961
Net liability for future policy benefits at original discount rates	13,452,904	12,854,328	12,121,418
Effect of changes in discount rate assumptions	1,124,063	2,526,523	1,880,015
Other Adjustments	173	9,438	12,714
Net liability for future policy benefits—long duration health	14,577,140	15,390,289	14,014,147
Reinsurance recoverable	(43,488)	(45,708)	(42,430)
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates	14,533,652	15,344,581	13,971,717
Policyholder benefits net of remeasurement gain (losses)	106,971	29,391	(47,426)
Life | Gain Loss From Expereince
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	50,125	31,404	(272)
Life | Gain (Loss) From Unlocking Assumptions
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	56,846	(2,013)	(47,154)
Health
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning balance	6,089,728	5,207,422	6,418,018
Beginning balance	6,069,295	5,366,305	5,328,427
Effect of changes in assumptions on future cash flows		14,968	390,156	(223,591)
Effect of actual variances from expected experience		(149,243)	(147,908)	(138,275)
Adjusted balance		5,935,020	5,608,553	4,966,561
Issuances	874,615	757,532	701,048
Interest accrual	281,648	238,966	213,461
Net premiums collected	(577,088)	(536,179)	(513,278)
Effect of changes in the foreign exchange rate	(2,132)	423	(1,487)
Ending balance	6,512,063	6,069,295	5,366,305
Effect of change from original to current discount rates	(197,915)	20,433	(158,883)
Ending balance	6,314,148	6,089,728	5,207,422
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning balance	8,441,002	7,394,349	9,353,001
Beginning balance	8,484,970	7,710,767	7,587,083
Effect of changes in assumptions on future cash flows		30,877	381,310	(233,911)
Effect of actual variances from expected experience		(150,406)	(154,411)	(143,822)
Adjusted balance		8,365,441	7,937,666	7,209,350
Issuances	873,150	756,377	701,159
Interest accrual	393,073	346,489	316,620
Benefit payments	(620,806)	(556,440)	(513,229)
Effect of changes in the foreign exchange rate	(4,128)	878	(3,133)
Ending balance	9,006,730	8,484,970	7,710,767
Effect of changes in discount rate assumptions	(420,477)	(43,968)	(316,418)
Ending balance	8,586,253	8,441,002	7,394,349
Net liability for future policy benefits at original discount rates	2,494,667	2,415,675	2,344,462
Effect of changes in discount rate assumptions	(222,562)	(64,401)	(157,535)
Other Adjustments	40,931	28,141	16,862
Net liability for future policy benefits—long duration health	2,313,036	2,379,415	2,203,789
Reinsurance recoverable	(3,754)	(15,322)	(14,345)
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates	2,309,282	2,364,093	2,189,444
Policyholder benefits net of remeasurement gain (losses)	(3,231)	11,849	15,561
Health | Gain Loss From Expereince
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	7,270	6,616	4,906
Health | Gain (Loss) From Unlocking Assumptions
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	(10,501)	5,233	10,655
American Income | Life
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning balance	4,681,888	4,273,156	4,925,192
Beginning balance	4,523,329	4,246,723	3,906,098
Effect of changes in assumptions on future cash flows		(82,348)	14,265	34,266
Effect of actual variances from expected experience		(229,772)	(155,293)	(121,230)
Adjusted balance		4,211,209	4,105,695	3,819,134
Issuances	798,952	733,702	760,857
Interest accrual	220,959	200,363	176,102
Net premiums collected	(551,066)	(521,521)	(491,168)
Effect of changes in the foreign exchange rate	(23,344)	5,090	(18,202)
Ending balance	4,656,710	4,523,329	4,246,723
Effect of change from original to current discount rates	(10,793)	158,559	26,433
Ending balance	4,645,917	4,681,888	4,273,156
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning balance	10,163,627	9,119,104	11,773,519
Beginning balance	9,061,833	8,409,761	7,744,201
Effect of changes in assumptions on future cash flows		(104,498)	13,344	48,534
Effect of actual variances from expected experience		(251,310)	(164,900)	(127,626)
Adjusted balance		8,706,025	8,258,205	7,665,109
Issuances	794,225	733,700	760,856
Interest accrual	492,966	452,640	410,201
Benefit payments	(426,723)	(396,031)	(382,142)
Effect of changes in the foreign exchange rate	(57,904)	13,319	(44,263)
Ending balance	9,508,589	9,061,833	8,409,761
Effect of changes in discount rate assumptions	362,103	1,101,794	709,343
Ending balance	9,870,692	10,163,627	9,119,104
Net liability for future policy benefits at original discount rates	4,851,879	4,538,504	4,163,038
Effect of changes in discount rate assumptions	372,896	943,235	682,910
Other Adjustments	122	297	115
Net liability for future policy benefits—long duration health	5,224,897	5,482,036	4,846,063
Reinsurance recoverable	(167)	(141)	(123)
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates	5,224,730	5,481,895	4,845,940
American Income | Life | Gain Loss From Expereince
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	19,606	9,430	1,965
American Income | Life | Gain (Loss) From Unlocking Assumptions
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	21,974	308	(8,707)
American Income | Health
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning balance	206,381	190,296	222,553
Beginning balance	201,869	192,631	178,801
Effect of changes in assumptions on future cash flows		12,207	(6,061)	(17,911)
Effect of actual variances from expected experience		(16,088)	(11,152)	7,911
Adjusted balance		197,988	175,418	168,801
Issuances	44,350	39,825	39,003
Interest accrual	9,787	8,528	7,399
Net premiums collected	(24,852)	(22,325)	(21,085)
Effect of changes in the foreign exchange rate	(2,132)	423	(1,487)
Ending balance	225,141	201,869	192,631
Effect of change from original to current discount rates	(1,894)	4,512	(2,335)
Ending balance	223,247	206,381	190,296
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning balance	335,504	312,750	380,915
Beginning balance	315,431	303,713	285,604
Effect of changes in assumptions on future cash flows		20,293	(6,407)	(21,559)
Effect of actual variances from expected experience		(18,601)	(12,661)	10,402
Adjusted balance		317,123	284,645	274,447
Issuances	44,353	39,825	39,006
Interest accrual	16,577	15,070	13,806
Benefit payments	(25,214)	(24,987)	(20,413)
Effect of changes in the foreign exchange rate	(4,128)	878	(3,133)
Ending balance	348,711	315,431	303,713
Effect of changes in discount rate assumptions	6,592	20,073	9,037
Ending balance	355,303	335,504	312,750
Net liability for future policy benefits at original discount rates	123,570	113,562	111,082
Effect of changes in discount rate assumptions	8,486	15,561	11,372
Other Adjustments	814	857	48
Net liability for future policy benefits—long duration health	132,870	129,980	122,502
Reinsurance recoverable	0	0	0
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates	132,870	129,980	122,502
American Income | Health | Gain Loss From Expereince
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	2,742	1,461	(2,545)
American Income | Health | Gain (Loss) From Unlocking Assumptions
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	(8,036)	119	3,615
Direct to Consumer | Life
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning balance	6,052,651	5,910,224	7,264,905
Beginning balance	5,664,259	5,680,864	5,533,741
Effect of changes in assumptions on future cash flows		(28,366)	36,170	79,571
Effect of actual variances from expected experience		(311,659)	(306,004)	(264,286)
Adjusted balance		5,324,234	5,411,030	5,349,026
Issuances	491,440	579,363	663,790
Interest accrual	292,843	287,615	273,494
Net premiums collected	(603,605)	(613,749)	(605,446)
Effect of changes in the foreign exchange rate	0	0	0
Ending balance	5,504,912	5,664,259	5,680,864
Effect of change from original to current discount rates	117,994	388,392	229,360
Ending balance	5,622,906	6,052,651	5,910,224
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning balance	9,714,516	9,225,451	11,859,408
Beginning balance	8,656,752	8,477,892	8,157,259
Effect of changes in assumptions on future cash flows		(50,106)	34,407	104,910
Effect of actual variances from expected experience		(335,087)	(318,687)	(259,285)
Adjusted balance		8,271,559	8,193,612	8,002,884
Issuances	491,437	579,365	663,786
Interest accrual	474,451	458,587	433,611
Benefit payments	(576,499)	(574,812)	(622,389)
Effect of changes in the foreign exchange rate	0	0	0
Ending balance	8,660,948	8,656,752	8,477,892
Effect of changes in discount rate assumptions	464,164	1,057,764	747,559
Ending balance	9,125,112	9,714,516	9,225,451
Net liability for future policy benefits at original discount rates	3,156,036	2,992,493	2,797,028
Effect of changes in discount rate assumptions	346,170	669,372	518,199
Other Adjustments	18	3,315	4,913
Net liability for future policy benefits—long duration health	3,502,224	3,665,180	3,320,140
Reinsurance recoverable	0	0	0
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates	3,502,224	3,665,180	3,320,140
Direct to Consumer | Life | Gain Loss From Expereince
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	21,681	12,201	(2,243)
Direct to Consumer | Life | Gain (Loss) From Unlocking Assumptions
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	21,744	1,763	(25,334)
Direct to Consumer | Health
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning balance	115,363	90,143	121,724
Beginning balance	109,880	87,751	96,776
Effect of changes in assumptions on future cash flows		4,449	16,553	(9,035)
Effect of actual variances from expected experience		(2,937)	(2,850)	(2,301)
Adjusted balance		111,392	101,454	85,440
Issuances	26,149	14,467	8,224
Interest accrual	5,838	4,616	4,554
Net premiums collected	(11,460)	(10,657)	(10,467)
Effect of changes in the foreign exchange rate	0	0	0
Ending balance	131,919	109,880	87,751
Effect of change from original to current discount rates	1,458	5,483	2,392
Ending balance	133,377	115,363	90,143
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning balance	109,482	87,532	119,888
Beginning balance	104,501	85,212	95,628
Effect of changes in assumptions on future cash flows		7,733	15,930	(8,270)
Effect of actual variances from expected experience		(2,420)	(3,325)	(2,621)
Adjusted balance		109,814	97,817	84,737
Issuances	26,116	14,446	8,202
Interest accrual	5,837	4,616	4,553
Benefit payments	(13,792)	(12,378)	(12,280)
Effect of changes in the foreign exchange rate	0	0	0
Ending balance	127,975	104,501	85,212
Effect of changes in discount rate assumptions	1,302	4,981	2,320
Ending balance	129,277	109,482	87,532
Net liability for future policy benefits at original discount rates	(3,944)	(5,379)	(2,539)
Effect of changes in discount rate assumptions	(156)	(502)	(72)
Other Adjustments	4,865	6,653	3,634
Net liability for future policy benefits—long duration health	765	772	1,023
Reinsurance recoverable	0	0	0
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates	765	772	1,023
Direct to Consumer | Health | Gain Loss From Expereince
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	22	23	148
Direct to Consumer | Health | Gain (Loss) From Unlocking Assumptions
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	(373)	8	(80)
Liberty National | Life
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning balance	1,129,716	1,094,407	1,332,469
Beginning balance	1,077,831	1,066,123	1,040,242
Effect of changes in assumptions on future cash flows		(29,292)	5,178	17,719
Effect of actual variances from expected experience		(42,620)	(40,961)	(20,027)
Adjusted balance		1,005,919	1,030,340	1,037,934
Issuances	120,683	127,048	104,982
Interest accrual	55,198	54,147	51,326
Net premiums collected	(134,778)	(133,704)	(128,119)
Effect of changes in the foreign exchange rate	0	0	0
Ending balance	1,047,022	1,077,831	1,066,123
Effect of change from original to current discount rates	1,425	51,885	28,284
Ending balance	1,048,447	1,129,716	1,094,407
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning balance	3,605,392	3,429,256	4,542,697
Beginning balance	3,338,252	3,272,980	3,206,164
Effect of changes in assumptions on future cash flows		(41,836)	6,156	33,457
Effect of actual variances from expected experience		(50,759)	(46,341)	(18,535)
Adjusted balance		3,245,657	3,232,795	3,221,086
Issuances	120,702	127,062	105,006
Interest accrual	178,617	174,995	169,578
Benefit payments	(204,757)	(196,600)	(222,690)
Effect of changes in the foreign exchange rate	0	0	0
Ending balance	3,340,219	3,338,252	3,272,980
Effect of changes in discount rate assumptions	37,298	267,140	156,276
Ending balance	3,377,517	3,605,392	3,429,256
Net liability for future policy benefits at original discount rates	2,293,197	2,260,421	2,206,857
Effect of changes in discount rate assumptions	35,873	215,255	127,992
Other Adjustments	0	5,764	7,638
Net liability for future policy benefits—long duration health	2,329,070	2,481,440	2,342,487
Reinsurance recoverable	(7,953)	(7,719)	(7,477)
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates	2,321,117	2,473,721	2,335,010
Liberty National | Life | Gain Loss From Expereince
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	3,966	5,013	(1,348)
Liberty National | Life | Gain (Loss) From Unlocking Assumptions
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	12,224	(1,248)	(7,872)
Liberty National | Health
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning balance	358,472	423,490	517,368
Beginning balance	348,570	415,442	414,409
Effect of changes in assumptions on future cash flows		(3,463)	(56,964)	19,846
Effect of actual variances from expected experience		(29,652)	(36,850)	(39,029)
Adjusted balance		315,455	321,628	395,226
Issuances	58,538	59,768	51,827
Interest accrual	16,566	18,255	19,141
Net premiums collected	(52,284)	(51,081)	(50,752)
Effect of changes in the foreign exchange rate	0	0	0
Ending balance	338,275	348,570	415,442
Effect of change from original to current discount rates	(1,156)	9,902	8,048
Ending balance	337,119	358,472	423,490
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning balance	865,808	941,574	1,201,317
Beginning balance	816,819	904,865	921,608
Effect of changes in assumptions on future cash flows		(2,775)	(60,437)	18,065
Effect of actual variances from expected experience		(30,258)	(36,910)	(40,597)
Adjusted balance		783,786	807,518	899,076
Issuances	57,862	59,158	52,257
Interest accrual	42,809	45,614	47,719
Benefit payments	(93,317)	(95,471)	(94,187)
Effect of changes in the foreign exchange rate	0	0	0
Ending balance	791,140	816,819	904,865
Effect of changes in discount rate assumptions	13,555	48,989	36,709
Ending balance	804,695	865,808	941,574
Net liability for future policy benefits at original discount rates	452,865	468,249	489,423
Effect of changes in discount rate assumptions	14,711	39,087	28,661
Other Adjustments	10,310	9,567	5,953
Net liability for future policy benefits—long duration health	477,886	516,903	524,037
Reinsurance recoverable	(986)	(1,317)	(1,498)
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates	476,900	515,586	522,539
Liberty National | Health | Gain Loss From Expereince
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	2,640	628	1,406
Liberty National | Health | Gain (Loss) From Unlocking Assumptions
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	(234)	2,171	1,463
Other premium | Life
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning balance	478,052	470,741	559,972
Beginning balance	443,949	449,209	416,141
Effect of changes in assumptions on future cash flows		(982)	8,419	35,214
Effect of actual variances from expected experience		(14,436)	(18,441)	(10,929)
Adjusted balance		428,531	439,187	440,426
Issuances	23,911	27,959	31,815
Interest accrual	22,875	22,804	21,150
Net premiums collected	(45,041)	(46,001)	(44,182)
Effect of changes in the foreign exchange rate	0	0	0
Ending balance	430,276	443,949	449,209
Effect of change from original to current discount rates	9,771	34,103	21,532
Ending balance	440,047	478,052	470,741
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning balance	4,239,623	3,976,150	5,488,684
Beginning balance	3,506,859	3,403,704	3,267,306
Effect of changes in assumptions on future cash flows		(2,027)	11,661	39,725
Effect of actual variances from expected experience		(20,954)	(24,195)	(12,787)
Adjusted balance		3,483,878	3,391,170	3,294,244
Issuances	23,912	27,959	31,815
Interest accrual	210,344	204,083	195,792
Benefit payments	(136,066)	(116,353)	(118,147)
Effect of changes in the foreign exchange rate	0	0	0
Ending balance	3,582,068	3,506,859	3,403,704
Effect of changes in discount rate assumptions	378,895	732,764	572,446
Ending balance	3,960,963	4,239,623	3,976,150
Net liability for future policy benefits at original discount rates	3,151,792	3,062,910	2,954,495
Effect of changes in discount rate assumptions	369,124	698,661	550,914
Other Adjustments	33	62	48
Net liability for future policy benefits—long duration health	3,520,949	3,761,633	3,505,457
Reinsurance recoverable	(35,368)	(37,848)	(34,830)
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates	3,485,581	3,723,785	3,470,627
Other premium | Life | Gain Loss From Expereince
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	4,872	4,760	1,354
Other premium | Life | Gain (Loss) From Unlocking Assumptions
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	904	(2,836)	(5,241)
United American | Health
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning balance	3,697,771	2,908,501	3,611,659
Beginning balance	3,625,803	2,941,262	2,949,851
Effect of changes in assumptions on future cash flows		9,892	466,883	(195,560)
Effect of actual variances from expected experience		(43,846)	(27,178)	(37,437)
Adjusted balance		3,591,849	3,380,967	2,716,854
Issuances	480,412	377,097	360,942
Interest accrual	174,269	139,824	122,064
Net premiums collected	(297,675)	(272,085)	(258,598)
Effect of changes in the foreign exchange rate	0	0	0
Ending balance	3,948,855	3,625,803	2,941,262
Effect of change from original to current discount rates	(63,325)	71,968	(32,761)
Ending balance	3,885,530	3,697,771	2,908,501
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning balance	3,814,328	3,046,829	3,810,559
Beginning balance	3,741,530	3,080,633	3,090,901
Effect of changes in assumptions on future cash flows		10,680	464,652	(194,936)
Effect of actual variances from expected experience		(35,532)	(26,718)	(40,316)
Adjusted balance		3,716,678	3,518,567	2,855,649
Issuances	479,653	376,573	360,642
Interest accrual	180,235	147,082	129,842
Benefit payments	(349,706)	(300,692)	(265,500)
Effect of changes in the foreign exchange rate	0	0	0
Ending balance	4,026,860	3,741,530	3,080,633
Effect of changes in discount rate assumptions	(66,428)	72,798	(33,804)
Ending balance	3,960,432	3,814,328	3,046,829
Net liability for future policy benefits at original discount rates	78,005	115,727	139,371
Effect of changes in discount rate assumptions	(3,103)	830	(1,043)
Other Adjustments	24,920	10,980	4,055
Net liability for future policy benefits—long duration health	99,822	127,537	142,383
Reinsurance recoverable	(2,768)	(3,287)	(3,820)
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates	97,054	124,250	138,563
United American | Health | Gain Loss From Expereince
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	(4,890)	(134)	3,502
United American | Health | Gain (Loss) From Unlocking Assumptions
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	1,205	762	(626)
Family Heritage | Health
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning balance	1,711,741	1,594,992	1,944,714
Beginning balance	1,783,173	1,729,219	1,688,590
Effect of changes in assumptions on future cash flows		(8,117)	(30,255)	(20,931)
Effect of actual variances from expected experience		(56,720)	(69,878)	(67,419)
Adjusted balance		1,718,336	1,629,086	1,600,240
Issuances	265,166	266,375	241,052
Interest accrual	75,188	67,743	60,303
Net premiums collected	(190,817)	(180,031)	(172,376)
Effect of changes in the foreign exchange rate	0	0	0
Ending balance	1,867,873	1,783,173	1,729,219
Effect of change from original to current discount rates	(132,998)	(71,432)	(134,227)
Ending balance	1,734,875	1,711,741	1,594,992
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning balance	3,315,880	3,005,664	3,840,322
Beginning balance	3,506,689	3,336,344	3,193,342
Effect of changes in assumptions on future cash flows		(5,054)	(32,428)	(27,211)
Effect of actual variances from expected experience		(63,595)	(74,797)	(70,690)
Adjusted balance		3,438,040	3,229,119	$ 3,095,441
Issuances	265,166	266,375	241,052
Interest accrual	147,615	134,107	120,700
Benefit payments	(138,777)	(122,912)	(120,849)
Effect of changes in the foreign exchange rate	0	0	0
Ending balance	3,712,044	3,506,689	3,336,344
Effect of changes in discount rate assumptions	(375,498)	(190,809)	(330,680)
Ending balance	3,336,546	3,315,880	3,005,664
Net liability for future policy benefits at original discount rates	1,844,171	1,723,516	1,607,125
Effect of changes in discount rate assumptions	(242,500)	(119,377)	(196,453)
Other Adjustments	22	84	3,172
Net liability for future policy benefits—long duration health	1,601,693	1,604,223	1,413,844
Reinsurance recoverable	0	(10,718)	(9,027)
Net liability for future policy benefits, after reinsurance recoverable, at current discount rates	1,601,693	1,593,505	1,404,817
Family Heritage | Health | Gain Loss From Expereince
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	6,756	4,638	2,395
Family Heritage | Health | Gain (Loss) From Unlocking Assumptions
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Policyholder benefits net of remeasurement gain (losses)	$ (3,063)	$ 2,173	$ 6,283

Policy Liabilities - Additional

Policy Liabilities - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Liability for Future Policy Benefit, Activity [Line Items]
Change in assumptions of lapse, mortality, and morbidity, remeasurement gain (loss)	$ (46,300)	$ 3,200	$ (36,500)
Change in expected experience, remeasurement gain (loss)	(57,400)	38,000	4,600
Life
Liability for Future Policy Benefit, Activity [Line Items]
PV of expected future gross premiums	28,448,310	28,899,367	27,077,677
PV of expected future net premiums	11,757,317	12,342,307	11,748,528	$ 14,082,538
PV of expected future policy benefits, not discounted	79,213,296	77,685,477	74,660,927
Health
Liability for Future Policy Benefit, Activity [Line Items]
PV of expected future gross premiums	12,071,436	11,834,715	10,334,511
PV of expected future net premiums	6,314,148	6,089,728	5,207,422	$ 6,418,018
PV of expected future policy benefits, not discounted	$ 16,050,185	$ 15,020,883	$ 13,507,844

Policy Liabilities - Schedule_2

Policy Liabilities - Schedule of Liability For Future Policy Benefits To Consolidated Balance Sheets (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
At Original Discount Rates
Deferred profit liability	$ 178,199	$ 174,717	$ 175,883
Deferred annuity	656,573	773,039	954,318
Interest sensitive life	723,389	732,948	739,105
Other	8,923	9,951	10,106
Total future policy benefits	17,552,564	16,984,615	16,355,726
At Current Discount Rates
Deferred profit liability	178,199	174,717	175,883
Deferred annuity	656,573	773,039	954,318
Interest sensitive life	723,389	732,948	739,105
Other	8,926	9,945	10,099
Net liability for future policy benefits—long duration health	18,457,263	19,460,353	18,097,341
Life
At Original Discount Rates
Net liability for future policy benefits—long duration life	13,453,055	12,854,655	12,121,521
At Current Discount Rates
Net liability for future policy benefits—long duration health	14,577,140	15,390,289	14,014,147
Net liability for future policy benefits—long duration health	14,577,140	15,390,289	14,014,147
Health
At Original Discount Rates
Net liability for future policy benefits—long duration life	2,532,425	2,439,305	2,354,793
At Current Discount Rates
Net liability for future policy benefits—long duration health	2,313,036	2,379,415	2,203,789
Net liability for future policy benefits—long duration health	2,313,036	2,379,415	2,203,789
American Income | Life
At Original Discount Rates
Net liability for future policy benefits—long duration life	4,851,995	4,538,775	4,163,111
At Current Discount Rates
Net liability for future policy benefits—long duration health	5,224,897	5,482,036	4,846,063
Net liability for future policy benefits—long duration health	5,224,897	5,482,036	4,846,063
American Income | Health
At Original Discount Rates
Net liability for future policy benefits—long duration life	124,309	114,407	111,128
At Current Discount Rates
Net liability for future policy benefits—long duration health	132,870	129,980	122,502
Net liability for future policy benefits—long duration health	132,870	129,980	122,502
Direct to Consumer | Life
At Original Discount Rates
Net liability for future policy benefits—long duration life	3,156,039	2,992,493	2,797,031
At Current Discount Rates
Net liability for future policy benefits—long duration health	3,502,224	3,665,180	3,320,140
Net liability for future policy benefits—long duration health	3,502,224	3,665,180	3,320,140
Direct to Consumer | Health
At Original Discount Rates
Net liability for future policy benefits—long duration life	738	737	979
At Current Discount Rates
Net liability for future policy benefits—long duration health	765	772	1,023
Net liability for future policy benefits—long duration health	765	772	1,023
Liberty National | Life
At Original Discount Rates
Net liability for future policy benefits—long duration life	2,293,197	2,260,421	2,206,857
At Current Discount Rates
Net liability for future policy benefits—long duration health	2,329,070	2,481,440	2,342,487
Net liability for future policy benefits—long duration health	2,329,070	2,481,440	2,342,487
Liberty National | Health
At Original Discount Rates
Net liability for future policy benefits—long duration life	462,712	476,559	494,155
At Current Discount Rates
Net liability for future policy benefits—long duration health	477,886	516,903	524,037
Net liability for future policy benefits—long duration health	477,886	516,903	524,037
Other premium | Life
At Original Discount Rates
Net liability for future policy benefits—long duration life	3,151,824	3,062,966	2,954,522
At Current Discount Rates
Net liability for future policy benefits—long duration health	3,520,949	3,761,633	3,505,457
Net liability for future policy benefits—long duration health	3,520,949	3,761,633	3,505,457
United American | Health
At Original Discount Rates
Net liability for future policy benefits—long duration life	100,480	124,021	141,362
At Current Discount Rates
Net liability for future policy benefits—long duration health	99,822	127,537	142,383
Net liability for future policy benefits—long duration health	99,822	127,537	142,383
Family Heritage | Health
At Original Discount Rates
Net liability for future policy benefits—long duration life	1,844,186	1,723,581	1,607,169
At Current Discount Rates
Net liability for future policy benefits—long duration health	1,601,693	1,604,223	1,413,844
Net liability for future policy benefits—long duration health	$ 1,601,693	$ 1,604,223	$ 1,413,844

Policy Liabilities - Schedule_3

Policy Liabilities - Schedule of Weighted Average Interest Rate of Liability For Future Policy Benefits (Details)	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
American Income | Life
Liability for Future Policy Benefit, Activity [Line Items]
Weighted average original discount rate	5.70%	5.70%	5.80%
Weighted average current discount rate	5.40%	4.90%	5.20%
American Income | Health
Liability for Future Policy Benefit, Activity [Line Items]
Weighted average original discount rate	5.80%	5.80%	5.90%
Weighted average current discount rate	5.20%	4.80%	5.10%
DTC | Life
Liability for Future Policy Benefit, Activity [Line Items]
Weighted average original discount rate	6%	6%	6%
Weighted average current discount rate	5.50%	5%	5.20%
DTC | Health
Liability for Future Policy Benefit, Activity [Line Items]
Weighted average original discount rate	5.10%	5.10%	5.20%
Weighted average current discount rate	5.20%	4.80%	5.10%
Liberty National | Life
Liability for Future Policy Benefit, Activity [Line Items]
Weighted average original discount rate	5.60%	5.60%	5.60%
Weighted average current discount rate	5.50%	5%	5.20%
Liberty National | Health
Liability for Future Policy Benefit, Activity [Line Items]
Weighted average original discount rate	5.80%	5.80%	5.80%
Weighted average current discount rate	5.40%	4.90%	5.20%
Other premium | Life
Liability for Future Policy Benefit, Activity [Line Items]
Weighted average original discount rate	6.20%	6.20%	6.20%
Weighted average current discount rate	5.50%	5%	5.20%
United American | Health
Liability for Future Policy Benefit, Activity [Line Items]
Weighted average original discount rate	5.10%	5.10%	5.20%
Weighted average current discount rate	5.20%	4.80%	5.10%
Family Heritage | Health
Liability for Future Policy Benefit, Activity [Line Items]
Weighted average original discount rate	4.20%	4.30%	4.30%
Weighted average current discount rate	5.30%	4.90%	5.20%

Policy Liabilities - Schedule_4

Policy Liabilities - Schedule of Weighted Average Duration of Liability For Future Policy Benefits (Details)	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
American Income | Life
Liability for Future Policy Benefit, Activity [Line Items]
At original discount rates	22 years 8 months 23 days	23 years 3 days	22 years 10 months 9 days
At current discount rates	22 years 9 months 3 days	23 years 5 months 12 days	23 years 3 months 10 days
American Income | Health
Liability for Future Policy Benefit, Activity [Line Items]
At original discount rates	12 years 5 months 26 days	12 years 2 months 15 days	12 years 1 month 13 days
At current discount rates	12 years 6 months 21 days	12 years 10 months 2 days	12 years 6 months 21 days
DTC | Life
Liability for Future Policy Benefit, Activity [Line Items]
At original discount rates	19 years 2 months 26 days	19 years 6 months 29 days	20 years 3 months 7 days
At current discount rates	20 years 3 months 21 days	21 years 2 months 15 days	21 years 9 months 18 days
DTC | Health
Liability for Future Policy Benefit, Activity [Line Items]
At original discount rates	11 years 8 months 19 days	11 years 5 months 15 days	11 years 4 months 13 days
At current discount rates	10 years 7 months 24 days	10 years 10 months 20 days	10 years 7 months 24 days
Liberty National | Life
Liability for Future Policy Benefit, Activity [Line Items]
At original discount rates	15 years 3 months 18 days	15 years 1 month 17 days	14 years 10 months 9 days
At current discount rates	15 years 3 months 29 days	15 years 9 months 21 days	15 years 4 months 20 days
Liberty National | Health
Liability for Future Policy Benefit, Activity [Line Items]
At original discount rates	9 years 3 months 21 days	9 years 2 months 1 day	9 years 3 months 3 days
At current discount rates	9 years 2 months 8 days	9 years 5 months 26 days	9 years 5 months 19 days
Other premium | Life
Liability for Future Policy Benefit, Activity [Line Items]
At original discount rates	15 years 11 months 26 days	16 years 3 months 3 days	16 years 7 months 2 days
At current discount rates	16 years 11 months 1 day	17 years 11 months 1 day	18 years 1 month 24 days
United American | Health
Liability for Future Policy Benefit, Activity [Line Items]
At original discount rates	11 years 8 months 19 days	11 years 5 months 15 days	11 years 4 months 13 days
At current discount rates	10 years 7 months 24 days	10 years 10 months 20 days	10 years 7 months 24 days
Family Heritage | Health
Liability for Future Policy Benefit, Activity [Line Items]
At original discount rates	15 years 3 months 29 days	14 years 11 months 26 days	14 years 10 months 13 days
At current discount rates	14 years 2 months 23 days	14 years 6 months 14 days	14 years 2 months 19 days

Policy Liabilities - Schedule_5

Policy Liabilities - Schedule of Liability For Future Policy Benefits To Consolidated Income Statement (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Life
Liability for Future Policy Benefit, Activity [Line Items]
Gross Premiums	$ 3,243,732	$ 3,118,237	$ 3,007,853
Interest expense	761,823	722,618	684,691
Health
Liability for Future Policy Benefit, Activity [Line Items]
Gross Premiums	1,189,092	1,113,028	1,059,694
Interest expense	110,573	106,684	102,400
American Income | Life
Liability for Future Policy Benefit, Activity [Line Items]
Gross Premiums	1,696,918	1,587,304	1,503,537
Interest expense	272,007	252,277	234,098
American Income | Health
Liability for Future Policy Benefit, Activity [Line Items]
Gross Premiums	117,644	113,605	111,623
Interest expense	6,790	6,542	6,408
Direct to Consumer | Life
Liability for Future Policy Benefit, Activity [Line Items]
Gross Premiums	977,302	979,739	973,429
Interest expense	181,470	170,745	159,945
Direct to Consumer | Health
Liability for Future Policy Benefit, Activity [Line Items]
Gross Premiums	15,033	14,283	14,290
Interest expense	0	0	0
Liberty National | Life
Liability for Future Policy Benefit, Activity [Line Items]
Gross Premiums	367,278	345,196	322,497
Interest expense	122,727	120,083	117,681
Liberty National | Health
Liability for Future Policy Benefit, Activity [Line Items]
Gross Premiums	189,650	187,095	186,268
Interest expense	26,144	27,248	28,477
Other premium | Life
Liability for Future Policy Benefit, Activity [Line Items]
Gross Premiums	202,234	205,998	208,390
Interest expense	185,619	179,513	172,967
United American | Health
Liability for Future Policy Benefit, Activity [Line Items]
Gross Premiums	439,125	401,834	380,710
Interest expense	5,739	7,002	7,532
Family Heritage | Health
Liability for Future Policy Benefit, Activity [Line Items]
Gross Premiums	427,640	396,211	366,803
Interest expense	$ 71,900	$ 65,892	$ 59,983

Policy Liabilities - Schedule_6

Policy Liabilities - Schedule of Undiscounted And Discounted Expected Future Gross Premiums And Expected Future Benefits And Expenses (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Life
Liability for Future Policy Benefit, Activity [Line Items]
PV of expected future gross premiums, Not discounted	$ 51,329,931	$ 50,158,449	$ 48,220,609
PV of expected future gross premiums, At original discount rates	28,149,266	27,455,738	26,406,710
PV of expected future gross premiums, At current discount rates	28,448,310	28,899,367	27,077,677
PV of expected future net premiums, Not discounted	21,449,048	21,584,244	21,057,389
PV of expected future net premiums, At original discount rates	11,638,920	11,709,368	11,442,919	$ 10,896,222
PV of expected future net premiums, At current discount rates	11,757,317	12,342,307	11,748,528	14,082,538
PV of expected future policy benefits, Not discounted	79,213,296	77,685,477	74,660,927
PV of expected future policy benefits, At original discount rates	25,091,824	24,563,696	23,564,337	22,374,930
PV of expected future policy benefits, At current discount rates	26,334,284	27,723,158	25,749,961	33,664,308
Health
Liability for Future Policy Benefit, Activity [Line Items]
PV of expected future gross premiums, Not discounted	20,652,684	19,516,632	17,330,117
PV of expected future gross premiums, At original discount rates	12,408,312	11,744,155	10,585,274
PV of expected future gross premiums, At current discount rates	12,071,436	11,834,715	10,334,511
PV of expected future net premiums, Not discounted	10,740,051	10,005,242	8,675,406
PV of expected future net premiums, At original discount rates	6,512,063	6,069,295	5,366,305	5,328,427
PV of expected future net premiums, At current discount rates	6,314,148	6,089,728	5,207,422	6,418,018
PV of expected future policy benefits, Not discounted	16,050,185	15,020,883	13,507,844
PV of expected future policy benefits, At original discount rates	9,006,730	8,484,970	7,710,767	7,587,083
PV of expected future policy benefits, At current discount rates	8,586,253	8,441,002	7,394,349	9,353,001
American Income | Life
Liability for Future Policy Benefit, Activity [Line Items]
PV of expected future gross premiums, Not discounted	25,492,032	24,265,464	22,662,540
PV of expected future gross premiums, At original discount rates	14,410,088	13,695,495	12,832,811
PV of expected future gross premiums, At current discount rates	14,471,277	14,264,077	13,006,579
PV of expected future net premiums, Not discounted	8,233,110	8,001,107	7,480,182
PV of expected future net premiums, At original discount rates	4,656,710	4,523,329	4,246,723	3,906,098
PV of expected future net premiums, At current discount rates	4,645,917	4,681,888	4,273,156	4,925,192
PV of expected future policy benefits, Not discounted	31,831,310	30,623,947	28,318,683
PV of expected future policy benefits, At original discount rates	9,508,589	9,061,833	8,409,761	7,744,201
PV of expected future policy benefits, At current discount rates	9,870,692	10,163,627	9,119,104	11,773,519
American Income | Health
Liability for Future Policy Benefit, Activity [Line Items]
PV of expected future gross premiums, Not discounted	1,770,862	1,768,231	1,750,393
PV of expected future gross premiums, At original discount rates	992,641	991,448	977,846
PV of expected future gross premiums, At current discount rates	1,012,919	1,047,348	1,004,239
PV of expected future net premiums, Not discounted	400,512	359,248	342,659
PV of expected future net premiums, At original discount rates	225,141	201,869	192,631	178,801
PV of expected future net premiums, At current discount rates	223,247	206,381	190,296	222,553
PV of expected future policy benefits, Not discounted	709,637	640,326	617,973
PV of expected future policy benefits, At original discount rates	348,711	315,431	303,713	285,604
PV of expected future policy benefits, At current discount rates	355,303	335,504	312,750	380,915
Direct to Consumer | Life
Liability for Future Policy Benefit, Activity [Line Items]
PV of expected future gross premiums, Not discounted	17,372,446	17,506,091	17,346,469
PV of expected future gross premiums, At original discount rates	9,077,304	9,150,049	9,086,945
PV of expected future gross premiums, At current discount rates	9,258,880	9,761,706	9,432,882
PV of expected future net premiums, Not discounted	10,481,376	10,774,655	10,769,174
PV of expected future net premiums, At original discount rates	5,504,912	5,664,259	5,680,864	5,533,741
PV of expected future net premiums, At current discount rates	5,622,906	6,052,651	5,910,224	7,264,905
PV of expected future policy benefits, Not discounted	25,841,419	25,723,752	25,356,573
PV of expected future policy benefits, At original discount rates	8,660,948	8,656,752	8,477,892	8,157,259
PV of expected future policy benefits, At current discount rates	9,125,112	9,714,516	9,225,451	11,859,408
Direct to Consumer | Health
Liability for Future Policy Benefit, Activity [Line Items]
PV of expected future gross premiums, Not discounted	248,646	236,776	177,131
PV of expected future gross premiums, At original discount rates	157,812	149,119	116,212
PV of expected future gross premiums, At current discount rates	159,862	156,612	119,457
PV of expected future net premiums, Not discounted	208,577	174,738	133,995
PV of expected future net premiums, At original discount rates	131,919	109,880	87,751	96,776
PV of expected future net premiums, At current discount rates	133,377	115,363	90,143	121,724
PV of expected future policy benefits, Not discounted	204,099	163,087	127,911
PV of expected future policy benefits, At original discount rates	127,975	104,501	85,212	95,628
PV of expected future policy benefits, At current discount rates	129,277	109,482	87,532	119,888
Liberty National | Life
Liability for Future Policy Benefit, Activity [Line Items]
PV of expected future gross premiums, Not discounted	4,837,598	4,660,783	4,396,685
PV of expected future gross premiums, At original discount rates	2,817,204	2,720,264	2,561,304
PV of expected future gross premiums, At current discount rates	2,775,304	2,784,916	2,562,342
PV of expected future net premiums, Not discounted	1,849,200	1,897,696	1,885,533
PV of expected future net premiums, At original discount rates	1,047,022	1,077,831	1,066,123	1,040,242
PV of expected future net premiums, At current discount rates	1,048,447	1,129,716	1,094,407	1,332,469
PV of expected future policy benefits, Not discounted	9,073,624	8,905,815	8,613,975
PV of expected future policy benefits, At original discount rates	3,340,219	3,338,252	3,272,980	3,206,164
PV of expected future policy benefits, At current discount rates	3,377,517	3,605,392	3,429,256	4,542,697
Liberty National | Health
Liability for Future Policy Benefit, Activity [Line Items]
PV of expected future gross premiums, Not discounted	2,039,441	2,089,005	2,271,423
PV of expected future gross premiums, At original discount rates	1,299,234	1,325,869	1,418,333
PV of expected future gross premiums, At current discount rates	1,316,967	1,390,066	1,458,880
PV of expected future net premiums, Not discounted	500,297	518,008	652,858
PV of expected future net premiums, At original discount rates	338,275	348,570	415,442	414,409
PV of expected future net premiums, At current discount rates	337,119	358,472	423,490	517,368
PV of expected future policy benefits, Not discounted	1,374,959	1,413,211	1,600,943
PV of expected future policy benefits, At original discount rates	791,140	816,819	904,865	921,608
PV of expected future policy benefits, At current discount rates	804,695	865,808	941,574	1,201,317
Other premium | Life
Liability for Future Policy Benefit, Activity [Line Items]
PV of expected future gross premiums, Not discounted	3,627,855	3,726,111	3,814,915
PV of expected future gross premiums, At original discount rates	1,844,670	1,889,930	1,925,650
PV of expected future gross premiums, At current discount rates	1,942,849	2,088,668	2,075,874
PV of expected future net premiums, Not discounted	885,362	910,786	922,500
PV of expected future net premiums, At original discount rates	430,276	443,949	449,209	416,141
PV of expected future net premiums, At current discount rates	440,047	478,052	470,741	559,972
PV of expected future policy benefits, Not discounted	12,466,943	12,431,963	12,371,696
PV of expected future policy benefits, At original discount rates	3,582,068	3,506,859	3,403,704	3,267,306
PV of expected future policy benefits, At current discount rates	3,960,963	4,239,623	3,976,150	5,488,684
United American | Health
Liability for Future Policy Benefit, Activity [Line Items]
PV of expected future gross premiums, Not discounted	9,350,851	8,682,707	6,801,987
PV of expected future gross premiums, At original discount rates	5,738,332	5,295,148	4,285,863
PV of expected future gross premiums, At current discount rates	5,643,454	5,396,402	4,233,647
PV of expected future net premiums, Not discounted	6,442,648	5,955,294	4,680,560
PV of expected future net premiums, At original discount rates	3,948,855	3,625,803	2,941,262	2,949,851
PV of expected future net premiums, At current discount rates	3,885,530	3,697,771	2,908,501	3,611,659
PV of expected future policy benefits, Not discounted	6,584,800	6,148,565	4,915,174
PV of expected future policy benefits, At original discount rates	4,026,860	3,741,530	3,080,633	3,090,901
PV of expected future policy benefits, At current discount rates	3,960,432	3,814,328	3,046,829	3,810,559
Family Heritage | Health
Liability for Future Policy Benefit, Activity [Line Items]
PV of expected future gross premiums, Not discounted	7,242,884	6,739,913	6,329,183
PV of expected future gross premiums, At original discount rates	4,220,293	3,982,571	3,787,020
PV of expected future gross premiums, At current discount rates	3,938,234	3,844,287	3,518,288
PV of expected future net premiums, Not discounted	3,188,017	2,997,954	2,865,334
PV of expected future net premiums, At original discount rates	1,867,873	1,783,173	1,729,219	1,688,590
PV of expected future net premiums, At current discount rates	1,734,875	1,711,741	1,594,992	1,944,714
PV of expected future policy benefits, Not discounted	7,176,690	6,655,694	6,245,843
PV of expected future policy benefits, At original discount rates	3,712,044	3,506,689	3,336,344	3,193,342
PV of expected future policy benefits, At current discount rates	$ 3,336,546	$ 3,315,880	$ 3,005,664	$ 3,840,322

Policy Liabilities - Schedule_7

Policy Liabilities - Schedule of Policyholder Account Balance (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Interest Sensitive Life
Policyholder Account Balance [Roll Forward]
Beginning Balance	$ 732,948	$ 739,105	$ 745,335
Issuances	0	0	0
Premiums received	20,928	22,036	23,439
Policy charges	(12,295)	(12,926)	(13,573)
Surrenders and withdrawals	(22,479)	(21,215)	(21,994)
Benefit payments	(30,512)	(29,909)	(32,889)
Interest credited	27,790	28,320	28,579
Other	7,009	7,537	10,208
Ending Balance	$ 723,389	$ 732,948	$ 739,105
Weighted-average credit rate	3.82%	3.85%	3.85%
Net amount at risk	$ 1,663,496	$ 1,766,170	$ 1,873,315
Cash surrender value	677,111	671,596	689,546
Deferred Annuity
Policyholder Account Balance [Roll Forward]
Beginning Balance	773,039	954,318	1,033,525
Issuances	875	896	1,528
Premiums received	11,332	13,209	22,873
Policy charges	0	0	0
Surrenders and withdrawals	(107,707)	(165,584)	(92,235)
Benefit payments	(43,955)	(57,937)	(44,456)
Interest credited	23,634	28,150	32,779
Other	(645)	(13)	304
Ending Balance	$ 656,573	$ 773,039	$ 954,318
Weighted-average credit rate	3.31%	3.26%	3.30%
Cash surrender value	$ 656,573	$ 773,039	$ 954,309
Other Policy-holders' Funds
Policyholder Account Balance [Roll Forward]
Beginning Balance	236,958	123,236	99,468
Issuances	0	0	0
Premiums received	240,802	122,136	30,591
Policy charges	0	0	0
Surrenders and withdrawals	(13,897)	(13,042)	(11,615)
Benefit payments	0	0	0
Interest credited	21,165	9,314	4,589
Other	(16,424)	(4,686)	203
Ending Balance	$ 468,604	$ 236,958	$ 123,236
Weighted-average credit rate	6%	5.17%	4.12%
Cash surrender value	$ 468,604	$ 236,958	$ 123,236

Policy Liabilities - Schedule_8

Policy Liabilities - Schedule of Policyholder Account Balance, Guaranteed Minimum Crediting Rate (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
51-150 basis points above | Minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range above guaranteed minimum crediting rates (percent)	0.0051	0.0051	0.0051
51-150 basis points above | Maximum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range above guaranteed minimum crediting rates (percent)	0.0150	0.0150	0.0150
Interest Sensitive Life
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	$ 723,389	$ 732,948	$ 739,105	$ 745,335
Interest Sensitive Life | At guaranteed minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	723,389	732,948	739,105
Interest Sensitive Life | 51-150 basis points above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	$ 0	$ 0	$ 0
Interest Sensitive Life | Less than 3.00% | At guaranteed minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates (percent)	3%	3%	3%
Range of guaranteed minimum crediting rates	$ 0	$ 0	$ 0
Interest Sensitive Life | Less than 3.00% | 51-150 basis points above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates (percent)	3%	3%	3%
Range of guaranteed minimum crediting rates	$ 0	$ 0	$ 0
Interest Sensitive Life | 3.00%-3.99% | At guaranteed minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	$ 29,251	$ 29,086	$ 28,867
Interest Sensitive Life | 3.00%-3.99% | At guaranteed minimum | Minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates (percent)	3%	3%	3%
Interest Sensitive Life | 3.00%-3.99% | At guaranteed minimum | Maximum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates (percent)	3.99%	3.99%	3.99%
Interest Sensitive Life | 3.00%-3.99% | 51-150 basis points above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	$ 0	$ 0	$ 0
Interest Sensitive Life | 3.00%-3.99% | 51-150 basis points above | Minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates (percent)	3%	3%	3%
Interest Sensitive Life | 3.00%-3.99% | 51-150 basis points above | Maximum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates (percent)	3.99%	3.99%	3.99%
Interest Sensitive Life | 4.00%-4.99% | At guaranteed minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	$ 604,412	$ 613,704	$ 620,594
Interest Sensitive Life | 4.00%-4.99% | At guaranteed minimum | Minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates (percent)	4%	4%	4%
Interest Sensitive Life | 4.00%-4.99% | At guaranteed minimum | Maximum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates (percent)	4.99%	4.99%	4.99%
Interest Sensitive Life | 4.00%-4.99% | 51-150 basis points above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	$ 0	$ 0	$ 0
Interest Sensitive Life | 4.00%-4.99% | 51-150 basis points above | Minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates (percent)	4%	4%	4%
Interest Sensitive Life | 4.00%-4.99% | 51-150 basis points above | Maximum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates (percent)	4.99%	4.99%	4.99%
Interest Sensitive Life | Greater than 5.00% | At guaranteed minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates (percent)	5%	5%	5%
Range of guaranteed minimum crediting rates	$ 89,726	$ 90,158	$ 89,644
Interest Sensitive Life | Greater than 5.00% | 51-150 basis points above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates (percent)	5%	5%	5%
Range of guaranteed minimum crediting rates	$ 0	$ 0	$ 0
Deferred Annuity
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	656,573	773,039	954,318	1,033,525
Deferred Annuity | At guaranteed minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	656,573	773,039	954,318
Deferred Annuity | 51-150 basis points above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	0	0	0
Deferred Annuity | Less than 3.00% | At guaranteed minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	1,812	1,945	2,040
Deferred Annuity | Less than 3.00% | 51-150 basis points above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	0	0	0
Deferred Annuity | 3.00%-3.99% | At guaranteed minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	473,191	574,939	743,299
Deferred Annuity | 3.00%-3.99% | 51-150 basis points above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	0	0	0
Deferred Annuity | 4.00%-4.99% | At guaranteed minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	181,570	195,390	208,979
Deferred Annuity | 4.00%-4.99% | 51-150 basis points above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	0	0	0
Deferred Annuity | Greater than 5.00% | At guaranteed minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	0	765	0
Deferred Annuity | Greater than 5.00% | 51-150 basis points above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	0	0	0
Other premium
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	468,604	236,958	123,236	$ 99,468
Other premium | At guaranteed minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	468,604	186,891	123,236
Other premium | 51-150 basis points above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	0	50,067	0
Other premium | Less than 3.00% | At guaranteed minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	373,584	138,684	23,042
Other premium | Less than 3.00% | 51-150 basis points above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	0	0	0
Other premium | 3.00%-3.99% | At guaranteed minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	3,182	3,790	4,074
Other premium | 3.00%-3.99% | 51-150 basis points above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	0	0	0
Other premium | 4.00%-4.99% | At guaranteed minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	55,876	6,861	58,251
Other premium | 4.00%-4.99% | 51-150 basis points above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	0	50,067	0
Other premium | Greater than 5.00% | At guaranteed minimum
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	35,962	37,556	37,869
Other premium | Greater than 5.00% | 51-150 basis points above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Range of guaranteed minimum crediting rates	$ 0	$ 0	$ 0

Deferred Acquisition Costs - Sc

Deferred Acquisition Costs - Schedule of Analysis of Deferred Acquisition Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Movement Analysis of Deferred Policy Acquisition Costs
Beginning Balance	$ 6,009,477	$ 5,535,697
Amortization expense	(410,001)	(379,700)	$ (348,824)
Ending Balance	6,495,589	6,009,477	5,535,697
Life
Movement Analysis of Deferred Policy Acquisition Costs
Beginning Balance	5,271,775	4,844,291	4,412,015
Capitalizations	801,893	751,704	742,572
Amortization expense	(356,223)	(327,426)	(298,841)
Foreign exchange adjustment	(16,690)	3,206	(11,455)
Ending Balance	5,700,755	5,271,775	4,844,291
Health
Movement Analysis of Deferred Policy Acquisition Costs
Beginning Balance	734,735	686,763	649,082
Capitalizations	111,651	98,465	86,371
Amortization expense	(52,224)	(50,598)	(48,184)
Foreign exchange adjustment	(741)	105	(506)
Ending Balance	793,421	734,735	686,763
American Income | Life
Movement Analysis of Deferred Policy Acquisition Costs
Beginning Balance	2,573,370	2,258,291	1,960,254
Capitalizations	524,980	471,771	450,600
Amortization expense	(181,431)	(159,898)	(141,108)
Foreign exchange adjustment	(16,690)	3,206	(11,455)
Ending Balance	2,900,229	2,573,370	2,258,291
American Income | Health
Movement Analysis of Deferred Policy Acquisition Costs
Beginning Balance	66,783	57,811	49,406
Capitalizations	14,955	12,849	12,378
Amortization expense	(4,678)	(3,982)	(3,467)
Foreign exchange adjustment	(741)	105	(506)
Ending Balance	76,319	66,783	57,811
DTC | Life
Movement Analysis of Deferred Policy Acquisition Costs
Beginning Balance	1,737,117	1,676,931	1,583,695
Capitalizations	145,538	159,650	188,083
Amortization expense	(101,425)	(99,464)	(94,847)
Foreign exchange adjustment	0	0	0
Ending Balance	1,781,230	1,737,117	1,676,931
DTC | Health
Movement Analysis of Deferred Policy Acquisition Costs
Beginning Balance	1,679	1,854	2,032
Capitalizations	2	0	4
Amortization expense	(148)	(175)	(182)
Foreign exchange adjustment	0	0	0
Ending Balance	1,533	1,679	1,854
Liberty National | Life
Movement Analysis of Deferred Policy Acquisition Costs
Beginning Balance	666,419	610,723	566,419
Capitalizations	119,203	107,230	90,385
Amortization expense	(56,832)	(51,534)	(46,081)
Foreign exchange adjustment	0	0	0
Ending Balance	728,790	666,419	610,723
Liberty National | Health
Movement Analysis of Deferred Policy Acquisition Costs
Beginning Balance	139,941	133,096	127,537
Capitalizations	23,775	20,309	18,737
Amortization expense	(14,796)	(13,464)	(13,178)
Foreign exchange adjustment	0	0	0
Ending Balance	148,920	139,941	133,096
Other premium | Life
Movement Analysis of Deferred Policy Acquisition Costs
Beginning Balance	294,869	298,346	301,647
Capitalizations	12,172	13,053	13,504
Amortization expense	(16,535)	(16,530)	(16,805)
Foreign exchange adjustment	0	0	0
Ending Balance	290,506	294,869	298,346
United American | Health
Movement Analysis of Deferred Policy Acquisition Costs
Beginning Balance	73,489	77,394	81,140
Capitalizations	2,608	1,941	2,135
Amortization expense	(5,567)	(5,846)	(5,881)
Foreign exchange adjustment	0	0	0
Ending Balance	70,530	73,489	77,394
Family Heritage | Health
Movement Analysis of Deferred Policy Acquisition Costs
Beginning Balance	452,843	416,608	388,967
Capitalizations	70,311	63,366	53,117
Amortization expense	(27,035)	(27,131)	(25,476)
Foreign exchange adjustment	0	0	0
Ending Balance	$ 496,119	$ 452,843	$ 416,608

Deferred Acquisition Costs - _2

Deferred Acquisition Costs - Schedule of Deferred Policy Acquisition Costs to Consolidated Balance Sheet (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs	$ 6,495,589	$ 6,009,477	$ 5,535,697
Life
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs	5,700,755	5,271,775	4,844,291	$ 4,412,015
Health
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs	793,421	734,735	686,763	649,082
Annuity Segment
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs	1,413	2,967	4,643
American Income | Life
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs	2,900,229	2,573,370	2,258,291	1,960,254
American Income | Health
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs	76,319	66,783	57,811	49,406
DTC | Life
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs	1,781,230	1,737,117	1,676,931	1,583,695
DTC | Health
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs	1,533	1,679	1,854	2,032
Liberty National | Life
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs	728,790	666,419	610,723	566,419
Liberty National | Health
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs	148,920	139,941	133,096	127,537
Other premium | Life
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs	290,506	294,869	298,346	301,647
United American | Health
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs	70,530	73,489	77,394	81,140
Family Heritage | Health
Deferred Policy Acquisition Cost [Line Items]
Deferred acquisition costs	$ 496,119	$ 452,843	$ 416,608	$ 388,967

Liability for Unpaid Claims - S

Liability for Unpaid Claims - Schedule of Liability for Unpaid Health Claims (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Activity in the Liability for Unpaid Health Claims
Beginning balance less reinsurance recoverable	$ 514,875
Paid related to:
Beginning balance plus reinsurance recoverable	532,832	$ 514,875
Health claims
Activity in the Liability for Unpaid Health Claims
Beginning balance	192,652	182,202	$ 171,109
Less reinsurance recoverables, beginning balance	(2,157)	(2,084)	(2,628)
Beginning balance less reinsurance recoverable	194,809	184,286	173,737
Incurred related to:
Current year	767,076	697,521	676,189
Prior years	(10,460)	(4,853)	(15,631)
Total incurred	756,616	692,668	660,558
Paid related to:
Current year	587,473	535,971	517,855
Prior years	152,322	146,247	131,610
Total paid	739,795	682,218	649,465
Ending balance	209,473	192,652	182,202
Plus reinsurance recoverables, ending balance	1,521	2,157	2,084
Beginning balance plus reinsurance recoverable	$ 210,994	$ 194,809	$ 184,286

Liability for Unpaid Claims -_2

Liability for Unpaid Claims - Schedule of Reconciliation of Policy Claims and Other Benefits Payable (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Policy claims and other benefits payable:
Policy claims and other benefits payable	$ 532,832	$ 514,875
Life insurance
Policy claims and other benefits payable:
Policy claims and other benefits payable	321,838	320,066
Health insurance
Policy claims and other benefits payable:
Policy claims and other benefits payable	$ 210,994	$ 194,809	$ 184,286	$ 173,737

Income Taxes - Schedule of Comp

Income Taxes - Schedule of Components of Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Current income tax expense (benefit)	$ 218,135	$ 145,880	$ 138,968
Deferred income tax expense (benefit)	37,740	77,631	68,757
Income tax expense (benefit)	255,875	223,511	207,725
Shareholders' equity:
Other comprehensive income (loss)	197,427	4,762	384,035
Income tax expense (benefit)	$ 453,302	$ 228,273	$ 591,760

Income Taxes - Schedule of Effe

Income Taxes - Schedule of Effective Income Tax Rate (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Effective Income Tax Rate Reconciliation, Amount [Abstract]
Expected federal income tax expense (benefit)	$ 278,594	$ 250,796	$ 231,443
Low-income housing investments	(9,700)	(14,291)	(11,443)
Share-based awards	1,341	(4,724)	(5,251)
Tax-exempt investment income	(9,644)	(9,644)	(8,961)
Other tax credits	(5,000)	0	0
Other	284	1,374	1,937
Income tax expense (benefit)	$ 255,875	$ 223,511	$ 207,725
Effective Income Tax Rate Reconciliation, Percent [Abstract]
Expected federal income tax expense (benefit)	21%	21%	21%
Low-income housing investments	(0.70%)	(1.20%)	(1.10%)
Share-based awards	0.10%	(0.40%)	(0.50%)
Tax-exempt investment income	(0.70%)	(0.80%)	(0.80%)
Other tax credits	(0.40%)	0%	0%
Other	0%	0.10%	0.20%
Income tax expense (benefit)	19.30%	18.70%	18.80%

Income Taxes - Schedule of Sign

Income Taxes - Schedule of Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Deferred tax assets:
Unrealized losses	$ 532,756	$ 732,750
Carryover of tax losses	10,342	4,227
Total gross deferred tax assets	543,098	736,977
Less valuation allowance	(3,383)	0
Net deferred tax assets	539,715	736,977
Deferred tax liabilities:
Employee and agent compensation	104,385	100,689
Deferred acquisition costs	961,406	892,149
Future policy benefits, unearned and advance premiums, and policy claims	228,117	267,564
Other liabilities	24,432	17,466
Total gross deferred tax liabilities	1,318,340	1,277,868
Net deferred tax liability	$ 778,625	$ 540,891

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($)	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Operating loss carryforwards	$ 49,200,000
Operating loss carryforwards, subject to expiration	7,200,000
Operating loss carryforwards, not subject to expiration	42,000,000
Deferred tax assets, valuation allowance	3,383,000	$ 0
Uncertain tax positions	$ 0	$ 0	$ 0

Postretirement Benefits - Total

Postretirement Benefits - Total Cost of Retirement Plans Charged to Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Retirement Benefits [Abstract]
Defined Contribution Plans	$ 6,605	$ 6,390	$ 5,824
Defined Benefit Pension Plans	$ 16,458	$ 15,225	$ 37,040

Postretirement Benefits - Addit

Postretirement Benefits - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Retirement Benefits [Abstract]
Capped eligible compensation	$ 1
SERP
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Contributions	$ 24.8	$ 24.4	$ 29.8

Postretirement Benefits - Sched

Postretirement Benefits - Schedule of Pension Assets by Component at Fair Value (Details) - Pension Plan - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 614,845	$ 570,767	$ 499,775
Percentage of plan assets	100%	100%
Investment funds, percentage ownership by pension plan	1%
Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 584,299	$ 552,453
Percentage of plan assets	95%	97%
Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 360,984	$ 341,570
Significant Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	223,315	210,883
Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 30,546	$ 18,314
Percentage of plan assets	5%	3%
Exchange traded fund
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	$ 35,483	$ 18,715
Percentage of total plan assets, within plan asset category	6%	3%
Investment grade securities issued term	10 years
Exchange traded fund | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	$ 35,483	$ 18,715
Exchange traded fund | Significant Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	0	0
Exchange traded fund | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	0	0
Equity Exchange Traded Fund
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	$ 322,846	$ 315,886
Percentage of total plan assets, within plan asset category	53%	55%
Equity Exchange Traded Fund | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	$ 322,846	$ 315,886
Equity Exchange Traded Fund | Significant Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	0	0
Equity Exchange Traded Fund | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	0	0
U.S. Government and Agency
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	$ 179,418	$ 167,450
Percentage of total plan assets, within plan asset category	29%	30%
U.S. Government and Agency | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	$ 0	$ 0
U.S. Government and Agency | Significant Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	179,418	167,450
U.S. Government and Agency | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	0	0
Other bonds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	$ 4	$ 5
Percentage of total plan assets, within plan asset category	0%	0%
Other bonds | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	$ 0	$ 0
Other bonds | Significant Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	4	5
Other bonds | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	0	0
Guaranteed annuity contract
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	$ 43,893	$ 43,428
Percentage of total plan assets, within plan asset category	7%	8%
Guaranteed annuity contract | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	$ 0	$ 0
Guaranteed annuity contract | Significant Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	43,893	43,428
Guaranteed annuity contract | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	0	0
Short-term investments
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	$ 1,235	$ 6,506
Percentage of total plan assets, within plan asset category	0%	1%
Short-term investments | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	$ 1,235	$ 6,506
Short-term investments | Significant Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	0	0
Short-term investments | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	0	0
Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	$ 1,420	$ 463
Percentage of total plan assets, within plan asset category	0%	0%
Other | Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	$ 1,420	$ 463
Other | Significant Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	0	0
Other | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets, within plan asset category	$ 0	$ 0

Postretirement Benefits - Sch_2

Postretirement Benefits - Schedule of Investment Funds (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Investment funds, unfunded commitments	$ 433,000
Minimum
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Expected life of non-redeemable funds	7 years
Expected life of non-redeemable funds with extension options	2 years
Maximum
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Expected life of non-redeemable funds	10 years
Expected life of non-redeemable funds with extension options	4 years
Multi-asset class
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Investment funds, Fair Value	$ 12,383	$ 14,714
Investment funds, unfunded commitments	0
Private equity
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Investment funds, Fair Value	18,163	3,600
Investment funds, unfunded commitments	48,167
Investment Funds
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Investment funds, Fair Value	30,546	$ 18,314
Investment funds, unfunded commitments	$ 48,167

Postretirement Benefits - Sch_3

Postretirement Benefits - Schedule of Information Regarding the SERP (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Retirement Benefits [Abstract]
Premiums paid for insurance coverage	$ 443	$ 443	$ 443
Total investments:
COLI	57,210	55,185
Exchange traded funds	98,314	86,156
Total investments of SERP	$ 155,524	$ 141,341

Postretirement Benefits - Sch_4

Postretirement Benefits - Schedule of Pension Liability (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Benefit obligation	$ 635,056	$ 627,560
ABO	568,438	562,372
Defined Benefit Plan, Pension Plan with Project Benefit Obligation in Excess of Plan Assets [Abstract]
Funded benefit pension plans PBO	561,615	554,957
Funded benefit pension plans fair value of plan assets	614,845	570,767
Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]
Funded benefit pension plans ABO	500,010	493,040
Funded benefit pension plans fair value of plan assets	614,845	570,767
Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Benefit obligation	635,056	627,560	$ 562,567
Qualified Plan | Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Benefit obligation	561,615	554,957
ABO	500,010	493,040
Nonqualified Plan | SERP
Defined Benefit Plan Disclosure [Line Items]
Benefit obligation	73,441	72,603
ABO	$ 68,428	$ 69,332

Postretirement Benefits - Weigh

Postretirement Benefits - Weighted Average Pension Plan Assumptions and Weighted Average Assumptions for Post-Retirement Benefit Plans Other Than Pensions (Details) - Pension Plan	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Discount rate	5.81%	5.40%
Rate of compensation increase	4.46%	4.40%
Discount rate	5.40%	5.71%	3.19%
Expected long-term returns	7.18%	6.98%	6.98%
Rate of compensation increase	4.40%	4.40%	4.43%

Postretirement Benefits - Sch_5

Postretirement Benefits - Schedule of Net Periodic Benefit Cost (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Retirement Benefits [Abstract]
Service cost—benefits earned during the period	$ 24,898	$ 21,568	$ 34,624
Interest cost on projected benefit obligation	33,123	31,367	24,445
Expected return on assets	(42,580)	(38,625)	(35,539)
Prior service cost	1,071	1,075	1,077
Recognition of actuarial gain (loss)	54	160	(12,433)
Net periodic benefit cost	$ 16,458	$ 15,225	$ 37,040
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Amortization of Prior Service Cost (Credit), Statement of Income or Comprehensive Income [Extensible Enumeration]	Amortization of pension costs	Amortization of pension costs	Amortization of pension costs

Postretirement Benefits - Analy

Postretirement Benefits - Analysis of Impact on Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plan, Impact on Other Comprehensive Income
Balance at January 1	$ (2,727)	$ 1,570	$ (131,239)
Prior service cost (credit)	1,071	1,075	1,077
Net actuarial (gain) loss	(597)	(1,465)	12,677
Total amortization	474	(390)	13,754
Plan amendments	(1,212)	0	0
Experience gain (loss)	29,659	(3,907)	119,055
Balance at December 31	26,194	(2,727)	1,570
Other Benefits
Defined Benefit Plan, Impact on Other Comprehensive Income
Total amortization	$ (622)	$ (732)	$ 289

Postretirement Benefits - Recon

Postretirement Benefits - Reconciliation of Benefit Obligation and Plan Assets, Pension Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Changes in PBO:
PBO at beginning of year	$ 627,560
Service cost	24,898	$ 21,568	$ 34,624
Interest cost	33,123	31,367	24,445
PBO at end of year	635,056	627,560
Pension Plan
Changes in PBO:
PBO at beginning of year	627,560	562,567
Service cost	24,898	21,568
Interest cost	33,123	31,367
Plan amendments	1,212	0
Actuarial loss (gain)	(22,964)	40,569
Benefits paid	(28,773)	(28,511)
PBO at end of year	635,056	627,560	562,567
Changes in plan assets:
Fair value at beginning of year	570,767	499,775
Return on assets	48,084	75,062
Contributions	24,767	24,441
Benefits paid	(28,773)	(28,511)
Fair value at end of year	614,845	570,767	$ 499,775
Funded status at year end	$ (20,211)	$ (56,793)

Postretirement Benefits - Sch_6

Postretirement Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net amounts recognized at year end	$ 26,194	$ (2,727)	$ 1,570	$ (131,239)
Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net loss (gain)	(28,720)	(227)
Prior service cost	6,636	6,494
Net amounts recognized at year end	$ (22,084)	$ 6,267

Postretirement Benefits - Estim

Postretirement Benefits - Estimated Future Payments for Pension Benefits and Other Postretirement Benefit Plans (Details) - Pension Plan $ in Thousands	Dec. 31, 2024 USD ($)
Defined Benefit Plan Disclosure [Line Items]
2025	$ 31,035
2026	33,565
2027	36,259
2028	39,032
2029	41,865
2030-2034	$ 243,598

Supplemental Disclosures of C_3

Supplemental Disclosures of Cash Flow Information - Schedule of Noncash Transactions (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Supplemental Cash Flow Elements [Abstract]
Stock-based compensation not involving cash	$ 40,118	$ 30,736	$ 35,650
Commitments for low-income housing interests	35,000	0	136,882
Exchanges of fixed maturity investments	105,595	50,936	147,612
Net unsettled security trades	2,334	3,833	0
Noncash tax credits	$ 0	$ 1,083	$ 1,000

Supplemental Disclosures of C_4

Supplemental Disclosures of Cash Flow Information - Schedule of Amount Paid (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Supplemental Cash Flow Elements [Abstract]
Interest paid	$ 116,993	$ 99,545	$ 88,814
Income taxes paid	175,400	121,034	114,888
Income taxes paid includes cash	$ 47,000	$ 0	$ 0

Debt - Additional Information (

Debt - Additional Information (Details)				12 Months Ended
	Aug. 23, 2024 USD ($)	Aug. 15, 2024 USD ($)	Sep. 30, 2021 extension_option	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Aug. 14, 2024 USD ($)	Mar. 29, 2024 USD ($)
Debt Instrument [Line Items]
Proceeds from issuance of debt				$ 530,000,000	$ 170,000,000	$ 250,492,000
Decrease in commercial paper				$ 100,000,000
Activity-based common stock ownership percentage				0.041
FHLB stock				$ 34,500,000	22,300,000
Short-term debt, face amount				419,000,000
Estimate of Fair Value Measurement | Asset Pledged as Collateral
Debt Instrument [Line Items]
Fair value of pledged assets				1,300,000,000
Federal Home Loan Bank Borrowings
Debt Instrument [Line Items]
Short-term debt, face amount				$ 0	0
Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity								$ 1,000,000,000
Potential maximum borrowing capacity								$ 1,250,000,000
Number of extension options | extension_option			2
Extension term			1 year
Junior Subordinated Debentures Due 2056
Debt Instrument [Line Items]
Interest rate				4.25%
Senior Notes
Debt Instrument [Line Items]
Optional redemption, period from issuance date				5 years
Senior Notes | 5.85% Senior notes due September 15, 2034
Debt Instrument [Line Items]
Balance of commercial paper at end of period (par value)	$ 450,000,000
Interest rate	5.85%
Proceeds from issuance of debt	$ 445,000,000
Term Loan Credit Agreement
Debt Instrument [Line Items]
Balance of commercial paper at end of period (par value)		$ 250,000,000					$ 170,000,000
Debt instrument, increase (decrease), net		$ 80,000,000
Federal Home Loan Bank Borrowings
Debt Instrument [Line Items]
Maximum borrowing capacity				$ 730,000,000
Long-term line of credit				$ 372,000,000	$ 138,000,000

Debt - Schedule of Selected Inf

Debt - Schedule of Selected Information about Debt Issues (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Long-term debt, par value, gross	$ 2,350,000,000
Total short-term debt, par value	419,000,000
Total debt, par value	2,769,000,000
Unamortized discount & issuance costs, noncurrent	(25,749,000)
Unamortized discount & issuance costs, current	(3,599,000)
Total debt, unamortized discount & issuance costs,	(29,348,000)
Long-term debt	2,324,251,000	$ 1,629,559,000
Total short-term debt, book value	415,401,000	486,113,000
Total debt, book value	2,739,652,000	2,115,672,000
Fair Value	2,122,772,000
Total short-term debt, fair value	415,401,000
Total debt, fair value	2,538,173,000
Commercial paper
Debt Instrument [Line Items]
Total short-term debt, par value	419,000,000
Unamortized discount & issuance costs, current	(3,599,000)
Total short-term debt, book value	415,401,000	316,564,000
Total short-term debt, fair value	415,401,000
Term Loan
Debt Instrument [Line Items]
Total short-term debt, par value	0
Unamortized discount & issuance costs, current	0
Total short-term debt, book value	0	169,549,000
Total short-term debt, fair value	$ 0
Senior Notes Due 2028
Debt Instrument [Line Items]
Coupon Rate	4.55%
Long-term debt, par value, gross	$ 550,000,000
Unamortized discount & issuance costs, noncurrent	(3,001,000)
Debt	546,999,000	546,283,000
Long-term debt, gross, fair value	$ 542,811,000
Senior Notes Due 2030
Debt Instrument [Line Items]
Coupon Rate	2.15%
Long-term debt, par value, gross	$ 400,000,000
Unamortized discount & issuance costs, noncurrent	(2,868,000)
Debt	397,132,000	396,670,000
Long-term debt, gross, fair value	$ 338,524,000
Senior Notes Due June 15 2032
Debt Instrument [Line Items]
Coupon Rate	4.80%
Long-term debt, par value, gross	$ 250,000,000
Unamortized discount & issuance costs, noncurrent	(3,728,000)
Debt	246,272,000	245,873,000
Long-term debt, gross, fair value	241,083,000
Senior Notes Due June 15 2032 | Consolidation Eliminations | Subsidiaries
Debt Instrument [Line Items]
Long-term debt, net, book value	$ 150,000,000
Senior Notes Due September 15 2034
Debt Instrument [Line Items]
Coupon Rate	5.85%
Long-term debt, par value, gross	$ 450,000,000
Unamortized discount & issuance costs, noncurrent	(5,186,000)
Debt	444,814,000	0
Long-term debt, gross, fair value	$ 451,665,000
Senior Notes Due November 17 2057
Debt Instrument [Line Items]
Coupon Rate	5.275%
Long-term debt, par value, gross	$ 125,000,000
Unamortized discount & issuance costs, noncurrent	(1,557,000)
Debt	123,443,000	123,427,000
Long-term debt, gross, fair value	$ 95,865,000
Junior Subordinated Debentures Due 2061
Debt Instrument [Line Items]
Coupon Rate	4.25%
Long-term debt, par value, gross	$ 325,000,000
Unamortized discount & issuance costs, noncurrent	(7,613,000)
Debt	317,387,000	317,306,000
Long-term debt, gross, fair value	$ 204,620,000
Junior Subordinated Debentures Due 2057
Debt Instrument [Line Items]
Basis spread	1.35%
Term Loan Due 2027
Debt Instrument [Line Items]
Coupon Rate	5.998%
Long-term debt, par value, gross	$ 250,000,000
Unamortized discount & issuance costs, noncurrent	(1,796,000)
Debt	248,204,000	$ 0
Long-term debt, gross, fair value	$ 248,204,000

Debt - Schedule of Amount of De

Debt - Schedule of Amount of Debt Due in Next Five Years (Details) $ in Thousands	Dec. 31, 2024 USD ($)
Debt Disclosure [Abstract]
2025	$ 419,000
2026	0
2027	250,000
2028	550,000
2029	0
Thereafter	$ 1,550,000

Debt - Schedule of Short-Term B

Debt - Schedule of Short-Term Borrowings (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Short-term Debt [Line Items]
Annualized interest rate	5.22%	5.71%
Letters of credit outstanding	$ 115,000	$ 115,000
Remaining amount available under credit line	$ 466,000	$ 316,000
Daily-weighted average interest rate (annualized)	5.65%	5.40%	1.89%
Maximum daily amount outstanding during period (par value)	$ 633,425	$ 477,700	$ 500,529
Short-term Debt
Short-term Debt [Line Items]
Balance of commercial paper at end of period (par value)	419,000	319,000
Commercial paper
Short-term Debt [Line Items]
Average balance of commercial paper outstanding during period (par value)	405,573	290,024	322,531
Commercial paper issued during period (par value)	2,052,056	2,029,000	2,269,444
Commercial paper matured during period (par value)	(1,952,056)	(1,995,000)	(2,314,477)
Net commercial paper issued (matured) during period (par value)	$ 100,000	$ 34,000	$ (45,033)

Shareholders' Equity - Schedule

Shareholders' Equity - Schedule of Common Stock Activity (Details) - shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Increase (Decrease) in Stockholders' Equity
Common stock, issued, beginning balance (in shares)	102,218,183
Treasury stock, beginning balance (in shares)	(8,426,854)
Grants of restricted stock (in shares)	210,040	194,864	166,202
Vesting of performance shares (in shares)	155,877	100,887	87,031
Issuance of common stock due to exercise of stock options (in shares)	584,993	1,375,313	1,519,728
Common stock, issued, ending balance (in shares)	97,218,183	102,218,183
Treasury stock, ending balance (in shares)	(13,240,616)	(8,426,854)
Performance Shares
Increase (Decrease) in Stockholders' Equity
Grants of restricted stock (in shares)	96,800	81,300	146,500
Common Stock
Increase (Decrease) in Stockholders' Equity
Common stock, issued, beginning balance (in shares)	102,218,183	105,218,183	109,218,183
Treasury stock, beginning balance (in shares)	(8,426,854)	(8,478,288)	(9,650,845)
Retirement of treasury stock (in shares)	(5,000,000)	(3,000,000)	(4,000,000)
Grants of restricted stock (in shares)	7,375	7,110	10,746
Issuance of common stock due to exercise of stock options (in shares)	584,993	1,375,313	1,519,728
Treasury stock acquired (in shares)	(10,549,341)	(4,415,287)	(4,424,668)
Retirement of treasury stock (in shares)	5,000,000	3,000,000	4,000,000
Common stock, issued, ending balance (in shares)	97,218,183	102,218,183	105,218,183
Treasury stock, ending balance (in shares)	(13,240,616)	(8,426,854)	(8,478,288)
Common Stock | Performance Shares
Increase (Decrease) in Stockholders' Equity
Vesting of performance shares (in shares)	143,211	84,298	66,751

Shareholders' Equity - Schedu_2

Shareholders' Equity - Schedule of Share Repurchase Program (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Globe Life Share Repurchase Program
Equity, Class of Treasury Stock [Line Items]
Shares Acquired (in shares)	10,086	3,369	3,322
Total Cost	$ 945,637	$ 380,103	$ 335,145
Average Price (in dollars per share)	$ 93.76	$ 112.84	$ 100.90
Share Repurchase for Dilution Purposes
Equity, Class of Treasury Stock [Line Items]
Shares Acquired (in shares)	501	1,080	1,103
Total Cost	$ 48,026	$ 127,155	$ 119,493
Average Price (in dollars per share)	$ 95.75	$ 117.72	$ 108.33

Shareholders' Equity - Addition

Shareholders' Equity - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Equity [Abstract]
Dividends paid by subsidiaries to parent company	$ 693,000	$ 460,000	$ 407,000
Maximum amount of dividends expected to be available from subsidiaries without regulatory approval during next year	664,000
Restricted net assets	1,030,000
Retained earnings restricted by lenders' covenants	5,500,000
Retained earnings	$ 8,002,521	$ 7,478,813

Shareholders' Equity - Schedu_3

Shareholders' Equity - Schedule of Reconciliation of Basic and Diluted Weighted Average Shares Outstanding (Details) - shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Equity [Abstract]
Basic weighted average shares outstanding (in shares)	89,278,574	95,098,474	97,927,770
Weighted average dilutive options outstanding (in shares)	382,848	1,265,367	1,056,874
Diluted weighted average shares outstanding (in shares)	89,661,422	96,363,841	98,984,644
Antidilutive shares (in shares)	2,140,787	422,739	31,269

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Details) - shares	12 Months Ended	36 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equity awards settled for cash (in shares)		0
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Minimum | Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares target distribution	0	0
Maximum | Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares target distribution	145,000	122,000
Director | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	6 months
Director | Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	6 months
Directors | Director | Equity Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options expiration term	7 years
Employee 10 Year Grants | Employee | Equity Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options expiration term	10 years

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Grant Contract and Vesting Periods (Details) - Equity Option	12 Months Ended
	Dec. 31, 2024
Director | Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contract Period	7 years
Director | Director | 6 Months
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage	100%
Employee 7 Year Grants | Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contract Period	7 years
Employee 7 Year Grants | Employee | Year 2
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage	50%
Employee 7 Year Grants | Employee | Year 3
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage	50%

Stock-Based Compensation - Sc_2

Stock-Based Compensation - Schedule of Stock Compensation Activity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Stock-based compensation expense recognized	$ 40,118,000	$ 30,736,000	$ 35,650,000
Tax benefit recognized	7,085,000	11,178,000	12,738,000
Stock-based compensation expense capitalized	$ 0	$ 0	$ 0

Stock-Based Compensation - Sc_3

Stock-Based Compensation - Schedule of Additional Stock Compensation Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Unrecognized compensation	$ 46,956	$ 36,599
Weighted average period of expected recognition (in years)	6 months 10 days	6 months 10 days

Stock-Based Compensation - Sc_4

Stock-Based Compensation - Schedule of Options Outstanding (Details) - $ / shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Number Outstanding (in shares)	5,825,957	5,940,320	6,962,374	7,197,662
Options Outstanding, Weighted- Average Remaining Contractual Life (Years)	3 years 1 month 24 days	3 years 8 months 4 days
Options Outstanding, Weighted- Average Exercise Price (in dollars per share)	$ 99.74	$ 96.19	$ 91.73	$ 85.11
Options Exercisable, Number Exercisable (in shares)	4,376,436	4,003,028	3,666,871
Options Exercisable, Weighted- Average Exercise Price (in dollars per share)	$ 93.73	$ 91.23	$ 84
Range One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Number Outstanding (in shares)	1,609,506
Options Outstanding, Weighted- Average Remaining Contractual Life (Years)	1 year 5 months 23 days
Options Outstanding, Weighted- Average Exercise Price (in dollars per share)	$ 81.93
Options Exercisable, Number Exercisable (in shares)	1,609,506
Options Exercisable, Weighted- Average Exercise Price (in dollars per share)	$ 81.93
Range One | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, Minimum (in dollars per share)	50.64
Range One | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, Maximum (in dollars per share)	$ 87.60
Range Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Number Outstanding (in shares)	1,994,603
Options Outstanding, Weighted- Average Remaining Contractual Life (Years)	2 years 7 months 28 days
Options Outstanding, Weighted- Average Exercise Price (in dollars per share)	$ 99.47
Options Exercisable, Number Exercisable (in shares)	1,994,603
Options Exercisable, Weighted- Average Exercise Price (in dollars per share)	$ 99.47
Range Two | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, Minimum (in dollars per share)	92.40
Range Two | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, Maximum (in dollars per share)	100.74
Range Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, Minimum (in dollars per share)	$ 103.23
Options Outstanding, Number Outstanding (in shares)	1,187,349
Options Outstanding, Weighted- Average Remaining Contractual Life (Years)	4 years 1 month 24 days
Options Outstanding, Weighted- Average Exercise Price (in dollars per share)	$ 103.23
Options Exercisable, Number Exercisable (in shares)	734,148
Options Exercisable, Weighted- Average Exercise Price (in dollars per share)	$ 103.23
Range Four
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Number Outstanding (in shares)	1,034,499
Options Outstanding, Weighted- Average Remaining Contractual Life (Years)	5 years 6 months 21 days
Options Outstanding, Weighted- Average Exercise Price (in dollars per share)	$ 123.96
Options Exercisable, Number Exercisable (in shares)	38,179
Options Exercisable, Weighted- Average Exercise Price (in dollars per share)	$ 108.55
Range Four | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, Minimum (in dollars per share)	105.56
Range Four | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, Maximum (in dollars per share)	$ 128.40
Range Five
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Number Outstanding (in shares)	5,825,957
Options Outstanding, Weighted- Average Remaining Contractual Life (Years)	3 years 1 month 24 days
Options Outstanding, Weighted- Average Exercise Price (in dollars per share)	$ 99.74
Options Exercisable, Number Exercisable (in shares)	4,376,436
Options Exercisable, Weighted- Average Exercise Price (in dollars per share)	$ 93.73
Range Five | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, Minimum (in dollars per share)	50.64
Range Five | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range of Exercise Prices, Maximum (in dollars per share)	$ 128.40

Stock-Based Compensation - Sc_5

Stock-Based Compensation - Schedule of Analysis of Option Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Options
Options Outstanding-beginning of year (in shares)	5,940,320	6,962,374	7,197,662
Options Exercised (in shares)	(584,993)	(1,375,313)	(1,519,728)
Options Expired and forfeited (in shares)	(50,180)	(143,801)	(15,771)
Options Outstanding-end of year (in shares)	5,825,957	5,940,320	6,962,374
Options Exercisable at end of year (in shares)	4,376,436	4,003,028	3,666,871
Weighted-Average Exercise Price
Outstanding-beginning of year, weighted average exercise price (in dollars per share)	$ 96.19	$ 91.73	$ 85.11
Options exercised in the period - weighted average exercise price (in dollars per share)	88.52	82.95	70.14
Options expired and forfeited in the period - weighted average exercise price (in dollars per share)	106.62	90.92	96.54
Outstanding-end of year, weighted average exercise price (in dollars per share)	99.74	96.19	91.73
Exercisable at end of year, weighted average exercise price (in dollars per share)	$ 93.73	$ 91.23	$ 84
7-year term
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contract Period	7 years
Options
Options Granted (in shares)	520,810	497,060	1,300,211
Weighted-Average Exercise Price
Options granted in the period- weighted average exercise price (in dollars per share)	$ 128.32	$ 120.49	$ 103.20

Stock-Based Compensation - Sc_6

Stock-Based Compensation - Schedule of Additional Information of Stock Option Activity (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Weighted-average remaining contractual term (in years)	3 years 1 month 24 days	3 years 8 months 4 days
Aggregate intrinsic value	$ 81,703	$ 151,685
Weighted-average remaining contractual term (in years)	2 years 5 months 23 days	3 years 3 days
Aggregate intrinsic value	$ 77,946	$ 122,052

Stock-Based Compensation - Sc_7

Stock-Based Compensation - Schedule of Selected Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Weighted-average grant-date fair value of options granted (in dollars per share)	$ 33.80	$ 32.25	$ 22.03
Intrinsic value of options exercised	$ 17,127	$ 49,163	$ 58,201
Cash received from options exercised	51,786	114,080	106,592
Actual tax benefit received	$ 2,489	$ 9,379	$ 11,907

Stock-Based Compensation - Sc_8

Stock-Based Compensation - Schedule of Additional Information on Unvested Options (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining contractual term (in years)	3 years 1 month 24 days	3 years 8 months 4 days
Aggregate intrinsic value	$ 81,703	$ 151,685
Unvested Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding (in shares)	1,449,521	1,937,292
Weighted-average exercise price (in dollars per share)	$ 117.88	$ 106.42
Weighted-average remaining contractual term (in years)	5 years 2 months 8 days	5 years 18 days
Aggregate intrinsic value	$ 3,757	$ 29,634

Stock-Based Compensation - Sc_9

Stock-Based Compensation - Schedule Of Restricted Stock Units Outstanding And Vested (Details) - shares	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Restricted stock units outstanding (in shares)	219,864	163,108	93,381

Stock-Based Compensation - S_10

Stock-Based Compensation - Schedule of Performance Shares Settled (Details) - Performance Shares - shares	Feb. 26, 2025	Feb. 28, 2024	Feb. 22, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Settlement of performance shares		143,211	84,298
Subsequent Event
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Settlement of performance shares	152,680

Stock-Based Compensation - S_11

Stock-Based Compensation - Schedule of Restricted Stock and Restricted Stock Units Granted (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants (in shares)	210,040	194,864	166,202
Directors Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants (in shares)	7,375	7,110	10,746
Price per share (in dollars per share)	$ 122.06	$ 119.59	$ 94.94
Aggregate value	$ 900	$ 850	$ 1,020
Percent vested	100%	100%	100%
Directors Restricted Stock Units Including Dividend Equivalents
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants (in shares)	4,854	9,479	8,956
Price per share (in dollars per share)	$ 120.16	$ 117.73	$ 95.62
Aggregate value	$ 583	$ 1,116	$ 856
Percent vested	100%	100%	100%
Employees Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants (in shares)	101,011	96,975	0
Price per share (in dollars per share)	$ 127.29	$ 120.18	$ 0
Aggregate value	$ 12,858	$ 11,654	$ 0
Percent vested	0%	0%	0%
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants (in shares)	96,800	81,300	146,500
Price per share (in dollars per share)	$ 128.40	$ 120.49	$ 103.23
Aggregate value	$ 12,429	$ 9,796	$ 15,123
Percent vested	0%	0%	0%

Stock-Based Compensation - S_12

Stock-Based Compensation - Schedule of Analysis of Unvested Restricted Stock (Details) - shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Beginning Balance (in shares)	446,645	398,535	342,966
Grants (in shares)	210,040	194,864	166,202
Additional performance shares	84,712	(28,857)	(16,102)
Restriction lapses (in shares)	(155,877)	(100,887)	(87,031)
Forfeitures (in shares)	(16,008)	(17,010)	(7,500)
Ending Balance (in shares)	569,512	446,645	398,535
Executive Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Beginning Balance (in shares)	354,080	398,535	342,388
Grants (in shares)	96,800	81,300	146,500
Additional performance shares	84,712	(28,857)	(16,102)
Restriction lapses (in shares)	(143,211)	(84,298)	(66,751)
Forfeitures (in shares)	(6,000)	(12,600)	(7,500)
Ending Balance (in shares)	386,381	354,080	398,535
Directors Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Beginning Balance (in shares)	0	0	289
Grants (in shares)	7,375	7,110	10,746
Additional performance shares	0	0	0
Restriction lapses (in shares)	(7,375)	(7,110)	(11,035)
Forfeitures (in shares)	0	0	0
Ending Balance (in shares)	0	0	0
Directors Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Beginning Balance (in shares)	0	0	289
Grants (in shares)	4,854	9,479	8,956
Additional performance shares	0	0	0
Restriction lapses (in shares)	(4,854)	(9,479)	(9,245)
Forfeitures (in shares)	0	0	0
Ending Balance (in shares)	0	0	0
Employees Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Beginning Balance (in shares)	92,565	0	0
Grants (in shares)	101,011	96,975	0
Additional performance shares	0	0	0
Restriction lapses (in shares)	(437)	0	0
Forfeitures (in shares)	(10,008)	(4,410)	0
Ending Balance (in shares)	183,131	92,565	0

Stock-Based Compensation - S_13

Stock-Based Compensation - Schedule of Weighted-Average Grant-Date Fair Value of Unvested Restricted Stock (Details) - $ / shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Executive Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Grant-date fair value per share, beginning of year (in dollars per share)	$ 105.28
Grants (in dollars per share)	128.40
Estimated additional performance shares (in dollars per share)	107.56
Restriction lapses (in dollars per share)	(98.32)
Forfeitures (in dollars per share)	0
Grant-date fair value per share, end of year (in dollars per share)	115.78	$ 105.28
Directors Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Grant-date fair value per share, beginning of year (in dollars per share)	0
Grants (in dollars per share)	122.06	119.59	$ 94.94
Estimated additional performance shares (in dollars per share)	0
Restriction lapses (in dollars per share)	(122.06)
Forfeitures (in dollars per share)	0
Grant-date fair value per share, end of year (in dollars per share)	0	0
Directors Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Grant-date fair value per share, beginning of year (in dollars per share)	0
Grants (in dollars per share)	122.06
Estimated additional performance shares (in dollars per share)	0
Restriction lapses (in dollars per share)	(122.06)
Forfeitures (in dollars per share)	0
Grant-date fair value per share, end of year (in dollars per share)	0	0
Employees Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Grant-date fair value per share, beginning of year (in dollars per share)	120.16
Grants (in dollars per share)	127.29	120.18	$ 0
Estimated additional performance shares (in dollars per share)	0
Restriction lapses (in dollars per share)	(94.40)
Forfeitures (in dollars per share)	(122.74)
Grant-date fair value per share, end of year (in dollars per share)	$ 124.02	$ 120.16

Business Segments - Schedule of

Business Segments - Schedule of Segment Premium Income by Distribution Channel (Details) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2024 segment	Dec. 31, 2024 USD ($) segment	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Segment Reporting [Abstract]
Number of segments | segment	4	3
Percentage of revenue		1%
Segment Reporting Information [Line Items]
Premium		$ 4,666,272	$ 4,456,017	$ 4,310,242
Premium		4,666,272	$ 4,456,017	4,310,241
Annuity		$ 1
Total premium				$ 4,310,242
% of Total		100%	100%	100%
Life
Segment Reporting Information [Line Items]
Premium		$ 3,261,347	$ 3,137,244
Premium		$ 3,261,347	$ 3,137,244	$ 3,027,824
% of Total		100%	100%	100%
Health
Segment Reporting Information [Line Items]
Premium		$ 1,404,925	$ 1,318,773
Premium		$ 1,404,925	$ 1,318,773	$ 1,282,417
% of Total		100%	100%	100%
American Income
Segment Reporting Information [Line Items]
Premium		$ 1,821,332	$ 1,709,034	$ 1,622,387
% of Total		39%	38%	38%
American Income | Life
Segment Reporting Information [Line Items]
Premium		$ 1,698,209	$ 1,588,702	$ 1,505,034
% of Total		52%	51%	50%
American Income | Health
Segment Reporting Information [Line Items]
Premium		$ 123,123	$ 120,332	$ 117,353
% of Total		9%	9%	9%
Direct to Consumer
Segment Reporting Information [Line Items]
Premium		$ 1,060,515	$ 1,059,981	$ 1,056,617
% of Total		23%	24%	24%
Direct to Consumer | Life
Segment Reporting Information [Line Items]
Premium		$ 988,522	$ 991,406	$ 985,488
% of Total		30%	32%	33%
Direct to Consumer | Health
Segment Reporting Information [Line Items]
Premium		$ 71,993	$ 68,575	$ 71,129
% of Total		5%	5%	5%
Liberty National
Segment Reporting Information [Line Items]
Premium		$ 561,442	$ 537,670	$ 514,710
% of Total		12%	12%	12%
Liberty National | Life
Segment Reporting Information [Line Items]
Premium		$ 371,061	$ 349,736	$ 327,469
% of Total		12%	11%	11%
Liberty National | Health
Segment Reporting Information [Line Items]
Premium		$ 190,381	$ 187,934	$ 187,241
% of Total		14%	14%	15%
United American
Segment Reporting Information [Line Items]
Premium		$ 598,374	$ 553,034	$ 547,840
% of Total		13%	13%	13%
United American | Life
Segment Reporting Information [Line Items]
Premium		$ 6,600	$ 7,311	$ 7,966
% of Total		0%	0%	0%
United American | Health
Segment Reporting Information [Line Items]
Premium		$ 591,774	$ 545,723	$ 539,874
% of Total		42%	42%	42%
Family Heritage
Segment Reporting Information [Line Items]
Premium		$ 434,315	$ 402,343	$ 372,406
% of Total		9%	9%	9%
Family Heritage | Life
Segment Reporting Information [Line Items]
Premium		$ 6,661	$ 6,134	$ 5,586
% of Total		0%	0%	0%
Family Heritage | Health
Segment Reporting Information [Line Items]
Premium		$ 427,654	$ 396,209	$ 366,820
% of Total		30%	30%	29%
Other
Segment Reporting Information [Line Items]
Premium		$ 190,294	$ 193,955	$ 196,281
% of Total		4%	4%	4%
Other | Life
Segment Reporting Information [Line Items]
Premium		$ 190,294	$ 193,955	$ 196,281
% of Total		6%	6%	6%
Other | Health
Segment Reporting Information [Line Items]
Premium		$ 0	$ 0	$ 0
% of Total		0%	0%	0%

Business Segments - Schedule _2

Business Segments - Schedule of Reconciliation of Segment Operating Information to Consolidated Statement of Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenue:
Premium	$ 4,666,272	$ 4,456,017	$ 4,310,241
Net investment income	1,135,631	1,056,884	991,800
Segment revenue	5,801,903	5,512,901	5,302,041
Annuity premium income			1
Other income	354	308	1,246
Realized gains (losses)	(24,188)	(65,676)	(76,548)
Total revenue	5,778,069	5,447,533	5,226,740
Expenses:
Policy obligations	2,873,523	2,836,212	2,792,931
Required interest on reserves	28,769	38,224	44,836
Amortization of acquisition costs	408,447	378,024	347,026
Commissions	318,572	295,870	285,468
Premium taxes	96,781	91,011	86,262
Non-deferred acquisition costs	186,387	172,269	134,267
Segment profit or (loss)	1,889,424	1,701,291	1,611,251
Insurance administrative expenses:
Salaries	129,369	119,699	129,711
Other employee costs	36,176	35,905	42,319
Information technology costs	80,555	64,998	55,526
Legal costs	30,478	15,335	12,056
Other administrative costs	65,852	65,224	59,729
Parent expense	12,400	10,866	11,156
Stock-based compensation expense	40,118	30,736	35,650
Interest expense	127,092	102,316	90,395
Legal proceedings	21,575	900	2,496
Non-operating expenses	2,620	4,170	5,311
Annuity	(7,282)	(8,492)	(10,510)
Insurance Administrative Expenses, Total	4,451,432	4,253,267	4,124,629
Income before income taxes	1,326,637	1,194,266	1,102,111
Life
Revenue:
Premium	3,261,347	3,137,244	3,027,824
Net investment income	0	0	0
Segment revenue	3,261,347	3,137,244	3,027,824
Expenses:
Policy obligations	2,000,977	2,050,789	2,035,693
Required interest on reserves	(811,147)	(772,701)	(735,688)
Amortization of acquisition costs	356,223	327,426	298,841
Commissions	159,703	145,678	140,283
Premium taxes	68,360	64,571	61,609
Non-deferred acquisition costs	134,634	128,509	97,561
Segment profit or (loss)	1,352,597	1,192,972	1,129,525
Health
Revenue:
Premium	1,404,925	1,318,773	1,282,417
Net investment income	0	0	0
Segment revenue	1,404,925	1,318,773	1,282,417
Expenses:
Policy obligations	851,577	776,362	752,866
Required interest on reserves	(110,342)	(106,516)	(102,315)
Amortization of acquisition costs	52,224	50,598	48,185
Commissions	158,869	150,192	145,185
Premium taxes	28,421	26,440	24,653
Non-deferred acquisition costs	51,753	43,760	36,706
Segment profit or (loss)	372,423	377,937	377,137
Investment
Revenue:
Premium	0	0	0
Net investment income	1,135,631	1,056,884	991,800
Segment revenue	1,135,631	1,056,884	991,800
Expenses:
Policy obligations	20,969	9,061	4,372
Required interest on reserves	950,258	917,441	882,839
Amortization of acquisition costs	0	0	0
Commissions	0	0	0
Premium taxes	0	0	0
Non-deferred acquisition costs	0	0	0
Segment profit or (loss)	$ 164,404	$ 130,382	$ 104,589

Business Segments - Schedule _3

Business Segments - Schedule of Assets by Segment (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting, Asset Reconciling Item [Line Items]
Accrued investment income	$ 269,791	$ 270,396
Deferred acquisition costs	6,495,589	6,009,477	$ 5,535,697
Goodwill	490,446	481,791
Total assets	29,076,181	28,051,499
Operating Segments
Segment Reporting, Asset Reconciling Item [Line Items]
Cash and invested assets	19,736,888	19,827,199
Accrued investment income	269,791	270,396
Deferred acquisition costs	6,494,176	6,006,510
Goodwill	490,446	481,791
Business Segment Selected Assets	26,991,301	26,585,896
Corporate & Other
Segment Reporting, Asset Reconciling Item [Line Items]
Annuity and other corporate	2,084,880	1,465,603
Life
Segment Reporting, Asset Reconciling Item [Line Items]
Deferred acquisition costs	5,700,755	5,271,775	4,844,291	$ 4,412,015
Life | Operating Segments
Segment Reporting, Asset Reconciling Item [Line Items]
Cash and invested assets	0	0
Accrued investment income	0	0
Deferred acquisition costs	5,700,755	5,271,775
Goodwill	309,609	309,609
Business Segment Selected Assets	6,010,364	5,581,384
Health
Segment Reporting, Asset Reconciling Item [Line Items]
Deferred acquisition costs	793,421	734,735	$ 686,763	$ 649,082
Health | Operating Segments
Segment Reporting, Asset Reconciling Item [Line Items]
Cash and invested assets	0	0
Accrued investment income	0	0
Deferred acquisition costs	793,421	734,735
Goodwill	180,837	172,182
Business Segment Selected Assets	974,258	906,917
Investment | Operating Segments
Segment Reporting, Asset Reconciling Item [Line Items]
Cash and invested assets	19,736,888	19,827,199
Accrued investment income	269,791	270,396
Deferred acquisition costs	0	0
Goodwill	0	0
Business Segment Selected Assets	$ 20,006,679	$ 20,097,595

Business Segments - Schedule _4

Business Segments - Schedule of Liabilities by Segment (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting, Other Significant Reconciling Item [Line Items]
Net liability for future policy benefits—long duration health	$ 18,457,263	$ 19,460,353	$ 18,097,341
Unearned and advance premium	257,631	254,567
Policy claims and other benefits payable	532,832	514,875
Debt	2,739,652	2,115,672
Total liabilities	23,770,661	23,564,696
Operating Segments
Segment Reporting, Other Significant Reconciling Item [Line Items]
Net liability for future policy benefits—long duration health	17,800,690	18,687,314
Unearned and advance premium	257,631	254,567
Policy claims and other benefits payable	532,832	514,875
Debt	2,739,652	2,115,672
Other	468,604	236,958
Total segment liabilities	21,799,409	21,809,386
Corporate & Other
Segment Reporting, Other Significant Reconciling Item [Line Items]
Annuity and other corporate	1,971,252	1,755,310
Life
Segment Reporting, Other Significant Reconciling Item [Line Items]
Net liability for future policy benefits—long duration health	14,577,140	15,390,289	14,014,147
Life | Operating Segments
Segment Reporting, Other Significant Reconciling Item [Line Items]
Net liability for future policy benefits—long duration health	15,484,596	16,304,797
Unearned and advance premium	198,127	196,630
Policy claims and other benefits payable	321,838	320,066
Debt	0	0
Other	96,604	98,958
Total segment liabilities	16,101,165	16,920,451
Health
Segment Reporting, Other Significant Reconciling Item [Line Items]
Net liability for future policy benefits—long duration health	2,313,036	2,379,415	$ 2,203,789
Health | Operating Segments
Segment Reporting, Other Significant Reconciling Item [Line Items]
Net liability for future policy benefits—long duration health	2,316,094	2,382,517
Unearned and advance premium	59,504	57,937
Policy claims and other benefits payable	210,994	194,809
Debt	0	0
Other	0	0
Total segment liabilities	2,586,592	2,635,263
Investment | Operating Segments
Segment Reporting, Other Significant Reconciling Item [Line Items]
Net liability for future policy benefits—long duration health	0	0
Unearned and advance premium	0	0
Policy claims and other benefits payable	0	0
Debt	2,739,652	2,115,672
Other	372,000	138,000
Total segment liabilities	$ 3,111,652	$ 2,253,672

Schedule II. Condensed Financ_2

Schedule II. Condensed Financial Information of Registrant (Condensed Balance Sheets) (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Assets:
Short-term investments	$ 85,035	$ 81,740
Total investments	19,571,563	19,724,043
Cash	165,325	103,156
Other receivables	691,907	630,223
Goodwill	490,446	481,791
Other assets	1,391,560	832,413
Total assets	29,076,181	28,051,499
Liabilities:
Short-term debt	415,401	486,113
Long-term debt	2,324,251	1,629,559
Other liabilities	583,424	487,632
Total liabilities	23,770,661	23,564,696
Shareholders' equity:
Preferred stock	0	0
Common stock	97,218	102,218
Additional paid-in-capital	527,795	532,474
Accumulated other comprehensive income	(2,029,720)	(2,772,419)
Retained earnings	8,002,521	7,478,813
Total shareholders' equity	5,305,520	4,486,803	$ 3,949,577	$ 2,003,808
Total liabilities and shareholders' equity	29,076,181	28,051,499
Parent Company
Assets:
Long-term investments	39,404	42,360
Short-term investments	29,005	1,005
Total investments	68,409	43,365
Cash	66,770	1,003
Investment in affiliates	7,740,073	6,539,183
Taxes receivable from affiliates	15,202	14,163
Total assets	8,362,118	6,884,436
Liabilities:
Short-term debt	415,401	486,113
Long-term debt	2,473,874	1,779,137
Total liabilities	3,056,598	2,397,633
Shareholders' equity:
Preferred stock	351	351
Common stock	97,218	102,218
Additional paid-in-capital	878,306	882,985
Accumulated other comprehensive income	(2,029,720)	(2,772,419)
Retained earnings	8,002,521	7,478,813
Treasury stock	(1,643,156)	(1,205,145)
Total shareholders' equity	5,305,520	4,486,803
Total liabilities and shareholders' equity	8,362,118	6,884,436
Parent Company | Related Party
Assets:
Other receivables	278,301	105,279
Liabilities:
Other liabilities	52,568	0
Parent Company | Nonrelated Party
Assets:
Other assets	193,363	181,443
Liabilities:
Other liabilities	$ 114,755	$ 132,383

Schedule II. Condensed Financ_3

Schedule II. Condensed Financial Information of Registrant (Condensed Statements of Operations) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Condensed Financial Statements, Captions [Line Items]
Net investment income	$ 1,135,631	$ 1,056,884	$ 991,800
Total revenue	5,778,069	5,447,533	5,226,740
General operating expenses	419,143	347,833	353,954
Interest expense	127,092	102,316	90,395
Total benefits and expenses	4,451,432	4,253,267	4,124,629
Income tax benefit (expense)	(255,875)	(223,511)	(207,725)
Net income	1,070,762	970,755	894,386
Other comprehensive income (loss):
Attributable to Parent Company	742,699	17,894	1,444,735
Comprehensive income (loss)	1,813,461	988,649	2,339,121
Parent Company
Condensed Financial Statements, Captions [Line Items]
Net investment income	38,341	36,237	33,664
Realized gains (losses)	4,158	5,924	(9,643)
Total revenue	42,499	42,161	24,021
General operating expenses	75,387	59,051	59,307
Reimbursements from affiliates	(53,136)	(59,796)	(51,312)
Interest expense	125,023	107,180	97,051
Total benefits and expenses	147,274	106,435	105,046
Operating income (loss) before income taxes and equity in earnings of affiliates	(104,775)	(64,274)	(81,025)
Income tax benefit (expense)	19,832	10,706	12,426
Net operating loss before equity in earnings of affiliates	(84,943)	(53,568)	(68,599)
Equity in earnings of affiliates, net of tax	1,155,705	1,024,323	962,985
Net income	1,070,762	970,755	894,386
Other comprehensive income (loss):
Attributable to Parent Company	21,326	1,113	75,076
Attributable to affiliates	721,373	16,781	1,369,659
Comprehensive income (loss)	$ 1,813,461	$ 988,649	$ 2,339,121

Schedule II. Condensed Financ_4

Schedule II. Condensed Financial Information of Registrant (Condensed Statement of Cash Flows) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Condensed Financial Statements, Captions [Line Items]
Net income	$ 1,070,762	$ 970,755	$ 894,386
Other, net	(17,582)	(24,799)	44,480
Cash provided from (used for) operating activities	1,402,440	1,482,425	1,422,194
Cash provided from (used for) investing activities:
Net decrease (increase) in short-term investments	(3,295)	32,381	(44,976)
Loaned money to affiliates	(71,045)	(49,553)	(27,929)
Cash provided from (used for) investing activities	(641,516)	(926,149)	(943,015)
Cash provided from (used for) financing activities:
Repayment of debt	0	(165,612)	(150,000)
Payment for debt issuance costs	(7,253)	(757)	(5,272)
Proceeds from commercial paper with original maturities greater than 90 days	484,726	0	0
Repayment of commercial paper with original maturities greater than 90 days	(372,011)	0	0
Issuance of stock	51,786	114,080	106,592
Acquisitions of treasury stock	(1,002,109)	(511,100)	(454,638)
Payment of dividends	(85,485)	(84,116)	(80,547)
Cash provided from (used for) financing activities	(715,835)	(541,487)	(492,453)
Net increase (decrease) in cash	62,169	10,597	396
Cash at end of year	165,325	103,156	92,559
Cash at beginning of year	103,156	92,559	92,163
Parent Company
Condensed Financial Statements, Captions [Line Items]
Net income	1,070,762	970,755	894,386
Equity in earnings of affiliates	(1,155,705)	(1,024,323)	(962,985)
Cash dividends from subsidiaries	692,690	459,535	407,042
Other, net	55,243	33,846	26,444
Cash provided from (used for) operating activities	662,990	439,813	364,887
Cash provided from (used for) investing activities:
Net decrease (increase) in short-term investments	(28,000)	13,996	(15,001)
Investment in subsidiaries	(12)	0	(10,010)
Acquisition of investments	(2,850)	(3,950)	(2,000)
Disposition of investments	1	0	0
Loaned money to affiliates	(557,016)	(479,629)	(846,002)
Repayments from affiliates	394,925	505,929	886,002
Additions to properties	(19,147)	(7,400)	0
Cash provided from (used for) investing activities	(212,099)	28,946	12,989
Cash provided from (used for) financing activities:
Repayment of debt	0	(165,612)	(300,000)
Proceeds from issuance of debt	530,000	170,000	400,000
Payment for debt issuance costs	(7,253)	(757)	(5,272)
Net change in commercial paper held less than 90 days	(13,878)	32,961	(46,289)
Proceeds from commercial paper with original maturities greater than 90 days	484,726	0	0
Repayment of commercial paper with original maturities greater than 90 days	(372,011)	0	0
Issuance of stock	51,756	114,080	111,970
Acquisitions of treasury stock	(1,002,109)	(511,100)	(454,638)
Borrowed money from affiliate	349,000	290,500	22,400
Repayments to affiliates	(296,600)	(290,500)	(22,400)
Payment of dividends	(108,755)	(107,386)	(103,817)
Cash provided from (used for) financing activities	(385,124)	(467,814)	(398,046)
Net increase (decrease) in cash	65,767	945	(20,170)
Cash at end of year	66,770	1,003	58
Cash at beginning of year	$ 1,003	$ 58	$ 20,228

Schedule II. Condensed Financ_5

Schedule II. Condensed Financial Information of Registrant (Notes To Condensed Financial Statements) (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Condensed Financial Statements, Captions [Line Items]
Stock-based compensation not involving cash	$ 40,118	$ 30,736	$ 35,650
Interest paid	116,993	99,545	88,814
Income taxes paid (received)	$ 175,400	$ 121,034	114,888
Preferred stock, shares outstanding (in shares)	0	0
Parent Company
Condensed Financial Statements, Captions [Line Items]
Cash dividends from subsidiaries	$ 692,690	$ 459,535	407,042
Stock-based compensation not involving cash	40,118	30,736	35,650
Interest paid	114,459	104,493	96,903
Income taxes paid (received)	$ (13,126)	$ (10,408)	$ (11,537)
Preferred stock, liquidation distribution available to stockholders, per share in thousands (in dollars per share)	$ 1,000
Preferred stock, liquidating distribution legally available, aggregate value	$ 351,000
Cumulative Series A Preferred Stock | Parent Company
Condensed Financial Statements, Captions [Line Items]
Preferred stock, shares issued (in shares)	351,000
Preferred stock, shares outstanding (in shares)	351,000
6.50% Cumulative Preferred Stock, Series A | Parent Company
Condensed Financial Statements, Captions [Line Items]
Preferred stock, shares issued (in shares)	280,000
Preferred stock, shares outstanding (in shares)	280,000
Preferred stock, dividend rate, percentage	6.50%
7.15% Cumulative Preferred Stock, Series A | Parent Company
Condensed Financial Statements, Captions [Line Items]
Preferred stock, shares issued (in shares)	71,000
Preferred stock, shares outstanding (in shares)	71,000
Preferred stock, dividend rate, percentage	7.15%

Schedule IV. Reinsurance (Detai

Schedule IV. Reinsurance (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Life insurance in force, gross amount	$ 227,975,584	$ 225,286,002	$ 222,098,389
Life insurance in force, ceded to other companies	671,056	685,289	662,569
Life insurance in force, assumed from other companies	1,823,957	1,996,223	2,172,728
Life insurance in force, net amount	$ 229,128,485	$ 226,596,936	$ 223,608,548
Life insurance in force, percentage of amount assumed to net	0.80%	0.90%	1%
Premium, gross amount	$ 4,619,824	$ 4,391,558	$ 4,238,135
Premium, ceded to other companies	7,098	7,317	7,452
Premium, assumed from other companies	41,288	58,877	66,019
Premium, net amount	$ 4,654,014	$ 4,443,118	$ 4,296,702
Percentage of amount assumed to net	0.90%	1.30%	1.50%
Policy charges	$ 12,300	$ 12,900	$ 13,500
Life insurance
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Premium, gross amount	3,235,744	3,109,838	2,999,637
Premium, ceded to other companies	4,649	4,597	4,361
Premium, assumed from other companies	17,994	19,104	19,009
Premium, net amount	$ 3,249,089	$ 3,124,345	$ 3,014,285
Percentage of amount assumed to net	0.60%	0.60%	0.60%
Health insurance
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Premium, gross amount	$ 1,384,080	$ 1,281,720	$ 1,238,498
Premium, ceded to other companies	2,449	2,720	3,091
Premium, assumed from other companies	23,294	39,773	47,010
Premium, net amount	$ 1,404,925	$ 1,318,773	$ 1,282,417
Percentage of amount assumed to net	1.70%	3%	3.70%

Subsequent Events (Details)

Subsequent Events (Details) $ in Millions	Feb. 03, 2025 USD ($)
Subsequent Event
Subsequent Event [Line Items]
Payments to acquire land	$ 80